Search

CMSC Abstracts Table

Search Accepted Abstracts
Sending

Search Results

Year ID Title Authors

[194]

AD01

[198]

Marnina Stimmel, B.A.1,2, Shaina Shagalow, B.A.3, Jeffrey G Portnoy, B.A.3, Roseann Archetti, B.S.3, Elana Mendelowitz, B.A.3, Jessica H Sloan, BA3 and Jason Botvinick, B.A.3, (1)Yeshiva University, Ferkauf Graduate School of Psychology, Bronx, NY, (2)MS Center, Holy Name Medical Center, Teaneck, NJ, (3)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY

[194]

AD01

[198]

Marnina Stimmel, B.A.1,2, Shaina Shagalow, B.A.3, Jeffrey G Portnoy, B.A.3, Roseann Archetti, B.S.3, Elana Mendelowitz, B.A.3, Jessica H Sloan, BA3 and Jason Botvinick, B.A.3, (1)Yeshiva University, Ferkauf Graduate School of Psychology, Bronx, NY, (2)MS Center, Holy Name Medical Center, Teaneck, NJ, (3)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY

[194]

CA01

[198]

Emma Richardson, PhD1, Robert W Motl, PhD2, Elizabeth Barstow, PhD3, Sarah Blaylock, PhD2 and Matthew Fifolt, PhD4, (1)Department of Physical Therapy, UAB, Birmingham, AL, (2)Department of Physical Therapy, University of Alabama at Birmingham, Birmingham, AL, (3)Department of Occupational Therapy, University of Alabama at Birmingham, Birmingham, AL, (4)Health Care Organization & Policy, University of Alabama at Birmingham, Birmingham, AL

[194]

CA01

[198]

Andrea Tacchino, PhD1, Mahdis Babazadeh, PT2, Gianluigi Mancardi, MD, PhD3 and Giampaolo Brichetto, MD, PhD1, (1)Scientific Research Area, Italian MS Society, Genoa, Italy, Genova, Italy, (2)Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy, (3)Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy

[194]

CA02

[198]

Renu Pokharna, MD1, Miles Reese, MD Candidate2 and Souvik Sen, MD, Neurology Chair1, (1)Neurology, University of South Carolina School of Medicine, Columbia, SC, (2)University of South Carolina School of Medicine, Columbia, SC

[194]

CA02

[198]

David E Weinstein, MD, PhD1, Alexey Boyko, MD2, Lisa Pugliese, BA3, Hong Tang, MS3, Barbara Mittleman, MD3, Robert Zivadinov, MD4, Dennis M Lanfear, MBA3 and Barbara Finck, MD3, (1)Coherus Biosciences, Inc., Redwood City, CA, (2)Moscow Multiple Sclerosis Center, Moscow, Russia, (3)Coherus Biosciences, Inc., Redwood City, CA, (4)University at Buffalo, Buffalo, NY

[194]

CA03

[198]

Myriam Venasse, BSc1, Thomas A Edwards, MSc2 and Lara A. Pilutti, PhD1, (1)Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, Canada, (2)School of Human Kinetics, University of Ottawa, Ottawa, ON, Canada

[194]

CA03

[198]

Jennifer A. Ruiz, DPT1, Christopher Gaunya, M.Ac., Dipl.Ac.2, Kayla M. Olson, MA1, Matthew Farr, M.S., P.T.1 and Kathleen Mueller, M.D.2, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Hartford, CT, (2)Center for Integrative Medicine, St. Francis Hospital and Medical Center, Hartford, CT

[194]

CA04

[198]

Theodore R Brown, MD, MPH, MS Center at Evergreen Health, Evergreen Health, Kirkland WA, WA and Virginia I Simnad, MD, EvergreenHealth Multiple Sclerosis Center, EvergreenHealth, Kirkland, WA

[194]

CA04

[198]

Scott Belliston, DO, Judy Markwardt-Oberheu, BS and Sharon G Lynch, MD, Neurology, University of Kansas Medical Center, Kansas City, KS

[194]

CA05

[198]

Lori Travis, MD, HonorHealth Neurology, Phoenix, AZ

[194]

CA06

[198]

[194]

CA07

[198]

Lita P Buttolph, PhD, Joshua Corn, ND, Douglas Hanes, PhD and Angela Senders, ND, MCR, Helfgott Research Institute, National University of Natural Medicine, Portland, OR

[194]

CA08

[198]

[194]

CAM01

[198]

Alice E Dias, Dr, Scientific Research, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil and Evanda S Oliveira, Reflexologist, Rehabilitation, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil

[194]

CAM01

[198]

[194]

CAM01

[198]

Claire Hara-Cleaver, CNP, The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH and Malissa C Ayers, Physician Assistant, Mellen Center, Cleveland Clinic Foundation, Cleveland, OH

[194]

CAM02

[198]

Megan Weigel, DNP, APRN, MSCN, APHN1,2,3, Linda Connelly, PhD, MSH, ARNP, CNOR1 and Mehgan Fox, BSH2, (1)Brooks College of Health, School of Nursing, University of North Florida, Jacksonville, FL, (2)First Coast Integrative Medicine, Jacksonville, FL, (3)oMS Yoga, Inc., Jacksonville Beach, FL

[194]

CAM02

[198]

Cassidy A Taylor, BA1, Michelle H Cameron, MD, PT, MCR1,2, Jodi Lapidus, PhD1,3, Naghmeh Daneshi, ABD3 and Rebecca I Spain, MD, MSPH1,2, (1)Oregon Health & Science University, Portland, OR, (2)VA Portland Health Care System, Portland, OR, (3)Oregon Health & Science University – Portland State University School of Public Health, Portland, OR

[194]

CAM03

[198]

Pamela K Newland, PhD, RN, Goldfarb School of Nursing, St Louis, IL, Karlie Lading, BS, RN, nursing, Goldfarb School of Nursing, St Louis, MO and Ling Chen, PhD, Biostatistics, Washington University St Louis, St Louis, MO

[194]

CAM03

[198]

Barbara Siminovich-Blok, ND, LAc, MS, NYU Langone Medical Center, New York, NY, Herb Karpatkin, PT, DSc, NCS, MSCS, Physical Therapy, Hunter College, New York, NY, Zabrina Langer, PT, DPT, NCS, Physical therapy, NYU Langone, New York, NY, Dana Lotan, PT, DPT, NCS, GCS, Physical therapy, Rusk Rehabilitation, New York, NY, Sophia Maguire, BSc, MA, NYU Langone medicaenterNew york, New york, NY and Stephanie Winsor, BA, NYU Langone Medcial Center, New York, NY

[194]

CAM03

[198]

Brant J. Oliver, PhD, MS, MPH, APRN-BC, Community of Family and Medicine, Dartmouth Health, Lebanon, NH, Nivethitha Manohar, MPH, Paul L. Foster School of Medicine, Texas Tech University, Al Paso, TX, Jackson Cabot, NA, University of New Hampshire, Durham, NH, Ann Cabot, DO, Multidisciplinary Multiple Sclerosis Clinic at Concord Hospital, Concord, NH and Jeanne Ann Whittington, NA, Multiple Sclerosis Specialty Care Program, Concord Hospital, Concord, NH

[194]

CAM04

[198]

Myriam Venasse, BSc1, Amanda Gauthier, MSc, RD2, Isabelle Giroux, PhD, RD3 and Lara A. Pilutti, PhD1, (1)Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, Canada, (2)Clinical Nutrition Department, Niagara Health System, Niagara Falls, ON, Canada, (3)School of Nutrition Sciences, University of Ottawa, Ottawa, ON, Canada

[194]

CAM04

[198]

Lita P Buttolph, PhD, DSOM1, Jamie Villanueva, DAOM2, Heena R Manglani, PhD3,4, Tanya Snyder, BS1, Lindsey Wooliscroft, MD, MCR5,6, Gloria Y Yeh, MD, MPH4,7, Ryan Bradley, ND, MPH1 and Heather Zwickey, PhD1, (1)Helfgott Research Institute, National University of Natural Medicine, Portland, OR, (2)School of Nursing, University of Washington, Seattle, WA, (3)Center for Health Outcomes and Interdisciplinary Research, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, (4)Osher Center for Integrative Medicine, Harvard Medical School and Brigham and Women’s Hospital, Boston, MA, (5)MS Center of Excellence, VA Portland Health Care System, Portland, OR, (6)Department of Neurology, Oregon Health & Science University, Portland, OR, (7)Division of General Medicine, Beth Deaconess Medical Center, Harvard Medical School, Boston, MA

[194]

CAM05

[198]

Babita Bisht, PT, PhD1, Linda G. Snetselaar, PhD2, Catherine A. Chenard, MS, RDN1 and Terry L. Wahls, MD1, (1)Department of Internal Medicine, University of Iowa, Iowa City, IA, (2)Department of Epidemiology, University of Iowa, Iowa City, IA

[194]

CAM05

[198]

Tyler J. Titcomb, PhD, RDN1, Max Sherwood, BS1, Mary Ehlinger, BS1, Solange M. Saxby, PhD, RDN1, Farnoosh Shemirani, PhD1, Patrick Ten Eyck, PhD2, Linda G. Snetselaar, PhD, RDN3 and Terry L. Wahls, MD1, (1)Internal Medicine, University of Iowa, Iowa City, IA, (2)Institute for Clinical and Translational Science, University of Iowa, Iowa City, IA, (3)Epidemiology, University of Iowa, Iowa City, IA

[194]

CAM06

[198]

Solange M. Saxby, PhD, RDN1, Tyler J. Titcomb, PhD, RDN1, Farnoosh Shemirani, PhD1, Mary Ehlinger, BS1, Lisa Brooks, MA, RDN1, Linda G. Snetselaar, PhD, RDN2 and Terry L. Wahls, MD1, (1)Internal Medicine, University of Iowa, Iowa City, IA, (2)Epidemiology, University of Iowa, Iowa City, IA

[194]

CC01

[198]

Colleen Harris, MN, NP, MSCN, MSCS, University of Calgary MS Clinic, Hackensack, NJ, Bonnie Blain, RN, MSCN, Medical Specialty Clinic, Red Deer Regional Hospital Centre, Alberta Health Services, Red Deer, AB, Canada, Janet Brown, RN, MSCN, MS Clinic-Eastern Health, St. John’s, NF, Canada, Peggy Cook, RN, BN, Saint John Regional Hospital, Saint John, NB, Canada and Josee Poirier, BSs, MSCN, Hopital Notre-Dame, Montreal, QC, Canada

[194]

CC01

[198]

Amber Salter, PhD, Division of Biostatistics, Washington University in St. Louis, St. Louis, MO, Nina Thomas, MPH, Genentech, Inc, South San Francisco, CA, Gary Cutter, PhD, University of Alabama at Birmingham, Birmingham, AL, Ruth Ann Marrie, MD, PhD, University of Manitoba, Winnipeg, MB, Canada and Tuula Tyry, PhD, Dignity Health, St. Joseph’s Hospital and Medical Center, Phoenix, AZ

[194]

CC02

[198]

Debra I Frankel, MS OTR, Advocacy, Services and Research Department, National Multiple Sclerosis Society, NY, NY and Sara Anne Tompkins, Ph.D., Program Planning and Evaluation Consulting, Madipen, LLC, Fort Collins, CO

[194]

CC02

[198]

James V Nguyen, BS1, Laura J Balcer, MD, MSCE2, Elliot M Frohman, MD, PhD3, Alissa M Rothman, BS1, Peter A Calabresi, MD1 and Shiv Saidha, MBBCh1, (1)Neurology, Johns Hopkins University, Baltimore, MD, (2)Neurology, New York University Langone Medical Center, New York, NY, (3)Neurology and Ophthamology, University of Texas Southwestern Medical Center, Dallas, TX

[194]

CC03

[198]

Elaine Rudell, CHCP1, Patty Peterson, CHCP1, Sandeep Pulim, MD1, Andrea L Griffin, none2 and James D Bowen, MD3, (1)@Point of Care, Livingston, NJ, (2)Multiple Sclerosis Association of America, Cherry Hill, NJ, (3)Swedish Medical Center, Seattle, WA

[194]

CC03

[198]

Bonnie Schaude, M.A. CCC/SLP, Shepherd Center, Atlanta, GA and Julia P Huerbin, OTR/L, MSCS, MS, Shepherd Center, atlanta, GA

[194]

CC04

[198]

Jeffrey B English, MD1, Lauren Alexander, Pre-Med Student2 and Nancy Flockhart, BS, CCRC2, (1)Multiple Sclerosis Center of Atlanta, Atlanta, GA, (2)Research, Multiple Sclerosis Center of Atlanta, Atlanta, GA

[194]

CC04

[198]

Karen VL Turpin, PhD Candidate, MSc, BScN1, Nadine Akbar, PhD2, Julie Petrin, PhD Student3, Penelope Smyth, MD, FRCPC4 and Marcia Finlayson, PhD, OT Reg (Ont), OTR3, (1)School of Public Health, University of Alberta, Edmonton, AB, Canada, (2)Neuroscience and Neuropsychology Laboratory (NNL), Kessler Foundation, West Orange, NJ, (3)School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada, (4)Division of Neurology, Department of Medicine, University of Alberta, Edmonton, AB, Canada

[194]

CC05

[198]

Hong Li, MS, Quantitative health Sciences, Cleveland Clinic, Cleveland, OH, Carolyn Bauer, BS, Biology, The Miami University, Oxford, OH and Mary R Rensel, MD, The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH

[194]

CC05

[198]

Kathleen M Healey, ARNP, PhD, NEUROLOGICAL SCIENCES, UNIVERSITY OF NEBRASKA MEDICAL CENTER, OMAHA, NE

[194]

CC06

[198]

Rachael Stacom, ANP, MSCN, Care Management, Independence Care System, New York, NY

[194]

CC06

[198]

Malachy Bishop, Ph.D1, Phillip D Rumrill, Ph.D2, Chung-yi Chiu, PhD3, Bradley McDaniels, MRC1 and Byung-Jin Kim, MS1, (1)EDSRC, University of Kentucky, Lexington, KY, (2)Center for Disability Studies, Kent State University, Kent, OH, (3)Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL

[194]

CC07

[198]

Ozioma Obiwuru, MS1, Melanie D’Andrea, MFA2, Lihua Liu, PhD3, Sarah Joseph, MS1, Ana Palomeque, BS1, Leslie Tarlow, NP, MSN1, Bryce Morgan, BA2 and Lilyana Amezcua, MD, MS1, (1)Neurology, University of Southern California, Los Angeles, CA, (2)University of Southern California, Los Angeles, CA, (3)Department of Preventative Medicine, Division of Biostatistics, University of Southern California, Los Angeles, CA

[194]

CC08

[198]

Rola Mahmoud, MD1, George J Hutton, MD1, Kenneth W Altman, MD PhD2, Felicia Carter, MA, CCC-SLP2 and S.Richard Dunham, MD1, (1)Neurology, Baylor College of Medicine, Houston, TX, (2)Otolaryngology-Head & Neck Surgery, Baylor College of Medicine, Houston, TX

[194]

CC09

[198]

Amy Sullivan, Psy.D.1, Mary R Rensel, MD1, Carrie M Hersh, DO, MS2 and Catherine Boyle, Manager3, (1)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, (2)Lou Ruvo Center for Brain Health, Cleveland Clinic, Las Vegas, NV, (3)Women’s Professional Staff Association, Cleveland Clinic, Cleveland, OH

[194]

CC10

[198]

Benjamin I Richter, BA1, Rivka R Green, BA2, Jillian Mohn, BS1, Parth B Saraiya, HSD1 and Krupa S Pandey, MD1, (1)Multiple Sclerosis Comprehensive Care Center, Barnabas Health, Livingston, NJ, (2)MS Comprehensive Care Center, NYU Langone, New York, NY

[194]

CC11

[198]

Bincy Varghese, PharmD, St. John University School of Pharmacy, New York, NY

[194]

CC12

[198]

Catherine Siengsukon, PT, PhD and Mayis Al dughmi, PT, Physical Therapy and Rehabilitation Science, University of Kansas Medical Center, Kansas City, KS

[194]

CC13

[198]

Debra I Frankel, MS OTR, Advocacy, Services and Research Department, National Multiple Sclerosis Society, NY, NY

[194]

CC14

[198]

Diane M Masciangelo, MS, BSN, ACNP-BC, CNRN, Colleen M O’Connell, MSN, BSN, ANP-BC and Deborah Zook, RN, Neurology/MS Clinic, OhioHealth/Riverside Methodist Hospital, Columbus, OH

[194]

CC15

[198]

Edward J. Fox, MD, PhD1, John Ko, Pharm.D, MS2, Paul Wicks, PhD3, Yujin Park, PharmD4, Pronabesh DasMahapatra, MD, MPH3, Kathryn Kendall, MBA3, Walter Hong, MD2, Erik Burton, MD2, Kathleen Hawker, MD2, Irina Kosoy, BBA5, Dimitri Liakhovitski, PhD5 and Vivian Herrera, DDS, MIA, MPH2, (1)Central Texas Neurology Consultants, Round Rock, TX, (2)Health Economics & Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ, (3)PatientsLikeMe Inc., Cambridge, MA, (4)Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD, (5)North America, Gfk, New York, NY

[194]

CC16

[198]

Jameson P Holloman Sr., MS, Medstar, Georgetown University Hospital, Arlington, VA, Safia Abdillahi, RN, Neurology, Georgetown University Hospital, Washington, DC and Faria S Amjad, MD, Neurology, Medstar Georgetown University Hospital, Washington DC, DC

[194]

CC17

[198]

Kimberly L Cooley, RN, CCRC, Research, OSF Saint Francis Medical Center, Peoria, IL

[194]

CC18

[198]

Marcia Finlayson, PhD, OT Reg (Ont), OTR, School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada, Ruth Ann Marrie, MD, PhD, University of Manitoba, Winnipeg, MB, Canada, Gregory S. Finlayson, PhD, Finlayson Consulting Inc., Kingston, ON, Canada, Okechukwu Ekuma, MSc, Manitoba Centre for Health Policy, Winnipeg, ON, Canada and Depeng Jiang, PhD, University of Manitoba, Winnipeg, ON, Canada

[194]

CC19

[198]

María E. Moscoso, Lic., MS Cuba, Cienfuegos, Cuba and Margarita Ruiz, MSc., MS Cuba, Havana, Cuba

[194]

CC20

[198]

Jong-Mi Lee, MSCN, MSN, Stanford, Palo Alto, CA, Lori Mayer, DNP, MSN, RN, MSCN, Central Texas Neurology Consultants,, Round Rock, TX, Marie Moore, NP, Neurology, Carolinas Healthcare System, Charlotte, NC, Marie Namey, APRN, MSCN, Cleveland Clinic, Cleveland, OH, Jennifer Smith, PA, MS Center of Excellence, Oklahoma Medical Research Foundation, Oklahoma City, OK, Karen DeBusk, MSN, Biogen, Cambridge, MA, Donna Butts, RN, BSN, MSN, NP, MSCN, Biogen, Cambridge, MA, United States Minor Outlying Islands and Jasmine Knight, PharmD, MS, Xcenda, Palm Harbor, FL

[194]

CC21

[198]

Michelle A Allan, RN BA Nursing GCert MS, Monash Neurology, Monash Health, Melbourne, Australia

[194]

CC22

[198]

Ronald O Bailey, M.D., Marlon V. Garcia, MA and Carina G. Sprague, LVN, Neurology, Riverside Medical Clinic, Riverside, CA

[194]

CC23

[198]

Smitha M Thotam, NP-C, MSCN, Stony Brook University, Stony brook, NY and Marijean Buhse, PhD, NP, RN, MSCN, Stony Brook University, Stony Brook, NY

[194]

CC24

[198]

Stacey S Cofield, PhD1, Tuula Tyry, PhD2, Amber Salter, PhD3, Sandre McNeal, MS1, Gary Cutter, PhD1, Ruth Ann Marrie, MD, PhD4 and Robert J Fox, MD, FAAN5, (1)Biostatistics, University of Alabama at Birmingham, Birmingham, AL, (2)Dignity Health, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, (3)Biostatistics, Washington University in St. Louis, St. Louis, MO, (4)University of Manitoba, Winnipeg, MB, Canada, (5)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH

[194]

CC25

[198]

Nicole Kelly, B.A.1, Thomas M Stewart, M.S., J.D., PA-C1, Michaela Welch, BSN, RN1, Alexandra Hempel, RN1 and Augusto A Miravalle, M.D.2, (1)Metro Community Provider Network, Aurora, CO, (2)Department of Neurology, University of Colorado, Aurora, CO

[194]

CC26

[198]

Vanessa Spyropoulos, MSc(A), Serena Slater, MSc(A) and Lucy Wardell, MSc(A), Nursing, Montreal Neurological Hospital, Montreal, QC, Canada

[194]

CC27

[198]

Vanessa Spyropoulos, MSc(A), Nursing, Montreal Neurological Hospital, Montreal, QC, Canada, Anne-Marie Trudelle, MD, FRCPC, Neurology, Montreal Neurological Hospital, Montreal, QC, Canada and Monique Lessard, RN, BScN candidate, Nursing, Bayshore Specialty RX, Mississauga, ON, Canada

[194]

CC28

[198]

Yvonne C Learmonth, PhD1, Brynn C Adamson, MSc1, Julia M Balto, BSc1, Chung-yi Chiu, PhD2, Isabel Molina-Guzmán, PhD3, Barry J Riskin, MD1, Daniel Wynn, MD4, Robert W Motl, PhD1 and Marcia Finlayson, PhD, OT Reg (Ont), OTR5, (1)Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL, (2)Department of Kinesiology and Community Health, University of Illinois at Urbana Champaign, Urbana, IL, (3)Department of Latina/Latino Studies, 1207 W. Oregon,, Urbana, IL, (4)Consultants in Neurology MS Center, Northbrook, IL, (5)School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada

[194]

CG01

[198]

Alexa Stuifbergen, RN, PhD, FAAN1, Heather Becker, PhD, Research Scientist1 and Francisco Perez, PhD2, (1)School of Nursing, The University of Texas at Austin, Austin, TX, (2)University of Texas at Austin, Austin, TX

[194]

CG01

[198]

Ana T Todd, PhD RN1, Heather Becker, PhD, Research Scientist2, Alexa Stuifbergen, PhD, RN, FAAN, Dean2, Wenshui Zhang, BSN3 and Vicki Kullberg, MA3, (1)School of Nursing, University of Texas at Austin, Austin, TX, (2)School of Nursing, The University of Texas at Austin, Austin, TX, (3)School of Nursing, University of Texas Nurs, Austin, TX

[194]

CG01

[198]

Cheri L Roseberry, PhD, RN, College of Nursing, University of Arizona, Phoenix, AZ

[194]

CG02

[198]

Jason A Berard, B.Sc.H.1,2, Lisa A.S. Walker, Ph.D.1,2,3,4 and Andra M Smith, Ph.D.1,2,4, (1)Psychology, University of Ottawa, Ottawa, ON, Canada, (2)The Ottawa Hospital Research Institute, Ottawa, ON, Canada, (3)Psychology, The Ottawa Hospital, Ottawa, ON, Canada, (4)University of Ottawa Brain and Mind Research Institute, Ottawa, ON, Canada

[194]

CG02

[198]

Caroline Altaras, B.A.1, Nicholas A Vissicchio, B.A.1, Shonna Schneider, B.A.2, Shaina Shagalow, B.A.2, Amanda A Parker, B.S.2, Jennifer Miller, B.A.2 and Frederick W Foley, Ph.D.3, (1)Yeshiva University Ferkauf Graduate School of Psychology, Bronx, NY, (2)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (3)School of Psychology, Yeshiva University, New York, NY

[194]

CG02

[198]

Eduardo R Estades, MD1, Angel Chinea, MD2, Yatzka G Hernandez Silvestrini, MD1, Ivonne Vicente, MD2, Cristina Rubi, BS2 and Carlos Rios, PhD2, (1)Research/Clinic, San Juan MS Center, Guaynabo, PR, (2)San Juan Multiple Sclerosis Center, Guaynabo, PR

[194]

CG03

[198]

Catherine Siengsukon, PT, PhD1, Mohammed Alshehri, PT, MS1, Michelle Drerup, Psy.D., C.BSM2 and Sharon G Lynch, MD3, (1)Physical Therapy and Rehabilitation Science, University of Kansas Medical Center, Kansas City, KS, (2)Sleep Disorders Center, Cleveland Clinic, Cleveland, OH, (3)Neurology, University of Kansas Medical Center, Kansas City, KS

[194]

CG03

[198]

Helen Genova, PhD1, Jean Lengenfelder, Ph.D.2, Chris Bober, BA1, John DeLuca, Ph.D.3 and Nancy D Chiaravalloti, PhD1, (1)Neuropsychology and Neuroscience, Kessler Foundation, East Hanover, NJ, (2)Traumatic Brain Injury, Kessler Foundation, East Hanover, NJ, (3)Neuropsychology and Neuroscience, Kessler Foundation, West Orange, NJ

[194]

CG03

[198]

Julia M Balto, BSc1, Lara A Pilutti, PhD1 and Robert W Motl, PhD2, (1)Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL, (2)Department of Kinesiology and Community Health, University of Illinois at Urbana Champaign, Urbana, IL

[194]

CG04

[198]

Susan Kasser, Ph.D.1, Kaley Ahern, BS1, Tyler Triquet, BS1, Kyle Hinsdale, BS1 and Ryan S McGinnis, Ph.D.2, (1)Rehabilitation and Movement Science, University of Vermont, Burlington, VT, (2)Electrical and Biomedical Engineering, University of Vermont, Burlington, VT

[194]

CG04

[198]

Karen VL Turpin, PhD Candidate, MSc, BScN, School of Public Health, University of Alberta, Edmonton, AB, Canada, Linda J Carroll, PhD, Public Health Sciences, University of Alberta, Edmonton, AB, Canada, Penelope Smyth, MD, FRCPC, Division of Neurology, Department of Medicine, University of Alberta, Edmonton, AB, Canada and Ruth Ann Marrie, MD, PhD, University of Manitoba, Winnipeg, MB, Canada

[194]

CG04

[198]

Laura T. Safar, MD, Psychiatry, Harvard Medical School, Boston, MA

[194]

CG05

[198]

Angela Senders, ND, MCR1,2, Douglas Hanes, PhD2, Dennis Bourdette, MD1, Lynn Marshall, Sc.D.3,4 and Lynne Shinto, ND, MPH1, (1)Neurology, Oregon Health & Science University, Portland, OR, (2)Helfgott Research Institute, National University of National Medicine, Portland, OR, (3)Orthopedics and Rehabilitation, Oregon Health & Science University, Portland, OR, (4)OHSU-PSU School of Public Health, Portland, OR

[194]

CG05

[198]

Margaret H Cadden, M.S., Peter A Arnett, Ph.D. and Jonathan E Cook, Ph.D., Department of Psychology, Pennsylvania State University, State College, PA

[194]

CG05

[198]

Mayis Al dughmi, PT, Physical Therapy and Rehabilitation Science, University of Kansas Medical Center, Kansas City, KS

[194]

CG06

[198]

Lauren B Strober, Ph.D., Neuropsychology & Neuroscience Research, Kessler Foundation, West Orange, NJ

[194]

CG06

[198]

Mark S Freedman, MD1, Douglas Jeffery, MD, PhD2,3, Aaron Miller, MD4, Eva Havrdova, MD, PhD5, Finn Sellebjerg, MD, PhD, DMSci6, Hans-Peter Hartung, MD7, Ih Chang, PhD8, Sarah Naoshy, MPH8 and Nolan Campbell, PhD8, (1)1University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada, (2)Cornerstone Healthcare, High Point, NC, (3)Piedmont HealthCare, Mooresville, NC, (4)Icahn School of Medicine at Mount Sinai, New York, NY, (5)First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic, (6)Danish Multiple Sclerosis Center, Ringshospitalet, University of Copenhagen, Copenhagen, Denmark, (7)Heinrich Heine University, Dusseldorf, Germany, (8)Biogen, Cambridge, MA

[194]

CG06

[198]

Melissa A Colbeck, OT Reg. (MB), Occupational Therapy, Health Sciences Centre, Winnipeg, MB, Canada

[194]

CG07

[198]

Ruchika S. Prakash, Ph.D.1, Brittney Schirda, MA1 and Hyunkyu Lee, PhD2, (1)Department of Psychology, The Ohio State University, Columbus, OH, (2)Posit Science, San Francisco, CA

[194]

CG07

[198]

Aliza Ben-Zacharia, DNP, ANP, MSCN, Neurology, Mount Sinai Hospital, New York, NY

[194]

CG08

[198]

Carolyn J Fisher, Ph.D.1,2, Leslie J. Heinberg, Ph.D.2, Ali Aminian, M.D.2, Stacy Brethauer, M.D.2 and Amy Sullivan, Psy.D.1, (1)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, (2)Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, OH

[194]

CG09

[198]

Annalisa F Sciullo, BA, Ferkauf school of psychology, yeshiva university, Bronx, NY, Frederick W Foley, Ph.D., School of Psychology, Yeshiva University, New York, NY, Elizabeth K Seng, Ph.D., Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY and Carly A Solon, BA, Ferkauf graduate school of psychology, Yeshiva university, bronx, NY

[194]

CG10

[198]

Brian D Hoyt, Ph.D., ABPP-CN1, Justin Honce, MD2, Stefan Silau, Ph.D.3, Brittany Wedeman, BS3, Eric Engebretson, BA3, Kristen Johnson, PhD, MPH4, Nadia Tenenbaum, MD5, Vivian Herrera, DDS, MIA, MPH6, Lisa Siconolfi, Ph.D.5, Enrique Alvarez, MD7 and Kavita Nair, Ph.D.8, (1)Neurology/Neurosurgery, University of Colorado School of Medicine, Aurora, CO, (2)Radiology, University of Colorado School of Medicine, Aurora, CO, (3)Neurology, University of Colorado School of Medicine, Aurora, CO, (4)Health Economics & Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ, (5)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (6)US Health Economics & Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ, (7)Neurology, University of Colorado, Aurora, CO, (8)University of Colorado School of Pharmacy, Aurora, CO

[194]

CG11

[198]

David P Marino, M.S.1,2, Jason A Berard, M.A.1,3, Denis Cousineau, Ph.D.3, Anthony Feinstein, PhD, MD4, Sarah A Morrow, MD5 and Lisa A.S. Walker, Ph.D.1, (1)The Ottawa Hosptial Research Institute, Ottawa, ON, Canada, (2)University of Toledo, Toledo, OH, (3)University of Ottawa, Ottawa, ON, Canada, (4)Psychiatry, University of Toronto, Toronto, ON, Canada, (5)Western University, London, ON, Canada

[194]

CG12

[198]

Mary Beth Mercer, MPH1, Paul Ford, Ph.D.1 and Deborah M Miller, Ph.D., LISW2, (1)Bioethics, Cleveland Clinic, Cleveland, OH, (2)Mellen Center, Cleveland Clinic, Cleveland, OH

[194]

CG13

[198]

Elizabeth S Gromisch, Ph.D.1,2, Robert D Kerns, Ph.D.2,3, Rebecca Czlapinski, M.A.3, Beth Beenken, Ph.D.1,2, John Otis, Ph.D.4,5 and John Beauvais, Ph.D.1,2, (1)Department of Psychology, VA Connecticut Healthcare System, West Haven, CT, (2)Yale University School of Medicine, New Haven, CT, (3)Pain Research, Informatics, Multimorbidities and Education (PRIME) Center, VA Connecticut Healthcare System, West Haven, CT, (4)Research Service, VA Boston Healthcare System, Boston, MA, (5)Boston University, Boston, MA

[194]

CG14

[198]

Elizabeth S Gromisch, Ph.D.1,2, Jessica H Sloan, BA3, Vance Zemon, Ph.D.3, Tuula Tyry, PhD4, Laura C Schairer, Ph.D.5, Stacey Snyder, Ph.D.6 and Frederick W Foley, Ph.D.3,7, (1)Department of Psychology, VA Connecticut Healthcare System, West Haven, CT, (2)Yale University School of Medicine, New Haven, CT, (3)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (4)Dignity Health, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, (5)VA NY Harbor Healthcare System, Manhattan, NY, (6)Mount Sinai Hospital, New York, NY, (7)Holy Name Medical Center, Teaneck, NJ

[194]

CG15

[198]

Gabriel Hoffnung, MA1, Nicholas A Vissicchio, B.A.2, Jeffrey G Portnoy, B.A.1, Caroline Altaras, B.A.2, Lisa Glukhovsky, M.A.1, Mary Ann Picone, M.D.3 and Frederick W Foley, Ph.D.4, (1)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (2)Yeshiva University Ferkauf Graduate School of Psychology, Bronx, NY, (3)Holy Name Medical Center, Teaneck, NJ, (4)School of Psychology, Yeshiva University, New York, NY

[194]

CG16

[198]

Gabriel Hoffnung, MA1, Nicholas A Vissicchio, B.A.2, Jeffrey G Portnoy, B.A.1, Eliana Pasternak, B.A.1, Lisa Glukhovsky, M.A.1, Mary Ann Picone, M.D.3 and Frederick W Foley, Ph.D.4, (1)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (2)Yeshiva University Ferkauf Graduate School of Psychology, Bronx, NY, (3)Holy Name Medical Center, Teaneck, NJ, (4)School of Psychology, Yeshiva University, New York, NY

[194]

CG17

[198]

Janet D Morrison, RN, MSN, MSCN, School of Nursing, The University of Texas at Austin, Austin, TX

[194]

CG18

[198]

Jason Botvinick, B.A.1, Jeffrey G Portnoy, B.A.1, Gabriel Hoffnung, MA1, Lisa Glukhovsky, M.A.1 and Frederick W Foley, Ph.D.2, (1)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (2)School of Psychology, Yeshiva University, New York, NY

[194]

CG19

[198]

Jason Botvinick, B.A.1, Jeffrey G Portnoy, B.A.1, Gabriel Hoffnung, MA1, Lisa Glukhovsky, M.A.1 and Frederick W Foley, Ph.D.2, (1)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (2)School of Psychology, Yeshiva University, New York, NY

[194]

CG20

[198]

Jason Botvinick, B.A.1, Jeffrey G Portnoy, B.A.1 and Frederick W Foley, Ph.D.2, (1)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (2)School of Psychology, Yeshiva University, New York, NY

[194]

CG21

[198]

Jeffrey G Portnoy, B.A.1, Jason Botvinick, B.A.1, Gabriel Hoffnung, MA1, Lisa Glukhovsky, M.A.1 and Frederick W Foley, Ph.D.2, (1)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (2)Holy Name Medical Center, Teaneck, NJ

[194]

CG22

[198]

Jeffrey G Portnoy, B.A.1, Marnina B Stimmel, B.A.1 and Frederick W Foley, Ph.D.2, (1)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (2)School of Psychology, Yeshiva University, New York, NY

[194]

CG23

[198]

Jeffrey G Portnoy, B.A.1, Eliana Pasternak, B.A.1 and Frederick W Foley, Ph.D.2, (1)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (2)School of Psychology, Yeshiva University, New York, NY

[194]

CG24

[198]

Jeffrey G Portnoy, B.A.1, Marnina B Stimmel, B.A.1, Roseann Archetti, B.S.1 and Frederick W Foley, Ph.D.2, (1)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (2)School of Psychology, Yeshiva University, New York, NY

[194]

CG25

[198]

Joshua D Lee, PhD, Stephanie A Grover, MSc and E Ann Yeh, MD, Departments of Neurology and Neurosciences and Mental Health, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada

[194]

CG26

[198]

Kaitlynne Leclaire, BA1, Bonnie I Glanz, PhD2, Allison LaRussa, BA1, Fiona Stuart, BA1, Brian C Healy, PhD1, Jeff Huffman, MD3, Tanuja Chitnis, MD4, Howard L Weiner, MD1 and Audrey H Cecil, MSW, LICSW5, (1)Neurology, Brigham and Women’s Hospital, Brookline, MA, (2)Partners Multiple Sclerosis Center, Brigham and Women’s Hospital, Brookline, MA, (3)Massachusetts General Hospital, Boston, MA, (4)Massachusetts General Hospital for Children, Boston, MA, (5)Social Work, Brigham & Women’s Hospital, Brookline, MA

[194]

CG27

[198]

Laura T. Safar, MD, Psychiatry, Harvard Medical School, Boston, MA

[194]

CG28

[198]

Lisa Glukhovsky, M.A.1, Gabriel Hoffnung, MA1, Jason Botvinick, B.A.1, Jeffrey G Portnoy, B.A.1, Marnina B Stimmel, B.A.1, Roee Holtzer, PhD1 and Frederick W Foley, Ph.D.2, (1)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (2)School of Psychology, Yeshiva University, New York, NY

[194]

CG29

[198]

Lori Hendin Travis, MD1, Jeffrey Chavin, MD2, Maria Melanson, MD, PhD2, Adel Gehchan, MD3 and Matt Mandel, MD2, (1)Phoenix Neurological Associates Ltd, Phoenix, AZ, (2)Genzyme, a Sanofi company, Cambridge, MA, (3)Genzyme Canada, Mississauga, ON, Canada

[194]

CG30

[198]

Louise M Gresham, B.Sc.H., Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada, Roxana M Barbu, M.Cog., Institute of Cognitive Science, Carleton University, Ottawa, ON, Canada, Jason A Berard, B.Sc.H., Psychology, University of Ottawa, Ottawa, ON, Canada and Lisa A.S. Walker, PhD, C.Psych., Psychology, The Ottawa Hospital, Ottawa, ON, Canada

[194]

CG31

[198]

Lucille J. Carriere, Ph.D.1, Amy B. Sullivan, Psy.D.2 and Lael A. Stone, M.D.2, (1)Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Murfreesboro, TN, (2)Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH

[194]

CG32

[198]

Maha Abu-AlHawa, B.Sc.H., Institute of Cognitive Science, Carleton University, Ottawa, ON, Canada, Jason A Berard, B.Sc.H., Psychology, University of Ottawa, Ottawa, ON, Canada, Leila Osman, BA., Ottawa Hospital Research Institute, Ottawa, ON, Canada, Louise M Gresham, B.Sc.H., Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada and Lisa A.S. Walker, PhD, C.Psych., Psychology, The Ottawa Hospital, Ottawa, ON, Canada

[194]

CG33

[198]

Eliot Lopez, Ph.D., Lara Stepleman, Ph.D. and Rebecca M. Floyd, Ph.D., Georgia Regents University, Augusta, GA

[194]

CG34

[198]

Rita M Carroll, Ph.D., CPCRT and Mark B Cola, B.A., CBIS, Main Line Rehabilitation Associates, Exton, PA

[194]

CG35

[198]

Serkan Ozakbas, Professor Of Neurology1, Bilge Piri Cinar, MD2, Gorkem Kosehasanogullari, MD3 and Pinar Yigit, Psycologist1, (1)Department of Neurology, Dokuz Eylul University, Izmir, Turkey, (2)Giresun State Hospital, Giresun, Turkey, (3)Usak State Hospital, Usak, Turkey

[194]

CG36

[198]

Silvana L Costa, PhD1,2, John DeLuca, Ph.D.1,2 and Nancy D Chiaravalloti, PhD1,2, (1)School of Medicine, Rutgers University, Newark, NJ, (2)Neuropsychology and Neuroscience Research, Kessler Foundation, West Orange, NJ

[194]

CG37

[198]

Thomas R Valentine, BS1, Brittney Schirda, MA1, Jacqueline A Nicholas, MD, MPH2 and Ruchika Prakash, PhD1, (1)Department of Psychology, The Ohio State University, Columbus, OH, (2)OhioHealth Multiple Sclerosis Center, Columbus, OH

[194]

CSR01

[198]

Clare T Hartigan, PT, MPT, Betty Mathew, SLP and Shannon Schneider, OTRL, Multiple Sclerosis Outpatient Rehabilitation, Shepherd Center, Atlanta, GA

[194]

CSR01

[198]

Alexandra B Kornbluh, MD1, Grant T Liu, MD2 and Sarah E Hopkins, MD, MSPH1, (1)Neurology, Children’s Hospital of Philadelphia, Philadelphia, PA, (2)Ophthalmology, Children’s Hospital of Philadelphia, Philadelphia, PA

[194]

CSR01

[198]

Matthew G Spilsbury, DPT, Physical Therapy, Encompass Health Rehabiliation Hospital, Colorado Springs, CO

[194]

CSR01

[198]

Alexandra C Simpson, MD, MA and Scott D Newsome, DO, MSCS, Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

CSR02

[198]

Nicole Bou Rjeily, MD, Bardia Nourbakhsh, MD, MAS and Ellen M Mowry, MD, MCR, Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

CSR02

[198]

Cameron S Mang, PhD1, Kristen E Plandowski, BSc1, Eduardo A Toledo-Aldana, BSc1 and Sarah J Donkers, PT, PhD2, (1)Kinesiology and Health Studies, University of Regina, Regina, SK, Canada, (2)School of Rehabilitation Science, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada

[194]

CSR02

[198]

Susan E Agland, Master Research with Training (Nursing), RN, MS Clinic, Neurology, Hunter New England Local Health District, Newcastle, Australia and Jeannette Lechner-Scott, FRACP, John Hunter Hospital, Newcastle, Australia

[194]

CSR02

[198]

Andreas Meier, MD, Clinical Development, Vigil Neuroscience, Watertown, MA, Leslie Leahy, PhD, Boston, MA, Cynthia Cassandro, BS, RN, Patient Engagement, Vigil Neuroscience, Watertown, MA and Spyros Papapetropoulos, MD, PhD, Clinical Development, Vigil Neuroscience (Former Employee), Watertown, MA

[194]

CSR03

[198]

Shlok Sarin, BS1, Alexander Wang, MD1,2, Mohamed Elkasaby, MD1,2 and Hesham Abboud, MD, PhD1,3, (1)Case Western Reserve School of Medicine – – Cleveland Heights, OH, Cleveland, OH, (2)University Hospitals Cleveland Medical Center, Cleveland, OH, (3)Multiple Sclerosis and Neuroimmunology Program, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH

[194]

CSR03

[198]

Christine Hampton, MOT, OTR/L, Shepherd Center, Atlanta, GA

[194]

CSR03

[198]

William A Kilgo, MD, Neurology, University of South Alabama, Mobile, AL

[194]

CSR03

[198]

Cecelia A Barry, B.A., University of Illinois College of Medicine, Chicago, IL, Evan Jameyfield, M.D., The University of Illinois at Chicago Department of Neurology and Rehabilitation, University of Illinois Hospital & Health Sciences System, Chicago, IL and Jeffrey Loeb, M.D., Ph.D, Department of Neurology and Rehabilitation, University of Illinois at Chicago, Chicago, IL

[194]

CSR04

[198]

Shuvro Roy, MD, Paula Barreras, MD, Carlos Pardo, MD and Scott D. Newsome, DO, MSCS, FAAN, FANA, Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

CSR04

[198]

[194]

CSR04

[198]

Loulwah Mukharesh, MD, Neurology, The George Washington University Hospital, Washington, DC and Ted L Rothstein, MD, Neurology, George Washington University, Washington, DC

[194]

CSR04

[198]

Hesham Abboud, MD, PhD1, Brian Steingo, MD2, Diana Vargas, MD3, Julie J Patel, PharmD, BCACP3,4, Nancy Nealon, MD5, Mary Alissa Willis, MD6, Yang Mao-Draayer, MD, PhD7, Dmitry Khaitov, MD8, Jose Avila Ornelas, MD9, Adnan Subei, DO10, Clifford Reed, MD11, Lisa Ferayorni, MD12, Xavier Laucirica, MD12 and Shervin Gholizadeh, PhD12, (1)Multiple Sclerosis and Neuroimmunology Program, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, (2)Infinity Clinical Research, Sunrise, FL, (3)Department of Neurology, Emory University School of Medicine, Atlanta, GA, (4)Department of Pharmacy, Emory University Hospital Midtown, Atlanta, GA, (5)Department of Neurology, Weill Cornell Medicine, New York, NY, (6)Department of Neurology, University of Mississippi Medical Center, Jackson, MS, (7)Department of Neurology, University of Michigan School of Medicine, Ann Arbor, MI, (8)Lehigh Valley Health Network, Allentown, PA, (9)HIMA Caguas Multiple Sclerosis Center, Caguas, Puerto Rico, (10)Department of Neurology, Memorial Healthcare System, Hollywood, FL, (11)Department of Neurology, Reading Hospital, West Reading, PA, (12)Genentech, Inc., South San Francisco, CA

[194]

CSR05

[198]

Gina S Perez, MD, Courtney Iser, MD, Sara Habib, MD, Juliane Chainakul, APRN-CNS, Sarah Durica, MD, Danny Samkutty, MD, Evgeny Sidorov, MD, Ahmad Al Awwad, MD, Masoom Desai, MD, Jorge Ortiz, MD, Nidhiben Anadani, MD and David Gordon, MD, Neurology, University of Oklahoma Health Sciences Center, Oklahoma City, OK

[194]

CSR05

[198]

Loulwah Mukharesh, MD and Amanda Tinsley, MD, Neurology, The George Washington University Hospital, Washington, DC

[194]

CSR06

[198]

Jacqueline Koshorek, DO and Shiv Saidha, MBBCh, MD, MRCPI, Neurology, Johns Hopkins University, Baltimore, MD

[194]

CSR06

[198]

Yasser Tajali, M.D.1, Max Ward, B.S.2, Yehuda Herschman, M.D.2, Boris Paskhover, M.D.3 and Machteld E Hillen, MD1, (1)Neurology, Rutgers New Jersey Medical School, Newark, NJ, (2)Neurosurgery, Rutgers New Jersey Medical School, Newark, NJ, (3)Otolaryngology, Rutgers New Jersey Medical School, Newark, NJ

[194]

CSR06

[198]

Mirla Avila, MD, Neurology, Texas Tech University Health Sciences Center, Lubbock, TX, Mirla Nicole Martinez, student, Texas Tech, Lubbock, TX and Texas Tech

[194]

CSR07

[198]

Jennifer Chester, FNP-BC, MSCN1, Leah Hurd, RN, BSN2, Tyler Kaplan, MD3,4, Mark Box, MD5 and Jeffrey Kaplan, MD2, (1)Kansas City MS Center at College Park Specialty, Overland Park, KS, (2)Kansas City MS Center, College Park Neurology, Overland Park, KS, (3)Rush University Medical Center, Chicago, United States Minor Outlying Islands, (4)University of Utah, Salt Lake City, UT, (5)Rheumatology, Carondolet, Kansas City, MO

[194]

CSR07

[198]

Aiga Rakhesh, MD1,2, Poonam Ochani, MD3, Lori Hoffman, NP3 and Steven Brose, DO3, (1)SCI Neurology, Syracuse VA Medical Center, Syracuse, NY, (2)Neurology, Suny Upstate Medical Univeristy, Syracuse, NY, (3)SCI, Syracuse VA Medical Center, Syracuse, NY

[194]

CSR07

[198]

Petra Brayo, MD1, Amy Safadi, MD1, In Guk (Josh) Kang, BS2, Rebecca Kumar, MD3, Bethany Schreiber, NP1 and Carlo Tornatore, MD1, (1)Department of Neurology, MedStar Georgetown University Hospital, Washington, DC, (2)Georgetown University School of Medicine, Washington, DC, (3)Department of Infectious Diseases, MedStar Georgetown University Hospital, Washigton, DC

[194]

CSR08

[198]

Lisa M. Fox, PA-C MPAS, Neurology/Neuroimmunology, Johns Hopkins Medical Center, Baltimore, MD and Scott D. Newsome, DO, MSCS, FAAN, FANA, Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

CSR08

[198]

Roberto A Cruz, MD1, Alexander B Ramos, MD1, Miguel F Molina, MD, PhD1, Bridget A Bagert, MD2 and Jesus F Lovera, MD1, (1)Neurology, Louisiana University Health Science Center, New Orleans, LA, (2)Neurology, Ochsner Clinic Foundation, New Orleans, LA

[194]

CSR08

[198]

Aisha Elfasi, MD1, Elsa Rodriguez, MD1, Samir Alkabie, MD, MSc2, Garrett Timmons, MD3, Mayra Montalvo, MD1, Fernando X Cuascut, MD, MPH4, Rhaisa Castrodad, MD4, George J Hutton, MD4, Revere Kinkel, MD5, Jennifer Graves, MD, PhD, MAS6 and Torge Rempe, MD1, (1)Neurology, University of Florida, Gainesville, FL, (2)Western University, London, ON, Canada, (3)Stanford University School of Medicine, Stanford, CA, (4)Baylor College of Medicine, Houston, TX, (5)University of California San Diego, La Jolla, CA, (6)University of California San Diego, San Diego, CA

[194]

CSR09

[198]

Michelle Maynard, PharmD, BCPS, Neurosciences, Froedtert and the Medical College of Wisconsin, Milwaukee, WI, Carmen Raschka, RN, Neurosciences, Froedtert Hospital, Milwaukee, WI, Mokshal H Porwal, BSc, Medical College of Wisconsin, Milwaukee, WI and Ahmed Z Obeidat, MD, PhD, Department of Neurology, Medical College of Wisconsin, Milwaukee, WI

[194]

CSR09

[198]

Roberto A Cruz, MD1, Christopher M Smith, MD1, Mary M Nguyen, MD2 and Jesus F Lovera, MD1, (1)Neurology, Louisiana University Health Science Center, New Orleans, LA, (2)Neurology, Louisiana University health Science Center, New Orleans, LA

[194]

CSR09

[198]

Rufaidah Rushdi, Master of Science in Pediatrics1, Nevin Shalaby, Professor of Neurology2 and Fawzia Mossad, Lecturer of Pediatric Neurology1, (1)Pediatrics, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt, (2)Neurology, Kasr Al-Ainy Faculty of Medicine, Cairo, Egypt

[194]

CSR10

[198]

Olinka K Hrebicek, MD, Neurology, Island Health MS Clinic, Victoria, BC, Canada and Niall I Murphy, BSc, University of Victoria, Victoria, BC, Canada

[194]

CSR10

[198]

Annessa L Nixon, PT, DPT, MSCS, Nashville, TN

[194]

CSR11

[198]

Samuel B Marcucci, BS1, Rosemarie Walch, DO1, Ameneh Zare-Shahabadi, MD/MPH2, Lawrence P Goldstick, MD1, Allison Jordan, DO1, Roman Kassa, MD/PhD1, Abdelkader Mahammedi, MD3 and Aram Zabeti, MD1, (1)Waddell Center for Multiple Sclerosis, University of Cincinnati, Cincinnati, OH, (2)Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, (3)Department of Radiology, University of Cincinnati, Cincinnati, OH

[194]

CSR11

[198]

Hannah M Geils, B.S., Joshua D Katz, M.D., Ellen S Lathi, MD and India C Stribling, B.S., The Elliot Lewis Center for Multiple Sclerosis Care, Wellesley, MA

[194]

CSR12

[198]

Siddharth Ninan, MBBS1, Gershon Timothy, MD, PhD1, Robert Greenwood, MD1, Clara Zelasky, PA-C1, Stephanie Iyer, PharmD, CPP2 and Irena Dujmovic-Basuroski, MD1, (1)Department of Neurology, UNC Hospitals, Chapel Hill, NC, (2)Department of Pharmacy, UNC Hospitals, Chapel Hill, NC

[194]

CSR12

[198]

Stephanie A Rout, MNS, BN, RN, Neurology Department, Nelson Marlborough District Health Board, Nelson, New Zealand

[194]

CSR13

[198]

Christopher M Perrone, MD and Dina Jacobs, MD, Neurology, University of Pennsylvania, Philadelphia, PA

[194]

CSR14

[198]

Yujie Wang, MD and Scott D. Newsome, DO, Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

CSR15

[198]

Swathy Chandrashekhar, MD, Christopher W Hollen, MD, Mausaminben Hathidara, MD and Nidhiben Anadani, MD, Neurology, University of Oklahoma Health Sciences Center, Oklahoma City, OK

[194]

CSR16

[198]

Ye Hu, MD, Michael Persenaire, MD, Gloria von Geldern, MD and Annette Wundes, MD, University of Washington, Seattle, WA

[194]

CSR17

[198]

Chantal Kahovec, RN(NP) and Dr. Michael C Levin, M.D., FRCPC, FAAN, FANA, Saskatoon MS Clinic, Saskatchewan Health Authority, Saskatoon, SK, Canada

[194]

CSR18

[198]

Allison N Block, DO1, Michelle Maynard, PharmD, BCPS2 and Ahmed Z Obeidat, MD, PhD1, (1)Neurology, Medical College of Wisconsin, Milwaukee, WI, (2)Neurosciences, Froedtert and the Medical College of Wisconsin, Milwaukee, WI

[194]

CSR19

[198]

Ye Hu, MD, Michael Persenaire, MD, Gloria von Geldern, MD, Pamela S Davies, MS, ARNP, FAANP, Deb Cramer, RN, BSN, MSCN, Deborah K Gallaro, R.Ph., MSCS, Melissa F Kennedy, RN and Annette Wundes, MD, University of Washington, Seattle, WA

[194]

CSR20

[198]

Barbara Bumstead, MS, ANCP, MSCN, Jared Srinivasan, BA, Myassar Zarif, MD, Lori Fafard, RN, BSN, CNRN, MSCN, CCRP, Marijean Buhse, PhD, NP, RN, MSCN and Mark Gudesblatt, MD, South Shore Neurologic Associates, Patchogue, NY

[194]

CSR21

[198]

Nicole Khezri, BA1, Caila B Vaughn, PhD, MPH2, Bianca Weinstock-Guttman, MD2 and Svetlana Eckert, MD1, (1)Jacobs School of Medicine and Biomedical Sciences at the University of Buffalo, Buffalo, NY, (2)Neurology, University at Buffalo, Buffalo, NY

[194]

CSR22

[198]

Brooke L Guerrero, MD, Neurology-Multiple Sclerosis, Cedars-Sinai Medical Center, Los Angeles, CA

[194]

CSR23

[198]

F Stephen Benesh, MD and John R Rinker, MD, Neurology, University of Alabama at Birmingham, Birmingham, AL

[194]

DA01

[198]

Kim D Jones, PhD, Nursing, Oregon Health & Science University, Portland, OR, Joseph S. Bubalo, Pharm D, Pharmacy, Oregon Health & Science University, Portland, OR, Colin M. Roberts, MD, Neurology, Oregon Health & Science University, Portland, OR and Michelle H Cameron, MD, PT, Neurology, VA Portland Health Care System, Portland, OR; Neurology, Oregon Health and Science University, Portland, OR

[194]

DA02

[198]

[194]

DA03

[198]

Scott D. Newsome, DO1, Thomas J Shoemaker, MD1, Sandra D Cassard, ScD1, Elizabeth Ogburn, PhD2, Jerry Prince, PhD3 and Ellen M Mowry, MD, MCR4, (1)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (2)Johns Hopkins School of Public Health, Baltimore, MD, (3)Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD, (4)Neurology, Johns Hopkins School of Medicine, Baltimore, MD

[194]

DA04

[198]

Kanika Sharma, MD1, Yubo Gao, PhD2, Junlin Liao, PhD3, John A Kamholz, MD, PhD1, Frank R Bittner, MD1 and Piyush Kalakoti, MD4, (1)Neurology, University of Iowa, Iowa City, IA, (2)Medicine, University of Iowa, Iowa City, IA, (3)Surgery, University of Iowa, Iowa City, IA, (4)University of Iowa, Iowa City, IA

[194]

DA05

[198]

Tatiana Wolfe, PhD1, Caio C Quini, PhD2, Philip J Horner, PhD2 and Ruchika S. Prakash, PhD1, (1)Department of Psychology, The Ohio State University, Columbus, OH, (2)Neuroregeneration – Regenerative Medicine, Houston Methodist Research Institute, Houston, TX

[194]

DA06

[198]

Kottil Rammohan, MD1, Anne Cross, MD2, David Jones, MD3, June Halper, MSN, ANP, FAAN4, Sara McCurdy Murphy, BA5, Lisa Patton, BA5, Edward J. Fox, MD, PhD6, Lori Mayer, DNP, MSN, RN, MSCN7 and Michael K Racke, MD8, (1)University of Miami, Miami, FL, (2)Washington University in St. Louis, St. Louis, MO, (3)UVA, Charlottesville, VA, (4)CEO-CMSC, Hackensack, NJ, (5)CRB, Social & Scientific Systems, Inc., Silver Spring, MD, (6)Central Texas Neurology Consultants, Round Rock, TX, (7)Central Texas Neurology Consultants,, Round Rock, TX, (8)Wexner Medical Center, Ohio State University, Columbus, OH

[194]

DA07

[198]

Farren B.S. Briggs, Ph.D. Sc.M.1, Justin Yu, MS(c) BS1, Jinghong Jiangyang, MS(c) B.S.1, Erica Utigard, DO2, Douglas D. Gunzler, Ph.D.1 and Daniel Ontaneda, MD3, (1)Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, (2)Department of Neurology, The Cleveland Clinic, Cleveland, OH, (3)Cleveland Clinic, Cleveland, OH

[194]

DA08

[198]

Julia O’Mahony, BSc1, Ruth Ann Marrie, MD, PhD2, Amit Bar-Or, MD3, E Ann Yeh, MD1 and Brenda Banwell, MD4, (1)Hospital for Sick Children, Toronto, ON, Canada, (2)University of Manitoba, Winnipeg, MB, Canada, (3)University of Pennsylvania, Philadelphia, PA, (4)Children’s Hospital of Philadelphia, Philadelphia, PA

[194]

DMT01

[198]

Carolyn H Goldschmidt, DO, Northshore University Healthsystem, Evanston, IL, Jordan Glassman, DO, Touro University College of Osteopathic Medicine, Henderson, NV, Brandon Ly, DO, Touro University College of Osteopathic Medicine,, Henderson, NV, Tucker Harvey, MS, Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH and Le H Hua, MD, Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV

[194]

DMT01

[198]

Bruce A.C. Cree, MD, PhD1, Ryan C. Ungaro, MD2, Jean-Frederic Colombel, MD2, Corey A. Siegel, MD, MS3, James K. Sheffield, MD4, John Vaile, PharmD4, Harris A. Ahmad, MD4, Ashwini Pai, MD4, Shabana Ather, MD4, Lorna Charles, MD4, AnnKatrin Petersen, MD4, Chun-Yen Cheng, PhD4, Sonia Afsari, MD4 and Krzysztof W. Selmaj, MD5, (1)Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, (2)Icahn School of Medicine at Mount Sinai, New York, NY, (3)Dartmouth-Hitchcock Medical Center, Lebanon, NH, (4)Bristol Myers Squibb, Princeton, NJ, (5)Center for Neurology, ?ód?, Poland, and Department of Neurology, University of Warmia & Mazury, Olsztyn, Poland

[194]

DMT02

[198]

Enrique Alvarez, MD1, Derrick Robertson, MD2, Daniel Wynn, MD3, Yihuan Xu, PhD4, Lily Lee, PhD4 and Sibyl Wray, MD5, (1)University of Colorado Anschutz Medical Campus, Aurora, CO, (2)Neurology, University of South Florida Morsani College of Medicine, Tampa, FL, (3)Consultants in Neurology MS Center, Northbrook, IL, (4)TG Therapeutics, New York, NY, (5)Hope Neurology MS Center, Knoxville, TN

[194]

DMT02

[198]

Xavier Montalban, MD PhD1, Jerry S Wolinsky, MD2, Douglas L Arnold, MD3,4, Martin S Weber, MD5, Ivan Staikov, MD PhD6, Karolina Piasecka-Stryczynska, PhD7, Davorka Tomic, PhD8, Emily C Martin, PhD9, Kristina H Holmberg, PhD9 and Hans Guehring, MD10, (1)Department of Neurology-Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d’Hebron, Barcelona, Spain, (2)McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, (3)Montreal Neurological Institute, McGill University, Montréal, QC, Canada, (4)NeuroRx Research, Montréal, QC, Canada, (5)Institute of Neuropathology and Department of Neurology, University Medical Center, University of Göttingen, Göttingen, Germany, (6)Department of Neurology, Acibadem City Clinic Tokuda Hospital, Sofia, Bulgaria, (7)Department of Neurology and Cerebrovascular Diseases, Pozna? University of Medical Sciences, Pozna?, Poland, (8)Ares Trading SA, an affiliate of Merck KGaA, Darmstadt, Germany, Eysins, Switzerland, (9)EMD Serono, Billerica, MA, (10)The healthcare business of Merck KGaA, Darmstadt, Germany

[194]

DMT03

[198]

Bruce A.C. Cree, MD1, Krzysztof W. Selmaj, MD, PhD, DSc2, Lawrence Steinman, MD3, Giancarlo Comi, MD4, Amit Bar-Or, MD5, Douglas L. Arnold, MD6, Hans-Peter Hartung, MD, FRCP, FEAN, FAAN, FANA7, Xavier Montalban, MD, PhD8, Eva Havrdova, MD, PhD9, James K. Sheffield, MD MBA MSMD10, Chun-Yen Cheng, MS10, Jon V. Riolo, MD10, Diego Silva, MD10, Ludwig Kappos, MD11 and Jeffrey A. Cohen, MD12, (1)Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, (2)Center for Neurology, Lodz, Poland, and Collegium Medicum, Department of Neurology, University of Warmia and Mazury, Olsztyn, Poland, (3)Department of Neurology and Neurological Sciences, Beckman Center for Molecular Medicine, Stanford University Medical Center, Stanford, CA, (4)Vita-Salute San Raffaele University and Casa di Cura del Policlinico, Milan, Italy, (5)Center for Neuroinflammation and Experimental Therapeutics, and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (6)NeuroRx Research and Montreal Neurological Institute, McGill University, Montreal, QC, Canada, (7)Department of Neurology, Palacky University Olomouc, Olomouc, Czech Republic, (8)Department of Neurology-Neuroimmunology, Centre d’Esclerosi Multiple de Catalunya (Cemcat), Hospital Universitario Vall d’Hebron, Barcelona, Spain, (9)Department of Neurology and Center for Clinical Neuroscience, First Medical Faculty, Charles University, Prague, Czech Republic, (10)Bristol Myers Squibb, Princeton, NJ, (11)Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, (12)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH

[194]

DMT03

[198]

Enrique Alvarez, MD, PhD, University of Colorado, Aurora, CO, Lawrence Steinman, MD, Beckman Center for Molecular Medicine, Stanford University Medical Center, Stanford, CA, Edward J Fox, MD, PhD, Central Texas Neurology Consultants, Multiple Sclerosis Clinic of Central Texas, Round Rock, TX, Hans-Peter Hartung, MD, Heinrich Heine University, Dusseldorf, Germany; Brain and Mind Centre, University of Sydney, Sydney, Australia; Department of Neurology, Medical University of Vienna, Vienna, Austria; Department of Neurology, Palacky University, Olomouc, Czech Republic, Peiqing Qian, MD, Swedish Medical Center, Seattle, WA, Sibyl Wray, MD, Hope Neurology, Knoxville, TN, Derrick Robertson, MD, University of South Florida, Tampa, FL, DeRen Huang, MD, PhD, Center for Multiple Sclerosis, Mount Carmel Health System, Westerville, OH, Krysztof Selmaj, MD, PhD, Center of Neurology, Lodz, Poland; Department of Neurology, University of Warmia & Mazury, Olsztyn, Poland, Daniel Wynn, MD, Consultants in Neurology MS Center, Northbrook, IL, Lily Lee, PhD, TG Therapeutics, New York, NY and Bruce A Cree, MD, PhD, MAS, UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA

[194]

DMT04

[198]

Xavier Montalban, MD, PhD, Department of Neurology-Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d’Hebron, Barcelona, Spain, Douglas L. Arnold, MD, Montreal Neurological Institute, Montreal, QC, Canada; NeuroRx Research, Montreal, QC, Canada, Martin S Weber, MD, Institute of Neuropathology and Department of Neurology, University Medical Center, University of Göttingen, Göttingen, Germany, Karolina Piasecka-Stryczynska, PhD, Department of Neurology and Cerebrovascular Diseases, Poznań University of Medical Sciences, Poznań, Poland, Davorka Tomic, PhD, Ares Trading SA, an affiliate of Merck KGaA, Darmstadt, Germany, Eysins, Switzerland, Anastasiia Kinkolykh, MD, Quartesian (a Veranex company), Princeton, NJ, Ying Li, MS, EMD Serono, Billerica, MA, Hans Guehring, MD, The healthcare business of Merck KGaA, Darmstadt, Germany, Enrique Alvarez, MD, PhD, MSCI, Department of Neurology, Rocky Mountain Multiple Sclerosis Center at the University of Colorado, Aurora, CO; Department of Neurology, University of Colorado, Aurora, CO and Jerry S Wolinsky, MD, Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX

[194]

DMT04

[198]

Jacqueline A Nicholas, MD, MPH1, Stephen L Hauser, PhD2, Anne H Cross, MD3, Kevin Winthrop, MD, MPH4, Heinz Wiendl, MD, MPH5, Sven G Meuth, MD, PhD6, Paul S Giacomini, MD7, Francesco Sacca, MD8, Ronald Zielman, MD, PhD9, Xixi Hu, PhD10, Ayan Das Gupta, Msc11, Roseanne Sullivan, PharmD10, Virginia DeLas Heras, MD12, Wendy Su, PhD10 and Ludwig Kappos, MD13, (1)OhioHealth Multiple Sclerosis Center, Columbus, OH, (2)UCSF Weill Institute for Neurosciences, University of California, San Francisco, CA, (3)Washington University School of Medicine, Saint Louis, MO, (4)Public Health and Preventive Medicine, Division of Infectious Diseases, Oregon Health and Sciences University, Portland, OR, (5)University of Muenster, Muenster, Germany, (6)Department of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany, (7)Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada, (8)NSRO Department, University “Federico II” of Naples, Naples, Italy, (9)Novartis Pharma B.V., Amsterdam, Netherlands, (10)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (11)Novartis Healthcare Pvt. Ltd, Hyderabad, India, (12)Novartis Pharma AG, Basel, Switzerland, (13)Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) and MS Center, Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland

[194]

DMT05

[198]

Anthony Traboulsee, MD1, Ingo Kleiter, MD, DM2, Jacqueline Palace, DM3, Kazuo Fujihara, MD4, Albert Saiz, MD, PhD5, Ivana Vodopivec, MD, PhD6, Gaelle Klingelschmitt, MSc6, Carole Marcillat, PharmD6 and Jeffrey L Bennett, MD, PhD7, (1)University of British Columbia, Vancouver, BC, Canada, (2)Ruhr University Bochum, Bochum, Germany, (3)John Radcliffe Hospital, Oxford, United Kingdom, (4)Fukushima Medical University School of Medicine, Fukushima, Japan, (5)Service of Neurology, Hospital Clinic and Institut d’Investigacio Biomedica August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain, (6)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (7)University of Colorado School of Medicine, Aurora, CO

[194]

DMT05

[198]

Jerry S Wolinsky, MD1, Hans-Peter Hartung, MD2,3, Stephen L. Hauser, MD4, Robert T. Naismith, MD5, Hans-Martin Schneble, MD6, Ben Townsend, PhD6, Qing Wang, PhD6 and Ludwig Kappos, PhD7, (1)McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, (2)Department of Neurology, UKD, Center of Neurology and Neuropsychiatry and LVR-Klinikum, Heinrich Heine University Düsseldorf, Düsseldorf, Germany, (3)Brain and Mind Centre, University of Sydney, Sydney, Australia, (4)UCSF Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, (5)Washington University School of Medicine, St. Louis, MO, (6)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (7)Research Center for Clinical Neuroimmunology and Neuroscience, University Hospital Basel, University of Basel, Basel, Switzerland

[194]

DMT06

[198]

Cody Gurski, BS1, Zivar Hajiyeva, MD, Ph.D.1, Kaylan Fenton, APNP2, Samantha O’Dell, BA2, Bonnie N Dittel, PhD1,3 and Ahmed Z Obeidat, MD, PhD2, (1)Versiti Blood Research Institute, Milwaukee, WI, (2)Neurology, Medical College of Wisconsin, Milwaukee, WI, (3)Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI

[194]

DMT06

[198]

Riley Bove, MD1, Noemi Pasquarelli, MSc, PhD2, Marina Gafarova, MD, PhD3, Christine Eighteen, MBA2, Natalie Joschko, PhD4, Corey Mandel, PhD5 and Ruth Dobson, PhD, FRCP6, (1)Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, (2)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (3)Roche Moscow JSC, Moscow, Russian Federation, (4)Roche Pharma AG, Grenzach-Wyhlen, Germany, (5)Genentech, Inc., San Francisco, CA, (6)Preventative Neurology Unit, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom

[194]

DMT07

[198]

Alexander Keenan, MA, MHP1, Kavita Gandhi, MS2, Hoa H. Le, PhD3, Ibrahim Turkoz, PhD4, Shien Guo, PhD5, Weiqin Liao, MPH, MS5 and Christopher Pelligra, MSc6, (1)Janssen Scientific Affairs, LLC, Titusville, NJ, (2)Janssen Global Market Access, LLC, Titusville, NJ, (3)Real World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, NJ, (4)Clinical Biostatistics, Janssen Research & Development, LLC, Titusville, NJ, (5)Evidera, Waltham, MA, (6)Evidera, Medellin, Colombia

[194]

DMT07

[198]

Camila Ishueva, BS1, Michelle Maynard, PharmD, BCPS2 and Ahmed Z Obeidat, MD, PhD1, (1)Neurology, Medical College of Wisconsin, Milwaukee, WI, (2)Neurosciences, Froedtert and the Medical College of Wisconsin, Milwaukee, WI

[194]

DMT08

[198]

David M. Kern, PhD, Janssen Research & Development, LLC, Titusville, NJ, Hoa H. Le, PhD, Real World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, NJ, Maria Ait-Tihyaty, PhD, Janssen Global Medical Affairs, LLC, Titusville, NJ and Alexander Keenan, MA, MHP, Janssen Scientific Affairs, LLC, Titusville, NJ

[194]

DMT08

[198]

[194]

DMT08

[198]

Alexander Keenan, MS, MHP1, Chiara Whichello, PhD2, Matt Quaife, PhD2, David M. Kern, PhD3, Gabriela Fernandez, PhD4, Vicky Turner, PhD2, Hoa H. Le, PhD5 and Amy Perrin Ross, APN, MSN, CNRN, MSCN6, (1)Janssen Scientific Affairs, Janssen Pharmaceuticals, Titusville, NJ, (2)Evidera, London, United Kingdom, (3)Janssen Research & Development, LLC, Titusville, NJ, (4)Evidera, Bethesda, MD, (5)Real World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, NJ, (6)Loyola University Chicago, Chicago, IL

[194]

DMT09

[198]

Allitia DiBernardo, MD1, Ibrahim Turkoz, PhD2, Michael Kutch, MS2 and Maria Ait-Tihyaty, PhD1, (1)Global Medical Affairs, Janssen Research & Development, LLC, Titusville, NJ, (2)Clinical Biostatistics, Janssen Research & Development, LLC, Titusville, NJ

[194]

DMT09

[198]

Alexander J. Keenan, MA, MHP, Ibrahim Turkoz, PhD, Robert Murray, MS and Maria Ait Tihyaty, PhD, Janssen Research & Development, Titusville, NJ

[194]

DMT09

[198]

Aliza B. Ben-Zacharia, PhD, DNP, ANP, FAAN1,2, Jenny Feng, MD3, Brandon Moss, MD4, Nick Belviso, PhD5, Yu Zhang, MSc5, Filipe Branco, MSc6, Jason P. Mendoza, PhD5, James B. Lewin, PharmD5 and Sarah M. England, PhD5, (1)Phillips School of Nursing at Mount Sinai, New York, NY, (2)Hunter College, New York, NY, (3)Ochsner Medical Center, New Orleans, LA, (4)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, (5)Biogen, Cambridge, MA, (6)Biogen, Baar, Switzerland

[194]

DMT10

[198]

Amber Salter, PhD1, Samantha Lancia, MS2, Ruth Ann Marrie, MD, PhD3, Gary R Cutter, PhD4, Robert J Fox, MD5, Sarah M England, PhD6, Shivani Kapadia, PharmD, RPh6, Sai L Shankar, PhD6 and James B Lewin, PharmD6, (1)Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, (2)Department of Biostatistics, UT Southwestern Medical Center, Dallas, TX, (3)Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada, (4)Biostatistics, University of Alabama at Birmingham, Birmingham, AL, (5)Mellen Center for Treatment and Research in Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, (6)Biogen, Cambridge, MA

[194]

DMT10

[198]

Alexander Keenan, MD1, Ibrahim Turkoz, PhD1, Robert Murray, MS2 and Maria Ait Tihyaty, PhD1, (1)Janssen Research & Development, Titusville, NJ, (2)Janssen Research & Development LLC, High Wycombe, NJ, United Kingdom

[194]

DMT10

[198]

Amparo Gutierrez, MD FAAN FANA1, Deborah Chandler, ARNP DNP1 and Andreina Neall, ARNP2, (1)Neurology, Orlando Health, Orlando, FL, (2)Orlando Health, Orlando, FL

[194]

DMT11

[198]

Amit Bar-Or, MD1, Kevin Winthrop, MD, MPH2, Heinz Wiendl, MD, MPH3, David Paling, MB ChB, MRCP, PhD4, Tobias Sejbaek, MD, PhD5,6, Carlo Pozzilli, MD, PhD7, Celine Louapre, MD, PhD8, Wendy Su, PhD9, Virginia DeLasHeras, MD10, Ronald Zielman, MD, PhD11, Roseanne Sullivan, PharmD9, Ayan Das Gupta, MSc12, Xixi Hu, PhD9 and Anne H. Cross, MD13, (1)Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (2)Public Health and Preventive Medicine, Division of Infectious Diseases, Oregon Health and Sciences University, Portland, OR, (3)University of Muenster, Muenster, Germany, (4)Department of Neurology, Royal Hallamshire Hospital, Sheffield, United Kingdom, (5)Department of Neurology, Hospital Southwest Jutland, University Hospital of Southern Denmark, Esbjerg, Denmark, (6)Department of Regional Health Research, University of Southern Denmark, Odense, Denmark, (7)Department of Human Neuroscience, La Sapienza University, Rome, Italy, (8)Institut du cerveau, ICM, Sorbonne université, hôpital de la Pitié-Salpêtrière, INSERM UMR S 1127, CNRS UMR 7225, Paris, France, (9)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (10)Novartis Pharma AG, Basel, Switzerland, (11)Novartis Pharma B.V., Amsterdam, Netherlands, (12)Novartis Healthcare Pvt. Ltd, Hyderabad, India, (13)Department of Neurology, Washington University in St. Louis, St. Louis, MO

[194]

DMT11

[198]

Amanda Hickman, PharmD, MPH, MSCS, Central Support Team, Trellis Rx, Atlanta, GA

[194]

DMT11

[198]

Amro Elrefaei, MD, Mokshal H Porwal, BSc and Ahmed Z Obeidat, MD, PhD, Neurology, Medical College of Wisconsin, Milwaukee, WI

[194]

DMT12

[198]

Amit Bar-Or, MD1, Yang Mao-Draayer, MD, PhD2, Silvia R Delgado, MD3, Robert J Fox, MD4, Linda-Ali Cruz, MD5, Xiangyi Meng, PhD5, Gina Mavrikis Cox, PhD5 and Stanley L Cohan, MD, PhD6, (1)Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (2)Autoimmunity Center of Excellence, Multiple Sclerosis Center, University of Michigan, Ann Arbor, MI, (3)Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, (4)Cleveland Clinic, Cleveland, OH, (5)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (6)Providence Multiple Sclerosis Center, Providence Brain Institute, Portland, OR

[194]

DMT12

[198]

[194]

DMT12

[198]

Amy Perrin Ross, APN, MSN, CNRN, MSCN1, Thomas Berger, MD, MSc2, Robert A. Bermel, MD3, Mark S Freedman, HBSc, MSc, MD, CSPQ, FANA, FAAN, FRCPC4, Trygve Holmøy, MD, PhD5,6, Francesco Patti, MD, PhD7, Inessa Kulyk, MD, MBA8, Karen Kadner, MD, PhD8, Thomas Kuenzel, PhD8 and Hans-Peter Hartung, MD, FRCP, FEAN, FAAN, FANA9,10,11, (1)Loyola University Chicago, Chicago, IL, (2)Department of Neurology, Medical University of Vienna, Vienna, Austria, (3)Mellen Center for MS, Department of Neurology, Cleveland Clinic, Cleveland, OH, (4)University of Ottawa and the Ottawa Hospital Research Institute, Ottawa, ON, Canada, (5)Institute of Clinical Medicine, University of Oslo, Oslo, Norway, (6)Department of Neurology, Akershus University Hospital, Lørenskog, Norway, (7)Department of Medical and Surgical Sciences and Advanced Technologies, GF Ingrassia, Neuroscience Section and Multiple Sclerosis Centre, University of Catania PO Policlinico G Rodolico, Catania, Italy, (8)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (9)Department of Neurology, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany, (10)Department of Neurology, Medical University Vienna, Vienna, Austria, (11)Brain and Mind Centre, University of Sydney, Sydney, Australia

[194]

DMT13

[198]

Deborah Chandler, ARNP DNP1, Amparo Gutierrez, MD FAAN1 and Orlando Health, (1)Neurology, Orlando Health, Orlando, FL

[194]

DMT13

[198]

Anne H. Cross, MD1, Silvia Delgado, MD2, Mario Habek, MD3, Maria Davydovskaya, PhD4, Natalia Totolyan, MD5, Ratnakar Pingili, MBBS6, Linda Mancione, BA6, Roseanne Sullivan, PharmD6, Martin Zalesak, MD, PhD7, Wendy Su, PhD8, Krishnan Ramanathan, PhD7, Xavier Montalban, MD, PhD9 and Kevin Winthrop, MD MPH10, (1)Neurology, Washington University School of Medicine, St Louis, MO, (2)Neurology, University of Miami Miller School of Medicine, Miami, FL, (3)University Hospital Center Zagreb, University of Zagreb, School of Medicine, Zagreb, Croatia, (4)Pirogov Russian National Research Medical University, Moscow, Russian Federation, (5)National Medical University, St Petersburg, Russian Federation, (6)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (7)Novartis Pharma AG, Basel, Switzerland, (8)Autoimmune, TG Therapeutics, Inc, New York, NY, (9)Vall d’Hebron University Hospital, Barcelona, Spain, (10)School of Public Health at Oregon Health & Science University, Portland, OR

[194]

DMT13

[198]

Amy Perrin Ross, APN, MSN, CNRN, MSCN1, Joep Killestein, MD, PhD2, Thomas Berger, MD, MSc3, Robert A. Bermel, MD4, Bruno Brochet, MD5, William M Carroll, AO, AM, MBBS, MD, FRACP, FRCP6, Mark S Freedman, MSc, MD7, Trygve Holmøy, MD, PhD8,9, Rana Karabudak, Prof., MD10, Carlos Nos, MD11, Francesco Patti, MD, PhD12, Ludo Vanopdenbosch, MD13, Timothy Vollmer, PhD14, Regine Buffels, MD15, Karen Kadner, MD, PhD15, Oscar Bortolami, PhD15, Hans-Peter Hartung, MD, FRCP, FEAN, FAAN, FANA16,17,18,19 and on behalf of the ENSEMBLE Investigators and Steering Committee, (1)Loyola University Chicago, Chicago, IL, (2)Department of Neurology, VU University Medical Centre, Amsterdam, Netherlands, (3)Department of Neurology, Medical University of Vienna, Vienna, Austria, (4)Mellen Center for MS, Department of Neurology, Cleveland Clinic, Cleveland, OH, (5)University of Bordeaux, Bordeaux, France, (6)Department of Neurology, Sir Charles Gairdner Hospital, Perron Institute for Neurological and Translational Science, the University of Western Australia, Nedlands, Australia, (7)Department of Medicine and the Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada, (8)Institute of Clinical Medicine, University of Oslo, Oslo, Norway, (9)Department of Neurology, Akershus University Hospital, Lørenskog, Norway, (10)Department of Neurology, Hacettepe University Faculty of Medicine, Ankara, Turkey, (11)Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Vall d’Hebron Hospital Universitari, Barcelona, Spain, (12)Department of Medical and Surgical Sciences and Advanced Technologies, GF Ingrassia, Neuroscience Section and Multiple Sclerosis Centre, University of Catania PO Policlinico G Rodolico, Catania, Italy, (13)Department of Neurology, AZ Sint-Jan Brugge-Oostende, Brugge, Belgium, (14)Department of Neurology, University of Colorado School of Medicine, Aurora, CO, (15)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (16)Department of Neurology, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany, (17)Department of Neurology, Palacky University Olomouc, Olomouc, Czech Republic, (18)Research Centre for Clinical Neuroimmunology and Neuroscience, University Hospital Basel, University of Basel, Basel, Switzerland, (19)Brain and Mind Centre, University of Sydney, Sydney, Australia

[194]

DMT14

[198]

Bruce A.C. Cree, MD1, Krzysztof W. Selmaj, MD2, Lawrence Steinman, MD3, Giancarlo Comi, MD4, Amit Bar-Or, MD5, Douglas L. Arnold, MD6, Hans-Peter Hartung, MD7,8,9,10, Xavier Montalban, MD, PhD11, Eva K Havrdova, MD, PhD12, James K. Sheffield, MD, MBA, MS13, Neil Minton, MD FFPM13, Chun-Yen Cheng, PhD13, Diego Silva, MD13, Ludwig Kappos, MD14 and Jeffrey A Cohen, MD15, (1)Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, (2)Center for Neurology, ?ód?, Poland and Collegium Medicum, Department of Neurology, University of Warmia and Mazury, Olsztyn, Poland, (3)Beckman Center for Molecular Medicine, Stanford University Medical Center, Stanford, CA, (4)Vita-Salute San Raffaele University and Casa di Cura del Policlinico, Milan, Italy, (5)Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (6)NeuroRx Research and Montréal Neurological Institute, McGill University, Montreal, QC, Canada, (7)Heinrich-Heine University, Düsseldorf, Germany, (8)Brain and Mind Center, University of Sydney, Sydney, NSW, Australia, (9)Medical University of Vienna, Vienna, Austria, (10)Palacky University Olomouc, Olomouc, Czech Republic, (11)Department of Neurology-Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d’Hebron, Barcelona, Spain, (12)Department of Neurology and Center for Clinical Neuroscience, First Medical Faculty, Charles University, Prague, Czech Republic, (13)Bristol Myers Squibb, Princeton, NJ, (14)Research Center for Clinical Neuroimmunology and Neuroscience, Departments of Medicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, (15)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH

[194]

DMT14

[198]

Benjamin Greenberg, MD1, Dewei She, Ph.D.2, Eliezer Katz, M.D.2 and Bruce A.C. Cree, MD, PhD, MAS3, (1)Department of Neurology, University of Texas Southwestern, Dallas, TX, (2)Viela Bio, Gaithersburg, MD, (3)Department of Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA

[194]

DMT14

[198]

Anna S. Blazier, PhD1, Gregory Wirak, PhD1, Pavithra Krishnaswami, MSc1, Mikhail Levit, PhD1, Dimitry Ofengheim, PhD1, Timothy J. Turner, PhD1, Steven Jacobson, PhD2 and Daniel S. Reich, MD, PhD2, (1)Sanofi, Cambridge, MA, (2)National Institute of Neurological Disorders and Stroke, Bethesda, MD

[194]

DMT15

[198]

Chris M Kozma, PhD1, Emily Evans, MD, MBE2, Lori A Lebson, PhD3, Amy L Phillips, PharmD4 and Carroline Lobo, PhD4, (1)CK Consulting Associates, LLC, Saint Helena Island, SC, (2)Neurology and Immunology, EMD Serono, Rockland, MA, (3)EMD Serono, Rockland, MA, (4)North American Evidence and Value Development, EMD Serono, Rockland, MA

[194]

DMT15

[198]

Bruce A.C. Cree, MD, PhD, MAS1, Gavin Giovannoni, MD, PhD2, Ralf Gold, MD3, Robert J. Fox, MD4, Patrick Vermersch, MD, PhD5, Ralph H.B. Benedict, PhD6, Amit Bar-Or, MD7, Nicolas Rouyrre, MSc8, Daniela Piani-Meier, PhD8, Shannon Ritter, MS9, Ajay Kilaru, MBBS8, Frank Dahlke, MD8, Goeril Karlsson, PhD8 and Ludwig Kappos, MD10, (1)Department of Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, (2)Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, (3)Department of Neurology, St Josef-Hospital, Ruhr-University Bochum, Bochum, Germany, (4)Mellen Center for Treatment and Research in Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, OH, (5)Univ. Lille, Inserm U1172, CHU Lille, FHU Precise, Lille, France, (6)Jacobs Multiple Sclerosis Center, University at Buffalo, Buffalo, NY, (7)Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (8)Novartis Pharma AG, Basel, Switzerland, (9)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (10)Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland

[194]

DMT15

[198]

Edward Li, PharmD MS, HEOR, Sandoz Inc, Princeton, NJ, Adrian Goh, M.Econ, V&A-Economic modeling, Novartis Corporation Sdn Bhd, Selangor, Malaysia, Soni Gupta, M.Econ, V&A, Novartis Healthcare Pvt. Ltd, Hyderabad, India, Anna Chen, PharmD, MSc, Associate Director HEOR/RWE, Sandoz inc, Princeton, NJ, Marion Schauf, Dipl.-Kff., Franchise Launches Biopharma, Sandoz International GmbH, Holzkirchen, Germany and Daniel Hartung, PharmD, MPH, College of Pharmacy,, Oregon State University, Portland, OR

[194]

DMT16

[198]

Daniel Sellers, MSCS, PA-C, Donald Negroski, MD, Amir Khiabani, DO and Devon Khiabani, DO, MS Center of Sarasota, Sarasota, FL

[194]

DMT16

[198]

Calin Dumitrescu, Medical Student Scholar, Neurology, Medical College of Wisconsin, Milwaukee, WI, Amber Salter, PhD, Biostatistics, Washington University in St. Louis, St. Louis, MO, Michelle Maynard, PharmD, BCPS, Neurosciences, Froedtert and the Medical College of Wisconsin, Milwaukee, WI and Ahmed Z Obeidat, MD, PhD, Department of Neurology, Medical College of Wisconsin, Milwaukee, WI

[194]

DMT16

[198]

Amit Bar-Or, MD1, Anne H. Cross, MD2, Anthony Cunningham, AO FAHMS3, Yann Hyvert, PhD4, Andrea Seitzinger, PhD4, Elise E. Drouin, PhD5, Nektaria Alexandri, MD, MSc6, Davorka Tomic, PhD7 and Xavier Montalban, MD PhD8, (1)Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (2)Washington University School of Medicine, St. Louis, MO, (3)The Westmead Institute for Medical Research, Director Centre for Virus Research, Sydney, Australia, (4)The healthcare business of Merck KGaA, Darmstadt, Germany, (5)EMD Serono, Billerica, MA, (6)The healthcare business of Merck KGaA,, Darmstadt, Germany, (7)Ares Trading SA, an affiliate of Merck KGaA, Darmstadt, Germany, Eysins, Switzerland, (8)Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d’Hebron, Barcelona, Spain

[194]

DMT17

[198]

Douglas L Arnold, MD1, Colm Elliott, MD1, Xavier Montalban, MD PhD2, Emily C Martin, PhD3, Yann Hyvert, PhD4 and Davorka Tomic, PhD4, (1)NeuroRx Research, Montréal, QC, Canada, (2)Department of Neurology-Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d’Hebron, Barcelona, Spain, (3)EMD Serono, Billerica, MA, (4)The healthcare business of Merck KGaA, Darmstadt, Germany

[194]

DMT17

[198]

[194]

DMT17

[198]

Anthony Krakovich, MD, MPH1, Giancarlo Comi, MD2, Marla C. Dubinsky, MD3, Uma Mahadevan, MD4, Lorna Charles, MD1, C. Janneke van der Woude, MD, PhD5 and Krzysztof W. Selmaj, MD, PhD, DSc6, (1)Bristol Myers Squibb, Princeton, NJ, (2)Vita-Salute San Raffaele University and Casa di Cura del Policlinico, Milan, Italy, (3)Icahn School of Medicine at Mount Sinai, New York, NY, (4)Gastroenterology Division, Department of Medicine, University of California San Francisco, San Francisco, CA, (5)Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, Netherlands, (6)Center for Neurology, Lodz, Poland, and Collegium Medicum, Department of Neurology, University of Warmia and Mazury, Olsztyn, Poland

[194]

DMT18

[198]

Jens Kuhle, MD PhD1, Ludwig Kappos, MD2, Xavier Montalban, MD PhD3, Ying Li, MS4, Karthinathan Thangavelu, PhD4, Yann Hyvert, PhD5 and Davorka Tomic, PhD5, (1)Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, and University of Basel, Basel, Switzerland, (2)Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel, and University of Basel, Basel, Switzerland, (3)Department of Neurology-Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d’Hebron, Barcelona, Spain, (4)EMD Serono, Billerica, MA, (5)The healthcare business of Merck KGaA, Darmstadt, Germany

[194]

DMT18

[198]

Chinmay Deshpande, PhD, BPharm1, Mengru Wang, MS2, Roshani Shah, MPH3, Yutong Chang, MS2, Fei Yang, PhD1, Wing Chow, PharmD, MPH1 and Gina M Cox, PhD1, (1)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (2)KMK Consulting, Inc., Morristown, NJ, (3)Previously employed by Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, NJ

[194]

DMT18

[198]

Anthony Traboulsee, MD1, Robert J. Fox, MD2, Douglas L. Arnold, MD3, Sana Syed, MD, MPH4, Larry Orogun, MD, MSc4, Deborah Dukovic, MS5, Timothy J. Turner, PhD4, Daniel S. Reich, MD, PhD6 and Jiwon Oh, MD, PhD7, (1)University of British Columbia, Vancouver, BC, Canada, (2)Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, (3)NeuroRx Research and Montreal Neurological Institute, McGill University, Montreal, QC, Canada, (4)Sanofi, Cambridge, MA, (5)Sanofi, Bridgewater, NJ, (6)National Institute of Neurological Disorders and Stroke, Bethesda, MD, (7)St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada

[194]

DMT19

[198]

Derrick Robertson, MD, University of South Florida, Tampa, FL, Lawrence Steinman, MD, Beckman Center for Molecular Medicine, Stanford University Medical Center, Stanford, CA, Edward J Fox, MD, PhD, Central Texas Neurology Consultants, Round Rock, TX, Hans-Peter Hartung, MD, Heinrich Heine University, Dusseldorf, Germany; Department of Neurology, Medical University of Vienna, Vienna, Austria; Brain and Mind Centre, University of Sydney, Sydney, Australia; Department of Neurology, Palacky University, Olomouc, Czech Republic, Enrique Alvarez, MD, PhD, University of Colorado, Aurora, CO, Peiqing Qian, MD, Swedish Medical Center, Seattle, WA, Sibyl Wray, MD, Hope Neurology, Knoxville, TN, DeRen Huang, MD, PhD, Center for Multiple Sclerosis, Mount Carmel Health System, Westerville, OH, Krysztof Selmaj, MD, PhD, Center of Neurology, Lodz, Poland; Department of Neurology, University of Warmia & Mazury, Olsztyn, Poland, Daniel Wynn, MD, Consultants in Neurology MS Center, Northbrook, IL, Koby Mok, PhD, TG Therapeutics, New York, NY, Christopher A Garner, PA-C, TG Therapeutics Inc, New York, NY and Bruce A Cree, MD, PhD, MAS, UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA

[194]

DMT19

[198]

Daniel Kantor, MD1, Timothy Pham, MS2, Xiu Chen, PhD2, Mayank Mittal, PhD2 and Qian Xia, PhD2, (1)Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, (2)Bristol Myers Squibb, Princeton, NJ

[194]

DMT19

[198]

Daniel S. Reich, MD, PhD1, Anthony Traboulsee, MD2, Sana Syed, MD, MPH3, Zhixing Xu, PhD4, Timothy J. Turner, PhD3 and Douglas L. Arnold, MD5,6, (1)National Institute of Neurological Disorders and Stroke, Bethesda, MD, (2)University of British Columbia, Vancouver, BC, Canada, (3)Sanofi, Cambridge, MA, (4)Sanofi, Bridgewater, NJ, (5)NeuroRx Research and Montreal Neurological Institute, McGill University, Montreal, QC, Canada, (6)NeuroRx Research, Montreal, QC, Canada

[194]

DMT20

[198]

Derrick Robertson, MD, College of Medicine, Neurology, University of South Florida, Tampa, FL, Stephen L Hauser, PhD, UCSF Weill Institute for Neurosciences, University of California, San Francisco, CA, Edward J Fox, MD, PhD, Central Texas Neurology Consultants, University of Texas Medical Branch, Round Rock, TX, Ludwig Kappos, MD, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) and MS Center, Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Jeffrey A Cohen, MD, Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, Angela Aungst, MPH, Multiple Sclerosis Division Department of Neurology University of South Florida, Florida, FL, Wendy Su, PhD, Novartis Pharmaceuticals Corporation, East Hanover, NJ, Ronald Zielman, MD, PhD, Novartis Pharma B.V., Amsterdam, Netherlands, Jing Xi, PhD, China Novartis Institutes For Biomedical Research Co., Ltd., Shanghai, China, Ayan Das Gupta, MSc, Novartis Healthcare Pvt. Ltd., Hyderabad, India and Dee Stoneman, MPharm, Novartis Pharma AG, Basel, Switzerland

[194]

DMT20

[198]

Daniel Kantor, MD, Florida Atlantic University, Boca Raton, FL

[194]

DMT20

[198]

Autumn Ramsrud, PharmD, CSP, MSCS, Tyler Cress, PharmD, MSCS, Katherine Gwin, RN, BSN, MSCS, MSCN, Kaelianne Newbold, RN, BSN, MSCS, MSCN, Cindy Smith, PharmD, CSP, Angie Critchfield, CPhT and Nina Bozinov, MD, MS, Neurology, Kootenai Clinic, Coeur d’Alene, ID

[194]

DMT21

[198]

Giordano Gentile, MSc1,2, Rozemarijn Mattiesing, MSc3, Iman Brouwer, MASc3, Dominic Jack, PhD4, Frederik Barkhof, MD, PhD3,5, Nicola De Stefano, MD, PhD1, Bernard MJ Uitdehaag, MD, PhD6, Hugo Vrenken, PhD3 and Marco Battaglini, PhD1,2, (1)Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy, (2)SIENA imaging SRL, Siena, Italy, (3)Department of Radiology and Nuclear Medicine, MS Center Amsterdam, Amsterdam, Netherlands, (4)Merck Serono Ltd, Feltham, UK, an affiliate of Merck KGaA, Darmstadt, Germany, Feltham, United Kingdom, (5)Institutes of Neurology and Healthcare Engineering, UCL London, London, United Kingdom, (6)Department of Neurology, MS Center Amsterdam, Amsterdam, Netherlands

[194]

DMT21

[198]

Daniel Kantor, MD, Florida Atlantic University, Boca Raton, FL

[194]

DMT21

[198]

Bruce A.C. Cree, MD1, Silvio Danese, MD2, Douglas C. Wolf, MD3, Olga Alekseeva, MD4, Lorna Charles, MD5, AnnKatrin Petersen, MD5, James K. Sheffield, MD MBA MSMD5, Chun-Yen Cheng, MS5, Jon V. Riolo, MD5, Diego Silva, MD5, Fred D. Lublin, MD6, David T. Rubin, MD7 and Jeffrey A. Cohen, MD8, (1)Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, (2)Humanitas University, Milan, Italy, (3)Atlanta Gastroenterology Associates, LLC, Atlanta, GA, (4)Nizhegorodskaya Regional Clinical, Nizhegorodskaya oblast’, Russian Federation, (5)Bristol Myers Squibb, Princeton, NJ, (6)Mount Sinai Medical Center, New York, NY, (7)University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, IL, (8)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH

[194]

DMT22

[198]

Rozemarijn Mattiesing, MSc1, Giordano Gentile, MSc2,3, Iman Brouwer, MASc1, Dominic Jack, PhD4, Frederik Barkhof, MD, PhD1,5, Nicola De Stefano, MD, PhD2, Bernard MJ Uitdehaag, MD, PhD6, Jos WR Twisk, PhD7, Marco Battaglini, PhD2,3 and Hugo Vrenken, PhD1, (1)Department of Radiology and Nuclear Medicine, MS Center Amsterdam, Amsterdam, Netherlands, (2)Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy, (3)SIENA imaging SRL, Siena, Italy, (4)Merck Serono Ltd, Feltham, UK, an affiliate of Merck KGaA, Darmstadt, Germany, Feltham, United Kingdom, (5)Institutes of Neurology and Healthcare Engineering, UCL London, London, United Kingdom, (6)Department of Neurology, MS Center Amsterdam, Amsterdam, Netherlands, (7)Department of Epidemiology and Data Science, Amsterdam UMC, Amsterdam, Netherlands

[194]

DMT22

[198]

Augusto A Miravalle, M.D., Advanced Neurology of Colorado, University of Colorado, Fort Collins, CO, Jacob A Sloane, MD PhD, BIDMC Department of Neurology, Harvard Medical School, Boston, MA, Julie Aldridge, MS, EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany, Billerica, MA, Danielle E Harlow, PhD, EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany, Rockland, MA and Joshua D Katz, M.D., The Elliot Lewis Center for Multiple Sclerosis Care, Wellesley, MA

[194]

DMT22

[198]

Carole Drexel, PhD, PlatformQ Health Education, Needham, MA, Emily Bixler, MBA, PlatformQ Health, Needham, MA, Robert K Shin, MD, Georgetown University Medical Center, Washington, DC, Lilyana Amezcua, MD, MS, Keck School of Medicine, University of Southern California, Los Angeles, CA and June Halpert, MSN, APN-C, MSCN, FAAN, Consortium of Multiple Sclerosis Centers, Hackensack, NJ

[194]

DMT23

[198]

Edward J Fox, MD, PhD, Central Texas Neurology Consultants, Round Rock, TX, Lawrence Steinman, MD, Beckman Center for Molecular Medicine, Stanford University Medical Center, Stanford, CA, Hans-Peter Hartung, MD, Heinrich Heine University, Dusseldorf, Germany; Department of Neurology, Medical University of Vienna, Vienna, Austria; Department of Neurology, Palacky University, Olomouc, Czech Republic; Brain and Mind Centre, University of Sydney, Sydney, Australia, Enrique Alvarez, MD, PhD, University of Colorado, Aurora, CO, Peiqing Qian, MD, Swedish Medical Center, Seattle, WA, Sibyl Wray, MD, Hope Neurology, Knoxville, TN, Derrick Robertson, MD, University of South Florida, Tampa, FL, DeRen Huang, MD, PhD, Center for Multiple Sclerosis, Mount Carmel Health System, Westerville, OH, Krysztof Selmaj, MD, PhD, Center of Neurology, Lodz, Poland; Department of Neurology, University of Warmia & Mazury, Olsztyn, Poland, Daniel Wynn, MD, Consultants in Neurology MS Center, Northbrook, IL, Koby Mok, PhD, TG Therapeutics, New York, NY, Denise Campagnolo, MD, TG Therapeutics Inc, New York, NY and Bruce A Cree, MD, PhD, MAS, UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA

[194]

DMT23

[198]

Dean Wingerchuk, M.D.1, Achim Berthele, MD2, Kazuo Fujihara, MD3,4,5, Celia Oreja-Guevara, MD6, Ho Jin Kim, MD, PhD7, Michael Levy, MD, PhD8,9, Ichiro Nakashima, MD, PhD4,10, Jacqueline Palace, DM11, Shulian Shang, PhD12, Marcus Yountz, MD12, Larisa Miller, PharmD12 and Sean J Pittock, M.D.13, (1)Mayo Clinic, Scottsdale, AZ, (2)Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany, (3)Southern TOHOKU Research Institute for Neuroscience (STRINS), Koriyama, Japan, (4)Tohoku University, Sendai, Japan, (5)Fukushima Medical University, Fukushima City, Japan, (6)Hospital Universitario Clinico San Carlos, Madrid, Spain, (7)Research Institute and Hospital, National Cancer Center, Goyang, Korea, Republic of (South), (8)Massachusetts General Hospital and Harvard Medical School, Boston, MA, (9)Johns Hopkins University, Baltimore, MD, (10)Tohoku Medical and Pharmaceutical University, Sendai, Japan, (11)John Radcliffe Hospital, Oxford, United Kingdom, (12)Alexion Pharmaceuticals, Boston, MA, (13)Mayo Clinic, Rochester, MN

[194]

DMT23

[198]

Caroline K Geiger, PhD, Daniel Sheinson, PhD, Tu My To, PhD, MPH, David E Jones, MD and Nicole G Bonine, PhD, MPH, Genentech, Inc., South San Francisco, CA

[194]

DMT24

[198]

Elizabeth A Douglas, MPH, Isabella O’Shea, B.S., Andrew J Bouley, M.D., Joshua D Katz, M.D. and Ellen S Lathi, M.D., The Elliot Lewis Center for Multiple Sclerosis Care, Wellesley, MA

[194]

DMT24

[198]

Denise R. Bruen, MSN1, Meghan Garabedian, CRNP, MSN, MSCN2, Cortnee Roman, MSN, FNP-BC3, Nicholas W. Robinson, MA4, Virginia R. Schobel, MSc4, Jason P. Mendoza, PhD5, James B. Lewin, PharmD5, Mary Zhang, PharmD5 and Sai L. Shankar, PhD5, (1)University of Virginia Neuroscience, Charlottesville, VA, (2)Neurology, Penn Neuroscience Center, Perelmen Center for Advanced Medicine, Philadelphia, PA, (3)Rocky Mountain Multiple Sclerosis Clinic and Research Group, Salt Lake City, UT, (4)Spherix Global Insights, Exton, PA, (5)Biogen, Cambridge, MA

[194]

DMT24

[198]

Kerstin Hellwig, MD, Department of Neurology, St Josef Hospital, Ruhr University, Bochum, Germany, Hugh H Tilson, MD, UNC Gillings School of Global Public Health, Chapel Hill, NC, Joerg Seebeck, MD, Global Patient Safety, Merck KGaA, Darmstadt, Germany, Aida Aydemir, MD, EMD Serono Research & Development Institute, Inc., Billerica, MA and Meritxell Sabidó, MD, PhD, Merck KGaA, Darmstadt, Germany

[194]

DMT25

[198]

Elizabeth A Douglas, MPH, Isabella O’Shea, B.S., Andrew J Bouley, M.D., Joshua D Katz, M.D. and Ellen S Lathi, M.D., The Elliot Lewis Center for Multiple Sclerosis Care, Wellesley, MA

[194]

DMT25

[198]

[194]

DMT25

[198]

Magdaliz Gorritz, MPH1, Chi-Chang Chen, PhD1, Rifat Tuly, MPH1, Yifan Gu, MS1, Qiujun Shao, PhD2, Abhijit Gadkari, PhD2, Brandon Brown, PharmD2 and Carrie M Hersh, DO, MS, FAAN3, (1)IQVIA, Plymouth Meeting, PA, (2)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (3)Mellen Program for Multiple Sclerosis Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV

[194]

DMT26

[198]

Emma McFadden, PhD and Virginia R. Schobel, MSc, Neurology, Spherix Global Insights, Exton, PA

[194]

DMT26

[198]

Elizabeth A Douglas, MPH, Rosie M Jungquist, B.S., Andrew J Bouley, M.D., Ellen S Lathi, M.D. and Joshua D Katz, M.D., The Elliot Lewis Center for Multiple Sclerosis Care, Wellesley, MA

[194]

DMT26

[198]

Jiahe Chen, MS1,2, Crystal Watson, MS3, Dhanalakshmi Thirumulai, PhD, MPH1, Arie Barlev, PharmD, MS3, Eddie Jones, BA4, Sasha Bogdanovich, MD, PhD1 and Kiren Kresa-Reahl, MD1, (1)Atara Biotherapeutics, Thousand Oaks, CA, (2)University of Southern California, Los Angeles, CA, (3)Atara Biotherapeutics, South San Francisco, CA, (4)Adelphi Real World, Bollington, Cheshire, United Kingdom

[194]

DMT27

[198]

Abbi Blevins, PharmD, MBA, CSP1, Evan Turco, PharmD1, Autumn D. Zuckerman, PharmD, BCPS, AAHIVP, CSP2, Aimee Banks, PharmD, BCPS, MSCS2, Julie Wawrzyniak, PharmD, BCACP, MSCS3, Elizabeth Rightmier, PharmD, BCPS, MSCS3, Alicia Zagel, PhD, MPH4, Dana Simonson, PharmD, BCPS4, Josh DeClercq, MS5 and Leena Choi, PhD5, (1)Allied Health Solutions Specialty Pharmacy, WVUMedicine, Morgantown, WV, (2)Vanderbilt Specialty Pharmacy, Vanderbilt University Medical Center, Nashville, TN, (3)University of Rochester Specialty Pharmacy, UR Medicine, Rochester, NY, (4)Fairview Specialty Pharmacy, Fairview Pharmacy Services, Minneapolis, MN, (5)Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN

[194]

DMT27

[198]

Elizabeth A Douglas, MPH, Rosie M Jungquist, B.S., Andrew J Bouley, M.D., Joshua D Katz, M.D. and Ellen S Lathi, M.D., The Elliot Lewis Center for Multiple Sclerosis Care, Wellesley, MA

[194]

DMT27

[198]

Derrick S Robertson, MD, Multiple Sclerosis Division, Department of Neurology, University of South Florida, Tampa, FL, Jeffrey A. Cohen, MD, Department of Neurology, Mellen MS Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, Stephen L. Hauser, MD, UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, Ronald Zielman, MD, PhD, Novartis Pharma B.V., Amsterdam, Netherlands, Jing Xi, PhD, China Novartis Institutes For Biomedical Research Co., Ltd., Shanghai, China, Amin Azmon, PhD, Novartis Pharma A.G., Basel, Switzerland, Ayan Das Gupta, MSc, Novartis Healthcare Pvt. Ltd, Hyderabad, India, Gina Mavrikis Cox, PhD, Novartis Pharmaceuticals Corporation, East Hanover, NJ, Heinz Wiendl, MD, Department of Neurology with Institute of Translational Neurology, Medical Faculty, University Hospital and University of Münster, Münster, Germany and Ludwig Kappos, MD, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland

[194]

DMT28

[198]

Gina Mavrikis Cox, PhD1, Jeffrey A Cohen, MD2, Harald Kropshofer, PhD3, Xiangyi Meng, PhD1 and James Stankiewicz, MD1, (1)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (2)Cleveland Clinic Mellen Center, Cleveland, OH, (3)Novartis Pharma AG, Basel, Switzerland

[194]

DMT28

[198]

Enrique Alvarez, MD, PhD, MSCI1, Kavita V Nair, PhD1, Hiangkiat Tan, MS2, Kapil Rathi, PhD2, Nicole Gabler, PhD2 and Chinmay Deshpande, PhD, BPharm3, (1)Rocky Mountain Multiple Sclerosis Center at the University of Colorado, Aurora, CO, (2)HealthCore Inc., Wilmington, DE, (3)Novartis Pharmaceuticals Corporation, East Hanover, NJ

[194]

DMT28

[198]

Elizabeth A Douglas, MPH, Isabella O’Shea, B.S., Paige Greenawalt, B.S., Andrew J Bouley, M.D., Ellen S Lathi, M.D. and Joshua D Katz, M.D., The Elliot Lewis Center for Multiple Sclerosis Care, Wellesley, MA

[194]

DMT29

[198]

Gregory F Wu, MD, PhD1, Claudia Cantoni, PhD1, Amber Salter, PhD2, Kenneth Lee, BA1, Olaf Stuve, MD, PhD2, Amit Bar-Or, MD3, Gabriel Pardo, MD, FAAN4, Ursula Boschert, PhD5, Brooke Hayward, SM, MBA6, Julie Korich, PhD6, Lori A Lebson, PhD6 and Anne H. Cross, MD1, (1)Department of Neurology, Washington University in St. Louis, St. Louis, MO, (2)Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, (3)Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (4)Oklahoma Medical Research Foundation, Oklahoma City, OK, (5)Ares Trading SA, an affiliate of Merck KGaA, Darmstadt, Germany, Eysins, Switzerland, (6)EMD Serono, Rockland, MA

[194]

DMT29

[198]

Evan Luxenberg, MD1, Gloria von Geldern, MD1,2, Meghan C Romba, MD1,2, Yujie Wang, MD1,2, Deborah Gallaro, R.Ph.2, Bren Hammond, RN, BSN, MSCN2, Jennie Toro, RN2, Wendy Durand, RN, BSN2, Melissa F Kennedy, RN, C-MSCN2, Samantha Kelly, RN2, Sarika Vyasarayani, RN, BSN2 and Annette Wundes, MD1,2, (1)Neurology, University of Washington, Seattle, WA, (2)University of Washington MS Center, Seattle, WA

[194]

DMT29

[198]

Cortnee Roman, MSN, FNP-BC, Rocky Mountain MS Clinic, Salt Lake City, UT, Carrie M Hersh, DO, MS, FAAN, Mellen Program for Multiple Sclerosis Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, Timothy West, MD, Rocky Mountain Multiple Sclerosis Clinic, Salt Lake City, UT, Stefan H Sillau, PhD, Neurology, Rocky Mountain MS center, aurora, CO and Enrique Alvarez, MD, PhD, MSCI, Department of Neurology, Rocky Mountain Multiple Sclerosis Center at the University of Colorado, Aurora, CO

[194]

DMT30

[198]

Hanke Zheng, PhD, Xiu Chen, PhD and Timothy Pham, MS, Bristol Myers Squibb, Princeton, NJ

[194]

DMT30

[198]

Francis C Staskon, PhD, MS1, Heather Kirkham, PhD, MPH1 and Kathleen Love, RN, BA2, (1)HealthCare Analytics, Research & Reporting, Walgreen, Co., Deerfield, IL, (2)Clinical Program Manager, AllianceRx Walgreens Prime, Deerfield, IL

[194]

DMT30

[198]

Evanthia Bernitsas, MD1, Anthony T Reder, MD2, Angel Chinea, MD3, Craig Herrman, MD4, Barbara C O’Brien, MD5, Richard A. Sater, MD, PhD6, Lilyana Amezcua, MD, MS7, Mitzi J Williams, MD8, Gregory F Wu, MD, PhD9, Timothy Vartanian, MD, PhD10, Jinglan Pei, PhD11, Juan Acosta, MD11 and Nancy L Monson, PhD12, (1)Wayne State University School of Medicine, Detroit, MI, (2)University of Chicago Medicine, Chicago, IL, (3)San Juan Bautista School of Medicine, Universidad Central del Caribe School of Medicine, Fundacion Eslerosis Multiple de PR, San Juan MS Center, Guaynabo, PR, Puerto Rico, (4)JWM Neurology, Indianapolis, IN, (5)Baptist Memorial Hospital-Collierville, Collierville, TN, (6)Cone Health Medical Group, Greensboro, NC, (7)Keck School of Medicine, University of Southern California, Los Angeles, CA, (8)Joi Life Wellness MS Center, Atlanta, GA, (9)Washington University in St. Louis, St. Louis, MO, (10)Brain and Mind Research Institute, Weill Cornell Medicine, Cornell University, New York, NY, (11)Genentech, Inc., South San Francisco, CA, (12)University of Texas Southwestern Medical Center, Dallas, TX

[194]

DMT31

[198]

Jeffrey Kaplan, MD1, Annette Okai, MD2, Peter Sguigna, MD3, Kyle Blackburn, MD3, Lauren Tardo, MD3, Brooke Hayward, SM, MBA4, Ursula Boschert, PhD5, Lori A Lebson, PhD4, Julie Korich, PhD4, Navid Manouchehri, MD3, Rehana Z Hussain, MSc3 and Olaf Stuve, MD, PhD6,7, (1)Kansas City Multiple Sclerosis and Headache Center, Overland Park, KS, (2)North Texas Institute of Neurology & Headache, Plano, TX, (3)University of Texas Southwestern Medical Center, Dallas, TX, (4)EMD Serono, Rockland, MA, (5)Ares Trading SA, an affiliate of Merck KGaA, Darmstadt, Germany, Eysins, Switzerland, (6)Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, (7)VA North Texas Health Care System, Dallas, TX

[194]

DMT31

[198]

Francis C Staskon, PhD, MS1, Heather Kirkham, PhD, MPH1 and Kathleen Love, RN, BA2, (1)HealthCare Analytics, Research & Reporting, Walgreen, Co., Deerfield, IL, (2)Clinical Program Manager, AllianceRx Walgreens Prime, Deerfield, IL

[194]

DMT31

[198]

Isabella O’Shea, B.S., Elizabeth A Douglas, MPH, Paige Greenawalt, B.S., Andrew J Bouley, M.D., Ellen S Lathi, M.D. and Joshua D Katz, M.D., The Elliot Lewis Center for Multiple Sclerosis Care, Wellesley, MA

[194]

DMT32

[198]

John DeLuca, PhD1,2, Jon V. Riolo, PhD3, Chun-Yen Cheng, PhD3, Robert T. Naismith, MD4, Sybil Wray, MD5, Ann Bass, MD6, Edward J Fox, MD, PhD7, Emily Riser, MD8, Diego Silva, MD3 and Robert Zivadinov, MD9, (1)Departments of Physical Medicine and Rehabilitation, and Neurology, Kessler Foundation, West Orange, NJ, (2)Rutgers – New Jersey Medical School, Newark, NJ, (3)Bristol Myers Squibb, Princeton, NJ, (4)Washington University School of Medicine, St Louis, MO, (5)Hope Neurology, Knoxville, TN, (6)Neurology Center of San Antonio, San Antonio, TX, (7)Central Texas Neurology Consultants, Round Rock, TX, (8)Alabama Neurology Associates, Birmingham, AL, (9)Neurology, Buffalo Neuroimaging Analysis Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY

[194]

DMT32

[198]

Jeffrey A. Cohen, MD1, Stephen L. Hauser, MD2, Anne H. Cross, MD3, Kevin Winthrop, MD, MPH4, Heinz Wiendl, MD5, Jacqueline Nicholas, MD, MPH6, Sven G. Meuth, MD, PhD7, Paul S. Giacomini, MD8, Francesco Saccà, MD9, Ronald Zielman, MD, PhD10, Ayan Das Gupta, MSc11, Xixi Hu, PhD12, Roseanne Sullivan, PharmD12, Virginia DeLasHeras, MD13 and Ludwig Kappos, MD14, (1)Department of Neurology, Mellen MS Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, (2)UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, (3)Washington University School of Medicine, St. Louis, MO, (4)Public Health and Preventive Medicine, Division of Infectious Diseases, Oregon Health and Sciences University, Portland, OR, (5)Department of Neurology with Institute of Translational Neurology, Medical Faculty, University Hospital and University of Münster, Münster, Germany, (6)OhioHealth Multiple Sclerosis Center, Columbus, OH, (7)Department of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany, (8)Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada, (9)NSRO Department, University “Federico II” of Naples, Naples, Italy, (10)Novartis Pharma B.V., Amsterdam, Netherlands, (11)Novartis Healthcare Pvt. Ltd, Hyderabad, India, (12)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (13)Novartis Pharma AG, Basel, Switzerland, (14)Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland

[194]

DMT33

[198]

John F Kramer, PA-C1, Patrick Vermersch, MD, PhD2, Roseanne Sullivan, PharmD3, Ronald Zielman, MD, PhD4, Xixi Hu, PhD3, Ayan Das Gupta, MSc5, Wendy Su, PhD3, Dee Stoneman, MPharm6, Elisabeth B Lucassen, MD3 and Olaf Hoffmann, PD Dr. med.7, (1)St Thomas Medical Partners, Nashville, TN, (2)Univ. Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France, (3)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (4)Novartis Pharma B.V., Amsterdam, Netherlands, (5)Novartis Healthcare Pvt. Ltd, Hyderabad, India, (6)Novartis Pharma AG, Basel, Switzerland, (7)Department of Neurology, Alexianer St. Josefs Hospital, Potsdam, Germany

[194]

DMT33

[198]

[194]

DMT33

[198]

Jacqueline Rosenthal, MD1, Lilyan Wright, PhD2, Jack Ratchford, PhD2, Alexandra Goodyear, PhD2 and Leorah Freeman, MD, PhD3, (1)Andrew C. Carlos Multiple Sclerosis Institute, Shepherd Center, Atlanta, GA, (2)Genentech, Inc., South San Francisco, CA, (3)Neurology, Dell Medical School, The University of Texas at Austin, Austin, TX

[194]

DMT34

[198]

Joseph R Berger, MD, FACP, FAAN, FANA1, Dina Jacobs, MD2, James Wilson, BA2, Emma Wilson, None2, Akash Virupakshaiah, MD2 and David Do, MD2, (1)Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (2)Neurology, University of Pennsylvania, Philadelphia, PA

[194]

DMT34

[198]

Jacob A Sloane, MD PhD1, Kyle E. Smoot, MD2, Bianca Weinstock-Guttman, MD3, Sibyl Wray, MD4, Miguel Rosales, MSc5, Sai L. Shankar, PhD5, Justin Bohn, ScD5, Catherine Miller, PharmD, MPH5, Jordan Messer, PharmD5, Jason P. Mendoza, PhD5 and James B. Lewin, PharmD5, (1)Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, (2)Providence Multiple Sclerosis Center, Providence Brain and Spine Institute, Portland, OR, (3)Jacobs Multiple Sclerosis Center for Treatment and Research, Jacobs School of Medicine and Biomedical Science, University at Buffalo, Buffalo, NY, (4)Hope Neurology, Knoxville, TN, (5)Biogen, Cambridge, MA

[194]

DMT35

[198]

Kerstin Hellwig, MD, Department of Neurology, St Josef Hospital, Ruhr University, Bochum, Germany, Bassem Yamout, MD, Harley Street Medical Center, Abu Dhabi, United Arab Emirates, Riley Bove, MD, University of California San Francisco, San Francisco, CA, Krishna Swetha Gummuluri, MBBS, Dip. Pharm. Med, Novartis Healthcare Pvt. Ltd., Hyderabad, India, Ulf Schulze Topphoff, PhD, Novartis Pharma GmbH, Nuremberg, Germany, Simone Fantaccini, MD, Novartis Pharma A.G., Basel, Switzerland, Ronald Zielman, MD, PhD, Novartis Pharma B.V., Amsterdam, Netherlands, Roseanne Sullivan, PharmD, Novartis Pharmaceuticals Corporation, East Hanover, NJ, Maria Pia Amato, MD, Department NEUROFARBA, University of Florence, Florence, Italy; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy, Ruth Dobson, PhD, FRCP, Department of Neurology, Royal London Hospital, BartsHealth NHS Trust, London, United Kingdom; Preventative Neurology Unit, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom and Maria Houtchens, MD, Brigham Multiple Sclerosis Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

[194]

DMT35

[198]

Jakai Nolan, DO, MPH1, Jacqueline Nicholas, MD, MPH1, Andrew Smith, MD1, Irene Koulinska, MD, ScD2, Arman Altincatal, MS2, Cyndi Grossman, PhD2, Scott Husak, Statistical Programmer3, Kedar Mahajan, MD, PhD3, Robert A Bermel, MD4, Jeff Cohen, MD3 and Brandon Moss, MD5, (1)OhioHealth, Columbus, OH, (2)Biogen, Cambridge, MA, (3)Cleveland Clinic, Cleveland, OH, (4)Mellen Center for MS, Cleveland Clinic, Cleveland, OH, (5)Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH

[194]

DMT35

[198]

David Medvedev, Student1, Jill R Nelson, RN, BScN, MSCN1, Anna Kazimirchik, RN, MSCN1 and Galina Vorobeychik, MD, FRCPS(C), FAAN1,2, (1)Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada, (2)Neurology, University of British Columbia, Vancouver, BC, Canada

[194]

DMT36

[198]

Kevin Winthrop, MD, MPH1, Silvia Delgado, MD2, Mario Habek, MD3, Maria Davydovskaya, PhD4, Brian Ward, MD5, Bruce A. C. Cree, MD, PhD6, Natalia Totolyan, MD7, Linda Mancione, BA8, Roseanne Sullivan, PharmD8, Ronald Zielman, MD, PhD9, Xixi Hu, PhD8, Ayan Das Gupta, MSc10, Xavier Montalban, MD PhD11 and Anne Cross, MD12, (1)Public Health and Preventive Medicine, Division of Infectious Diseases, Oregon Health and Sciences University, Portland, OR, (2)University of Miami Miller School of Medicine, Miami, Florida, USA, FL, (3)University Hospital Center Zagreb, University of Zagreb, School of Medicine, Zagreb, Croatia, Croatia, (4)Moscow state Public Healthcare InszCity Clinical Hospital 24, Moscow, Russia, Russian Federation, (5)Infectious Diseases Division, Research Institute of the McGill University Health Centre, Montreal, QC, Canada, (6)Neurology, UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, California, USA, San Francisco, CA, (7)First Saint Petersburg State Medical University, St Petersburg, Russian Federation, (8)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (9)Novartis Pharma B.V., Amsterdam, Netherlands, (10)Novartis Healthcare Pvt. Ltd, Hyderabad, India, (11)Department of Neurology-Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d’Hebron, Barcelona, Spain, (12)Neurology, Washington University School of Medicine, Saint Louis, St. Louis, MO

[194]

DMT36

[198]

John F Kramer, PA-C, Neurology, St Thomas Medical Partners, Nashville, TN

[194]

DMT36

[198]

Jiwon Oh, MD, PhD1, Sana Syed, MD, MPH2, Tong Li, PhD3, Naji Salloum, MD2, Timothy J. Turner, PhD2 and Robert J. Fox, MD4, (1)St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada, (2)Sanofi, Cambridge, MA, (3)Sanofi, Bridgewater, NJ, (4)Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH

[194]

DMT37

[198]

Laura Balcer, MD, MSCE1, Jeffrey A Cohen, MD2, Fred D. Lublin, MD3, Christopher B. Lock, MD, PhD4, Daniel Pelletier, MD5, Tanuja Chitnis, MD6, Munish Mehra, PhD7, Yael Gothelf, Ph.D.8, Revital Aricha, PhD9, Stacy Lindborg, PhD10, Chaim Lebovits, CEO8 and Ralph Kern, MD, MHSc10, (1)New York University Langone Medical Center, New York, NY, (2)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, (3)Corinne Goldsmith Dickinson Center for Multiple Sclerosis, New York, NY, (4)Stanford School of Medicine, Palo Alto, CA, (5)Keck School of Medicine of University of Southern California, Los Angeles, CA, (6)Brigham and Women’s Hospital, Boston, MA, (7)Tigermed, Somerset, NJ, (8)R&D, Brainstorm Cell Therapeutics, Petach Tikva, NY, Israel, (9)R&D, Brainstorm Cell Therapeutics, Petach Tikva, Israel, (10)R&D, Brainstorm Cell Therapeutics, New York, NY

[194]

DMT37

[198]

Gavin Giovannoni, MD, PhD, Queen Mary University of London, London, United Kingdom, Joseph Berger, MD, FACP, FAAN, FANA, Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, Thomas P. Leist, MD, Comprehensive Multiple Sclerosis Center, Division of Clinical Neuroimmunology, Jefferson University, Philadelphia, PA, Dominic Jack, PhD, Merck KGaA, Darmstadt, Germany, Andrew Galazka, MD, Merck KGaA, Darmstadt, Germany, Aubonne, Switzerland, Axel Nolting, MD, Merck KGaA, Darmstadt, Germany, Darmstadt, Germany and Doris Damian, PhD, EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, a business of Merck KGaA, Darmstadt, Germany, Billerica, MA

[194]

DMT37

[198]

Joash Lazarus, MD, Nancy Ross, PharmD, BCACP, MSCS, CSP and Collins Yates, RN, BSN, MSCN, Atlanta Neuroscience Institute, Atlanta, GA

[194]

DMT38

[198]

Ludwig Kappos, MD1, Robert J Fox, MD2, Michel Burcklen, PhD3, Mark S Freedman, MSc, MD4, Brian Hennessy, PhD3, Antoine Stos, MSc3, Philippe Linscheid, PhD3, Andrea Vaclavkova, MD3, Hilke Kracker, PhD3, Tatiana Sidorenko, MD, PhD3 and Carlo Pozzilli, MD, PhD5, (1)Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel, and University of Basel, Basel, Switzerland, (2)Mellen Center for Treatment and Research in Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, (3)Actelion Pharmaceuticals, Part of Janssen Pharmaceutical Companies, Allschwil, Switzerland, (4)Department of Medicine and the Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada, (5)Department of Human Neuroscience, La Sapienza University, Rome, Italy

[194]

DMT38

[198]

[194]

DMT38

[198]

John DeLuca, PhD1, Jon V. Riolo, MD2, Chun-Yen Cheng, MS2, Robert T. Naismith, MD3, Sibyl Wray, MD4, Ann Bass, MD5, Edward Fox, MD, PhD, FAAN6, Emily Riser, MD7, Burhan Chaudhry, MD2, Diego Silva, MD2 and Robert Zivadinov, MD, PhD8, (1)Kessler Foundation, West Orange, New Jersey, and Departments of Physical Medicine and Rehabilitation, and Neurology, Rutgers – New Jersey Medical School, Newark, NJ, (2)Bristol Myers Squibb, Princeton, NJ, (3)Department of Neurology, Washington University in St. Louis School of Medicine, St. Louis, MO, (4)Hope Neurology MS Center, Knoxville, TN, (5)Neurology Center of San Antonio, San Antonio, TX, (6)Central Texas Neurology Consultants, Round Rock, TX, (7)Alabama Neurology Associates, Birmingham, AL, (8)Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY

[194]

DMT39

[198]

Mali Coray, PhD1, Andrea Seitzinger, PhD2, Sanjeev Roy, MD3, Mark S Freedman, MSc, MD4, Frederik Barkhof, MD, PhD5,6, Giancarlo Comi, MD7, Nicola De Stefano, MD, PhD8, Ludwig Kappos, PhD9,10, Jens Kuhle, MD, PhD9,11 and Matthias Mehling, PhD1,9,11, (1)Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland, (2)the healthcare business of Merck KGaA, Darmstadt, Germany, (3)Ares Trading S.A, Eysins, Switzerland, (4)Department of Medicine and the Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada, (5)Department of Radiology and Nuclear Medicine, MS Center Amsterdam, Amsterdam, Netherlands, (6)UCL Institute of Neurology, London, United Kingdom, (7)Casa di Cura Privata del Policlinico, Università Vita-Salute San Raffaele, Milan, Italy, (8)Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy, (9)Research Center for Clinical Neuroimmunology and Neuroscience, Basel, Switzerland, (10)Research Center for Clinical Neuroimmunology and Neuroscience, University Hospital Basel, University of Basel, Basel, Switzerland, (11)Neurology Departments of Head, Spine and Neuromedicine, Biomedical Engineering and Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland

[194]

DMT39

[198]

Kathryn C Fitzgerald, ScD1, Carrie M Hersh, DO, MS2, Lana Zhovtis Ryerson, MD3, Ellen M Mowry, MD, MCR4, Shirley Liao, PhD5, Arman Altincatal, MS5 and Maria L Naylor, PhD5, (1)Johns Hopkins Medicine, Department of Neurology, Baltimore, MD, (2)Cleveland Clinic, Lou Ruvo Center for Brain Health, Las Vegas, NV, (3)NYU Grossman School of Medicine, Department of Neurology, New York, NY, (4)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (5)Biogen, Cambridge, MA

[194]

DMT39

[198]

Julia A Bass, PharmD1, Michelle Maynard, PharmD, BCPS2, Staley Brod, MD3, Ahmed Z Obeidat, MD, PhD3 and Sam I Hooshmand, DO4, (1)Froedtert & the Medical College of Wisconsin, Milwaukee, WI, (2)Neurosciences, Froedtert and the Medical College of Wisconsin, Milwaukee, WI, (3)Neurology, Medical College of Wisconsin, Milwaukee, WI, (4)Department of Neurology, Medical College of Wisconsin, Milwaukee, WI

[194]

DMT40

[198]

Mark S Freedman, MSc, MD, Department of Medicine and the Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada, Milorad Todorovi?, PhD, the healthcare business of Merck KGaA, Darmstadt, Germany, Zuzana Murgašová, MD, Merck spol. s r.o., an affiliate of Merck KGaA, Darmstadt, Germany, Bratislava, Slovakia and Dominic Jack, PhD, Merck Serono Ltd, Feltham, UK, an affiliate of Merck KGaA, Darmstadt, Germany, Feltham, United Kingdom

[194]

DMT40

[198]

[194]

DMT40

[198]

Julie Wawrzyniak, PharmD, BCACP, MSCS1, Andrew Choma, PharmD, BCPS, BCGP1, Tiffany Otto, CPhT2 and Erin Collins, MS2, (1)University of Rochester Specialty Pharmacy, UR Medicine, Rochester, NY, (2)Neurology, UR Medicine, Rochester, NY

[194]

DMT41

[198]

Aliya Jaber, BS1, Meera Patel, BS1, Andrew Sylvester, MD1, Mary Yarussi, BSN1, J. Tamar Kalina, PhD2, Jason P Mendoza, PhD2, Robin L Avila, PhD2 and Matthew A Tremblay, MD, Ph.D1, (1)Multiple Sclerosis Comprehensive Care Center, RWJ Barnabas Health, Livingston, NJ, (2)Biogen, Cambridge, MA

[194]

DMT41

[198]

Le H. Hua, MD1, Amit Bar-Or, MD2, Fred D. Lublin, MD3, Xiangyi Meng, PhD4, Gina Mavrikis Cox, PhD4, Bruce A.C. Cree, MD, PhD, MAS5 and Robert J. Fox, MD6, (1)Lou Ruvo Center for Brain Health, Las Vegas, NV, (2)Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (3)Icahn School of Medicine at Mount Sinai, New York, NY, (4)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (5)Department of Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, (6)Cleveland Clinic, Cleveland, OH

[194]

DMT41

[198]

Calli L Cook, DNP, FNP-C, FAANP1,2, Kiran Sayani, FNP-C1 and Julie J Patel, PharmD, BCACP1,3, (1)General Neurology, The Emory Clinic, Atlanta, GA, (2)Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA, (3)Department of Pharmacy, Emory University Hospital Midtown, Atlanta, GA

[194]

DMT42

[198]

Mauricio Rosas-Ballina, MD, PhD1, Annette Wooller, MS2, Robyn Jones, MD3, Andrea Vaclavkova, MD1 and Eva K Havrdova, MD, PhD4, (1)Actelion Pharmaceuticals, Part of Janssen Pharmaceutical Companies, Allschwil, Switzerland, (2)EMEA Medical Affairs, Janssen-Cilag, High Wycombe, United Kingdom, (3)Johnson & Johnson, New Brunswick, NJ, (4)First Medical Faculty, Charles University in Prague, Prague, Czech Republic

[194]

DMT42

[198]

Le H. Hua, MD1, Roshani Shah, MS2, Gina Mavrikis Cox, PhD2, Tim Bancroft, PhD3, Rachel Halpern, PhD3 and Miriam G. Cisternas, MA3, (1)Lou Ruvo Center for Brain Health, Las Vegas, NV, (2)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (3)Health Economics and Outcomes Research, Optum, Eden Prairie, MN

[194]

DMT42

[198]

Samuel JK Abraham, MD, Ph.D1,2,3,4, Vidyasagar Devaprasad Dedeepiya, MD, DNB3, Chocanathan Vetrievel, MS5, Sudhakar Subramanian, MD6, Naoki Yamamoto, MD, Ph.D7, Nobunao Ikewaki, Ph.D8,9, Rajappa Senthilkumar, Ph.D2,3, Senthilkumar Preethy, BDS, M.Sc3, Koji Ichiyama, PhD10, Subramaniam Srinivasan, MD, FACP, FRCP(L)11 and Hiroto Kawashima, PhD12, (1)Centre for Advancing Clinical Research (CACR), University of Yamanashi, Chuo, Japan, (2)GN Corporation Co. Ltd, Kofu, Japan, (3)Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India, (4)Sophy Inc., Kochi, Japan, (5)BeWell Hospitals, Chennai, India, (6)Department of Anesthesia, Thunder Bay Regional Health Sciences Centre, Thunder Bay, ON, Canada, (7)National Center for Global Health and Medicine (NCGM), Chiba, Japan, (8)Kyushu University of Health and Welfare, Nobeoka, Japan, (9)Junsei Educational Institute, Nobeoka, Japan, (10)Antony-Xavier Inter-disciplinary Scholastics (AXIS), GN Corporation Co Ltd, Kofu, Yamanashi, Japan, (11)Mary- Yoshio Translational Hexagon (MYTH), Nichi-in Centre for Regerenative Medicine (NCRM), Chennai, TN, India, (12)Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan

[194]

DMT43

[198]

Mauricio Rosas-Ballina, MD, PhD1, Annette Wooller, MS2, Verena Walter, MS1, Maria Ait-Tihyaty, PhD3, Andrea Vaclavkova, MD1 and Carlo Pozzilli, MD, PhD4, (1)Actelion Pharmaceuticals, Part of Janssen Pharmaceutical Companies, Allschwil, Switzerland, (2)EMEA Medical Affairs, Janssen-Cilag, High Wycombe, United Kingdom, (3)Global Medical Affairs, Janssen Research & Development, LLC, Titusville, NJ, (4)Department of Human Neuroscience, La Sapienza University, Rome, Italy

[194]

DMT43

[198]

Le H Hua, MD1, Enrique Alvarez, MD, PhD, MSCI2, Roland G Henry, PhD3, Joel Brown, PhD, PharmD4, Elizabeth Camacho, MBA4, Xiangyi Meng, PhD4, Marina Ziehn, PhD5, Brandon Brown, PharmD4 and Benjamin M Greenberg, MD, MHS6, (1)Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, (2)Department of Neurology, University of Colorado, Aurora, CO, (3)UCSF Neurology, Weill Institute for Neurosciences, San Francisco, CA, (4)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (5)Novartis Pharma AG, Basel, Switzerland, (6)Neurology & Neurotherapeutics – MS Clinic, UT Southwestern Medical Center, Dallas, TX

[194]

DMT43

[198]

Lana Zhovtis Ryerson, MD1,2, Dunia Gragui, .3, Francesca Chinea, BA4 and Eugene Toth, ba4, (1)Neurology, HMH JSUMC, Neptune, NJ, (2)Department of Neurology, NYU Langone Health, New York University, New York, NY, (3)Neurology, NYU Langone Health, New York, NY, (4)NYU, New York, NY

[194]

DMT44

[198]

Meghan Garabedian, CRNP, MSN, MSCN1, Cortnee Roman, MSN, FNP-BC2, Denise R Bruen, MSN3, Kevin Benny, BS4, Elizabeth Luce, BS, MBA4, Beth Schneider, Senior Research Director4, Shivani Kapadia, PharmD, RPh5, Jason P Mendoza, PhD5, James B Lewin, PharmD5, Mary Zhang, PharmD5 and Sai L Shankar, PhD5, (1)Neurology, Penn Neuroscience Center, Perelmen Center for Advanced Medicine, Philadelphia, PA, (2)Rocky Mountain Multiple Sclerosis Clinic and Research Group, Salt Lake City, UT, (3)University of Virginia Neuroscience, Charlottesville, VA, (4)MyHealthTeam, San Francisco, CA, (5)Biogen, Cambridge, MA

[194]

DMT44

[198]

Ling Jin, MD, Zheng Ren, PhD, Prabjot Hunjan, BSc, PgDip, Seth Levin, MD and Stephanie Licata, PhD, Biogen, Cambridge, MA

[194]

DMT44

[198]

Nicola De Stefano, MD, PhD1, Anat Achiron, MD, PhD2, Frederik Barkhof, MD, PhD3,4, Andrew Chan, MD5, Tobias Derfuss, MD6, Suzanne Hodgkinson, MBBS, PhD7, Letizia Leocani, MD, PhD8, Xavier Montalban, MD, PhD9, Alexandre Prat, MD, PhD10, Klaus Schmierer, MD, PhD11,12, Finn Sellebjerg, MD, PhD, DMSci13,14, Patrick Vermersch, MD, PhD15, Heinz Wiendl, MD16, Annette Lehn, PhD17, Andrzej Smyk, MD17 and Lidia Gardner, PhD18, (1)Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy, (2)Multiple Sclerosis Center, Sheba Academic Medical Center, Ramat Gan, Israel, (3)UCL Institute of Neurology, London, United Kingdom, (4)Department of Radiology, VU University Medical Center, Amsterdam, Netherlands, (5)Department of Neurology, , Bern University Hospital, University of Bern, Bern, Switzerland, (6)Department of Neurology, University Hospital Basel, Basel, Switzerland, (7)Ingham Institute for Applied Medical Research, University of New South Wales Medicine, Sydney, Australia, (8)Experimental Neurophysiology Unit, Vita-Salute San Raffaele University, Milan, Italy, (9)Department of Neurology-Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d’Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain, (10)Department of Neurosciences, Université de Montréal, Montréal, QC, Canada, (11)The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, United Kingdom, (12)Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom, (13)Danish MS Center, Department of Neurology, Copenhagen University Hospital – Rigshospitalet, Glostrup, Denmark, (14)Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark, (15)Univ. Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France, (16)Department of Neurology with Institute of Translational Neurology, Medical Faculty, University Hospital and University of Münster, Münster, Germany, (17)the healthcare business of Merck KGaA, Darmstadt, Germany, (18)EMD Serono Research and Development Institute, Inc., Billerica, MA

[194]

DMT45

[198]

Michelle Maynard, PharmD, BCPS1, Carmen Raschka, RN2, Staley Brod, MD3, Ahmed Z Obeidat, MD, Ph.D.3 and Sam I Hooshmand, DO4, (1)Neurosciences, Froedtert and the Medical College of Wisconsin, Milwaukee, WI, (2)Neurosciences, Froedtert Hospital, Milwaukee, WI, (3)Neurology, Medical College of Wisconsin, Milwaukee, WI, (4)Department of Neurology, Medical College of Wisconsin, Milwaukee, WI

[194]

DMT45

[198]

Marc Bigaud, PhD1, Frank Dahlke, MD1, Thomas Hach, MD1, Daniela Piani-Meier, PhD1 and Ralf Gold, MD2, (1)Novartis Pharma AG, Basel, Switzerland, (2)Department of Neurology, St Josef-Hospital, Ruhr-University Bochum, Bochum, Germany

[194]

DMT45

[198]

Mark S Freedman, MSc MD1, Xavier Montalban, MD, PhD2, Timothy Vollmer, MD3, Jerry S Wolinsky, MD4, Regine Buffels, MD5, Cathy Chognot, PhD5, Nikki Jessop, MbChB, FCForPath5, Kalpesh Prajapati, MSc, M.Phil6 and Ludwig Kappos, PhD7, (1)Department of Medicine and the Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada, (2)Department of Neurology-Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Vall d’Hebron Hospital Universitari, Barcelona, Spain, (3)Department of Neurology, Rocky Mountain Multiple Sclerosis Center at Anschutz Medical Campus, University of Colorado Denver, Denver, CO, (4)Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, (5)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (6)IQVIA Solutions Inc., Amsterdam, Netherlands, (7)Research Centre for Clinical Neuroimmunology and Neuroscience, University Hospital Basel, University of Basel, Basel, Switzerland

[194]

DMT46

[198]

Mitzi J Williams, MD1, Lilyana Amezcua, MD2, Angel Chinea, MD3, Stanley L Cohan, MD, PhD4, Annette Okai, MD5, Darin T Okuda, MD6, Wendy Vargas, MD7, Nicholas Belviso, PhD8, Ivan Bozin, MD9, Xiaotong Jiang, PhD8, James B Lewin, PharmD8, Jennifer Lyons, MD8, Changyu Shen, PhD8, Sarah M England, PhD8 and Nydjie Grimes, MPH, BA10, (1)Joi Life Wellness Group MS Center, Smyrna, GA, (2)Keck School of Medicine, University of Southern California, Los Angeles, CA, (3)San Juan MS Center, Guaynabo, PR, Puerto Rico, (4)Providence Multiple Sclerosis Center, Providence Brain Institute, Portland, OR, (5)North Texas Institute of Neurology and Headache, Plano, TX, (6)Neuroinnovation Program, UT Southwestern Medical Center, Dallas, TX, (7)Columbia University Medical Center, New York, NY, (8)Biogen, Cambridge, MA, (9)Biogen, Baar, Switzerland, (10)Biogen, at the time of this analysis, Cambridge, MA

[194]

DMT46

[198]

Mark S. Freedman, HBSc, MSc, MD, CSPQ, FANA, FAAN, FRCPC1, Hans Guehring, MD2, Zuzana Murgasova, MD2 and Dominic Jack, PhD2, (1)University of Ottawa, Department of Medicine and the Ottawa Hospital Research Institute, Ottawa, ON, Canada, (2)Merck KGaA, Darmstadt, Germany

[194]

DMT46

[198]

Mitzi J. Williams, MD1, Laura Airas, MD, PhD2, Tanuja Chitnis, MD3, Sarbjit Saini, MD4, Michihiro Hide, MD, PhD5, Gordon Sussman, MD6, Jin Nakahara, MD, PhD7, Robert A. Bermel, MD8, Thomas Dörner, MD9, Brett Loop, MPH10, Marina Ziehn, PhD11, Roman Willi, PhD11, Bernd C. Kieseier, MD11,12, Ivan Nikolaev, MD11, Sibylle Haemmerle, PhD11, Artem Zharkov, MD11, Richard Siegel, MD, PhD13, Bruno Cenni, PhD13, Heinz Wiendl, MD, PhD14, Marcus Maurer, MD15,16, Ana Giménez-Arnau, MD, PhD17 and Xavier Montalban, MD, PhD18, (1)Joi Life Wellness Group, Atlanta, GA, (2)Turku University Hospital and University, Turku, Finland, (3)Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, (4)Johns Hopkins Asthma and Allergy Center, Baltimore, MD, (5)Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan, (6)University of Toronto, Toronto, ON, Canada, (7)Department of Neurology, Keio University School of Medicine, Tokyo, Japan, (8)Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, (9)Department of Rheumatology and Clinical Immunology, Charite Universitätsmedizin Berlin; DRFZ, Berlin, Germany, (10)Novartis Pharmaceutical Corporation, Cambridge, MA, (11)Novartis Pharma AG, Basel, Switzerland, (12)Department of Neurology, Heinrich-Heine University, Duesseldorf, Germany, (13)Novartis Institutes for BioMedical Research, Basel, Switzerland, (14)Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany, (15)Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, (16)Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany, (17)Hospital del Mar – IMIM, Universitat Pompeu Fabra, Barcelona, Spain, (18)Department of Neurology-Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d’Hebron, Barcelona, Spain

[194]

DMT47

[198]

Mitzi J Williams, MD1, Lilyana Amezcua, MD2, Stanley L Cohan, MD, PhD3, Jeffrey A Cohen, MD4, Silvia R Delgado, MD5, Le H Hua, MD6, Elisabeth B Lucassen, MD7, Xiangyi Meng, PhD7 and James Stankiewicz, MD7, (1)Joi Life Wellness, MS Neurology Center, Smyrna, GA, (2)Keck School of Medicine, University of Southern California, Los Angeles, CA, (3)Providence Multiple Sclerosis Center, Providence Brain Institute, Portland, OR, (4)Cleveland Clinic Mellen Center, Cleveland, OH, (5)Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, (6)Lou Ruvo Center for Brain Health, Las Vegas, NV, (7)Novartis Pharmaceuticals Corporation, East Hanover, NJ

[194]

DMT47

[198]

Mark Gudesblatt, MD1, Myassar Zarif, MD1, Barbara Bumstead, MS, ANP-C, MSCN1, Marijean Buhse, NP-C, PhD1, Olivia Kaczmarek, BS1, Jared Srinivasan, BS2, Nuno Barros, PhD3, Annemie Ribbens, PhD3, Wim Van Hecke, PhD3, Elise Digga, BA4, Jason P. Mendoza, PhD2 and Stephen Krieger, MD4, (1)South Shore Neurologic Associates, Patchogue, NY, (2)Biogen, Cambridge, MA, (3)icometrix, Leuven, Belgium, (4)Icahn School of Medicine at Mt. Sinai, New York, NY

[194]

DMT47

[198]

Moein Amin, MD1, Tucker Harvey, MS2, Dan Michael Pineda, MD3, Brandon Moss, MD1, Mindy Tai, PhD4, Qiujun Shao, PhD4, Abhijit Gadkari, PhD4, Brandon Brown, PharmD4, Devon S Conway, MD, MS1 and Carrie M Hersh, DO, MS, FAAN5, (1)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, (2)Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, (3)Lahey Hospital and Medical Center, Burlington, MA, (4)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (5)Mellen Program for Multiple Sclerosis Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV

[194]

DMT48

[198]

Natalie Abramov, MSc1, Ralph Kern, MD, MHSc2, Haggai Kaspi, PhD1, Stacy Lindborg, PhD2, Yael Gothelf, Ph.D.3, Chaim Lebovits, CEO3 and Revital Aricha, PhD1, (1)R&D, Brainstorm Cell Therapeutics, Petach Tikva, Israel, (2)R&D, Brainstorm Cell Therapeutics, New York, NY, (3)R&D, Brainstorm Cell Therapeutics, Petach Tikva, NY, Israel

[194]

DMT48

[198]

Michael Levy, MD, PhD1,2, Achim Berthele, MD3, Ho Jin Kim, MD, PhD4, Kazuo Fujihara, MD5,6,7, Ichiro Nakashima, MD, PhD6,8, Celia Oreja-Guevara, MD9, Jacqueline Palace, DM10, Sean J Pittock, M.D.11, Murat Terzi, MD12, Natalia Totolyan, MD13, Shanthi Viswanathan, MRCP14, Kai-Chen Wang, MD, PhD15,16, Amy Pace, ScD17, Marcus Yountz, MD17, Diane Lawson, PharmD, RPh17, Eva Laudon-Meyer, MD PhD18 and Dean Wingerchuk, M.D.19, (1)Massachusetts General Hospital and Harvard Medical School, Boston, MA, (2)Johns Hopkins University, Baltimore, MD, (3)Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany, (4)Research Institute and Hospital, National Cancer Center, Goyang, Korea, Republic of (South), (5)Southern TOHOKU Research Institute for Neuroscience (STRINS), Koriyama, Japan, (6)Tohoku University, Sendai, Japan, (7)Fukushima Medical University, Fukushima City, Japan, (8)Tohoku Medical and Pharmaceutical University, Sendai, Japan, (9)Hospital Universitario Clinico San Carlos, Madrid, Spain, (10)John Radcliffe Hospital, Oxford, United Kingdom, (11)Mayo Clinic, Rochester, MN, (12)Ondokuz Mayis University, Samsun, Turkey, (13)National Medical University, St Petersburg, Russian Federation, (14)Kuala Lumpur Hospital, Kuala Lumpur, Malaysia, (15)School of Medicine, National Yang Ming University, Taipei, Taiwan, (16)Cheng-Hsin General Hospital, Taipei, Taiwan, (17)Alexion Pharmaceuticals, Boston, MA, (18)Alexion Pharmaceuticals, Zurich, Switzerland, (19)Mayo Clinic, Scottsdale, AZ

[194]

DMT48W

[198]

Xavier Montalban, MD, PhD1, Douglas L. Arnold, MD2,3, Amit Bar-Or, MD4, Bruce A.C. Cree, MD5, Anne H. Cross, MD6, Eva Havrdova, MD, PhD7, Ludwig Kappos, MD8, Olaf Stuve, MD, PhD9, Heinz Wiendl, MD10, Jerry S Wolinsky, MD11, Christian Baumgaertner, MD12, Elise E. Drouin, PhD13, Li Shen Loo, MD13, Ana Mijuskovic, MD12, Michaela Sedova, MD14, Nadia Tenenbaum, MD13, Davorka Tomic, PhD15 and Patrick Vermersch, MD, PhD16, (1)Department of Neurology-Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d’Hebron, Barcelona, Spain, (2)Montreal Neurological Institute, Montreal, QC, Canada, (3)NeuroRx Research, Montreal, QC, Canada, (4)Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (5)Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, (6)Department of Neurology, Division of Neuroimmunology, Washington University School of Medicine, St Louis, MO, (7)General University Hospital, Charles University, Prague, Czech Republic, (8)Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, (9)Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, (10)Department of Neurology with Institute of Translational Neurology, Medical Faculty, University Hospital and University of Münster, Münster, Germany, (11)Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, (12)the healthcare business of Merck KGaA, Darmstadt, Germany, (13)EMD Serono, Billerica, MA, (14)Cytel Czech Republic, s.r.o., Prague, MA, Czech Republic, (15)Ares Trading SA, an affiliate of Merck KGaA, Darmstadt, Germany, Eysins, Switzerland, (16)Univ. Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France

[194]

DMT49

[198]

Patricia K. Coyle, MD1, Magdaliz Gorritz, MPH2, Rolin L Wade, RPh, MS2, Zifan Zhou, MS2, Subhan Khalid, MS2, Chinmay Deshpande, PhD, BPharm3 and Qiujun Shao, PhD3, (1)Department of Neurology, Stony Brook University, Stony Brook, NY, (2)IQVIA, Plymouth Meeting, PA, (3)Novartis Pharmaceuticals Corporation, East Hanover, NJ

[194]

DMT49

[198]

Mitzi J Williams, MD1, Janine Robinson, MS2, Katarzyna Elliott-Maksymowicz, MSc2, Bianca Luscher, BS2 and Chinmay Deshpande, PhD, BPharm3, (1)Joi Life Wellness Group, LLC, Smyrna, GA, (2)W2O Group, Philadelphia, PA, (3)Novartis Pharmaceuticals Corporation, East Hanover, NJ

[194]

DMT49

[198]

Riley Bove, MD, UCSF Weill Institute for Neuroscience, University of California San Francisco, San Francisco, CA, Maria Pia Amato, MD, IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy; Department NEUROFARBA, University of Florence, Florence, Italy, Ruth Dobson, PhD, FRCP, Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom; Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom, Kristen M Krysko, MD MAS, Division of Neurology, Department of Medicine, St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada; Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, ON, Canada, Sharon Stoll, DO, MS, Department of Neurology, Yale University, New Haven, CT, Sandra Vukusic, MD, PhD, Service de neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Hôpital neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France; Centre des Neurosciences de Lyon, INSERM 1028 et CNRS UMR5292, Observatoire Français de la Sclérose en Plaques, Lyon, France; Université Claude Bernard Lyon 1, Villeurbanne, Lyon, France, Bassem Yamout, MD, American University of Beirut Medical Center, Beirut, Lebanon; Harley Street Medical Center, Abu Dhabi, United Arab Emirates, Ronald Zielman, MD, PhD, Novartis Pharma B.V., Amsterdam, Netherlands, Krishna Swetha Gummuluri, MBBS, Dip. Pharm. Med, Novartis Healthcare Pvt. Ltd., Hyderabad, India, Valentine Jehl, MSc, Novartis Pharma AG, Basel, Switzerland, Ulf Schulze Topphoff, PhD, Novartis Pharma GmbH, Nuremberg, Germany, Roseanne Sullivan, PharmD, Novartis Pharmaceuticals Corporation, East Hanover, NJ and Kerstin Hellwig, MD, St. Josef-Hospital/Ruhr-University Bochum, Bochum, Germany

[194]

DMT50

[198]

Reemal Zaheer, PharmD1, Roma Amin, PharmD, BCACP2, LaTasha Riddick, PharmD, BCACP2, Shuvro Roy, MD3,4, Paulina Kepczynska, PharmD Candidate 20221, Sujin Wolff, PharmD1, Amy Nathanson, PharmD, BCACP2 and Scott D. Newsome, DO, MSCS, FAAN, FANA3,4, (1)Johns Hopkins Medicine (Home Care Group), Baltimore, MD, (2)Johns Hopkins Homecare Group, Baltimore, MD, (3)Department of Neurology, Johns Hopkins University, Baltimore, MD, (4)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

DMT50

[198]

Mokshal H Porwal, BSc, Medical College of Wisconsin, Milwaukee, WI, Amber Salter, PhD, Washington University School in St. Louis, St Louis, MO and Ahmed Z Obeidat, MD, PhD, Department of Neurology, Medical College of Wisconsin, Milwaukee, WI

[194]

DMT50

[198]

Robert A. Bermel, MD1, Hans-Peter Hartung, MD2,3, Robert T. Naismith, MD4, Jacqueline A Nicholas, MD5, Timothy Vollmer, PhD6, Qing Wang, PhD7, Ben Townsend, PhD7, Hans-Martin Schneble, MD7, Regine Buffels, MD7 and Stephen L. Hauser, MD8, (1)Mellen Center for MS, Department of Neurology, Cleveland Clinic, Cleveland, OH, (2)Brain and Mind Centre, University of Sydney, Sydney, Australia, (3)Department of Neurology, UKD, Centre of Neurology and Neuropsychiatry and LVR-Klinikum, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany, (4)Washington University School of Medicine, St. Louis, MO, (5)OhioHealth Multiple Sclerosis Center, Columbus, OH, (6)Department of Neurology, University of Colorado School of Medicine, Aurora, CO, (7)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (8)UCSF Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA

[194]

DMT51

[198]

Regina Berkovich, MD, PhD1, Wing Chow, PharmD, MPH2, Qiujun Shao, PhD2, Magdaliz Gorritz, MPH3, Zifan Zhou, MS3, Hsiu-Ching Chang, PhD3 and Rolin L Wade, RPh, MS3, (1)Neurology Program, Los Angeles County and University of Southern California Medical Center, Los Angeles, CA, (2)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (3)IQVIA, Plymouth Meeting, PA

[194]

DMT51

[198]

Mokshal H Porwal, BSc, Medical College of Wisconsin, Milwaukee, WI, Dhruvkumar Patel, BMSc, Arizona College of Osteopathic Medicine, Glendale, AZ, Michelle Maynard, PharmD, BCPS, Neurosciences, Froedtert and the Medical College of Wisconsin, Milwaukee, WI and Ahmed Z Obeidat, MD, PhD, Department of Neurology, Medical College of Wisconsin, Milwaukee, WI

[194]

DMT51

[198]

Robert J. Fox, MD1, Christian Wolf, MD2, Matej Ondrus, MD3, Valentina Sciacca, RN3 and Andreas Muehler, MD3, (1)Mellen Center for Treatment and Research in Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, (2)Lycalis sprl, Brussls, Belgium, (3)Immunic AG, Gräfelfing, Germany

[194]

DMT52

[198]

Sarah Harris, PhD1, Giancarlo Comi, MD2, Bruce A.C. Cree, MD3, Douglas L. Arnold, MD4, Lawrence Steinman, MD5, James K. Sheffield, MD, MBA, MS1, Harry Southworth, PhD6, Rachel Maddux, PhD1, Ludwig Kappos, MD7 and Jeffrey A Cohen, MD8, (1)Bristol Myers Squibb, Princeton, NJ, (2)Vita-Salute San Raffaele University and Casa di Cura del Policlinico, Milan, Italy, (3)Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, (4)NeuroRx Research and Montréal Neurological Institute, McGill University, Montreal, QC, Canada, (5)Beckman Center for Molecular Medicine, Stanford University Medical Center, Stanford, CA, (6)Data Clarity Consulting Ltd., Stockport, United Kingdom, (7)Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, (8)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH

[194]

DMT52

[198]

Nicole Tsao, PhD, Shaobin Dong, MBA, Maria L Naylor, PhD, Qiang Hou, PhD and Mandakini Awasthy, MS, Biogen, Cambridge, MA

[194]

DMT52

[198]

Robert T. Naismith, MD1, Jeffrey A. Cohen, MD2, Amit Bar-Or, MD3, Giancarlo Comi, MD4, Krzysztof W. Selmaj, MD, PhD, DSc5, Hans-Peter Hartung, MD, FRCP, FEAN, FAAN, FANA6, James K. Sheffield, MD MBA MSMD7, Anthony Krakovich, MD, MPH7, Chun-Yen Cheng, MS7, Jennifer Reardon, MSN, ANP-BC, CNRN, MSCN7, Jon V. Riolo, MD7, Diego Silva, MD7 and Bruce A.C. Cree, MD8, (1)Department of Neurology, Washington University in St. Louis School of Medicine, St. Louis, MO, (2)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, (3)Center for Neuroinflammation and Experimental Therapeutics, and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (4)Vita-Salute San Raffaele University and Casa di Cura del Policlinico, Milan, Italy, (5)Center for Neurology, Lodz, Poland and Collegium Medicum, Department of Neurology, University of Warmia and Mazury, Olsztyn, Poland, (6)Department of Neurology, Palacky University Olomouc, Olomouc, Czech Republic, (7)Bristol Myers Squibb, Princeton, NJ, (8)Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA

[194]

DMT53

[198]

Sarah Harris, PhD1, Harry Southworth, PhD2, James K. Sheffield, MD1, Rachel Maddux, PhD1 and Jeffrey A. Cohen, MD3, (1)Bristol Myers Squibb, Princeton, NJ, (2)Data Clarity Consulting Ltd., Stockport, United Kingdom, (3)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH

[194]

DMT53

[198]

Patricia K. Coyle, MD1, Magdaliz Gorritz, MPH2, Rolin L Wade, RPh, MS2, Zifan Zhou, MS2, Yao Cao, MS2 and Chinmay Deshpande, PhD, BPharm3, (1)Department of Neurology, Stony Brook University, Stony Brook, NY, (2)IQVIA, Plymouth Meeting, PA, (3)Novartis Pharmaceuticals Corporation, East Hanover, NJ

[194]

DMT53

[198]

Robin L. Avila, PhD1, Julie Steverson, MS1, Liesel Dsilva, PhD1, Kerry McCarthy, BSN1 and Aaron Galluzzi, PhD2, (1)Biogen, Cambridge, MA, (2)Cytel, Cambridge, MA

[194]

DMT54

[198]

Sean J Pittock, M.D.1, Kerstin Allen, MA2, Yasmin Mashhoon, PhD2 and Marcus Yountz, MD2, (1)Mayo Clinic, Rochester, MN, (2)Alexion Pharmaceuticals, Boston, MA

[194]

DMT54

[198]

Ralph H.B. Benedict, PhD1, Iris-Katharina Penner, PhD2, Ludwig Kappos, MD3, Patrick Vermersch, MD, PhD4, Bruce A.C. Cree, MD, PhD, MAS5, Ralf Gold, MD6, Amit Bar-Or, MD7, Daniela Piani-Meier, PhD8, Shannon Ritter, MS8, Sophie Arnould, MSc8, Goeril Karlsson, PhD8, Frank Dahlke, MD8, Thomas Hach, MD8, Robert J. Fox, MD9 and Douglas L. Arnold, MD10,11, (1)Jacobs Multiple Sclerosis Center, University at Buffalo, Buffalo, NY, (2)Medical Faculty, Department of Neurology, Heinrich Heine University, COGITO Center for Applied Neurocognition and Neuropsychological Research, Dusseldorf, Germany, (3)Neurologic Clinic and Policlinic and Research Center for Clinical Neuroimmunology and Neuroscience, Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, (4)FHU Imminent, Univ. Lille, Inserm UMR U1172 LilNCog, CHU Lille, Lille, France, (5)UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, (6)Department of Neurology, St Josef-Hospital, Ruhr-University Bochum, Bochum, Germany, (7)Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (8)Novartis Pharma AG, Basel, Switzerland, (9)Mellen Center for Treatment and Research in Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, OH, (10)NeuroRx Research, Montreal, QC, Canada, (11)Brain Imaging Centre, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada

[194]

DMT54

[198]

Adrienne Castillo, NP1, Aaron Galluzzi, PhD2, Julie Steverson, MS3, Kerry McCarthy, BSN3, Liesel Dsilva, PhD3, Robin L. Avila, PhD3, Danette Rutledge, BSP, PhD3 and Revere P. Kinkel, MD4, (1)RUSH University Medical Group, Chicago, IL, (2)Cytel, Cambridge, MA, (3)Biogen, Cambridge, MA, (4)Department of Neurosciences, School of Medicine, University of California San Diego, La Jolla, CA

[194]

DMT55

[198]

Shiv Saidha, MBBCh, MD, MRCPI1, Judith Bell, BS2, Sydney Harold, MS2, Jose Marcano Belisario, PhD2, Emma Hawe, MS2, Qiujun Shao, PhD3, Kerri Wyse, Pharm.D., CCRC, CMD3 and Eric M. Maiese, PhD3, (1)Neurology, Johns Hopkins University, Baltimore, MD, (2)RTI Health Solutions, Manchester, United Kingdom, (3)Novartis Pharmaceuticals Corporation, East Hanover, NJ

[194]

DMT55

[198]

Renato Mantegazza, MD1, Todd Levine, MD2, Celia Oreja-Guevara, MD3, Cynthia Carrillo-Infante, MD4, Eva Laudon-Meyer, MD PhD4, Shulian Shang, PhD4, Sean J Pittock, M.D.5 and James F. Howard Jr., MD6, (1)Fondazione IRCCS, Istituto Neurologico Carlo Besta, Milan, Italy, (2)Phoenix Neurological Associates, Phoenix, AZ, (3)Hospital Universitario Clinico San Carlos, Madrid, Spain, (4)Alexion Pharmaceuticals, Boston, MA, (5)Mayo Clinic, Rochester, MN, (6)Department of Neurology, University of North Carolina, Chapel Hill, NC

[194]

DMT55

[198]

Samuel F. Hunter, MD, PhD1, John W. Lindsey, MD2, Benjamin Osborne, MD3, Bethany Schreiber, NP3, Filipe Branco, MSc4, Seth Levin, MD5, James B. Lewin, PharmD5, Matthew Scaramozza, MS5, Zhe Tian, MSc5 and Ariel Antezana, MD6, (1)Advanced Neurosciences Institute, Franklin, TN, (2)Multiple Sclerosis And Neuroimmunology, McGovern Medical School, Houston, TX, (3)Department of Neurology, MedStar Georgetown University Hospital, Washington, DC, (4)Biogen, Baar, Switzerland, (5)Biogen, Cambridge, MA, (6)Neuromedical Clinic of Central Louisiana, Alexandria, LA

[194]

DMT56

[198]

Silvia R Delgado, MD1, Lilyana Amezcua, MD2, Stanley L Cohan, MD, PhD3, Jeffrey A Cohen, MD4, Le H Hua, MD5, Elisabeth B Lucassen, MD6, Xiangyi Meng, PhD6, Mitzi J Williams, MD7 and James Stankiewicz, MD6, (1)Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, (2)Keck School of Medicine, University of Southern California, Los Angeles, CA, (3)Providence Multiple Sclerosis Center, Providence Brain Institute, Portland, OR, (4)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, (5)Lou Ruvo Center for Brain Health, Las Vegas, NV, (6)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (7)Joi Life Wellness, MS Neurology Center, Smyrna, GA

[194]

DMT56

[198]

Douglas L. Arnold, MD1,2, Ludwig Kappos, MD3, Patrick Vermersch, MD, PhD4, Ralf Gold, MD5, Amit Bar-Or, MD6, Gavin Giovannoni, MD, PhD7, Bruce A.C. Cree, MD, PhD, MAS8, Daniela Piani-Meier, PhD9, Shannon Ritter, MS10, Goeril Karlsson, PhD9, Frank Dahlke, MD9, Thomas Hach, MD9 and Robert J. Fox, MD11, (1)NeuroRx Research, Montreal, QC, Canada, (2)Brain Imaging Centre, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada, (3)Neurologic Clinic and Policlinic and Research Center for Clinical Neuroimmunology and Neuroscience, Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, (4)FHU Imminent, Univ. Lille, Inserm UMR U1172 LilNCog, CHU Lille, Lille, France, (5)Department of Neurology, St Josef-Hospital, Ruhr-University Bochum, Bochum, Germany, (6)Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (7)Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, (8)UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, (9)Novartis Pharma AG, Basel, Switzerland, (10)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (11)Mellen Center for Treatment and Research in Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, OH

[194]

DMT56

[198]

Elias Abou Zeid, PhD, Xiaoyu Jiang, PhD, Larry Orogun, MD, MSc, Hillol Sarker, PhD and Sana Syed, MD, MPH, Sanofi, Cambridge, MA

[194]

DMT57

[198]

Sybil Wray, MD1, Cong Zhu, PhD2, Barry A Singer, MD3, Jelena Drulovic, MD, PhD4, Donald Negroski, MD5, Valencia Hood-Humphrey, MSc2, Sai L Shankar, PhD2, Seth Levin, MD2, Shivani Kapadia, PharmD, RPh2 and Florian Then Bergh, MD6, (1)Hope Neurology, Knoxville, TN, (2)Biogen, Cambridge, MA, (3)The MS Center for Innovations in Care, Missouri Baptist Medical Center, St. Louis, MO, (4)Clinic of Neurology, University of Belgrade, Belgrade, Serbia, (5)MS Center of Sarasota, Sarasota, FL, (6)Department of Neurology, University of Leipzig, Leipzig, Germany

[194]

DMT57

[198]

[194]

DMT57

[198]

Robert J. Fox, MD1, Jiwon Oh, MD, PhD2, Douglas L. Arnold, MD3,4, Sana Syed, MD, MPH5, Zhixing Xu, PhD6, Timothy J. Turner, PhD5, Anthony Traboulsee, MD7 and Daniel S. Reich, MD, PhD8, (1)Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, (2)St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada, (3)NeuroRx Research and Montreal Neurological Institute, McGill University, Montreal, QC, Canada, (4)NeuroRx Research, Montreal, QC, Canada, (5)Sanofi, Cambridge, MA, (6)Sanofi, Bridgewater, NJ, (7)University of British Columbia, Vancouver, BC, Canada, (8)National Institute of Neurological Disorders and Stroke, Bethesda, MD

[194]

DMT58

[198]

Tyler Kaplan, MD, Neurology, Loyola University Medical Center, Chicago, IL and Jeffrey Kaplan, MD, Kansas City Multiple Sclerosis Center, College Park Specialty Center, Overland Park, KS

[194]

DMT58

[198]

Rose-Marie M Jungquist, B.S.1, Martin Malik, B.S.2, Zoe Rimler, B.S.2, Elizabeth A Douglas, MPH1, Andrew J Bouley, M.D.1, Ellen S Lathi, M.D.1, Joshua D Katz, M.D.1 and Ilya Kister, MD3, (1)The Elliot Lewis Center for Multiple Sclerosis Care, Wellesley, MA, (2)Neurology, NYU Langone Health, New York, NY, (3)Multiple Sclerosis Comprehensive Care Center, Barnabas Health Medical Group, Livingston, NJ

[194]

DMT58

[198]

Sarah A. Morrow, MD, MS, FRCPC, FAAN1, Robert Zivadinov, MD, PhD2, John DeLuca, PhD3, Jon V. Riolo, MD4, Chun-Yen Cheng, MS4, Sibyl Wray, MD5, Ann Bass, MD6, Edward Fox, MD, PhD, FAAN7, Emily Riser, MD8, Burhan Chaudhry, MD4, Jennifer Reardon, MSN, ANP-BC, CNRN, MSCN4, Diego Silva, MD4 and Robert T. Naismith, MD9, (1)London Health Sciences Centre, University Hospital, University of Western Ontario, London, ON, Canada, (2)Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, (3)Kessler Foundation, West Orange, New Jersey, and Departments of Physical Medicine and Rehabilitation, and Neurology, Rutgers – New Jersey Medical School, Newark, NJ, (4)Bristol Myers Squibb, Princeton, NJ, (5)Hope Neurology MS Center, Knoxville, TN, (6)Neurology Center of San Antonio, San Antonio, TX, (7)Central Texas Neurology Consultants, Round Rock, TX, (8)Alabama Neurology Associates, Birmingham, AL, (9)Department of Neurology, Washington University in St. Louis School of Medicine, St. Louis, MO

[194]

DMT59

[198]

Emma McFadden, PhD and Virginia R. Schobel, MSc, Neurology, Spherix Global Insights, Exton, PA

[194]

DMT59

[198]

Rosie M Jungquist, B.S., Elizabeth A Douglas, MPH, Andrew J Bouley, M.D., Ellen S Lathi, M.D. and Joshua D Katz, M.D., The Elliot Lewis Center for Multiple Sclerosis Care, Wellesley, MA

[194]

DMT59

[198]

Selmaj W. Krzysztof, MD, PhD, DSc1, Jeffrey A. Cohen, MD2, Lawrence Steinman, MD3, Giancarlo Comi, MD4, Amit Bar-Or, MD5, Hans-Peter Hartung, MD, FRCP, FEAN, FAAN, FANA6, Xavier Montalban, MD, PhD7, Ludwig Kappos, MD8, James K. Sheffield, MD MBA MSMD9, Anthony Krakovich, MD, MPH9, Chun-Yen Cheng, MS9, Jon V. Riolo, MD9, Diego Silva, MD9 and Bruce A.C. Cree, MD10, (1)Center for Neurology, Lodz, Poland, and Collegium Medicum, Department of Neurology, University of Warmia and Mazury, Olsztyn, Poland, (2)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, (3)Department of Neurology and Neurological Sciences, Beckman Center for Molecular Medicine, Stanford University Medical Center, Stanford, CA, (4)Vita-Salute San Raffaele University and Casa di Cura del Policlinico, Milan, Italy, (5)Center for Neuroinflammation and Experimental Therapeutics, and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (6)Department of Neurology, Palacky University Olomouc, Olomouc, Czech Republic, (7)Department of Neurology-Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d’Hebron, Barcelona, Spain, (8)Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, (9)Bristol Myers Squibb, Princeton, NJ, (10)Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA

[194]

DMT60

[198]

Radmila Karan, MD, Merck KGaA, Darmstadt, Germany, Darmstadt, Germany, Sanjeev Roy, MD, Merck KGaA, Darmstadt, Germany, Aubonne, Switzerland and Nektaria Alexandri, MD, MSc, Neurology and Immunology, Merck KGaA, Darmstadt, Germany, Darmstadt, Germany

[194]

DMT61

[198]

Sean J Pittock, M.D.1, Kazuo Fujihara, MD2,3,4, Jacqueline Palace, DM5, Achim Berthele, MD6, Ho Jin Kim, MD, PhD7, Celia Oreja-Guevara, MD8, Ichiro Nakashima, MD, PhD3,9, Michael Levy, MD, PhD10,11, Shulian Shang, PhD12, Marcus Yountz, MD12, Larisa Miller, PharmD12, Roisin Armstrong, PhD12 and Dean Wingerchuk, M.D.13, (1)Mayo Clinic, Rochester, MN, (2)Southern TOHOKU Research Institute for Neuroscience (STRINS), Koriyama, Japan, (3)Tohoku University, Sendai, Japan, (4)Fukushima Medical University, Fukushima City, Japan, (5)John Radcliffe Hospital, Oxford, United Kingdom, (6)Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany, (7)Research Institute and Hospital, National Cancer Center, Goyang, Korea, Republic of (South), (8)Hospital Universitario Clinico San Carlos, Madrid, Spain, (9)Tohoku Medical and Pharmaceutical University, Sendai, Japan, (10)Massachusetts General Hospital and Harvard Medical School, Boston, MA, (11)Johns Hopkins University, Baltimore, MD, (12)Alexion Pharmaceuticals, Boston, MA, (13)Mayo Clinic, Scottsdale, AZ

[194]

DMT61W

[198]

Ali Ghadiri, Student1, Sharon R Tingen, PharmD, BCPS, MSCS2, Rylan Q Pearsall, Student3 and Myla D Goldman, MD, Msc2, (1)VCU, Richmond, VA, (2)Neurology, VCU Health, Richmond, VA, (3)College of Arts & Sciences, University of Virginia, Charlottesville, VA

[194]

DMT62

[198]

Sibyl Wray, MD1, Marco Salvetti, MD2, Gereon Nelles, MD3, Arman Altincatal, MS4, Nydjie Grimes, MPH, BA4, Achint Kumar, MBBS, MD4 and Maria L Naylor, PhD4, (1)Hope Neurology MS Center, Knoxville, TN, (2)Sapienza University, S. Andrea Hospital, Rome, Italy, (3)Neurology, NeuroMed Campus Hohenlind, Cologne, Germany, (4)Biogen, Cambridge, MA

[194]

DMT62

[198]

Krzysztof W. Selmaj, MD, PhD, DSc1, Karsten Roth, PhD2, Josef Höfler, PhD3, Rafa? Derlacz, PhD2, Klaus Vitzithum, PhD2, Cyrill Hornuss, MD4, Oliver von Richter, PhD4, Johann Poetzl, PhD4, Laura Jacobs, PhD4 and Steven Hall, PharmD5, (1)Center for Neurology, Lodz, Poland, and Collegium Medicum, Department of Neurology, University of Warmia and Mazury, Olsztyn, Poland, (2)Polpharma Biologics S.A., Gdansk, Poland, (3)Staburo GmbH, Munich, Germany, (4)Hexal AG (A Sandoz company), Holzkirchen, Germany, (5)Sandoz Inc. / Sandoz Biopharmaceuticals, Princeton, NJ

[194]

DMT63

[198]

Silvia Delgado, MD1, Mitzi J Williams, MD2, Morten Bagger, PhD3, Gordon Graham, PhD3, Etienne Pigeolet, PhD3, Huixin Yu, PhD3, Dieter A. Haering, PhD3, Roman Willi, PhD3, Cecile Kerloeguen, MSc3, Chao Xu, PhD4, Masaru Hirano, PhD5, Dee Stoneman, MPharm3, Wendy Su, PhD6, Krishnan Ramanathan, PhD3 and Jin Nakahara, MD, PhD7, (1)Neurology, University of Miami Miller School of Medicine, Miami, FL, (2)Joi Life Wellness MS Center, Atlanta, GA, (3)Novartis Pharma AG, Basel, Switzerland, (4)China Novartis Institute of Biomedical Research, Shanghai, China, (5)Novartis Pharmaceutics, K.K., Tokyo, Japan, (6)Autoimmune, TG Therapeutics, Inc, New York, NY, (7)Department of Neurology, Keio University School of Medicine, Tokyo, Japan

[194]

DMT63

[198]

Svetlana M Khanin, Bachelors1, Emily Demmon, Bachelors2 and Jai Perumal, MD2, (1)CUNY, Brooklyn College, Brooklyn, NY, (2)Neurology, Weill Cornell Medical College, New York, NY

[194]

DMT64

[198]

Smathorn Thakolwiboon, MD1, Hannah Zhao-Fleming, MD, PhD2, Amputch Karukote, MD1 and Mirla Avila, MD1, (1)Neurology, Texas Tech University Health Sciences Center, Lubbock, TX, (2)Neurology, Mayo Clinic, Rochester, MN

[194]

DMT64

[198]

Tammy Hoyt, MS1, Angelene Christensen, BS1, Katrina Bawden, MSN, MSCN, FNP-C1 and John Foley, MD2, (1)Rocky Mountain MS Research Group, Salt Lake City, UT, (2)Rocky Mountain MS Clinic, Salt Lake City, UT

[194]

DMT65

[198]

Sonia Afsari, MD1, Alyssa Henry, MD1, Giancarlo Comi, MD2, Marla C. Dubinsky, MD3, Uma Mahadevan, MD4, Lorna Charles, MD1, C. Janneke van der Woude, MD, PhD5 and Krzysztof Selmaj, MD6, (1)Bristol Myers Squibb, Princeton, NJ, (2)University Vita-Salute San Raffaele, Milan, Italy, (3)Icahn School of Medicine, Mount Sinai, NY, (4)University of California San Francisco, San Francisco, CA, (5)Erasmus MC, Rotterdam, Netherlands, (6)Center for Neurology, Lodz, Poland

[194]

DMT65

[198]

Ross C. Gruber, PhD1, Anna S. Blazier, PhD2, Lan Lee, MS1, Sean Ryan, PhD1, Agnes Cheong, PhD1, Evis Havari, MSc, MBA1, Timothy J. Turner, PhD2 and Dimitry Ofengeim, PhD2, (1)Sanofi, Framingham, MA, (2)Sanofi, Cambridge, MA

[194]

DMT66

[198]

Stanley Cohan, MD, PhD1, Le H. Hua, MD2, Amit Bar-Or, MD3, Fred D. Lublin, MD4, Xiangyi Meng, PhD5, Gina Mavrikis Cox, PhD5, Patricia K. Coyle, MD6 and Robert J. Fox, MD7, (1)Providence Brain and Spine Institute, and Providence Multiple Sclerosis Center, Providence Health & Services, Portland, OR, (2)Lou Ruvo Center for Brain Health, Las Vegas, NV, (3)Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (4)Icahn School of Medicine at Mount Sinai, New York, NY, (5)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (6)Multiple Sclerosis Comprehensive Care Center, Stony Brook University, Stony Brook, NY, (7)Mellen Center for Treatment and Research in Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, OH

[194]

DMT66

[198]

Timothy J. Turner, PhD1, Olivier Nicolas, PhD, PharmD2, Priscilla Brun, MSc2, Dimitry Ofengheim, PhD1 and Ross C. Gruber, PhD3, (1)Sanofi, Cambridge, MA, (2)Sanofi, Montpelier, France, (3)Sanofi, Framingham, MA

[194]

DMT67

[198]

Stephanie L Reyes, BA, University of Michigan Medical School, Ann Arbor, MI and Andrew Romeo, MD, Neurology, University of Michigan, Ann Arbor, MI

[194]

DMT68

[198]

Thomas Finnegan, PhD1, Catherine Murray, MA1, John Maeglin, BA1 and Patricia K. Coyle, MD2, (1)Medscape Education, New York, NY, (2)Department of Neurology, Stony Brook University, Stony Brook, NY

[194]

DMT69

[198]

Gavin Giovannoni, MD, PhD, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, Aida Aydemir, MSc, EMD Serono Research & Development Institute Inc., Billerica, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany, Billerica, MA, Elisabetta Verdun di Cantogno, MD, PhD, Merck KGaA, Darmstadt, Germany, Thomas P. Leist, MD, Comprehensive Multiple Sclerosis Center, Division of Clinical Neuroimmunology, Jefferson University, Philadelphia, PA and CLASSIC-MS Steering Committee

[194]

DMT70

[198]

Tyler E Smith, M.D.1, Maya Madhavan, M.D.1, Daniel Gratch, M.D.1, Aneek Patel, B.S.2, Valerie Saha, NP1, Carrie Sammarco, DrNP1, Zoe Rimler, B.S.1, Guadalupe Zuniga, .1, Dunia Gragui, .1, Leigh E Charvet, PhD1, Gary Cutter, PhD3, Lauren Krupp, MD1, Ilya Kister, MD1 and Lana Zhovtis Ryerson, M.D.1, (1)Neurology, NYU Langone Health, New York, NY, (2)NYU School of Medicine, New York, NY, (3)University of Alabama at Birmingham, Birmingham, AL

[194]

DMT71

[198]

Virginia R. Schobel, MSc, Spherix Global Insights, Exton, PA

[194]

DMT72

[198]

Virginia R. Schobel, MSc, Spherix Global Insights, Exton, PA

[194]

DMT73

[198]

[194]

DMT74

[198]

[194]

DMT75

[198]

Timothy Vollmer, MD1, Daniel Pelletier, MD2, Sibyl Wray, MD3, Barry Hendin, MD4, Linda-Ali Cruz, MD5, James Stankiewicz, MD5, Ratnakar Pingili, MBBS5, Xiangyi Meng, PhD5, Andy Cheadle, PhD5 and Jeffrey A Cohen, MD6, (1)Rocky Mountain MS Center, Aurora, CO, (2)Multiple Sclerosis Comprehensive Care Center At USC, Los Angeles, CA, (3)Hope Neurology, Knoxville, TN, (4)Center for Neurology and Spine, Phoenix, AZ, (5)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (6)Cleveland Clinic Mellen Center, Cleveland, OH

[194]

DMX01

[198]

Tatum M Moog, B.S., Alexander D Smith, B.S., Katy W Burgess, PA-C, Morgan McCreary, PhD and Darin T Okuda, MD, Neurology, UT Southwestern Medical Center, Dallas, TX

[194]

DMX02

[198]

Emma Chase, MS1,2, Michael A Lane, MD2,3, Priya Srikanth, MS4, Lindsey Wooliscroft, MD, MCR5,6, Elizabeth Silbermann, MD2,4, Vicky Chen, MD2,4, Kayla Martin, MD2,4, Christopher Hollen, MD2,4, Claire Adams, MS4, Carly Vong, MPH4, Anna Orban, BS4, Allison Fryman, MPH2, Jessica Rice, MD2,4, Angela Horgan, PhD7, Akram Khan, MD7 and Vijayshree Yadav, MD2,4, (1)Neurology, Oregon Health & Science University, Portand, OR, (2)VA Portland Health Care System, Portland, OR, (3)Neurology, Oregon Health & Science University, Porltand, OR, (4)Neurology, Oregon Health & Science University, Portland, OR, (5)Department of Neurology, Oregon Health & Science University, Portland, OR, (6)MS Center of Excellence, VA Portland Health Care System, Portland, OR, (7)Oregon Health & Science University, Portland, OR

[194]

DMX03

[198]

Valerie J Block, PT, DPTSc, Physical Therapy and Rehabilitation Science, University of California San Francisco, San Francisco, CA; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, Anne M Suskind, MD, FACS, MS, Urology, University of California San Francisco, San Francisco, CA and Riley Bove, MD, Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA

[194]

DMX04

[198]

Farren B.S. Briggs, PhD, ScM1, Tucker Harvey, MS2, Kathryn C. Fitzgerald, ScD3, Ellen M Mowry, MD, MCR3, Jeffrey A. Cohen, MD4 and Daniel Ontaneda, MD PhD4, (1)Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, (2)Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, (3)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (4)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH

[194]

DMX05

[198]

Jennifer Graves, MD PhD MAS, University of California San Diego, San Diego, CA, Tanja Kuhlmann, MD, University Hospital Münster, Münster, Germany, Marcello Moccia, MD, Federico II University of Naples, Naples, Italy, Timothy Coetzee, PhD, National MS Society, New York, NY, Jeffrey A. Cohen, MD, Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, Jorge Correale, MD, FLENI Institute, Buenos Aires, Argentina, Ruth Ann Marrie, MD, PhD, FRCPC, University of Manitoba, Winnipeg, MB, Canada, V. Wee Yong, PhD, University of Calgary, Calgary, AB, Canada, Xavier Montalban, MD PhD, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d’Hebron, Barcelona, Spain, Alan J Thompson, MD, University College London, London, United Kingdom, Daniel S. Reich, MD, PhD, National Institute of Neurological Disorders and Stroke, Bethesda, MD and the International Advisory Committee on Clinical Trials in MS

[194]

DMX06

[198]

Nahid Iseyas, MD Candidate, Temerty Faculty of Medicine, The University of Toronto, Toronto, ON, Canada, Samantha Stephens, PhD, Department of Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada and Ann Yeh, M.D., Dept. of Paediatrics, Div. of Neurology, The Hospital for Sick Children, Toronto, ON, Canada

[194]

DP01

[198]

Anna Kazimirchik, RN MSCN, Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada

[194]

DP02

[198]

Erika Mitchell, FNP-C and Faria Amjad, MD, Neurology, MedStar Georgetown University Hospital, Washington, DC

[194]

DP03

[198]

Helena Bulka, DO, Suzanne Croll, BSc, Stanton Elias, MD and Mirela Cerghet, MD, PhD, Neurology, Henry Ford Hospital, Detroit, MI

[194]

DP04

[198]

Jay H Rosenberg, MD, Staff Physician MS Center of Southern CA, Carlsbad, CA and Michael Zorniak, Ph.D., MSL at Teva Pharmaceuticals, San Diego, CA

[194]

DP05

[198]

Joseph J Sabatino Jr., MD/PhD, Neurology, Johns Hopkins Hospital, Baltimore, MD and Scott D Newsome, D.O., Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD

[194]

DP06

[198]

Joshua D Katz, M.D.1, Ellen S Lathi, M.D.1, Lauren M Heyda, B.S.1 and David Titelbaum, M.D.2, (1)The Elliot Lewis Center for Multiple Sclerosis Care, Brighton, MA, (2)Shields MRI, Brockton, MA

[194]

DP07

[198]

Kathryn B Holroyd, BA1, Kathryn Fitzgerald, ScD2, Scott D Newsome, D.O.3, Shiv Saidha, MD4, Peter A Calabresi, MD4 and Ellen Mowry, MD, MCR5, (1)School of Medicine, Johns Hopkins, Baltimore, MD, (2)Neurology, Johns Hopkins Hospital, Baltimore, MD, (3)Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, (4)Neurology, Johns Hopkins University, Baltimore, MD, (5)Neurology, Johns Hopkins School of Medicine, Baltimore, MD

[194]

DP08

[198]

Weredeselam M Olango, MD, Larysa Gromko, MD, Michael Jaker, MD and Machteld Hillen, MD, Neurology, Rutgers NJMS, Newarks, NJ

[194]

DP09

[198]

Weredeselam M Olango, MD and Machteld Hillen, MD, Neurology, Rutgers NJMS, Newarks, NJ

[194]

DX01

[198]

Thomas Carattini, PharmD1, Emeline Bacque, PharmD1, Karl Wisseman, N/A2, Elizabeth Poole, PhD1, Lori Fafard, RN, BSN, CNRN, MSCN, CCRP2, Myassar Zarif, MD2, Marijean Buhse, NP-C, PhD2, Karen Blitz, DO2, Jared Srinivasan, N/A2, Carly Skudin, N/A3, Samy Zarif, N/A2, Barbara Bumstead, MS, ANCP, MSCN2, Lobat Hashemi, ScD1 and Mark Gudesblatt, MD2, (1)Sanofi, Cambridge, MA, (2)South Shore Neurologic Associates, Patchogue, NY, (3)Colgate University, Hamilton, NY

[194]

DX01

[198]

Amy Lovett-Racke, PhD1, Yue Liu, MS1, Michael K Racke, MD2, Sibyl Wray, MD3, Richard Shubin, MD4, Cary L Twyman, MD5, Wendy Su, PhD6, James Eubanks, PhD6 and Edward J. Fox, MD, PhD7, (1)Microbial Infection and Immunity, Ohio State University Medical Center, Columbus, OH, (2)Wexner Medical Center, Ohio State University, Columbus, OH, (3)Hope Neurology Multiple Sclerosis Center, Knoxville, TN, (4)SC3 Research Group, Inc, Pasadena, CA, (5)Associates in Neurology PSC, Lexington, KY, USA, Lexington, KY, (6)Autoimmune, TG Therapeutics, New York, NY, (7)Central Texas Neurology Consultants, Round Rock, TX

[194]

DX01

[198]

Annette Okai, MD1, Keith R Edwards, MD2, Brian Steingo, MD3, David H Margolin, MD, PhD4, Sourav Santra, PhD4 and Mitzi J. Williams, MD5, (1)Multiple Sclerosis Treatment Center of Dallas, Dallas, TX, (2)Multiple Sclerosis Center of Northeastern New York, Latham, NY, (3)Fort Lauderdale Multiple Sclerosis Center, Pompano Beach, FL, (4)Genzyme, a Sanofi company, Cambridge, MA, (5)Multiple Sclerosis Center of Atlanta, Atlanta, GA

[194]

DX02

[198]

Thomas Carattini, PharmD1, Emeline Bacque, PharmD1, Karl Wisseman, N/A2, Elizabeth Poole, PhD1, Lori Fafard, RN, BSN, CNRN, MSCN, CCRP2, Myassar Zarif, MD2, Marijean Buhse, NP-C, PhD2, Karen Blitz, DO2, Jared Srinivasan, N/A2, Sean Tan, N/A2, Michael Zarif, N/A2, Haneet Chadha, N/A2, Barbara Bumstead, MS, ANCP, MSCN2, Lobat Hashemi, ScD1 and Mark Gudesblatt, MD2, (1)Sanofi, Cambridge, MA, (2)South Shore Neurologic Associates, Patchogue, NY

[194]

DX02

[198]

Barry A Singer, MD1, Simon Broadley, MD2, Angel Chinea, MD3, Mark S Freedman, MD4, Guillermo Izquierdo, MD5, Jan Lycke, MD6, Basil Sharrack, MD, PhD7, Brian Steingo, MD8, Heinz Wiendl, MD9, Sibyl Wray, MD10, David H Margolin, MD, PhD11, Sourav Santra, PhD12, Karthinathan Thangavelu, PhD11, Aaron Boster, MD13 and on behalf of the CARE-MS II and CAMMS03409 Investigators, n/a14, (1)MS Center for Innovations in Care, Missouri Baptist Medical Center, St Louis, MO, (2)School of Medicine, Gold Coast Campus, Griffith University, Gold Coast, Australia, (3)San Juan Multiple Sclerosis Center, San Juan, PR, (4)University of Ottawa and the Ottawa Hospital Research Institute, Ottowa, ON, Canada, (5)Virgen Macarena University Hospital, Seville, Spain, (6)University of Gothenburg, Gothenburg, Sweden, (7)Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom, (8)Fort Lauderdale Multiple Sclerosis Center, Fort Lauderdale, FL, (9)University of Munster, Munster, Germany, (10)Hope Neurology Multiple Sclerosis Center, Knoxville, TN, (11)Sanofi Genzyme, Cambridge, MA, (12)Cytel, Cambridge, MA, (13)Ohio State University, Columbus, OH, (14)MA

[194]

DX02

[198]

Christopher LaGanke, MD1, Aaron Boster, MD2, Samuel F. Hunter, MD, PhD3, David H Margolin, MD, PhD4, Karthinathan Thangavelu, PhD4 and Eva Havrdova, MD, PhD5, (1)North Central Neurology Associates, Cullman, AL, (2)OhioHealth Neurological Physicians, Columbus, OH, (3)Advanced Neurosciences Institute, Franklin, TN, (4)Genzyme, a Sanofi company, Cambridge, MA, (5)Department of Neurology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic

[194]

DX03

[198]

Kristen R. Taylor Meadows, PhD, Kevin C. Dines, PhD, Gregory J. Opiteck, PhD and Fiona L. Scott, PhD, Receptos, a wholly owned subsidiary of Celgene, San Diego, CA

[194]

DX03

[198]

Devyn Parsons, BSc1, Virginia Devonshire, MD2, Robert Carruthers, MD2, Lorne Kastrukoff, MD2 and Anthony Traboulsee, MD1, (1)University of British Columbia, Vancouver, BC, Canada, (2)Neurology, University of British Columbia, Vancouver, BC, Canada

[194]

DX03

[198]

J Theodore Phillips, MD, PhD, FAAN1, Amit Bar-Or, MD, FRCPC2, Ralf Gold, MD3, Gavin Giovannoni, MBBCh, PhD4, Robert J Fox, MD, FAAN5, James Potts, PhD6, Teesta Soman, MD, MBA6 and Jing L Marantz, MD, PhD6, (1)Multiple Sclerosis Program, Baylor Institute for Immunology Research, Dallas, TX, (2)Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada, (3)Neurology, St. Josef Hospital, Ruhr University, Bochum, Germany, (4)Queen Mary University of London, Blizard Institute, London, United Kingdom of Great Britain and Northern Ireland, (5)Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, (6)Biogen, Cambridge, MA

[194]

DX04

[198]

Robert W Baumhefner, MD, neurology, VA West Los Angeles MC, Los Angeles, CA

[194]

DX04

[198]

Gavin Giovannoni, MD1, Giancarlo Comi, MD2, Stuart Cook, MD3, Peter Rieckmann, MD4, Kottil Rammohan, MD5, Per Soelberg-Sorensen, MD6, Patrick Vermersch, MD7, Abidemi Adeniji, PhD8 and Fernando Dangond, MD8, (1)Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom, (2)University Vita-Salute San Raffaele, Milan, Italy, (3)Rutgers, The State University of New Jersey, Newark, NJ, (4)Akademisches Krankenhaus Sozialstiftung Bamberg, Bamberg, Germany, (5)Ohio State University Hospital, Columbus, OH, (6)Copenhagen University Hospital, Copenhagen, Denmark, (7)Univ. Lille, CHU Lille, LIRIC – INSERM U995, Lille, France, (8)EMD Serono, Inc., Billerica, MA

[194]

DX04

[198]

Jai Perumal, MD1, Roumen Balabanov, MD2, Mary-Jean Fanelli, MD3, Christophe Hotermans, MD3, Allie McGinty, BA3, Qunming Dong, MD3, Laura J Balcer, MD, MSCE4, Steven Galetta, MD5, Jeffrey B English, MD6, Robert J Fox, MD, FAAN7, Lily Lee, MD3 and Denise Campagnolo, MD3, (1)Judith Jaffe Multiple Sclerosis Center, New York, NY, (2)Rush University Multiple Sclerosis Center, Chicago, IL, (3)Biogen, Cambridge, MA, (4)Neurology, New York University Langone Medical Center, New York, NY, (5)New York University Langone Medical Center, New York, NY, (6)Multiple Sclerosis Center of Atlanta, Atlanta, GA, (7)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH

[194]

DX05

[198]

Edward J. Fox, MD, PhD1, Fred Lublin, MD2, Jerry S Wolinsky, MD3, Jeffrey A Cohen, MD4, Xiangyi Meng, PhD5, Marina Ziehn, PhD5, Scott Kolodny, MD5, Norman Putzki, MD5 and Bruce AC Cree, MD, PhD6, (1)Central Texas Neurology Consultants, Round Rock, TX, (2)Icahn School of Medicine at Mount Sinai, New York, NY, (3)McGovern Medical School, UTHealth, Houston, TX, (4)Cleveland Clinic Foundation, Cleveland, OH, (5)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (6)UCSF Neurology, Weill Institute for Neurosciences, San Francisco, CA

[194]

DX05

[198]

Giancarlo Comi, MD1, Douglas L Arnold, MD2, Amit Bar-Or, MD2, Krzysztof Selmaj, MD, PhD3, Lawrence Steinman, MD4, Eva Havrdova, MD5, Bruce AC Cree, MD6, Hans-Peter Hartung, MD7, Ludwig Kappos, MD8, Brett E Skolnick, PhD9 and Jeffrey A Cohen, MD10, (1)Vita-Salute San Raffaele University, Milan, Italy, (2)Montreal Neurological Institute and Hospital McGill University, Montreal, QC, Canada, (3)Medical Academy of Lodz, Lodz, Poland, (4)Stanford University School of Medicine, Stanford, CA, (5)Charles University, Prague, Czech Republic, (6)Multiple Sclerosis Center, San Francisco, CA, (7)Heinrich-Heine-University Dusseldorf, Dusseldorf, Germany, (8)University of Basel, Basel, Switzerland, (9)Receptos Services LLC, San Diego, CA, (10)Mellen Center U-10 Cleveland Clinic, Cleveland, OH

[194]

DX05

[198]

Richard A Nash, MD1, George J Hutton, MD2, Michael K Racke, MD3, Uday Popat, MD4, Steven M Devine, MD3, George E Georges, MD5,6, Linda M Griffith, MD PhD7, Paolo A Muraro, MD8, Harry Openshaw, MD9, Peter Sayre, MD10,11, Olaf Stuve, MD12, Douglas L Arnold, MD13, Kaitlyn C McConville, MS14, Annette Wundes, MD15, George H Kraft, MD15 and James D Bowen, MD16, (1)Colorado Blood Cancer Institute, Denver, CO, (2)Baylor College of Medicine, Houston, TX, (3)The Ohio State University Wexner Medical Center, Columbus, OH, (4)MD Anderson Cancer Center, Houston, TX, (5)Fred Hutchinson Cancer Research Center, Seattle, WA, (6)University of Washington, Seattle, WA, (7)National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, (8)Imperial College, London, United Kingdom, (9)City of Hope National Medical Center, Duarte, CA, (10)Immune Tolerance Network, San Francisco, CA, (11)University of California San Francisco, San Francisco, CA, (12)University of Texas Southwestern Medical Center at Dallas, Dallas, TX, (13)McGill University, Montreal, QC, Canada, (14)Rho Federal Systems Division, Inc., Chapel Hill, NC, (15)Rehabilitation Medicine, University of Washington, Seattle, WA, (16)Swedish Medical Center, Seattle, WA

[194]

DX06

[198]

Barry A Singer, MD1, Raed Alroughani, MD2, Aaron Boster, MD3, Ann D. Bass, MD4, Regina Berkovich, MD, PhD5, Giancarlo Comi, MD6, Oscar Fernandez, MD7, Ho Jin Kim, MD8, Volker Limmroth, MD, PhD9, Jan Lycke, MD10, Richard AL Macdonell, MD11, Basil Sharrack, MD, PhD12, Patrick Vermersch, MD13, Heinz Wiendl, MD14, Tjalf Ziemssen, MD, PhD15, Maria Melanson, MD, PhD16, Nadia Daizadeh, PhD16, Anthony Traboulsee, MD17 and on behalf of the CARE-MS II and CAMMS03409, Investigators18, (1)MS Center for Innovations in Care, Missouri Baptist Medical Center, St. Louis, MO, (2)Amiri Hospital, Sharq, Kuwait, (3)OhioHealth Neurological Physicians, Columbus, OH, (4)Neurology Center of San Antonio, San Antonio, TX, (5)University of Southern California, Keck School of Medicine, Los Angeles, CA, (6)University Vita-Salute San Raffaele, Milan, Italy, (7)Fundacion IMABIS, Hospital Universitario Carlos Haya, Malaga, Spain, (8)Research Institute and Hospital of National Cancer Center, Goyang, Korea, Republic of (South), (9)Klinik fur Neurologie und Palliativmedizin, Cologne, Germany, (10)Sahlgrenska University Hospital, Gothenburg, Sweden, (11)Austin Health and Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia, (12)Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom, (13)University of Lille, Lille, France, (14)University of Munster, Munster, Germany, (15)Carl Gustav Carus University Hospital, Dresden, Germany, (16)Sanofi, Cambridge, MA, (17)University of British Columbia, Vancouver, BC, Canada, (18)on behalf of the CARE-MS II and CAMMS03409 Investigators, NJ

[194]

DX06

[198]

Mary Ann Picone, MD1, Laura Schiraldi, MS2, Fred Foley, PhD1 and Jeffrey Portnoy, PhD Candidate1, (1)Holy Name Medical Center, Teaneck, NJ, (2)Touro College of Osteopathic Medicine, New York, NY

[194]

DX06

[198]

Jerry Wolinsky, MD1, Douglas L Arnold, MD2,3, Amit Bar-Or, MD, FRCPC2, Jérôme de Seze, MD, PhD4, Gavin Giovannoni, MBBCh, PhD, FCP (Neurol., SA), FRCP, FRCPath5, Bernhard Hemmer, MD6,7, Kottil Rammohan, MD8, Peter Chin, MD9, Paulo Fontoura, MD, PhD10, Hideki Garren, MD, PhD10, Donna Masterman, MD9, Annette Sauter, MD10 and Xavier Montalban, MD, PhD11, (1)University of Texas Health Science Center at Houston, Houston, TX, (2)McGill University, Montreal, QC, Canada, (3)NeuroRx Research, Montreal, QC, Canada, (4)University Hospital of Strasbourg, Strasbourg, France, (5)Queen Mary University of London, London, United Kingdom of Great Britain and Northern Ireland, (6)Technische Universität München, Munich, Germany, (7)Munich Cluster for Systems Neurology (SyNergy), Munich, Germany, (8)University of Miami, Miami, FL, (9)Genentech, Inc., South San Francisco, CA, (10)F. Hoffmann-La Roche Ltd., Basel, Switzerland, (11)Hospital Vall d’Hebron University, Barcelona, Spain

[194]

DX07

[198]

Barry A Singer, MD1, Raed Alroughani, MD2, Simon Broadley, MD3, Hans-Peter Hartung, MD4, Eva Kubala Havrdova, MD, PhD5, Ho Jin Kim, MD6, Celia Oreja-Guevara, MD7, Carlo Pozzilli, MD8, Patrick Vermersch, MD9, Sibyl Wray, MD10, Luke Chung, MD, MPH11, Nadia Daizadeh, PhD11, Madalina Chirieac, MD, MPH11, Krzysztof W Selmaj, MD12 and on behalf of the CARE-MS II, CAMMS03409, and TOPAZ, Investigators13, (1)MS Center for Innovations in Care, Missouri Baptist Medical Center, St. Louis, MO, (2)Amiri Hospital, Sharq, Kuwait, (3)School of Medicine, Gold Coast Campus, Griffith University, Queensland, Australia, (4)Department of Neurology, Medical Faculty, Heinrich-Heine University, Dusseldorf, Germany, (5)First Medical Faculty, Charles University in Prague, Prague, Czech Republic, (6)Research Institute and Hospital of National Cancer Center, Goyang, Korea, Republic of (South), (7)University Hospital San Carlos, Madrid, Spain, (8)Sapienza University of Rome, Rome, Italy, (9)University of Lille, Lille, France, (10)Hope Neurology MS Center, Knoxville, TN, (11)Sanofi, Cambridge, MA, (12)Medical University of Lodz, Lodz, Poland, (13)on behalf of the CARE-MS II, CAMMS03409, and TOPAZ Investigators, NJ

[194]

DX07

[198]

Robert T Naismith, MD1, Mark Cascione, MD2, Luigi ME Grimaldi, MD3, Stephen L Hauser, MD4, Ludwig Kappos, MD5, Xavier Montalban, MD, PhD6, Jerry Wolinsky, MD7, Peter Chin, MD8, Hideki Garren, PhD, MD8, Laura Julian, PhD8, Fabian Model, PhD9 and David Honeycutt, MD10, (1)Washington University School of Medicine, St. Louis, MO, (2)Axiom Clinical Research of Florida, Tampa, FL, (3)Fondazione Istituto – G. Giglio, Cefalu, PA, Italy, (4)University of California, San Francisco, San Francisco, CA, (5)University Hospital Basel, University of Basel, Basel, Switzerland, (6)Vall d’Hebron University Hospital, Barcelona, Spain, (7)McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, (8)Genentech Inc., South San Francisco, CA, (9)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (10)Neurology Associates P.A., Multiple Sclerosis Center of Greater Orlando, Maitland, FL

[194]

DX07

[198]

Ping-Chang Kuo, Ph.D.1, Dennis A Brown, Ph.D.2, Barbara A Scofield, B.S.1, I-Chen Yu, Ph.D.3, Fen-Lei Chang, M.D., Ph.D.4 and Jui-Hung Yen, Ph.D.1, (1)Department of Microbiology and Immunology, Indiana University School of Medicine, Fort Wayne, IN, (2)Department of Pharmaceutical Sciences, Manchester University College of Pharmacy, Fort Wayne, IN, (3)Department of Anatomy and Cell Biology, Indiana University School of Medicine, Fort Wayne, IN, (4)Department of Neurology, Indiana University School of Medicine, Fort Wayne, IN

[194]

DX08

[198]

Ann D. Bass, MD1, Bart Van Wijmeersch, MD, PhD2, Aaron Boster, MD3, Lori Mayer, DNP, MSN, RN, MSCN4, Mathias Maurer, MD5, Matt Mandel, MD6, Kersten Sharrock, MS6, Colin P Mitchell, PhD6 and Barry A Singer, MD7, (1)Neurology Center of San Antonio, San Antonio, TX, (2)Rehabilitation & MS-Centre Overpelt, BIOMED, Hasselt University, Hasselt, Belgium, (3)OhioHealth Neurological Physicians, Columbus, OH, (4)Central Texas Neurology Consultants, Round Rock, TX, (5)Klinikum Wurzburg Mitte gGmbH, Wurzburg, Germany, (6)Sanofi, Cambridge, MA, (7)MS Center for Innovations in Care, Missouri Baptist Medical Center, St. Louis, MO

[194]

DX08

[198]

Aaron Boster, MD1, Raed Alroughani, MD2, Regina Berkovich, MD, PhD3, Giancarlo Comi, MD4, Guillermo Izquierdo, MD5, Daniel Kantor, MD6, Christopher LaGanke, MD7, Richard AL Macdonell, MD, FRACP8, Thibault Moreau, MD9, Basil Sharrack, MD, PhD10, Heinz Wiendl, MD11, Bart Van Wijmeersch, MD, PhD12, David H Margolin, MD, PhD13, Karthinathan Thangavelu, PhD13, Maria Melanson, MD, PhD13 and Mark S Freedman, MD14, (1)Ohio State University, Columbus, OH, (2)Amiri Hospital, Sharq, Kuwait, (3)University of Southern California, Keck School of Medicine, Los Angeles, CA, (4)University Vita-Salute San Raffaele, Milan, Italy, (5)Virgen Macarena University Hospital, Seville, Spain, (6)Kantor Neurology, Coconut Creek, FL, (7)North Central Neurology Associates, Cullman, AL, (8)Brain Research Institute, Florey Institute of Neuroscience and Mental Health, Melbourne, Australia, (9)University of Burgundy, Dijon, France, (10)Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom, (11)University of Munster, Munster, Germany, (12)Rehabilitation & MS-Centre Overpelt, Hasselt University, Hasselt, Belgium, (13)Sanofi Genzyme, Cambridge, MA, (14)1University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada

[194]

DX08

[198]

Pavle Repovic, MD, PhD1, Göril Karlsson, PhD2, Martin Merschhemke, MD2 and Dieter A Häring, PhD2, (1)Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA, (2)Novartis Pharma AG, Basel, Switzerland

[194]

DX09

[198]

Suma Shah, MD1, Anastasie Dunn-Pirio, MD, MS1, Jenelle M. Hall, PharmD2, Bryan Walker, PA-C1, Nick Hudak, PA-C1, Fletcher Hartsell, MD1, Mark Skeen, MD1 and Christopher Eckstein, MD1, (1)Neurology, Duke University, Durham, NC, (2)Duke University Health System, Durham, NC

[194]

DX09

[198]

Aaron E Miller, MD1, Jerome de Seze, MD2, Stephen L Hauser, MD3, Ludwig Kappos, MD4, Jerry Wolinsky, MD5, Jian Han, PhD6, Laura Julian, PhD6, Julie Napieralski, PhD7 and Fred Lublin, MD8, (1)Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, New York, NY, (2)University Hospital of Strasbourg, Strasbourg, France, (3)University of California, San Francisco, San Francisco, CA, (4)University Hospital Basel, University of Basel, Basel, Switzerland, (5)McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, (6)Genentech Inc., South San Francisco, CA, (7)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (8)Icahn School of Medicine at Mount Sinai, New York, NY

[194]

DX09

[198]

Aaron E Miller, MD1, Jiwon Oh, MD2, Karthinathan Thangavelu, PhD3, Philippe Truffinet, MD4, Steve Cavalier, MD3 and David Rog, MD5, (1)Icahn School of Medicine at Mount Sinai, New York, NY, (2)St. Michael’s Hospital, Toronto, ON, Canada, (3)Genzyme, a Sanofi company, Cambridge, MA, (4)Genzyme, a Sanofi company, Chilly-Mazarin, France, (5)Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, United Kingdom of Great Britain and Northern Ireland

[194]

DX10

[198]

Gavin Giovannoni, MBBCh, PhD, FCP (Neurol., SA), FRCP, FRCPath, Queen Mary University London, Blizard Institute, Barts and the London School of Medicine and Dentistry, London, United Kingdom, Kottil Rammohan, MD, Ohio State University Hospital, Columbus, OH, Stuart Cook, MD, Rutgers, The State University of New Jersey, New Jersey Medical School, Newark, NJ, Giancarlo Comi, MD, Vita-Salute San Raffaele University, Milan, Italy, Peter Rieckmann, MD, Akademisches Krankenhaus Sozialstiftung Bamberg, Bamberg, Germany, Per Soelberg Soerensen, MD, Department of Neurology, University of Copenhagen, Copenhagen, Denmark, Patrick Vermersch, MD, University of Lille, Lille, France, Fernando Dangond, MD, EMD Serono, Inc., Billerica, MA and Christine Hicking, MS, Merck KGaA, Darmstadt, Germany

[194]

DX10

[198]

Aly Jordan, DO, Neurology, Ohio State University, Columbus, OH and Brett Alldredge, DO, Neurology, Ohio State University, Columubs, OH

[194]

DX10

[198]

Aaron E Miller, MD1, Ludwig Kappos, MD2, Jiwon Oh, MD3, Karthinathan Thangavelu, PhD4, Pascal Rufi, MD5, Steve Cavalier, MD4, Philippe Truffinet, MD5 and Giancarlo Comi, MD6, (1)Icahn School of Medicine at Mount Sinai, New York, NY, (2)University Hospital Basel, Basel, Switzerland, (3)St. Michael’s Hospital, Toronto, ON, Canada, (4)Genzyme, a Sanofi company, Cambridge, MA, (5)Genzyme, a Sanofi company, Chilly-Mazarin, France, (6)University Vita-Salute San Raffaele, Milan, Italy

[194]

DX11

[198]

Gavin Giovannoni, MBBCh, PhD, FCP (Neurol., SA), FRCP, FRCPath, Queen Mary University London, Blizard Institute, Barts and the London School of Medicine and Dentistry, London, United Kingdom, Kottil Rammohan, MD, Ohio State University Hospital, Columbus, OH, Stuart Cook, MD, Rutgers, The State University of New Jersey, New Jersey Medical School, Newark, NJ, Giancarlo Comi, MD, Vita-Salute San Raffaele University, Milan, Italy, Peter Rieckmann, MD, Akademisches Krankenhaus Sozialstiftung Bamberg, Bamberg, Germany, Per Soelberg Soerensen, MD, Department of Neurology, University of Copenhagen, Copenhagen, Denmark, Patrick Vermersch, MD, University of Lille, Lille, France, Fernando Dangond, MD, EMD Serono, Inc., Billerica, MA and Christine Hicking, MS, Merck KGaA, Darmstadt, Germany

[194]

DX11

[198]

Maria K Houtchens, MD, Brigham and Women’s Hospital, Brookline, MA, Natalie C Edwards, MSc, Health Services Consulting Corporation, Boxborough, MA and Amy L Phillips, PharmD, EMD Serono, Inc., Rockland, MA

[194]

DX11

[198]

Amal Fuad Almahroos, BSc, Zahra Almosawi, BSc, Hawra Alalwan, BSc, Reem Abdulla, Bsc, Fajer Alammadi, BSc, Ahmed Al-Mahrezi, BSc, Ahmmed Almubarak, BSc, Ayman Mohamed, BSc and Amer Kamal, Professor, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain

[194]

DX12

[198]

Aaron Boster, MD1, Bart Van Wijmeersch, MD, PhD2, Raed Alroughani, MD3, Giancarlo Comi, MD4, Regina Berkovich, MD, PhD5, Guillermo Izquierdo, MD6, Daniel Kantor, MD7, Christopher LaGanke, MD8, Volker Limmroth, MD, PhD9, Richard AL Macdonell, MD10, Heinz Wiendl, MD11, Maria Melanson, MD, PhD12, Karthinathan Thangavelu, PhD12, Mark S Freedman, MD13 and on behalf of the CAMMS223, CARE-MS I, and CARE-MS II, Investigators14, (1)OhioHealth Neurological Physicians, Columbus, OH, (2)Rehabilitation & MS-Centre Overpelt, BIOMED, Hasselt University, Hasselt, Belgium, (3)Amiri Hospital, Sharq, Kuwait, (4)University Vita-Salute San Raffaele, Milan, Italy, (5)University of Southern California, Keck School of Medicine, Los Angeles, CA, (6)Virgen Macarena University Hospital, Seville, Spain, (7)Florida Atlantic University, Boca Raton, FL, (8)North Central Neurology Associates, Cullman, AL, (9)Klinik fur Neurologie und Palliativmedizin, Cologne, Germany, (10)Austin Health and Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia, (11)University of Munster, Munster, Germany, (12)Sanofi, Cambridge, MA, (13)University of Ottawa and the Ottawa Hospital Research Institute, Ottawa, ON, Canada, (14)on behalf of the CAMMS223, CARE-MS I, and CARE-MS II Investigators, NA, NJ

[194]

DX12

[198]

Maria K Houtchens, MD, Brigham and Women’s Hospital, Brookline, MA, Natalie C Edwards, MSc, Health Services Consulting Corporation, Boxborough, MA and Amy L Phillips, PharmD, EMD Serono, Inc., Rockland, MA

[194]

DX12

[198]

Amit Bar-Or, MD, FRCPC1, Douglas L Arnold, MD1,2, Giancarlo Comi, MD3, Hans-Peter Hartung, MD, FRCP, FAAN, FANA4, Stephen L Hauser, MD5, Fred Lublin, MD6, Krzysztof Selmaj, MD, PhD7, Anthony Traboulsee, MD, FRCPC8, Peter Chin, MD9, Paulo Fontoura, MD, PhD10, Hideki Garren, MD, PhD10, Gaelle Klingelschmitt, MSc10, Donna Masterman, MD9 and Ludwig Kappos, MD, PhD11, (1)McGill University, Montreal, QC, Canada, (2)NeuroRx Research, Montreal, QC, Canada, (3)University Vita-Salute San Raffaele, Milan, Italy, (4)Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany, (5)University of California, San Francisco, CA, (6)Icahn School of Medicine at Mount Sinai, New York, NY, (7)Medical University of Lodz, Lodz, Poland, (8)University of British Columbia, Vancouver, BC, Canada, (9)Genentech, Inc., South San Francisco, CA, (10)F. Hoffmann-La Roche Ltd., Basel, Switzerland, (11)University Hospital Basel, Basel, Switzerland

[194]

DX13

[198]

Serkan Ozakbas, Professor Of Neurology, Department of Neurology, Dokuz Eylul University, Izmir, Turkey, Bilge Piri Cinar, MD, Bulent Ecevit University, Zonguldak, Turkey, Turhan Kahraman, Phd, Katip Celebi University, Izmir, Turkey and Gorkem Kosehasanogullari, MD, Usak State Hospital, Usak, Turkey

[194]

DX13

[198]

Ana Cristina Wing Marques dos Santos, Fellow and Marcelo Kremenchutzky, Director of London MS Clinics, CNS, University of Western Ontario, London, ON, Canada

[194]

DX13

[198]

Chris M Kozma, PhD1, Frederick Munschauer, MD2 and Amy L Phillips, PharmD2, (1)CK Consulting Associates, LLC, Saint Helena Island, SC, (2)EMD Serono, Inc., Rockland, MA

[194]

DX14

[198]

Amber Salter, PhD1, Tuula Tyry, PhD2, Robert J Fox, MD3, Ruth Ann Marrie, MD, PhD4, Lobat Hashemi, ScD5, Kathryn Munoz, MPH, PhD5, Thomas Carattini, PharmD5, Alden Smith, PharmD5 and Gary Cutter, PhD6, (1)Washington University in St Louis, St Louis, MO, (2)Dignity Health, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, (3)Cleveland Clinic, Cleveland, OH, (4)University of Manitoba, Winnipeg, MB, Canada, (5)Sanofi, Cambridge, MA, (6)University of Alabama at Birmingham, Birmingham, AL

[194]

DX14

[198]

Anthony T Reder, MD, University of Chicago, Chicago, IL, Gary Cutter, PhD, University of Alabama at Birmingham, Birmingham, AL, Kathleen Hawker, MD, EMD Serono, Inc., Rockland, MA, Julie Aldridge, MS, EMD Serono, Inc., Billerica, MA and Flavia Nelson, MD, University of Texas – McGovern Medical School, Houston, TX

[194]

DX14

[198]

Chris M Kozma, PhD1, Frederick Munschauer, MD2 and Amy L Phillips, PharmD2, (1)CK Consulting Associates, LLC, Saint Helena Island, SC, (2)EMD Serono, Inc., Rockland, MA

[194]

DX15

[198]

Amber Salter, PhD1, Tuula Tyry, PhD2, Samantha Lancia, MS1, Robert J Fox, MD3, Ruth Ann Marrie, MD, PhD4, Lobat Hashemi, ScD5, Kathryn Munoz, MPH, PhD5, Thomas Carattini, PharmD, MBA5, Alden Smith, PharmD5 and Gary Cutter, PhD6, (1)Washington University in St Louis, St Louis, MO, (2)Dignity Health, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, (3)Cleveland Clinic, Cleveland, OH, (4)University of Manitoba, Winnipeg, MB, Canada, (5)Sanofi, Cambridge, MA, (6)University of Alabama at Birmingham, Birmingham, AL

[194]

DX15

[198]

Anthony Traboulsee, MD1, Michael H Barnett, PhD/MD2, Regina Berkovich, MD, PhD3, Aaron Boster, MD4, Giancarlo Comi, MD5, Christopher Laganke, MD6, Daniel Pelletier, MD3, Alex Rovira, MD7, Sven Schippling, MD8, Barry A Singer, MD9, David H Margolin, MD, PhD10, Sourav Santra, PhD11, Douglas L Arnold, MD12,13 and on behalf of the CARE-MS I and CAMMS03409 Investigators, n/a14, (1)University of British Columbia, Vancouver, BC, Canada, (2)Sydney Neuroimaging Analysis Centre, Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia, (3)University of Southern California, Keck School of Medicine, Los Angeles, CA, (4)Ohio State University, Columbus, OH, (5)University Vita-Salute San Raffaele, Milan, Italy, (6)North Central Neurology Associates, Cullman, AL, (7)University Hospital Vall d’Hebron, Barcelona, Spain, (8)Neuroimmunology and Multiple Sclerosis Research, University Hospital Zurich and University of Zurich, Zurich, Switzerland, (9)MS Center for Innovations in Care, Missouri Baptist Medical Center, St Louis, MO, (10)Sanofi Genzyme, Cambridge, MA, (11)Cytel, Cambridge, MA, (12)NeuroRx Research, Montreal, QC, Canada, (13)Montreal Neurological Institute and Hospital McGill University, Montreal, QC, Canada, (14)MA

[194]

DX15

[198]

Jacqueline Nicholas, MD, MPH1, Aaron Boster, MD2, Wei-Shi Yeh, PhD3, Robert Garland, MS3, Monica A Fay, PharmD4, Ravi Iyer, PhD3 and Andrew Lee, PhD3, (1)Health Economics & Outcomes Research, Novartis Pharmaceutical Corporation, East Hanover, NJ, (2)OhioHealth Neurological Physicians, Columbus, OH, (3)Global Health Economics and Outcomes Research, Biogen, Cambridge, MA, (4)US Medical Affairs, Biogen, Weston, MA

[194]

DX16

[198]

Florian P Thomas, MD, PhD, MA1,2, Samuel F Hunter, MD3, Xiangyi Meng, PhD4, Lesley Schofield, PhD4, Scott Kolodny, MD4, Nadia Tenenbaum, MD4 and Bruce AC Cree, MD, PhD5, (1)Neurology, Hackensack University Medical Center, Hackensack, NJ, (2)Seton Hall-Hackensack Meridian School of Medicine, South Orange, NJ, (3)Advanced Neurosciences Institute, Franklin, TN, (4)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (5)UCSF Neurology, Weill Institute for Neurosciences, San Francisco, CA

[194]

DX16

[198]

Ashok Vegesna, PharmD1, Huanxue Zhou, MS2, John J Ko, Pharm.D., MS3, Dendy Macaulay, PhD4, Jenny Zhou, PhD4, Luke Schmerold, BS4, Cassie Tang, MS4 and James Signorovitch, PhD4, (1)Health Economics & Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ, (2)KMK Consulting, Inc., Florham Park, NJ, (3)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (4)Analysis Group, Inc., New York, NY

[194]

DX16

[198]

Anthony Traboulsee, MD, FRCPC1, Regina Berkovich, MD, PhD2, Hao Zhang, PhD3, Fernando Dangond, MD, FAAN, MBA4 and David Li, MD1, (1)University of British Columbia, Vancouver, BC, Canada, (2)University of Southern California, Los Angeles, CA, (3)EMD Serono, Inc., Rockland, MA, (4)EMD Serono, Inc., Billerica, MA

[194]

DX17

[198]

Virginia R Schobel, MSc, Neurology Market Intelligence, Spherix Global Insights, Exton, PA and Jennifer Robinson, BS, President, Spherix Global Insights, Exton, PA

[194]

DX17

[198]

Bhupendra Khatri, MD1, Stanley Cohan, MD, PhD2, Sibyl Wray, MD3, Xiaolan Ye, PhD4, Oksana Mokliatchouk, PhD5, Sami Fam, PhD5 and Craig Wakeford, MA5, (1)The Regional MS Center, Center for Neurological Disorders, Wheaton Franciscan Health Care St. Francis Hospital, Milwaukee, WI, (2)Providence Multiple Sclerosis Center, Portland, OR, (3)Hope Neurology MS Center, Knoxville, TN, (4)AbbVie, Mettawa, IL, (5)Biogen, Cambridge, MA

[194]

DX17

[198]

Barry A Singer, MD1, Stephen Krieger, MD2, Regina Berkovich, MD3, Mark S Freedman, MD4, David H Margolin, MD, PhD5, Karthinathan Thangavelu, PhD5 and Aaron Boster, MD6, (1)The MS Center for Innovations in Care, Missouri Baptist Medical Center, St Louis, MO, (2)Icahn School of Medicine, Corinne Goldsmith Dickinson Center for Multiple Sclerosis, New York, NY, (3)Keck School of Medicine, University of Southern California, Los Angeles, CA, (4)University of Ottawa and the Ottawa Hospital Research Institute, Ottawa, ON, Canada, (5)Genzyme, a Sanofi company, Cambridge, MA, (6)OhioHealth Neurological Physicians, Columbus, OH

[194]

DX18

[198]

Virginia R Schobel, MSc, Neurology Market Intelligence, Spherix Global Insights, Exton, PA and Jennifer Robinson, BS, President, Spherix Global Insights, Exton, PA

[194]

DX18

[198]

Bianca Weinstock-Guttman, MD1,2,3, Caila B Vaughn, PhD, MPH1,2,3, Katelyn S. Kavak, MS1,2,3, Barbara E. Teter, PhD, MPH1, S. Ahmed Sanai, MD3, Andrew Goodman, MD1,4, Patricia K Coyle, MD1,5, Lauren Krupp, MD1,6, Malcolm Gottesman, MD1,7 and Keith R Edwards, MD1,8, (1)New York State Multiple Sclerosis Consortium, Buffalo, NY, (2)Jacobs MS Center of Treatment and Research, Buffalo, NY, (3)Department of Neurology, University at Buffalo, Buffalo, NY, (4)Neurology, University of Rochester, Rochester, NY, (5)Stony Brook University, Stony Brook, NY, (6)NYU Langone Medical Center, New York, NY, (7)Winthrop Comprehensive MS Care Center, Mineola, NY, (8)MS Center of Northeastern New York, Latham, NY

[194]

DX18

[198]

Bianca Weinstock-Guttman, MD1,2,3, Caila B Vaughn, PhD, MPH1,2,3, Katelyn S. Kavak, MS1,2,3, Barbara E. Teter, PhD, MPH1, S. Ahmed Sanai, MD3, Andrew Goodman, MD1,4, Patricia K Coyle, MD1,5, Lauren Krupp, MD1,6, Malcolm Gottesman, MD1,7 and Keith R Edwards, MD1,8, (1)New York State Multiple Sclerosis Consortium, Buffalo, NY, (2)Jacobs MS Center of Treatment and Research, Buffalo, NY, (3)Department of Neurology, University at Buffalo, Buffalo, NY, (4)Neurology, University of Rochester, Rochester, NY, (5)Stony Brook University, Stony Brook, NY, (6)NYU Langone Medical Center, New York, NY, (7)Winthrop Comprehensive MS Care Center, Mineola, NY, (8)MS Center of Northeastern New York, Latham, NY

[194]

DX18

[198]

Bianca Weinstock-Guttman, MD1,2,3, Caila B Vaughn, PhD, MPH1,2,3, Katelyn S. Kavak, MS1,2,3, Barbara E. Teter, PhD, MPH1, S. Ahmed Sanai, MD3, Andrew Goodman, MD1,4, Patricia K Coyle, MD1,5, Lauren Krupp, MD1,6, Malcolm Gottesman, MD1,7 and Keith R Edwards, MD1,8, (1)New York State Multiple Sclerosis Consortium, Buffalo, NY, (2)Jacobs MS Center of Treatment and Research, Buffalo, NY, (3)Department of Neurology, University at Buffalo, Buffalo, NY, (4)Neurology, University of Rochester, Rochester, NY, (5)Stony Brook University, Stony Brook, NY, (6)NYU Langone Medical Center, New York, NY, (7)Winthrop Comprehensive MS Care Center, Mineola, NY, (8)MS Center of Northeastern New York, Latham, NY

[194]

DX18

[198]

Bing Zhu, MD, PhD1, Karin Galil, MD, MPH1, Ivan Nestorov, PhD1, Guolin Zhao, PhD1, Venkata Meka, MD1, Jeanelle Kam, MD, CPI2 and Sarah I. Sheikh, MD1, (1)Biogen, Cambridge, MA, (2)Covance Clinical Research Unit, Dallas, TX

[194]

DX19

[198]

Virginia R Schobel, MSc, Neurology Market Intelligence, Spherix Global Insights, Exton, PA and Jennifer Robinson, BS, President, Spherix Global Insights, Exton, PA

[194]

DX19

[198]

Lisa Laing, BSN, RN, MSCN1, Shannon Haas, MS2, Maayan Elyashiv, BS2, Carrie L Sammarco, DNP, FNP-C, MSCN1 and Cara Desanctis, BSN, RN, MSCN1, (1)MS Comprehensive Care Center, NYU Langone Medical Center, New York, NY, (2)MS Comprehensive Care Center, NYU School of Medicine, New York, NY

[194]

DX19

[198]

Carrie M Hersh, DO, MS1, Samuel Cohn, MD2, Claire Hara-Cleaver, CNP3, Robert Bermel, MD3, Robert J Fox, MD, FAAN3, Jeffrey A Cohen, MD3 and Daniel Ontaneda, MD3, (1)Lou Ruvo Center for Brain Health, Cleveland Clinic, Las Vegas, NV, (2)Cleveland Clinic, Cleveland, OH, (3)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH

[194]

DX20

[198]

Till Sprenger, MD1,2, Aaron Boster, MD3, Xiangyi Meng, PhD4, Shannon Ritter, MS4, Daniela Piani Meier, PhD5, Davorka Tomic, PhD5, Diego Silva, MD, PhD5, Frederik Barkhof, MD, PhD6,7 and Pavle Repovic, MD, PhD8, (1)Department of Neurology, DKD HELIOS Klinik, Wiesbaden, Germany, (2)Medical Image Analysis Center, University Hospital Basel, Basel, Switzerland, (3)OhioHealth Neurological Physicians, Columbus, OH, (4)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (5)Novartis Pharma AG, Basel, Switzerland, (6)Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, Netherlands, (7)Institutes of Neurology and Healthcare Engineering, University College London, London, United Kingdom, (8)Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA

[194]

DX20

[198]

Carrie L Sammarco, DNP, FNP-C, MSCN1, Lana Zhovtis Ryerson, MD2 and Lisa Laing, BSN, RN, MSCN1, (1)MS Comprehensive Care Center, NYU Langone, New York, NY, (2)New York State Multiple Sclerosis Consortium, Buffalo, NY

[194]

DX21

[198]

Fletcher L Hartsell III, MD MPH, Neurology, Duke University School of Medicine, Durham, NC

[194]

DX21

[198]

Crystal Dixon, MD, Angela Aungst, MPH, Yasir Durrani, MBBS, Lise Casady, ARNP and Derrick Robertson, MD, Neurology, University of South Florida, Tampa, FL

[194]

DX21

[198]

Cecilie Fjeldstad, PhD, Tania Reyna, MD, Jennifer Smith, PA, Tony Sharp, PA and Gabriel Pardo, MD, MS Center of Excellence, Oklahoma Medical Research Foundation, Oklahoma City, OK

[194]

DX22

[198]

Kelly F Luciani, B.S., Joshua D Katz, M.D., Ellen S Lathi, M.D. and Hannah M Geils, B.S., The Elliot Lewis Center for Multiple Sclerosis Care, Wellesley, MA

[194]

DX22

[198]

Daniel Jones, PhD1, Mehul Jhaveri, PharmD, MPH2, Ning Wu, PhD2, Kun Yang, PharmD1 and Crystal Watson, MS2, (1)Biogen, Weston, MA, (2)Biogen, Cambridge, MA

[194]

DX22

[198]

Christopher M Perrone, MD and Eric Williamson, MD, Neurology, University of Pennsylvania, Philadelphia, PA

[194]

DX23

[198]

Vineet Nadkarni, BS, Tirisham V Gyang, MD, Lindsay Falk, ARNP and Augusto Miravalle, MD, Neurology, University of Florida, Gainesville, FL

[194]

DX23

[198]

David Rog, MD, MRCP1, Nicola Seferta, N/A1, Tatiana Mihalova, MRCP1, Miqun Robinson, MD, PhD2, Susan Colilla, PhD, MPH2, Yang Zhao, PhD2, Tanya Z Fischer, MD, PhD2 and David H Margolin, MD, PhD2, (1)Salford Royal NHS Foundation Trust, Salford, United Kingdom, (2)Sanofi Genzyme, Cambridge, MA

[194]

DX23

[198]

Daniel Hewes, B.S.1, Adam Kruszewski, B.S.1, Dallas Boodhoo, B.S.1, Alexandru Tatomir, M.D.1, Vinh Nguyen, D.D.S.2, Gautam K Rao, B.S.1, Walter Royal III, M.D.3, Christopher T Bever Jr., M.D., M.B.A.1, Violeta Rus, M.D., Ph.D2 and Horea Rus, M.D., Ph.D.3, (1)Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, (2)Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Maryland School of Medicine, Baltimore, MD, (3)Veterans Administration Multiple Sclerosis Center of Excellence, Baltimore, MD

[194]

DX24

[198]

Sharon R Tingen, PharmD, BCPS, Neurology, University of Virginia, Charlottesville, VA, Myla D Goldman, MD, Msc, University of Virginia, Charlottesville, VA and Robert D’Eramo, PharmD, Pharmacy, University of Virginia, Charlottesville, VA

[194]

DX24

[198]

Deborah M Miller, PhD, LISW1, Stephen L Hauser, MD2, Ludwig Kappos, MD3, Fred Lublin, MD4, Xavier Montalban, MD, PhD5, Fiona Mc Dougall, PhD, ClinPsyD6, Gurpreet Deol-Bhullar, BSc, OT7, Jian Han, PhD8, Laura Julian, PhD8, Bruno Musch, MD, PhD8 and Jerry Wolinsky, MD9, (1)Mellen Center, Cleveland Clinic, Cleveland, OH, (2)University of California, San Francisco, San Francisco, CA, (3)University Hospital Basel, University of Basel, Basel, Switzerland, (4)Icahn School of Medicine at Mount Sinai, New York, NY, (5)Multiple Sclerosis Center of Catalonia, Hospital Vall d’Hebron University, Barcelona, Spain, (6)Roche Products Limited, Welwyn Garden City, United Kingdom, (7)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (8)Genentech Inc., South San Francisco, CA, (9)McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX

[194]

DX24

[198]

Daniel Pelletier, MD1, Gavin Giovannoni, MBBCh, PhD2, Douglas L Arnold, MD3,4, Sven Schippling, MD5, David H Margolin, MD, PhD6, Karthinathan Thangavelu, PhD6 and Anthony Traboulsee, MD, FRCPC7, (1)University of Southern California, Los Angeles, CA, (2)Queen Mary University London, Barts and The London School of Medicine, London, United Kingdom, (3)McGill University, Montreal, QC, Canada, (4)NeuroRx Research, Montreal, QC, Canada, (5)University Hospital Zurich and University of Zurich, Zurich, Switzerland, (6)Genzyme, a Sanofi company, Cambridge, MA, (7)University of British Columbia, Vancouver, BC, Canada

[194]

DX25

[198]

Anthony M Iuso, BS, Clinical Research, Holy Name Medical Center, Teaneck, NJ, Mary Ann Picone, MD, Holy Name Medical Center, Teaneck, NJ and Karen Blitz, DO, South Shore Neurologic Associates, Patchogue, NY

[194]

DX25

[198]

Edward J Fox, MD1, Florian P Thomas, MD, PhD, MA2, Mark Cascione, MD3, Xiangyi Meng, PhD4, Lesley Schofield, PhD4, Fernanda Boulos, MD4 and Nadia Tenenbaum, MD4, (1)Central Texas Neurology Consultants, Round Rock, TX, (2)Neurology, Hackensack University Medical Center, Hackensack, NJ, (3)Tampa Neurology Associates, Tampa, FL, (4)Novartis Pharmaceuticals Corporation, East Hanover, NJ

[194]

DX25

[198]

Daniel Wynn, MD1, Chris Laganke, MD2, Lesley Schofield, PhD3, Xiangyi Meng, PhD3 and Nadia Tenenbaum, MD3, (1)Consultants in Neurology MS Center, Northbrook, IL, (2)North Central Neurology Associates, Cullman, AL, (3)Novartis Pharmaceuticals Corporation, East Hanover, NJ

[194]

DX26

[198]

Carlo Tornatore, MD1, Teri Schreiner, MD MPH2, Kyle E Smoot, MD3, Natasha Frost, M.D.4, Oksana Mokliatchouk, PhD5, Christophe Hotermans, MD5 and Irene Koulinska, MD, ScD5, (1)Department of Neurology, Medstar Georgetown University Hospital, Washington, DC, (2)Neurology, Children’s Hospital Colorado, Aurora, CO, (3)Providence Multiple Sclerosis Center, Portland, OR, (4)Neurology, School of Medicine and Public Health, University of Wisconsin, Madison, WI, (5)Biogen, Cambridge, MA

[194]

DX26

[198]

Elena Grebenciucova, MD and Eric Williamson, MD, Neurology, University of Pennsylvania, Philadelphia, PA

[194]

DX26

[198]

David Li, MD, FRCPC1, Anthony Traboulsee, MD, FRCPC1, Eric Williamson, MD2, Hao Zhang, PhD3 and Fernando Dangond, MD, FAAN, MBA4, (1)University of British Columbia, Vancouver, BC, Canada, (2)University of Pennsylvania, Philadelphia, PA, (3)EMD Serono, Inc., Rockland, MA, (4)EMD Serono, Inc., Billerica, MA

[194]

DX27

[198]

Denise Campagnolo, MD1, Catherine Montero-Embalsado, BS2, Susan Meier-Davis, DVM, PhD, DABT2 and Neil Minton, MD2, (1)Celgene Corporation, Summit, NJ, (2)Receptos, a wholly owned subsidiary of Celgene, San Diego, CA

[194]

DX27

[198]

Felecia Hart, PharmD, MSCS1, Jacquelyn Bainbridge, PharmD, FCCP, MSCS1 and Augusto A Miravalle, M.D.2, (1)University of Colorado, Aurora, CO, (2)Department of Neurology, University of Colorado, Aurora, CO

[194]

DX27

[198]

Demetrios Skias, MD, Neurology, Jesse Brown VA Medical Center, Chicago, IL; Neurology and Rehabilitation, University of Illinois-Chicago, Chicago, IL

[194]

DX28

[198]

Surachat Ngorsuraches, Ph.D.1, Natasha Frost, M.D.2, Jerome Freeman, M.D., F.A.C.P.3, Diana Brixner, R.Ph., Ph.D., FAMCP4, Jane Mort, Pharm.D.1 and James Clem, Pharm.D.1, (1)Pharmacy Practice, College of Pharmacy and Allied Health Professions, South Dakota State University, Brookings, SD, (2)Neurology, School of Medicine and Public Health, University of Wisconsin, Madison, WI, (3)Neurosciences, Sanford School of Medicine, University of South Dakota, Sioux Falls, SD, (4)Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT

[194]

DX28

[198]

Florian P Thomas, MD, PhD, MA1, Douglas L Arnold, MD2,3, Mark Cascione, MD4, Edward J Fox, MD5, Maria C Vieria, MD6, John J Ko, Pharm.D., MS6, Xiangyi Meng, PhD6, Lesley Schofield, PhD6, Fernanda Boulos, MD6, Nadia Tenenbaum, MD6 and Bruce AC Cree, MD7, (1)Neurology, Hackensack University Medical Center, Hackensack, NJ, (2)NeuroRx Research, Montreal, QC, Canada, (3)Neurology and Neuroscience, McGill University, Montreal, QC, Canada, (4)Tampa Neurology Associates, Tampa, FL, (5)Central Texas Neurology Consultants, Round Rock, TX, (6)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (7)Multiple Sclerosis Center, San Francisco, CA

[194]

DX28

[198]

Eduardo R Estades, MD1,2, Angel Chinea, MD3, Yatzka G Hernandez Silvestrini, MD2, Ivonne Vicente, MD3, Cristina Rubi, BS3 and Kenneth Stein, MD3,4, (1)Internal Medicine, Christiana Care Health System, Newark, DE, (2)Research/Clinic, San Juan MS Center, Guaynabo, PR, (3)San Juan Multiple Sclerosis Center, Guaynabo, PR, (4)Neuroradiology, San Juan MRI, San Juan, PR

[194]

DX29

[198]

Amputch Karukote, MD1, Volker Neugebauer, MD, PHD2 and Mirla Avila, MD1, (1)Neurology, Texas Tech University Health Sciences Center, Lubbock, TX, (2)Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX

[194]

DX29

[198]

Florian P Thomas, MD, PhD, MA1, Bruce AC Cree, MD2, Heidi Crayton, MD3, Xiangyi Meng, PhD4, Lesley Schofield, PhD4, Fernanda Boulos, MD4 and Nadia Tenenbaum, MD4, (1)Neurology, Hackensack University Medical Center, Hackensack, NJ, (2)Multiple Sclerosis Center, San Francisco, CA, (3)MS Center of Greater Washington, Vienna, VA, (4)Novartis Pharmaceuticals Corporation, East Hanover, NJ

[194]

DX29

[198]

Edward J. Fox, MD, PhD1, Hans-Peter Hartung, MD, FRCP, FAAN, FANA2, Eva Havrdova, MD, PhD3, Brian Steingo, MD4, David H Margolin, MD, PhD5, Karthinathan Thangavelu, PhD5 and Gavin Giovannoni, MBBCh, PhD6, (1)Central Texas Neurology Consultants, Round Rock, TX, (2)Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany, (3)Department of Neurology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic, (4)Fort Lauderdale Multiple Sclerosis Center, Pompano Beach, FL, (5)Genzyme, a Sanofi company, Cambridge, MA, (6)Queen Mary University London, Barts and The London School of Medicine, London, United Kingdom

[194]

DX30

[198]

Ronald Bailey, M.D.1, Marco Pasco, MPH1, Taif Kaissi, M.D.1, Shard Yaqoot, R.N.2, Bhavesh Desai, D. Pharm, J.D.2 and Maria Aziz, A.S.1, (1)Neurology, The Neurology Group, Pomona, CA, (2)Pharmacy, CA Specialty Pharmacy, Whittier, CA

[194]

DX30

[198]

Gavin Giovannoni, MD1, Giancarlo Comi, MD2, Stuart Cook, MD3, Peter Rieckmann, MD4, Kottil Rammohan, MD5, Per Soelberg-Sorensen, MD6, Patrick Vermersch, MD7, Christine Hicking, MS8, Abidemi Adeniji, PhD9 and Fernando Dangond, MD9, (1)Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom, (2)University Vita-Salute San Raffaele, Milan, Italy, (3)Rutgers, The State University of New Jersey, Newark, NJ, (4)Akademisches Krankenhaus Sozialstiftung Bamberg, Bamberg, Germany, (5)Ohio State University Hospital, Columbus, OH, (6)Copenhagen University Hospital, Copenhagen, Denmark, (7)Univ. Lille, CHU Lille, LIRIC – INSERM U995, Lille, France, (8)Merck KGaA, Darmstadt, Germany, (9)EMD Serono, Inc., Billerica, MA

[194]

DX30

[198]

Edward J Fox, MD, Central Texas Neurology Consultants, Round Rock, TX, Gilles Edan, MD, CHU Hopital Pontchaillou, Rennes, France, Mark S Freedman, MD, University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada, Xavier Montalban, MD, PhD, Hospital Universitari Vall d’Hebron, Barcelona, Spain, Hans-Peter Hartung, MD, FRCP, FAAN, FANA, Department of Neurology, Heinrich-Heine Universität, Düsseldorf, Germany, Bernhard Hemmer, MD, Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; Technische Universität München, Munich, Germany, Frederik Barkhof, MD, PhD, VU University Medical Center, Amsterdam, Netherlands, Sven Schippling, MD, University Hospital Zurich, Zurich, Switzerland, Frederick W Foley, Ph.D., School of Psychology, Yeshiva University, New York, NY, Iris-Katharina Penner, PD, COGITO Center for Applied Neurocognition and Neuropsychological Research, Düsseldorf, Germany, Ralf Koelbach, MSc, PAREXEL International, Berlin, Germany, Dirk Pleimes, MD, Myelo Therapeutics GmbH, Berlin, Germany, Gustavo Suarez, MD, Bayer HealthCare Pharmaceuticals, Whippany, NJ, Eva-Maria Wicklein, MD, Bayer Pharma AG, Berlin, Germany and Ludwig Kappos, MD, PhD, Neurology, Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital Basel, Basel, Switzerland

[194]

DX31

[198]

Ronald Bailey, M.D.1, Marco Pasco, MPH1 and Shard Yaqoot, R.N.2, (1)Neurology, The Neurology Group, Pomona, CA, (2)Pharmacy, CA Specialty Pharmacy, Whittier, CA

[194]

DX31

[198]

Gavin Giovannoni, MD, Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom, Xavier Montalban, MD, Hospital Universitari Vall d’Hebron, Barcelona, Spain, Christine Hicking, MS, Merck KGaA, Darmstadt, Germany and Fernando Dangond, MD, EMD Serono, Inc., Billerica, MA

[194]

DX31

[198]

Erin E Longbrake, MD, PhD1, Anne H Cross, MD1 and Amber Salter, PhD2, (1)Neurology, Washington University School of Medicine, St Louis, MO, (2)Biostatistics, Washington University in St. Louis, St. Louis, MO

[194]

DX32

[198]

Barbara Willekens, MD, Neurology, Antwerp University Hospital, Edegem, Belgium, Vincent Van Pesch, MD, PhD, Neurology, Cliniques Universitaires Saint-Luc, Brussels, Belgium, Souraya El Sankari, MD, PhD, Neurology, Cliniques Universitaires St-Luc, Brussels, Belgium, Benedicte Dubois, PhD/MD, Laboratory for Neuroimmunology, Department of Neurosciences, KU Leuven, Leuven, Belgium, Marie D’Hooghe, MD, PhD, Neurology, National MS Center, Melsbroek, Belgium, Guy Nagels, MD, PhD, Neurology, National Multiple Sclerosis Center, Melsbroek, Belgium, Daniel Guillaume, MD, PhD, neurology, Centre neurologique et de readaption fonctionelle de Fraiture-en-Condroz, Fraiture-en-Condroz, Belgium, Pierrette Seeldrayers, MD, PhD, Neurology, Centre Hospitalier Universitaire Charleroi, Charleroi, Belgium and On behalf of the Belgian Study Group for Multiple Sclerosis, -, BSGMS, Brussels, Belgium

[194]

DX32

[198]

Gavin Giovannoni, MD, Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom, Giancarlo Comi, MD, University Vita-Salute San Raffaele, Milan, Italy, Xavier Montalban, MD, Hospital Universitari Vall d’Hebron, Barcelona, Spain, Christine Hicking, MS, Merck KGaA, Darmstadt, Germany and Fernando Dangond, MD, EMD Serono, Inc., Billerica, MA

[194]

DX32

[198]

Fabian Sierra Morales, MD, Igor Koralnik, MD and Jacob A. Sloane, MD PhD, Neurology, Beth Israel Deaconess Medical Center, Boston, MA

[194]

DX33

[198]

Barry Hendin, M.D.1, Lori Mayer, DNP, MSN, RN, MSCN2, Marie Namey, APRN, MSCN3, Michael R Edwards, PhD4, Beth Jordan, MBA4, Leslie Beth Herbert, PhD5 and Irene Koulinska, MD, ScD4, (1)Phoenix Neurological Associates, Phoenix, AZ, (2)Central Texas Neurology Consultants, Round Rock, TX, (3)Cleveland Clinic, Cleveland, OH, (4)Biogen, Cambridge, MA, (5)Health Union, LLC, Philadelphia, PA

[194]

DX33

[198]

Gavin Giovannoni, MD, Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom, Xavier Montalban, MD, Hospital Universitari Vall d’Hebron, Barcelona, Spain, Christine Hicking, MS, Merck KGaA, Darmstadt, Germany and Fernando Dangond, MD, EMD Serono, Inc., Billerica, MA

[194]

DX33

[198]

Fred Lublin, MD1, Douglas L Arnold, MD2,3, Amit Bar-Or, MD, FRCPC3, Giancarlo Comi, MD4, Stephen L Hauser, MD5, Krzysztof Selmaj, MD, PhD6, Anthony Traboulsee, MD, FRCPC7, Peter Chin, MD8, Paulo Fontoura, MD, PhD9, Hideki Garren, MD, PhD9, Gaelle Klingelschmitt, MSc9, Donna Masterman, MD8, Ludwig Kappos, MD, PhD10 and Hans-Peter Hartung, MD, FRCP, FAAN, FANA11, (1)Icahn School of Medicine at Mount Sinai, New York, NY, (2)NeuroRx Research, Montreal, QC, Canada, (3)McGill University, Montreal, QC, Canada, (4)University Vita-Salute San Raffaele, Milan, Italy, (5)University of California, San Franscisco, CA, (6)Medical University of Lodz, Lodz, Poland, (7)University of British Columbia, Vancouver, BC, Canada, (8)Genentech, Inc., South San Francisco, CA, (9)F. Hoffmann-La Roche Ltd., Basel, Switzerland, (10)University Hospital Basel, Basel, Switzerland, (11)Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany

[194]

DX34

[198]

Aliaksei Barysau Sr., MD, Department of Neurology and Neurosurgery, Belarusian state medical university, Minsk, Belarus

[194]

DX34

[198]

Giancarlo Comi, MD1, Thomas Leist, MD2, Mark S Freedman, MD3, Bruce AC Cree, MD4, Patricia K Coyle, MD5, Hans-Peter Hartung, MD6, Patrick Vermersch, MD7, Doris Damian, PhD8 and Fernando Dangond, MD8, (1)University Vita-Salute San Raffaele, Milan, Italy, (2)Thomas Jefferson University, Philadelphia, PA, (3)University of Ottawa and the Ottawa Hospital Research Institute, Ottowa, ON, Canada, (4)Multiple Sclerosis Center, San Francisco, CA, (5)Stony Brook University, Stony Brook, NY, (6)Heinrich Heine University, Dusseldorf, Germany, (7)Univ. Lille, CHU Lille, LIRIC – INSERM U995, Lille, France, (8)EMD Serono, Inc., Billerica, MA

[194]

DX34

[198]

Fred Lublin, MD1, Douglas L Arnold, MD2,3, Amit Bar-Or, MD, FRCPC3, Giancarlo Comi, MD4, Hans-Peter Hartung, MD, FRCP, FAAN, FANA5, Stephen L Hauser, MD6, Krzysztof Selmaj, MD, PhD7, Anthony Traboulsee, MD, FRCPC8, Peter Chin, MD9, Paulo Fontoura, MD, PhD10, Hideki Garren, MD, PhD10, Gaelle Klingelschmitt, MSc10, Donna Masterman, MD9 and Ludwig Kappos, MD, PhD11, (1)Icahn School of Medicine at Mount Sinai, New York, NY, (2)NeuroRx Research, Montreal, QC, Canada, (3)McGill University, Montreal, QC, Canada, (4)University Vita-Salute San Raffaele, Milan, Italy, (5)Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany, (6)University of California, San Franscisco, CA, (7)Medical University of Lodz, Lodz, Poland, (8)University of British Columbia, Vancouver, BC, Canada, (9)Genentech, Inc., South San Francisco, CA, (10)F. Hoffmann-La Roche Ltd., Basel, Switzerland, (11)University Hospital Basel, Basel, Switzerland

[194]

DX35

[198]

Mirela Cerghet, MD, PhD1, Ahmad M Siddiqi, MD2, Lonni Schultz, PhD3, Helena Bulka, DO1, Carol Freeman, BSci, NP4 and Stanton Elias, MD1, (1)Neurology, Henry Ford Hospital, Detroit, MI, (2)Neurology, Henry Ford Health System, detroit, MI, (3)Public Health Science, Henry Ford Health System, Detroit, MI, (4)Neurology, Henry Ford Health System, Detroit, MI

[194]

DX35

[198]

Heather Yong, Undergraduate Student1, Philippe Beauchemin, MD2, Robert Carruthers, MD3, Krista Barclay, RN4, Virginia Devonshire, MD3, Ana-Luiza Sayao, MD3 and Anthony Traboulsee, MD4, (1)Integrated Sciences, University of British Columbia, Vancouver, BC, Canada, (2)UBC MS Clinic, Vancouver, BC, Canada, (3)Neurology, University of British Columbia, Vancouver, BC, Canada, (4)University of British Columbia, Vancouver, BC, Canada

[194]

DX35

[198]

Chris M Kozma, PhD1, Frederick Munschauer, MD2 and Amy L Phillips, PharmD2, (1)CK Consulting Associates, LLC, Saint Helena Island, SC, (2)EMD Serono, Inc., Rockland, MA

[194]

DX36

[198]

Mark Waheed, DO, John W Rose, MD, Ka-ho Wong, BS, Stacey Clardy, MD PhD, Julia Klein, APRN, M. Mateo Paz Soldan, MD PhD, Lucy D Dewitt, MD and John Steffens, MD, Neurology, University of Utah School of Medicine, Salt Lake City, UT

[194]

DX36

[198]

Jeffrey Wilken, PhD1,2, Timothy Fratto, PhD2, Robert L Kane, PhD, ABPP-CN1,2,3, Shannon Kolind, PhD4, Akanksha Mittal, PhD5, Alan K Jacobs, MD5 and Anthony Traboulsee, MD4, (1)Georgetown University, Washington, DC, (2)Washington Neuropsychology Research Group, Washington, DC, (3)University of Maryland School of Medicine, Baltimore, MD, (4)University of British Columbia, Vancouver, BC, Canada, (5)Sanofi Genzyme, Cambridge, MA

[194]

DX36

[198]

Jeffrey Wilken, PhD1,2, Timothy Fratto, PhD2, Robert L Kane, PhD, ABPP-CN1,2,3, Shannon Kolind, PhD4, Akanksha Mittal, PhD5, Alan K Jacobs, MD5 and Anthony Traboulsee, MD4, (1)Georgetown University, Washington, DC, (2)Washington Neuropsychology Research Group, Washington, DC, (3)University of Maryland School of Medicine, Baltimore, MD, (4)University of British Columbia, Vancouver, BC, Canada, (5)Sanofi Genzyme, Cambridge, MA

[194]

DX36

[198]

Guosheng Yin, PhD1, Xiangyi Meng, PhD2 and M. Zahur Islam, PhD2, (1)The University of Hong Kong, Hong Kong, Hong Kong, (2)Novartis Pharmaceuticals Corporation, East Hanover, NJ

[194]

DX37

[198]

Alexander L Pearson, BA1, Stephanie A Grover, MSc, CCRP2, Danusha Nandamalavan, BSc, CCRA2, Tara Berenbaum, BSc3, Robert W Motl, PhD4, Marcia Finlayson, PhD, OT Reg (Ont), OTR5, Brenda Banwell, MD6 and E. Ann Yeh, MD, MA, FRCPC, Dip ABPN3, (1)Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada, (2)Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada, (3)Neurology, The Hospital for Sick Children, Toronto, ON, Canada, (4)Department of Physical Therapy, University of Alabama at Birmingham, Birmingham, AL, (5)School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada, (6)Children’s Hospital of Philadelphia, Philadelphia, PA

[194]

DX37

[198]

Jiwon Oh, MD1, Ludwig Kappos, MD2, Giancarlo Comi, MD3, Mark S Freedman, MD4, Jerome de Seze, MD5, Jerry S Wolinsky, MD6, Philippe Truffinet, MD7, Myriam Benamor, MD7, Karthinathan Thangavelu, PhD8 and Aaron E Miller, MD9, (1)St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada, (2)University Hospital Basel, University of Basel, Basel, Switzerland, (3)University Vita-Salute San Raffaele, Milan, Italy, (4)University of Ottawa and the Ottawa Hospital Research Institute, Ottowa, ON, Canada, (5)University Hospital of Strasbourg, Strasbourg, France, (6)University of Texas Health Science Center at Houston, Houston, TX, (7)Sanofi Genzyme, Chilly-Mazarin, France, (8)Sanofi Genzyme, Cambridge, MA, (9)Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, New York, NY

[194]

DX37

[198]

Janet Moores, RN, BN, MBA, University of Calgary MS Clinic, Calgary, AB, Canada

[194]

DX38

[198]

Mihir Kakara, M.D., Jay Kinariwala, M.D., Shitiz K Sriwastava, M.D. and Evanthia Bernitsas, MD, Neurology, Wayne State University School of Medicine, Detroit, MI

[194]

DX38

[198]

John R Rinker II, MD, Neurology, Birmingham VA Medical Center, Birmingham, AL, Patrizia De Sarno, PhD, Neurology, University of Alabama at Birmingham, Birmingham, AL and Chander Raman, PhD, Medicine, University of Alabama at Birmingham, Birmingham, AL

[194]

DX38

[198]

Jeffrey B English, MD1, Sophia Strickland, pre-medical student2 and Patrick J English, pre-business student2, (1)Multiple Sclerosis Center of Atlanta, Atlanta, GA, (2)Clinical Research, Multiple Sclerosis Center of Atlanta, Atlanta, GA

[194]

DX39

[198]

[194]

DX39

[198]

Keith R Edwards, MD1, Stanley Cohan, MD, PhD2, Lore Garten, MD, Ph. D.1, James Thomas, M.D.3, Kyle E Smoot, MD2, Kiren Kresa-Reahl, MD2, Judy O’Connor, BSW, CCRC1, Tiffany Gervasi, Clinical Research Coordinator2, Chiayi Chen, Ph.D.2, Jessica Siuta, BSMT, ASCP, Clinical Research Coordinator1 and Vineetha Kamath, BS1, (1)MS Center of Northeastern New York, Latham, NY, (2)Providence Multiple Sclerosis Center, Portland, OR, (3)Radiology, Community Care Physicians, P.C., Latham, NY

[194]

DX39

[198]

Jeffrey B English, MD1, Debra K Johnson, RN2, Mitzi J. Williams, MD1 and Donna M Court, MN, RN2, (1)Multiple Sclerosis Center of Atlanta, Atlanta, GA, (2)Clinical Research, Multiple Sclerosis Center of Atlanta, Atlanta, GA

[194]

DX40

[198]

Sibyl Wray, MD1, Ludwig Kappos, MD2, Sandra Vukusic, MD, PhD3, Silvia Bader-Weder, MD4, Regine Buffels, MD4, Donna Masterman, MD, MS5, Julie Napieralski, PhD4 and Stephen L Hauser, MD6, (1)Sibyl Wray MD Neurology PC, Knoxville, TN, (2)Neurologic Clinic and Policlinic, University Hospital Basel, University of Basel, Basel, Switzerland, (3)Service de Neurologie et Sclerose en Plaques, Fondation EDMUS pour la Sclerose en Plaques, Hopital Neurologique Pierre Wertheimer, Lyon, France, (4)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (5)Genentech Inc., South San Francisco, CA, (6)University of California, San Francisco, San Francisco, CA

[194]

DX40

[198]

Kendra L Yale, MMS, PA-C, MSCS1, Kristin Stockman, MSN, ANP-BC, MSCS1 and Shannon Cornell, MSN, ANP-BC, MSCS2, (1)Neurology, University of Colorado, Aurora, CO, (2)University of Colorado, Aurora, CO

[194]

DX40

[198]

Jennifer Smrtka, MSN, ARNP-BC, MSCN, Neurology, University of Miami, Miami, FL and Lori Mayer, DNP, MSN, RN, MSCN, MS Clinic of Central Texas/Central Texas Neurology Consultants, Round Rock, TX

[194]

DX41

[198]

[194]

DX41

[198]

Kiren Kresa-Reahl, MD1, Natalie C Edwards, MSc2, Gary Schneider, ScD3, Kevin Stern, BS3 and Amy L Phillips, PharmD4, (1)Providence MS Center, Portland, OR, (2)Health Services Consulting Corporation, Boxborough, MA, (3)Boston Health Economics, Inc., Waltham, MA, (4)EMD Serono, Inc., Rockland, MA

[194]

DX41

[198]

Kathleen Costello, MS, ANP-BC, MSCN, Vice President, Healthcare Access, National Multiple Sclerosis Society, New York, NY, Helmut Butzkueven, MBBS, PhD, Melbourne Brain Centre, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia, Suhayl Dhib-Jalbut, MD, Department of Neurology, RUTGERS Robert Wood Johnson Medical School, New Brunswick, NJ, Jeremy Hobart, PhD FRCP, Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, United Kingdom of Great Britain and Northern Ireland, Gisela Kobelt, PhD, European Health Economics, Mulhouse, France, George Pepper, ., Shift.ms, Leeds, United Kingdom of Great Britain and Northern Ireland, Maria Pia Sormani, PhD, Biostatistics Unit, University of Genoa, Genoa, Italy, Christoph Thalheim, ., Patient Advocate in Multiple Sclerosis, Brussels, Belgium, Anthony Traboulsee, MD, FRCPC, Department of Medicine, University of British Colombia, Vancouver, BC, Canada, Timothy Vollmer, MD, Department of Neurology, University of Colorado Denver, Aurora, CO and Gavin Giovannoni, MBBCh, PhD, Queen Mary University London, Barts and The London School of Medicine, London, United Kingdom; Queen Mary University London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom of Great Britain and Northern Ireland

[194]

DX42

[198]

Jerry S Wolinsky, MD1, Xavier Montalban, MD, PhD2,3, Stephen L Hauser, MD4, Ludwig Kappos, MD5, Laura Julian, PhD6, Marianna Manfrini, MD PhD7, Shibeshih Belachew, MD, PhD7, Fabian Model, PhD7, Stanislas Hubeaux, MSc7 and Amit Bar-Or, MD8, (1)McGovern Medical School, UTHealth, Houston, TX, (2)Division of Neurology, University of Toronto, Toronto, ON, Canada, (3)Vall d’Hebron University Hospital, Barcelona, Spain, (4)University of California, San Francisco, San Francisco, CA, (5)University Hospital Basel, University of Basel, Basel, Switzerland, (6)Genentech, Inc., South San Francisco, CA, (7)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (8)University of Pennsylvania, Philadelphia, PA

[194]

DX42

[198]

Kirstin Nygren, MSN, FNP-BC, MSCN and Barbara Giesser, MD, Neurology, UCLA, Los Angeles, CA

[194]

DX42

[198]

Krzysztof Selmaj, MD, PhD1, Douglas L Arnold, MD2,3, Amit Bar-Or, MD, FRCPC2, Giancarlo Comi, MD4, Hans-Peter Hartung, MD, FRCP, FAAN, FANA5, Stephen L Hauser, MD6, Fred Lublin, MD7, Anthony Traboulsee, MD, FRCPC8, Nicole Mairon, MD9, Peter Chin, MD10, Paulo Fontoura, MD, PhD9, Hideki Garren, MD, PhD9, Gaelle Klingelschmitt, MSc9, Donna Masterman, MD10 and Ludwig Kappos, MD, PhD11, (1)Medical University of Lodz, Lodz, Poland, (2)McGill University, Montreal, QC, Canada, (3)NeuroRx Research, Montreal, QC, Canada, (4)University Vita-Salute San Raffaele, Milan, Italy, (5)Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany, (6)University of California, San Franscisco, CA, (7)Icahn School of Medicine at Mount Sinai, New York, NY, (8)University of British Columbia, Vancouver, BC, Canada, (9)F. Hoffmann-La Roche Ltd., Basel, Switzerland, (10)Genentech, Inc., South San Francisco, CA, (11)University Hospital Basel, Basel, Switzerland

[194]

DX43

[198]

Daniela Stokmaier, MSc Pharm PhD1, Kevin Winthrop, MD MPH2, Cathy Chognot, PhD3, Joanna Evershed, BSc4, Marianna Manfrini, MD PhD3, John McNamara, BSc MSc CStat5 and Amit Bar-Or, MD6, (1)F.Hoffmann-La Roche Ltd, Basel, Switzerland, (2)Division of Infectious Diseases, OHSU, Portland, OR, (3)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (4)Roche Products Ltd, Welwyn Garden City, United Kingdom, (5)John McNamara Consulting Limited, Cambridge, United Kingdom, (6)University of Pennsylvania, Philadelphia, PA

[194]

DX43

[198]

Laura J Balcer, MD, MSCE1, Steven Galetta, MD1, Jai Perumal, MD2, Roumen Balabanov, MD3, Robert J Fox, MD, FAAN4, Qunming Dong, MD5, Shavy Makh, MPhil5, Christophe Hotermans, MD5, John S Walsh, MD5, Denise Campagnolo, MD6 and Lily Lee, MD5, (1)New York University Langone Medical Center, New York, NY, (2)Judith Jaffe Multiple Sclerosis Center, New York, NY, (3)Rush University Multiple Sclerosis Center, Chicago, IL, (4)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, (5)Biogen, Cambridge, MA, (6)Formerly Biogen, Cambridge, MA

[194]

DX43

[198]

Laurie Millar, PhD, Carrie Li, PhD, Henry Bennett, BSc and Hideki Garren, MD, PhD, F. Hoffmann-La Roche Ltd., Basel, Switzerland

[194]

DX44

[198]

Patricia K Coyle, MD1, Sandra Vukusic, MD, PhD2, Stephanie Jurgensen, MPH3, Philippe Truffinet, MD4, Myriam Benamor, MD4, Elizabeth Poole, PhD3, Jeffrey Chavin, MD3 and Christina Chambers, PhD5, (1)Stony Brook University, Stony Brook, NY, (2)University Hospital of Lyon, Lyon, France, (3)Sanofi, Cambridge, MA, (4)Sanofi, Chilly-Mazarin, France, (5)University of California San Diego, La Jolla, CA

[194]

DX44

[198]

Lori Mayer, DNP, MSN, RN1, Ludwig Kappos, MD2, Michael K Racke, MD3, Kottil Rammohan, MD4, Anthony Traboulsee, MD5, Jerry Wolinsky, MD6, Cathy Chognot, PhD7, Laura Julian, PhD8, Julie Napieralski, PhD7, Johan van Beek, PhD7, Hanzhe Zheng, PhD8 and Stephen L Hauser, MD9, (1)Central Texas Neurology Consultants, Multiple Sclerosis Clinic of Central Texas, Round Rock, TX, (2)University Hospital Basel, University of Basel, Basel, Switzerland, (3)Wexner Medical Center, Ohio State University, Columbus, OH, (4)University of Miami, Miami, FL, (5)University of British Columbia, Vancouver, BC, Canada, (6)McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, (7)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (8)Genentech Inc., South San Francisco, CA, (9)University of California, San Francisco, San Francisco, CA

[194]

DX44

[198]

Lori Mayer, DNP, MSN, RN, MSCN1, Edward J. Fox, MD, PhD1, Christopher LaGanke, MD2, Bhupendra Khatri, MD3, Ann D Bass, MD4, David H Margolin, MD, PhD5, Linda Kasten, MA6 and Patricia A Pagnotta, ARNP, MSN, MSCN, CCRN7, (1)Central Texas Neurology Consultants, Round Rock, TX, (2)North Central Neurology Associates, Cullman, AL, (3)Wheaton Franciscan Regional MS Center, Milwaukee, WI, (4)Neurology Center of San Antonio, San Antonio, TX, (5)Genzyme, a Sanofi company, Cambridge, MA, (6)PROMETRIKA, LLC, Cambridge, MA, (7)Neurology Associates, PA, Maitland, FL

[194]

DX45

[198]

[194]

DX45

[198]

Louise M Rath, RN, MA (Bioethics), Neurosciences, Alfred Health, Melbourne, Australia

[194]

DX45

[198]

Madé Wenten, PhD, MPH, Teesta Soman, MD, MBA, Cathy Lally, MSPH, Maneesh Juneja, BSc, Susan Eaton, MSPH, MT (ASCP), Claudia Prada, MD, PhD and Anne Dilley, BA, MPH, PhD, Biogen, Cambridge, MA

[194]

DX46

[198]

[194]

DX46

[198]

[194]

DX46

[198]

Roochi S Ghodasara, MD1, Madelyn B Rarick, BSN1, Miranda C Mosley, BS1, Rachel A Morgan, BA1, S.R. Sparrow Smith, BS, MA1, Laurel Kagan, NP1, Daniel Kantor, MD2,3, Joy Derwenskus, DO, MS1 and Samuel F. Hunter, MD, PhD1,2, (1)Advanced Neurosciences Institute, Franklin, TN, (2)NeuroNexus Center – Novel Pharmaceutics Institute, Franklin, TN, (3)Kantor Neurology, Coconut Creek, FL

[194]

DX47

[198]

Aaron E Miller, MD1, Giancarlo Comi, MD2, Myriam Benamor, MD3, Philippe Truffinet, MD3, Karthinathan Thangavelu, PhD4, Jeffrey Chavin, MD4 and Mark S Freedman, MD5, (1)Icahn School of Medicine at Mount Sinai, New York, NY, (2)University Vita-Salute San Raffaele, Milan, Italy, (3)Sanofi, Chilly-Mazarin, France, (4)Sanofi, Cambridge, MA, (5)University of Ottawa and the Ottawa Hospital Research Institute, Ottawa, ON, Canada

[194]

DX47

[198]

Malissa C Ayers, Physician Assistant, Mellen Center, Cleveland Clinic Foundation, Cleveland, OH and Mary A Willis, MD, Mellen Center, Cleveland Clinic, Cleveland, OH

[194]

DX47

[198]

Mark Cascione, MD1, Bruce AC Cree, MD, PhD2, Daniel Wynn, MD3, Xiangyi Meng, PhD4, Lesley Schofield, PhD4 and Nadia Tenenbaum, MD4, (1)Tampa Neurology Associates, South Tampa Multiple Sclerosis Center, South Tampa, FL, (2)University of California San Francisco, San Francisco, CA, (3)Consultants in Neurology MS Center, Northbrook, IL, (4)Novartis Pharmaceuticals Corporation, East Hanover, NJ

[194]

DX48

[198]

Mark S Freedman, MD1, Aaron E Miller, MD2, Elizabeth Poole, PhD3, Jeffrey Chavin, MD3, Philippe Truffinet, MD4 and Ludwig Kappos, MD5, (1)University of Ottawa and the Ottawa Hospital Research Institute, Ottawa, ON, Canada, (2)Icahn School of Medicine at Mount Sinai, New York, NY, (3)Sanofi, Cambridge, MA, (4)Sanofi, Chilly-Mazarin, France, (5)Neurologic Clinic and Policlinic, University Hospital Basel, University of Basel, Basel, Switzerland

[194]

DX48

[198]

Mehul Jhaveri, PharmD, MPH1, Ning Wu, PhD1, Crystal Watson, MS1, Kun Yang, PharmD2 and Daniel Jones, PhD2, (1)Biogen, Cambridge, MA, (2)Biogen, Weston, MA

[194]

DX48

[198]

Mark S Freedman, MD1, Ludwig Kappos, MD2, Giancarlo Comi, MD3, Aaron E Miller, MD4, Jerry Wolinsky, MD5, Karthinathan Thangavelu, PhD6, Philippe Truffinet, MD7, Myriam Benamor, MD7, Pascal Rufi, MD7 and Paul O’Connor, MD8, (1)University of Ottawa and the Ottawa Hospital Research Institute, Ottawa, ON, Canada, (2)University Hospital Basel, Basel, Switzerland, (3)University Vita-Salute San Raffaele, Milan, Italy, (4)Icahn School of Medicine at Mount Sinai, New York, NY, (5)University of Texas Health Science Center at Houston, Houston, TX, (6)Genzyme, a Sanofi company, Cambridge, MA, (7)Genzyme, a Sanofi company, Chilly-Mazarin, France, (8)University of Toronto, Toronto, ON, Canada

[194]

DX49

[198]

Konstantin Balashov, MD1, Richard Macdonell, MD2, Kathryn Giles, MD, MSc, FRCPC3, Nicholas Everage, PhD4, Claudia Prada, MD, PhD4, Katherine Riester, MPH4, Dane Cloutier, MSc5 and Mihaela Vlaicu, MD5, (1)Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, (2)Austin Health, University of Melbourne, Melbourne, Australia, (3)Cambridge Memorial Hospital, Cambridge, ON, Canada, (4)Biogen, Cambridge, MA, (5)Biogen, Mississauga, ON, Canada

[194]

DX49

[198]

Michael A Mercurio, MD1, Michael Y Ko, MD2, Roumen Balabanov, MD3, Jennifer A Strong, MS3 and Dusan Stefoski, MD2, (1)Neurology, Rush University Medical Center, Chicago, IL, (2)Rush University Medical Center, Chicago, IL, (3)Rush University Multiple Sclerosis Center, Chicago, IL

[194]

DX50

[198]

David Wormser, MSc, MPhil PhD1, Pierre Engel, PharmD, MPH, PhD2, Kristen Hahn, MPH, PhD3, Silvia Bader-Weder, MD1, Eva-Maria Didden, PhD1, Joanna Evershed, BSc4, Monika Garas, PhD1, Qing Wang, PhD1 and Kerstin Hellwig, PhD MD5, (1)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (2)QuintilesIMS, Paris, France, (3)QuintilesIMS, Cambridge, MA, (4)Roche Products Ltd, Welwyn Garden City, United Kingdom, (5)St. Josef-Hospital, Ruhr University, Bochum, Germany

[194]

DX50

[198]

Mitzi J Williams, MD1, Lilyana Amezcua, MD, MS2, Alexander Green, MD, MPH3, Hollie Schmidt, MS4, Jia Zhou, MS5, Qiang Hou, PhD5, Jaanai Babb, PharmD6, Jessica Royall, MBA6 and Terrie Livingston, PharmD6, (1)Multiple Sclerosis Center of Atlanta, Atlanta, GA, (2)Neurology, University of Southern California, Los Angeles, CA, (3)Division of General Internal Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, (4)Accelerated Cure Project for MS, Waltham, MA, (5)Biogen, Cambridge, MA, (6)Biogen, Weston, MA

[194]

DX50

[198]

Michelle A Allan, RN BA Nursing GCert MS1 and Lindsay Grant, B.Pharm1,2, (1)Monash Neurology, Monash Health, Melbourne, Australia, (2)Medical, Biogen, Sydney, Australia

[194]

DX51

[198]

Andrea V Margulis, MD ScD1, Elizabeth B Andrews, PhD MPH2, Sonia Hernandez-Diaz, MD DrPH3, Melinda Magyari, MD PhD4, Elena Rivero-Ferrer, MD MPH1, Silvia Bader-Weder, MD5, Joanna Evershed, BSc6, Monika Garas, PhD5, Qing Wang, PhD5 and David Wormser, MSc, MPhil PhD5, (1)RTI Health Solutions, Barcelona, Spain, (2)RTI Health Solutions, Research Triangle Park, NC, (3)Harvard University, Boston, MA, (4)Danish Multiple Sclerosis Center, Copenhagen University Hospital, Copenhagen, Denmark, (5)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (6)Roche Products Ltd, Welwyn Garden City, United Kingdom

[194]

DX51

[198]

Nasima Afsari, MBBS, MPH, Neurology, Medstar Georgetown University Hospital, Washington DC, DC

[194]

DX51

[198]

Aaron Boster, MD1, Jacqueline Nicholas, MD, MPH2, Ning Wu, Ph.D.3, Wei-Shi Yeh, PhD3, Monica A Fay, PharmD4, Michael R Edwards, PhD5, Ming-Yi Huang, PhD3 and Andrew Lee, PhD3, (1)OhioHealth Neurological Physicians, Columbus, OH, (2)Health Economics & Outcomes Research, Novartis Pharmaceutical Corporation, East Hanover, NJ, (3)Global Health Economics and Outcomes Research, Biogen, Cambridge, MA, (4)US Medical Affairs, Biogen, Weston, MA, (5)Global Medical Affairs, Biogen, Cambridge, MA

[194]

DX52

[198]

Samuel F Hunter, MD1, Florian P Thomas, MD, PhD, MA2,3, Xiangyi Meng, PhD4, Lesley Schofield, PhD4, Scott Kolodny, MD4, Nadia Tenenbaum, MD4 and Bruce AC Cree, MD, PhD5, (1)Advanced Neurosciences Institute, Franklin, TN, (2)Seton Hall-Hackensack Meridian School of Medicine, South Orange, NJ, (3)Neurology, Hackensack University Medical Center, Hackensack, NJ, (4)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (5)UCSF Neurology, Weill Institute for Neurosciences, San Francisco, CA

[194]

DX52

[198]

Patricia K Coyle, MD1, Bhupendra Khatri, MD2, Keith R Edwards, MD3, Steve Cavalier, MD4, Pascal Rufi, MD5, Karthinathan Thangavelu, PhD4, Myriam Benamor, MD5 and Ralf Gold, MD6, (1)Stony Brook University, Stony Brook, NY, (2)The Regional MS Center, Center for Neurological Disorders at Wheaton Franciscan Healthcare, Milwaukee, WI, (3)Multiple Sclerosis Center of Northeastern New York, Latham, NY, (4)Sanofi Genzyme, Cambridge, MA, (5)Sanofi Genzyme, Chilly-Mazarin, France, (6)St Josef Hospital, Ruhr University Bochum, Bochum, Germany

[194]

DX52

[198]

Demetrios Konstas, MD1, Natalie K Moreo, MD1, Chetan P Gandhy, MD1, Michelle Lyman, MSII2, Doris Deng, MSII2, Robert Soares, BS1, Steven Aradi, MD3 and Derrick S Robertson, MD1, (1)Neurology, University of South Florida, Tampa, FL, (2)University of South Florida College of Medicine, Tampa, FL, (3)Neurology, University of Pennslyvania Perelman School of Medicine, Philadelphia, PA

[194]

DX53

[198]

Jai Perumal, MD1, Robert J Fox, MD2, Roumen Balabanov, MD3, Laura J Balcer, MD, MSCE4, Steven Galetta, MD4, Shavy Makh, MPhil5, Sourav Santra, PhD5, Elizabeth Fisher, PhD5, Christophe Hotermans, MD, PhD5 and Lily Lee, MD5, (1)Judith Jaffe Multiple Sclerosis Center, New York, NY, (2)Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, (3)Northwestern University, Chicago, IL, (4)New York University Langone Medical Center, New York, NY, (5)Biogen, Cambridge, MA

[194]

DX53

[198]

Patricia A Pagnotta, ARNP, MSN, MSCN, CCRN, Neurology Associates, PA, Maitland, FL, Christopher LaGanke, MD, North Central Neurology Associates, Cullman, AL and Constance B Easterling, RN, MSN, ANP, MSCN, Multiple Sclerosis Care Center of Neurological Services, Hackensack, NJ

[194]

DX53

[198]

Demetrios Konstas, MD1, Natalie K Moreo, MD1, Chetan P Gandhy, MD1, Doris Deng, MSII2, Michelle Lyman, MSII2, Robert Soares, BS1 and Derrick S Robertson, MD1, (1)Neurology, University of South Florida, Tampa, FL, (2)University of South Florida College of Medicine, Tampa, FL

[194]

DX54

[198]

Lakshman Arcot Jayagopal, MD, Deb Cramer, RN, BSN, MSCN, Wendy Durand, RN BSN, Deborah Gallaro, RPH, Bren Hammond, RN, BSN, MSCN, Michael Persenaire, MD, Gary Stobbe, MD, Jennie Toro, RN, Gloria von Geldern, MD and Annette Wundes, MD, University of Washington, Seattle, WA

[194]

DX54

[198]

Paul Ford, Ph.D.1, Stacey S Cofield, PhD2, Tuula Tyry, PhD3, Carol Cosenza, MSW4, Amber Salter, PhD5, Mary Beth Mercer, MPH1, Sneha Natarajan, PhD6, Lauren Cripps, MA4, Gary Cutter, PhD7 and Robert J Fox, MD, FAAN6, (1)Bioethics, Cleveland Clinic, Cleveland, OH, (2)Biostatistics, University of Alabama at Birmingham, Birmingham, AL, (3)Dignity Health, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, (4)Center for Survey Research, University of Massachusetts, Boston, Boston, MA, (5)Biostatistics, Washington University in St. Louis, St. Louis, MO, (6)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, (7)University of Alabama at Birmingham, Birmingham, AL

[194]

DX54

[198]

Nicholas Everage, PhD1, Claudia Prada, MD, PhD1, Shifang Liu, PhD1, Konstantin Balashov, MD, PhD, FAAN2, Richard Macdonell, MD, FRACP3, Jörg Windsheimer, MD4 and Kathryn Giles, MD, MSc, FRCPC5, (1)Biogen, Cambridge, MA, (2)Robert Wood Johnson Medical School, New Brunswick, NJ, (3)Department of Neurology, Austin Health, Univ. of Melbourne, Melbourne, Australia, (4)Praxis für Neurologie und Psychiatrie, Nürnberg, Germany, (5)Cambridge Memorial Hospital, Cambridge, ON, Canada

[194]

DX55

[198]

Maria L Naylor, PhD1, Marco Salvetti, MD2, Jang Yun, MS, PhD1, Craig Wakeford, MA1 and Sibyl Wray, MD3, (1)Biogen, Cambridge, MA, (2)Sapienza University, Sant’ Andrea Hospital, Rome, Italy, (3)Hope Neurology MS Center, Knoxville, TN

[194]

DX55

[198]

Aaron Boster, MD1, Pavle Repovic, MD, PhD2, Shannon Ritter, MS3, Davorka Tomic, PhD4, Xiangyi Meng, PhD3, Daniela P Meier, MD4, Fernanda Boulos, MD3, Frederik Barkhof, MD, PhD5 and Till Sprenger, MD6, (1)Ohio State University, Columbus, OH, (2)Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA, (3)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (4)Novartis Pharma AG, Basel, Switzerland, (5)Department of Radiology & Nuclear Medicine, VU University Medical Center, Amsterdam, Netherlands, (6)Medical Image Analysis Center and Department of Neurology, University Hospital Basel, Basel, Switzerland

[194]

DX55

[198]

Patricia A Pagnotta, ARNP, MSN, MSCN, CCRN, MS Center of Greater Orlando, Maitland, FL

[194]

DX56

[198]

Dante M Grassi, Pharm D., BCPS, Enterprise Pharmacy, Center for Pharmacy Innovation and Outcomes, Geisinger, Danville, PA, Amanda Sharry-Rogers, Pharm D., BCPS, Enterprise Pharmacy, Geisinger, Wilkes-Barre, PA, Ashley L Lauver, Pharm D., Enterprise Pharmacy, Geisinger, Danville, PA, Douglas C Nathanson, MD, Neuroscience, Geisinger, Wilkes-Barre, PA, Joseph J Chronowski, MBA, BA, Care Support Services, Geisinger, Danville, PA and Jove Graham, PhD, Center for Pharmacy Innovation and Outcomes, Geisinger, Danville, PA

[194]

DX56

[198]

Aaron Boster, MD1, Pavle Repovic, MD, PhD2, Xiangyi Meng, PhD3, Daniela P Meier, MD4, Fernanda Boulos, MD3, Till Sprenger, MD5 and Frederik Barkhof, MD, PhD6, (1)Ohio State University, Columbus, OH, (2)Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA, (3)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (4)Novartis Pharma AG, Basel, Switzerland, (5)Medical Image Analysis Center and Department of Neurology, University Hospital Basel, Basel, Switzerland, (6)Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, Netherlands

[194]

DX56

[198]

Robert Kuhelj, PhD1, Gurpreet Deol-Bhullar, BSc, OT1, Monika Garas, PhD1, Peter Chin, MD2, Stephen L Hauser, MD3 and Xavier Montalban, MD, PhD4, (1)F. Hoffmann-La Roche Ltd., Basel, Switzerland, (2)Genentech, Inc., South San Francisco, CA, (3)University of California, San Franscisco, CA, (4)Hospital Vall d’Hebron University, Barcelona, Spain

[194]

DX57

[198]

Cindy Darius, MS, RN1, Maureen A. Mealy, PhD(c), RN2, Megan Esch, MD3, Salman Aljarallah, MBBS FRCPC4, Kathleen Costello, MS, ANP-BC, MSCN5, Lisa Fox, PA-C MPAS4 and Shiv Saidha, MBBCh6, (1)Neurology, Johns Hopkins School of Medicine, Balitmore, MD, (2)Acute and Chronic Care, Johns Hopkins University School of Nursing, Baltimore, MD, (3)Neurology, The Johns Hopkins School of Medicine, Baltimore, MD, (4)Neurology, Johns Hopkins School of Medicine, Baltimore, MD, (5)Vice President, Healthcare Access, National Multiple Sclerosis Society, New York, NY, (6)Neurology, Johns Hopkins University, Baltimore, MD

[194]

DX57

[198]

Ralph HB Benedict, PhD1, Douglas L Arnold, MD2,3, Bruce AC Cree, MD4, Xiangyi Meng, PhD5, Lesley Schofield, PhD5, Fernanda Boulos, MD5 and Nadia Tenenbaum, MD5, (1)University at Buffalo, State University of New York, Buffalo, NY, (2)NeuroRx Research, Montreal, QC, Canada, (3)McGill University, Montreal, QC, Canada, (4)Multiple Sclerosis Center, San Francisco, CA, (5)Novartis Pharmaceuticals Corporation, East Hanover, NJ

[194]

DX57

[198]

Roochi S Ghodasara, MD1, Miranda C Mosley, BS1, Rachel A Morgan, BA1, S.R. Sparrow Smith, BS, MA1, Madelyn B Rarick, BSN1, Laurel Kagan, NP1, Daniel Kantor, MD1, Joy Derwenskus, DO, MS1 and Samuel F. Hunter, MD, PhD2, (1)Neurology, Advanced Neurosciences Institute, Franklin, TN, (2)NeuroNexus Center – Novel Pharmaceutics Institute, Franklin, TN

[194]

DX58

[198]

Daniel Golan, MD1, Mark Gudesblatt, MD2, Karl Wisseman, N/A2, Myassar Zarif, MD2, Barbara Bumstead, MS, ANCP, MSCN2, Lori Fafard, RN, BSN, CNRN, MSCN, CCRP2, Cynthia Sullivan, PhD3, Jeffrey Wilken, PhD4, Jared Srinivasan, N/A2, Karen Blitz, DO2, Marijean Buhse, PhD, NP, RN, MSCN5 and Glen Doniger, PhD6, (1)Rapparport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel, (2)South Shore Neurologic Associates, Patchogue, NY, (3)Nursing, State University of New York @ Stony Brook, Stony Brook, NY, (4)Washington Neuropsychology Research Group, Washington, DC, (5)Stony Brook University, Stony Brook, NY, (6)NeuroTrax Corporation, Modiin, Israel

[194]

DX58

[198]

Regina Berkovich, MD1, Hao Zhang, PhD2, Julie Aldridge, MS2, Scott Baver, PhD3 and Eric Williamson, MD4, (1)University of Southern California, Los Angeles, CA, (2)EMD Serono, Inc., Billerica, MA, (3)EMD Serono, Inc., Rockland, MA, (4)University of Pennsylvania Penn Neuroscience Center, Philadelphia, PA

[194]

DX58

[198]

Shannon Ritter, MS1, Anthony T Reder, MD2, Daniela Piani Meier, PhD3, Davorka Tomic, PhD3 and Bruce AC Cree, MD, PhD4, (1)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (2)University of Chicago, Chicago, IL, (3)Novartis Pharma AG, Basel, Switzerland, (4)University of California San Francisco, San Francisco, CA

[194]

DX59

[198]

Angel Chinea, MD1, Ivonne Vicente, MD2, Cristina M Rubi, BS2, Allan J Reyes, BA3, Astrid Diaz, BS4 and Genesis Burgos, HS5, (1)San Juan Multiple Sclerosis Center, San Juan, PR, (2)San Juan Multiple Sclerosis Center, Guaynabo, PR, (3)Neurology, San Juan MS Center, Guaynabo, PR, Puerto Rico, (4)San Juan MS Center, Guaynabo, PR, (5)San Juan MS Center, Guaynabo, PR, Puerto Rico

[194]

DX59

[198]

Richard Macdonell, MD1, Mark S Freedman, MD2, Xianhao Xu, MD3, Steve Vucic, MD4, Philippe Truffinet, MD5, Myriam Benamor, MD5, Karthinathan Thangavelu, PhD6 and Aaron E Miller, MD7, (1)Austin Health, Heidelberg, Australia, (2)University of Ottawa and the Ottawa Hospital Research Institute, Ottowa, ON, Canada, (3)Beijing Hospital, Beijing, China, (4)University of Sydney, Sydney, Australia, (5)Sanofi Genzyme, Chilly-Mazarin, France, (6)Sanofi Genzyme, Cambridge, MA, (7)Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, New York, NY

[194]

DX59

[198]

Steven H Nye, Ph.D., Discovery, ENDECE Neural, LLC, Mequon, WI and James G Yarger, Ph.D., ENDECE Neural, LLC, Mequon, WI

[194]

DX60

[198]

Daniel Kantor, MD1,2, Asya I. Wallach, MD3, Samuel F Hunter, MD4, Christopher W. Milligan, MS, PA-C4, Ajay S Gupta, MD5, Richard A. Sater, MD, PhD6, Marcus Rice, MD7 and Ilya Kister, MD3, (1)Medical Partnership 4 MS (MP4MS), Coconut Creek, FL, (2)Florida Atlantic University, Boca Raton, FL, (3)MS Comprehensive Care Center, NYU School of Medicine, New York, NY, (4)Advanced Neurosciences Institute, Franklin, TN, (5)Fort Wayne Neurological Center, Fort Wayne, IN, (6)Guilford Neurological Associates, Greensboro, NC, (7)Neurology Specialists, Norfolk, VA

[194]

DX60

[198]

Robert T Naismith, MD1, Richard A Leigh-Pemberton, MD2, Amy E Claxton, PhD2, Marjie L Hard, Ph.D.2, Yangchun Du, PhD2, Lisa von Moltke, MD2, Anthony J Lembo, MD3 and Jerry Wolinsky, MD4, (1)Neurology, Washington University School of Medicine, St Louis, MO, (2)Alkermes, Inc., Waltham, MA, (3)Beth Israel Deaconess Medical Center, Boston, MA, (4)University of Texas Health Science Center at Houston, Houston, TX

[194]

DX60

[198]

Tania A Reyna, MD1, Tony Sharp, PA2, Cecilie Fjeldstad, PhD2, Jennifer Smith, PA2 and Gabriel Pardo, MD2, (1)Oklahoma Medical Research Foundation, Oklahoma City, OK, (2)MS Center of Excellence, Oklahoma Medical Research Foundation, Oklahoma City, OK

[194]

DX61

[198]

Rohini D Samudralwar, MD and Ann Cross, MD, Neurology, Washington University in St. Louis, St.Louis, MO

[194]

DX61

[198]

Robert Zivadinov, MD1, Michael G Dwyer, PhD1, Ellen Carl, PhD1, Karthinathan Thangavelu, PhD2, Steve Cavalier, MD2 and Niels Bergsland, PhD1, (1)University at Buffalo, Buffalo, NY, (2)Sanofi Genzyme, Cambridge, MA

[194]

DX61

[198]

Virginia Devonshire, MD, Department of Neurology, University of British Columbia, Vancouver, BC, Canada, Anthony Feinstein, MPhil, PhD, FRCP, Department of Psychiatry, University of Toronto, Sunnybrook Health Sciences Centre, Toronto, ON, Canada and Alan Gillett, PhD, EMD Serono, Mississauga, ON, Canada

[194]

DX62

[198]

Matilde Inglese, MD, PhD1, Maria Petracca, MD, PhD2, Sirio Cocozza, MD2, Sibyl Wray, MD3, Michael K Racke, MD4, Richard Shubin, MD5, Cary L Twyman, MD6, Wendy Su, PhD7, James Eubanks, PhD7, Koby Mok, PhD7, Michael Weiss, JD7 and Edward J. Fox, MD, PhD8, (1)Department of Neurology, Radiology and Neuroscience, Mount Sinai School of Medicine, New York, NY, (2)Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, (3)Hope Neurology MS Center, Knoxville, TN, (4)Wexner Medical Center, Ohio State University, Columbus, OH, (5)SC3 Research Group, Inc, Pasadena, CA, (6)Associates in Neurology PSC, Lexington, KY, USA, Lexington, KY, (7)Autoimmune, TG Therapeutics, Inc, New York, NY, (8)Central Texas Neurology Consultants, Round Rock, TX

[194]

DX62

[198]

Xavier Montalban, MD, PhD1, Douglas L Arnold, MD2,3, Amit Bar-Or, MD, FRCPC2, Jérôme de Seze, MD, PhD4, Gavin Giovannoni, MBBCh, PhD, FCP (Neurol., SA), FRCP, FRCPath5, Bernhard Hemmer, MD6,7, Kottil Rammohan, MD8, Nicole Mairon, MD9, Peter Chin, MD10, Paulo Fontoura, MD, PhD9, Hideki Garren, MD, PhD9, Donna Masterman, MD10, Annette Sauter, MD9 and Jerry Wolinsky, MD11, (1)Vall d’Hebron University Hospital, Barcelon, Spain, (2)McGill University, Montreal, QC, Canada, (3)NeuroRx Research, Montreal, QC, Canada, (4)University Hospital of Strasbourg, Strasbourg, France, (5)Queen Mary University of London, London, United Kingdom of Great Britain and Northern Ireland, (6)Munich Cluster for Systems Neurology (SyNergy), Munich, Germany, (7)Technische Universität München, Munich, Germany, (8)University of Miami, Miami, FL, (9)F. Hoffmann-La Roche Ltd., Basel, Switzerland, (10)Genentech, Inc., South San Francisco, CA, (11)University of Texas Health Science Center at Houston, Houston, TX

[194]

DX63

[198]

Kimberley Chang, .1, Irene Vavasour, PhD1, Roger Tam, .1, David Clayton, .2, Victoria Levesque, PhD2, David Li, MD, FRCPC1, Anthony Traboulsee, MD1 and Shannon Kolind, PhD1, (1)University of British Columbia, Vancouver, BC, Canada, (2)Genentech, Inc., South San Francisco, CA

[194]

DX63

[198]

Salvatore Q Napoli, MD and Sarah B Cardoso, Research Coordinator, Neurology Center of New England P.C., Foxboro, MA

[194]

DX63

[198]

Zahra Almosawi, BSc, Amal Almahroos, Bsc, Reem Abdulla, Bsc, Ayman Mohamed, BSc, Hawra Alalwan, BSc, Ahmmed Almubarak, BSc, Fajer Alammadi, BSc, Amer Kamal, Professor and Ahmed Al-Mahrezi, BSc, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain

[194]

DX64

[198]

[194]

DX64

[198]

Samuel F Hunter, MD, PhD1, David H Margolin, MD, PhD2, Kastytis Sestakauskas, MD3, James Thomas, MD2, Claudio E Rodriguez, MD2, Vladimir Evilevitch, MD2 and Alan K Jacobs, MD2, (1)Advanced Neurosciences Institute, Franklin, TN, (2)Sanofi Genzyme, Cambridge, MA, (3)Sanofi Research & Development, Chilly-Mazarin, France

[194]

DX65

[198]

Daniel Pelletier, MD1, Anthony Traboulsee, MD2, Michael Barnett, PhD, MD3, Giancarlo Comi, MD4, Jerome de Seze, MD PhD5, Alex Rovira, MD6, Sven Schippling, MD7, Luke Chung, MD, MPH8, Nadia Daizadeh, PhD8, Kunio Nakamura, PhD9, Douglas L Arnold, MD10,11 and on behalf of the CARE-MS II, CAMMS03409, and TOPAZ, Investigators12, (1)Keck School of Medicine of University of Southern California, Los Angeles, CA, (2)University of British Columbia, Vancouver, BC, Canada, (3)University of Sydney, Sydney, NSW, Australia, (4)University Vita-Salute San Raffaele, Milan, Italy, (5)University Hospital of Strasbourg, Strasbourg, France, (6)Vall d’Hebron University Hospital, Barcelona, Spain, (7)Neuroimmunology and Multiple Sclerosis Research, University Hospital Zurich and University of Zurich, Zurich, Switzerland, (8)Sanofi, Cambridge, MA, (9)Cleveland Clinic, Cleveland, OH, (10)Montreal Neurological Institute, McGill University, Montreal, QC, Canada, (11)NeuroRx Research, Montreal, QC, Canada, (12)on behalf of the CARE-MS II, CAMMS03409, and TOPAZ Investigators, NJ

[194]

DX65

[198]

Santrina Fletcher, RN, MSN, CNP1, Rhonda Cortright, MSCS1, Mary Pat Bartoszek, CNP, MSCN2 and Colleen E Miller, DNS2, (1)Riverhills Neuroscience, Cincinnati, OH, (2)Sanofi Genzyme, Cambridge, MA

[194]

DX66

[198]

Samuel F Hunter, MD1, Rany A Aburashed, DO2, Raed Alroughani, MD3, Steven M Bromley, MD, FAAN4,5, Dominique Dive, MD, PhD6, Guillermo Izquierdo, MD7, Ho Jin Kim, MD8, Jan Lycke, MD9, Richard AL Macdonell, MD10, Carlo Pozzilli, MD11, Basil Sharrack, MD, PhD12, Patrick Vermersch, MD13, Andreas Lysandropoulos, MD, PhD14, Luke Chung, MD, MPH15, Nadia Daizadeh, PhD15, Heinz Wiendl, MD16 and on behalf of the CARE-MS II and CAMMS03409, Investigators17, (1)Advanced Neurosciences Institute, Franklin, TN, (2)Institute for Neurosciences and Multiple Sclerosis, Owosso, MI, (3)Amiri Hospital, Sharq, Kuwait, (4)South Jersey MS Center, Audubon, NJ, (5)Bromley Neurology, PC, Linwood, NJ, (6)University Hospital Centre of Liege, Liege, Belgium, (7)Virgen Macarena University Hospital, Seville, Spain, (8)Research Institute and Hospital of National Cancer Center, Goyang, Korea, Republic of (South), (9)Sahlgrenska University Hospital, Gothenburg, Sweden, (10)Austin Health and Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia, (11)Sapienza University of Rome, Rome, Italy, (12)Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom, (13)University of Lille, Lille, France, (14)Sanofi, Naarden, Netherlands, (15)Sanofi, Cambridge, MA, (16)University of Munster, Munster, Germany, (17)on behalf of the CARE-MS II and CAMMS03409 Investigators, NA, NJ

[194]

DX66

[198]

Sara Razmjou, MD, M.Sc, Maziar Eslami Farsani, MD, Sheridan Reed, BS, Samuel Lichtman-Mikol, BA, Navid Seraji-Bozorgzad, MD, M.Sc and Evanthia Bernitsas, MD, Neurology, Wayne State School of Medicine, Detroit, MI

[194]

DX67

[198]

Ralph H Benedict, PhD1, Jerome de Seze, MD, PhD2, Stephen L Hauser, MD3, Ludwig Kappos, MD4, Jerry S Wolinsky, MD5, Hanzhe Zheng, PhD6, Shibeshih Belachew, MD, PhD7, Laura Julian, PhD6, Ashish Pradhan, MD6, Fred Lublin, MD8 and Stanley Cohan, MD, PhD9, (1)Department of Neurology, University at Buffalo, Buffalo, NY, (2)University Hospital of Strasbourg, Strasbourg, France, (3)University of California, San Francisco, San Francisco, CA, (4)University Hospital Basel, University of Basel, Basel, Switzerland, (5)McGovern Medical School, UTHealth, Houston, TX, (6)Genentech, Inc., South San Francisco, CA, (7)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (8)Icahn School of Medicine at Mount Sinai, New York, NY, (9)Providence Multiple Sclerosis Center, Portland, OR

[194]

DX67

[198]

Sibyl Wray, MD1, Silvia Bader-Weder, MD2, Regine Buffels, MD2, Donna Masterman, MD, MS3, Julie Napieralski, PhD2 and Stephen L Hauser, MD4, (1)Hope Neurology MS Center, Knoxville, TN, (2)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (3)Genentech Inc., South San Francisco, CA, (4)University of California, San Francisco, San Francisco, CA

[194]

DX68

[198]

Douglas L Arnold, MD1,2, Brenda Banwell, MD3, Amit Bar-Or, MD4,5, Angelo Ghezzi, MD6, Benjamin Greenberg, MD, MHS7, Emmanuelle Waubant, MD, PhD8, Gavin Giovannoni, PhD9, Jerry S Wolinsky, MD10, Jutta Gaertner, MD11, Kevin Rostasy, MD12, Lauren Krupp, MD13, Marc Tardieu, MD14, Wolfgang Brueck, MD15, Tracy Stites, PhD16, Gregory L Pearce, PhD16, Martin Merschhemke, MD, PhD17 and Tanuja Chitnis, MD18, (1)NeuroRx Research, Montreal, QC, Canada, (2)Montreal Neurological Institute, McGill University, Montreal, QC, Canada, (3)Children’s Hospital of Philadelphia, Philadelphia, PA, (4)Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (5)Neuroimmunology Unit, Montreal Neurological Institute and Hospital, Montreal, QC, Canada, (6)Gallarate Hospital, Gallarate, Italy, (7)Neurology & Neurotherapeutics – MS Clinic, UT Southwestern Medical Center, Dallas, TX, (8)UCSF Neurology, Weill Institute for Neurosciences, San Francisco, CA, (9)Queen Mary University of London, Blizard Institute, Barts and the London School of Medicine and Dentistry, London, UK, London, United Kingdom, (10)McGovern Medical School, UTHealth, Houston, TX, (11)Department of Paediatrics and Adolescent Medicine, German Centre for Multiple Sclerosis in Childhood and Adolescence University Medical Centre, Goettingen, Germany, (12)Division of Paediatric Neurology, Children’s Hospital Datteln, University Witten/Herdecke, Datteln, Germany, (13)Pediatric MS Center, NYU Langone Medical Center, New York, NY, (14)Bicetre Hospital, Paris, France, (15)Department of Neuropathology, University Medical Centre, Goettingen, Germany, (16)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (17)Novartis Pharma AG, Basel, Switzerland, (18)Massachusetts General Hospital, Partners Pediatric MS Center, Boston, MA

[194]

DX68

[198]

Stuart Cook, MD1, Thomas Leist, MD2, Giancarlo Comi, MD3, Xavier Montalban, MD4, Elke Sylvester, MD5, Christine Hicking, MS5 and Fernando Dangond, MD6, (1)Rutgers, The State University of New Jersey, Newark, NJ, (2)Thomas Jefferson University, Philadelphia, PA, (3)University Vita-Salute San Raffaele, Milan, Italy, (4)Hospital Universitari Vall d’Hebron, Barcelona, Spain, (5)Merck KGaA, Darmstadt, Germany, (6)EMD Serono, Inc., Billerica, MA

[194]

DX69

[198]

[194]

DX69

[198]

Stuart Cook, MD1, Thomas Leist, MD2, Giancarlo Comi, MD3, Xavier Montalban, MD4, Elke Sylvester, MD5, Christine Hicking, MS5 and Fernando Dangond, MD6, (1)Rutgers, The State University of New Jersey, Newark, NJ, (2)Thomas Jefferson University, Philadelphia, PA, (3)University Vita-Salute San Raffaele, Milan, Italy, (4)Hospital Universitari Vall d’Hebron, Barcelona, Spain, (5)Merck KGaA, Darmstadt, Germany, (6)EMD Serono, Inc., Billerica, MA

[194]

DX70

[198]

Thomas Finnegan, PhD, Medscape LLC, New York, NY, Gena Dolson, MS, Medscape Education, New York, NY and Stephen Krieger, MD, Icahn School of Medicine, Corinne Goldsmith Dickinson Center for Multiple Sclerosis, New York, NY

[194]

DX71

[198]

Edward J. Fox, MD, PhD1, Amy Lovett-Racke, PhD2, Matilde Inglese, MD, PhD3, Maria Petracca, MD, PhD4, Sibyl Wray, MD5, Michael K Racke, MD6, Richard Shubin, MD7, Cary L Twyman, MD8, Michael Weiss, JD9, James Eubanks, PhD9, Koby Mok, PhD9 and Wendy Su, PhD9, (1)Central Texas Neurology Consultants, Round Rock, TX, (2)Microbial Infection and Immunity, Ohio State University Medical Center, Columbus, OH, (3)Department of Neurology, Radiology and Neuroscience, Mount Sinai School of Medicine, New York, NY, (4)Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, (5)Hope Neurology MS Center, Knoxville, TN, (6)Wexner Medical Center, Ohio State University, Columbus, OH, (7)SC3 Research Group, Inc, Pasadena, CA, (8)Associates in Neurology PSC, Lexington, KY, USA, Lexington, KY, (9)Autoimmune, TG Therapeutics, Inc, New York, NY

[194]

DX71

[198]

Thomas Leist, MD1, Giancarlo Comi, MD2, Mark S Freedman, MD3, Bruce AC Cree, MD4, Patricia K Coyle, MD5, Hans-Peter Hartung, MD6, Patrick Vermersch, MD7, Elke Sylvester, MD8, Doris Damian, PhD9 and Fernando Dangond, MD9, (1)Thomas Jefferson University, Philadelphia, PA, (2)University Vita-Salute San Raffaele, Milan, Italy, (3)University of Ottawa and the Ottawa Hospital Research Institute, Ottowa, ON, Canada, (4)Multiple Sclerosis Center, San Francisco, CA, (5)Stony Brook University, Stony Brook, NY, (6)Heinrich Heine University, Dusseldorf, Germany, (7)Univ. Lille, CHU Lille, LIRIC – INSERM U995, Lille, France, (8)Merck KGaA, Darmstadt, Germany, (9)EMD Serono, Inc., Billerica, MA

[194]

DXA01

[198]

Michelle H Cameron, MD, PT, MCR1, Jeffrey A Cohen, MD2, Aaron E Miller, MD3, Andrew Goodman, MD4, Myla D Goldman, MD, Msc5, Dustin Chernick, PhD6, Robert Elfont, M.D.6, Cindy Souza-Prien, B.S.6, Larissa Felt, B.S.6 and Rajiv Patni, MD6, (1)Oregon Health & Science University, Portland, OR, (2)Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, (3)Icahn School of Medicine at Mount Sinai, New York, NY, (4)Neurology, University of Rochester, Rochester, NY, (5)University of Virginia, Charlottesville, VA, (6)Adamas Pharmaceuticals, Inc., Emeryville, CA

[194]

DXA02

[198]

Stephanie A Grover, MSc, CCRP1, Samantha Stephens, PhD1, Kimberly Young, BHSc, MSc1, Tara Berenbaum, BSc1, Renisha Iruthayanathan, BSc1, Austin Noguera, BA1, Michelle J Jaeggi, MD2, Marcia Finlayson, PhD, OT Reg (Ont), OTR3, Robert W Motl, PhD4, Shelly Weiss, MD, FRCPC2,5, Indra Narang, MEDSCI, MBBCH, FRCPCH, MD6 and E Ann Yeh, MD2,5,7, (1)Department of Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada, (2)Division of Neurology, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada, (3)School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada, (4)Department of Physical Therapy, University of Alabama at Birmingham, Birmingham, AL, (5)Faculty of Medicine, University of Toronto, Toronto, ON, Canada, (6)Division of Respiratory Medicine, The Hospital for Sick Children, Toronto, ON, Canada, (7)Department of Paediatrics, Division of Neurology, The Hospital for Sick Children, Toronto, ON, Canada

[194]

DXA03

[198]

Giulia Longoni, M.D.1, Beyza Ciftci-Kavaklioglu, MD1, Carmen Yea, MSc2, Stephanie A Grover, MSc, CCRP2, Fahad Albassam, MD1, Renisha Iruthayanathan, BSc2 and E Ann Yeh, MD1, (1)Department of Paediatrics, Division of Neurology, The Hospital for Sick Children, Toronto, ON, Canada, (2)Department of Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada

[194]

DXA04

[198]

Stacy Coffyn, SPT1, Alexandra Wileman, SPT1, Samantha D’Silva, SPT1, Mohammed Alshehri, PT, MS1, Michelle Drerup, Psy.D., D.BSM2, Sharon G Lynch, MD3 and Catherine Siengsukon, PT, PhD1, (1)Physical Therapy and Rehabilitation Science, University of Kansas Medical Center, Kansas City, KS, (2)Sleep Disorders Center, Cleveland Clinic, Cleveland, OH, (3)Neurology, University of Kansas Medical Center, Kansas City, KS

[194]

DXA05

[198]

Katie LJ Cederberg, MS1, Jessica F Baird, PhD1, Stephanie L Silveira, PhD1, Brenda Jeng, MS1, E. Morghen Sikes, MS, OTR/L1 and Robert W Motl, PhD2, (1)Physical Therapy, University of Alabama at Birmingham, Birmingham, AL, (2)Department of Physical Therapy, University of Alabama at Birmingham, Birmingham, AL

[194]

DXA06

[198]

Terrie Livingston, PharmD1, Yang Mao-Draayer, MD, PhD2, Kottil Rammohan, MD3, David Li, MD, FRCPC4, June Halper, MSN, ANP, FAAN5, Sara McCurdy Murphy, BA6 and Lisa Patton, BA6, (1)EMD Serono, Rockland, MA, (2)Department of Neurology, University of Michigan Medical School, Ann Arbor, MI, (3)University of Miami, Miami, FL, (4)The University of British Columbia, Vancouver, BC, Canada, (5)CEO-CMSC, Hackensack, NJ, (6)CRB, Social & Scientific Systems, Inc., Silver Spring, MD

[194]

DXM01

[198]

Annette F Okai, MD1, Mitzi J Williams, MD2, Megan Weigel, DNP3, Dana Jones, NP4, Steve Cole, MD5, Richard Frankel, PhD6, Amanda Montague, EdM7, Barry Hendin, MD8, Jennifer Reardon, MD9, Shawn Keogan, MD9, Jean-Pierre Morello, MD9 and Leorah Freeman, MD, PhD10, (1)North Texas Institute of Neurology & Headache, Plano, TX, (2)Joi Life Wellness, MS Neurology Center, Smyrna, GA, (3)First Coast Integrative Medicine, Jacksonville, FL, (4)Holy Name Medical Center, Teaneck, NJ, (5)Stony Brook University School of Medicine, Stony Brook, NY, (6)Indiana University of Medicine, Indianapolis, IN, (7)Multiple Sclerosis Association of America, Cherry Hill, NJ, (8)Center for Neurology and Spine, Phoenix, AZ, (9)Bristol Myers Squibb, Princeton, NJ, (10)Neurology, Dell Medical School, The University of Texas at Austin, Austin, TX

[194]

DXM01

[198]

Annette Okai, MD1, Lilyana Amezcua, MD, MS2, Regina Berkovich, MD2,3, Angel Chinea, MD4, Keith Edwards, MD5, Brian Steingo, MD6, Aljoeson Walker, MD7, Alan Jacobs, MD8, Nadia Daizadeh, PhD8, Mitzi Williams, MD9 and on behalf of the CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ Investigators, (1)Multiple Sclerosis Treatment Center of Dallas, Dallas, TX, (2)Keck School of Medicine, University of Southern California, Los Angeles, CA, (3)Synergy Healthcare Medical Associates, Los Angeles, CA, (4)San Juan Multiple Sclerosis Center, Guaynabo, PR, (5)MS Center of Northeastern New York, Latham, NY, (6)Fort Lauderdale Multiple Sclerosis Center, Fort Lauderdale, FL, (7)Medical University of South Carolina, Charleston, SC, (8)Sanofi, Cambridge, MA, (9)Multiple Sclerosis Center of Atlanta, Mableton, GA

[194]

DXM02

[198]

Barry Hendin, MD1, Ben W Thrower, MD2, Scott D. Newsome, DO, MSCS, FAAN, FANA3, Robert Chinnapongse, MD4, Sherry Danese, BS, MBA5 and Jenifer Patterson, ARNP, MSCN4, (1)Center for Neurology and Spine, Phoenix, AZ, (2)Crawford Research Institute, Shepherd Center, Atlanta, GA, (3)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (4)Jazz Pharmaceuticals, Carlsbad, CA, (5)Outcomes Insights, Agoura Hills, CA

[194]

DXM02

[198]

Benjamin Greenberg, MD, MHS1, Scott Kolodny, MD2, Mengru Wang, MS3 and Chinmay Deshpande, PhD2, (1)Department of Neurology, UT Southwestern, Dallas, TX, (2)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (3)KMK Consulting Inc, Morristown, NJ

[194]

DXM03

[198]

Helen-Margaret O Onuorah, BA1, Odelin Charron, MSc, MSE1, Ethan Meltzer, MD1, Amanda Montague, EdM2, Alexis Crispino, BA2, Avery Largent, BA1, Ashlea Lucas, PA-C1 and Leorah Freeman, MD, PhD1, (1)Neurology, Dell Medical School, The University of Texas at Austin, Austin, TX, (2)Multiple Sclerosis Association of America, Cherry Hill, NJ

[194]

DXM03

[198]

Yang Mao-Draayer, MD, PhD1, Jeffrey A Cohen, MD2, Amit Bar-Or, MD3, Bruce A C Cree, MD, PhD, MAS4, May H Han, MD5, Barry A Singer, MD6, Scott Kolodny, MD7, Xiangyi Meng, PhD7, Lesley Schofield, PhD7 and Marina Ziehn, PhD7, (1)University of Michigan, Ann Arbor, MI, (2)Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, (3)Center for Neuroinflammation and Experimental Therapeutics, and Multiple Sclerosis Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (4)Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, (5)Stanford University, Stanford, CA, (6)Missouri Baptist Medical Center, St. Louis, MO, (7)Novartis Pharmaceuticals Corporation, East Hanover, NJ

[194]

DXM04

[198]

Hesham Abboud, MD, PhD, Case Western Reserve School of Medicine – – Cleveland Heights, OH, Cleveland, OH; Multiple Sclerosis and Neuroimmunology Program, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, Rongyi Sun, BS, Case Western Reserve University School of Medicine, Cleveland, OH and Nikhil Modak, MD, University Hospitals of Cleveland, Cleveland, OH

[194]

DXM04

[198]

Mitzi Williams, MD1, Lilyana Amezcua, MD, MS2, Stephen Krieger, MD3, Annette Okai, MD4, Darin T Okuda, MD5, Ray Su, PhD6, Sami Fam, PhD6, James B. Lewin, PharmD6 and Cynthia C Jones, PhD6, (1)Multiple Sclerosis Center of Atlanta, Mableton, GA, (2)Keck School of Medicine, University of Southern California, Los Angeles, CA, (3)Icahn School of Medicine at Mount Sinai, New York City, NY, (4)Multiple Sclerosis Treatment Center Of Dallas at Baylor University Medical Center, Dallas, TX, (5)UT Southwestern Medical Center, Dallas, TX, (6)Biogen, Cambridge, MA

[194]

DXM05

[198]

Lilyana Amezcua, MD1, Annette F Okai, MD2, Anne H Cross, MD3, Nancy L Monson, PhD4, Ben W Thrower, MD5, Anthony T Reder, MD6, Jeffrey B English, MD7, Gregory F Wu, MD, PhD3, Evanthia Bernitsas, MD8, Shereen Yap, MSc9, Jugena Ndrio, PharmD9, Jinglan Pei, PhD9, Ellen M Mowry, MD, MCR10, Fabio Magrini, MD9 and Mitzi J Williams, MD11, (1)Keck School of Medicine, University of Southern California, Los Angeles, CA, (2)North Texas Institute of Neurology & Headache, Plano, TX, (3)Washington University School of Medicine, St. Louis, MO, (4)University of Texas Southwestern Medical Center, Dallas, TX, (5)Crawford Research Institute, Shepherd Center, Atlanta, GA, (6)University of Chicago Medicine, Chicago, IL, (7)Multiple Sclerosis Center of Atlanta, Atlanta, GA, (8)Wayne State University School of Medicine, Detroit, MI, (9)Genentech, Inc., South San Francisco, CA, (10)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (11)Joi Life Wellness Group MS Center, Smyrna, GA

[194]

DXM05

[198]

Thomas Leist, MD1, Doris Damian, PhD2, Yann Hyvert, PhD3, Fernando Dangond, MD4, Daniel Jones, PhD3 and Bruce Hughes, MD5, (1)Thomas Jefferson University, Philadelphia, PA, (2)EMD Serono, Inc., Billerica, MA, (3)EMD Serono, Inc., Rockland, MA, (4)Global Clinical Development Center, EMD Serono, Inc., Billerica, MA, (5)Mercy Ruan Multiple Sclerosis Center, Des Moines, IA

[194]

DXM06

[198]

Olivia Kaczmarek, BS1, Ellie Teng, BS2, Avtej Sethi, MS2, Barbara Bumstead, MS, ANCP, MSCN2, Marijean Buhse, NP-C, PhD2, Myassar Zarif, MD2 and Mark Gudesblatt, MD3, (1)South Shore Neurologic Associates, Patchogue, NY, (2)South Shore Neurologic Associates, P.C., Patchogue, NY, (3)South Shore Neurologic Associates, P.C., Islip, NY

[194]

DXM06

[198]

[194]

DXM07

[198]

Caitlyn Nguyen, HS1, Sarah A Raskin, PhD2,3, Aaron P Turner, Ph.D. ABPP (RP)4,5,6, Zaenab Dhari, MD7,8, Lindsay O Neto, MPH7,8 and Elizabeth S Gromisch, PhD, MSCS8,9,10, (1)Trinity College, Hartford, CT, (2)Neuroscience Program, Trinity College, Hartford, CT, (3)Department of Psychology, Trinity College, Hartford, CT, (4)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (5)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (6)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA, (7)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (8)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (9)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (10)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT

[194]

DXM08

[198]

Andrew J Solomon, MD1, Jiwon Oh, MD PhD FRCPC2, Robert A Bermel, MD3, Adnan Subei, DO4, Chloe Gianatasio, MS5, Natalie Goldberg, PhD5, Wendy Cerenzia, MS6 and Brian Moss, MBA5, (1)Neurological Sciences, University of Vermont College of Medicine, Burlington, VT, (2)Medicine, Division of Neurology, St. Michael’s Hospital, Univ of Toronto, Toronto, ON, Canada, (3)Mellen Center for MS, Cleveland Clinic, Cleveland, OH, (4)Neurology, Memorial Healthcare System, Hollywood, FL, (5)Efficient CME, Fort Lauderdale, FL, (6)CE Outcomes, LLC, Birmingham, AL

[194]

DXM09

[198]

Odelin Charron, MSc, MSE1, Kenneth Onuorah, AS Candidate1, Helen-Margaret O Onuorah, BA1, Amanda Montague, EdM2, Alexis Crispino, BA2, Randa Hamden, PhD, MPH3, Trudy Krause, DrPH, MS3, Avery Largent, BA1, Ashlea Lucas, PA-C1, Ethan Meltzer, MD1 and Leorah Freeman, MD, PhD1, (1)Neurology, Dell Medical School, The University of Texas at Austin, Austin, TX, (2)Multiple Sclerosis Association of America, Cherry Hill, NJ, (3)Center for Healthcare Data, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX

[194]

DXM10

[198]

Louise C Palmer, MA1, Mark Sweatman, PhD2, James Krause, Ph.D.3, Melinda Jarnecke, BS4 and Deborah Backus, PT, PhD1, (1)Shepherd Center, Atlanta, GA, (2)Georgia Gwinnett College, Lawrenceville, GA, (3)Professor and Associate Dean for Research, Medical University of South Carolina, Columbia, SC, (4)Medical University of South Carolina, Charleston, SC

[194]

DXM11

[198]

Marek Podyma, PhD, Pixel Technology, Lodz, Poland and Malgorzata Siger, MD PhD, Neurology, Medical University of Lodz, Lodz, Poland

[194]

DXM12

[198]

Tiffany Malone, MSW, MSCS1, John Schafer, MD2, Lacey Sayre, CNA1 and Brian Hutchinson, PT, MSCS3, (1)Multiple Sclerosis Achievement Center, Dignity Health, Citrus Heights, CA, (2)Multiple Sclerosis Achievement Center, Citrus Heights, CA, (3)Multiple Sclerosis Achievement Center, Dignity Health, Sacramento, CA

[194]

DXT01

[198]

Gavin Giovannoni, MBBCh, PhD, FCP, FRCP, FRCPath, Queen Mary University of London, London, United Kingdom, Birgit Keller, Diplom, Merck KGaA, Darmstadt, Germany and Dominic Jack, PhD, Merck Serono Ltd, Middlesex, United Kingdom

[194]

DXT02

[198]

Maria Pia Sormani, PhD, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy, Mark S Freedman, MD, University of Ottawa and the Ottawa Hospital Research Institute, Ottawa, ON, Canada, Julie Aldridge, MS, Research & Development Institute, EMD Serono, Inc., Billerica, MA, Kurt Marhardt, MD, Merck GmbH, Vienna, Austria and Nicola De Stefano, MD, Department of Medicine, Surgery, and Neurosciences, University of Siena, Siena, Italy

[194]

DXT03

[198]

Virginia R Schobel, MSc, Neurology Market Intelligence, Spherix Global Insights, Exton, PA and Jennifer Robinson, BS, President, Spherix Global Insights, Exton, PA

[194]

DXT04

[198]

Virginia R Schobel, MSc, Neurology Market Intelligence, Spherix Global Insights, Exton, PA and Jennifer Robinson, BS, President, Spherix Global Insights, Exton, PA

[194]

DXT05

[198]

Ann D Bass, MD1, Rafael Arroyo, MD2, Aaron Boster, MD3, Alexey N Boyko, MD4, Sara Eichau, MD, PhD5, Donna Graves, MD6, Mary Margaret Hillstrand, DNP, ANP7, Carolina Ionete, MD, PhD8, Volker Limmroth, MD, PhD9, Carlos Navas, MD10, Daniel Pelletier, MD11, Carlo Pozzilli, MD12, Jennifer Ravenscroft, PA-C, MSCS13, Livia Sousa, MD14, Mar Tintore, MD, PhD15, Bernard MJ Uitdehaag, MD, PhD16, Darren P Baker, PhD17, Nadia Daizadeh, PhD17, Zia Choudhry, MD, PhD, MBA17, David Rog, MD18 and on behalf of the CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ Investigators, (1)Neurology Center of San Antonio, San Antonio, TX, (2)Hospital Universitario Quirónsalud Madrid, Madrid, Spain, (3)OhioHealth Multiple Sclerosis Center, Columbus, OH, (4)Pirogov Russian National Research University & Demyelinating Diseases Center, Usupov Hospital, Moscow, Russia, (5)Hospital Universitario Virgen Macarena, Seville, Spain, (6)Neuroscience Institute-Neurology, Atrium Health, Charlotte, NC, (7)Neurological Services, Anchorage, AK, (8)Department of Neurology, University of Massachusetts Memorial Medical Center, Worcester, MA, (9)Klinik fur Neurologie und Palliativmedizin, Cologne, Germany, (10)Clinica Universitaria Colombia, Bogota, Colombia, (11)Keck School of Medicine of University of Southern California, Los Angeles, CA, (12)University of Rome, Rome, Italy, (13)Kansas City MS Center, Overland Park, KS, (14)Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal, (15)University Hospital Vall d’Hebron, Barcelona, Spain, (16)VU University Medical Center, Amsterdam, Netherlands, (17)Sanofi, Cambridge, MA, (18)Salford Royal NHS Foundation Trust, Salford, United Kingdom

[194]

DXT06

[198]

Julie Kidd, PharmD, MPH, BCPS, CPP, Specialty Pharmacy, Novant Health, Winston-Salem, NC, Sandrine Tchinda, PharmD, Novant Health Prince William Medical Center, Manassas, VA, Matthew Carraro, MD, Center for Multiple Sclerosis, Novant Health, Charlotte, NC and Nora Schuette, PA, Center for Multiple Sclerosis, Novant Health, Charlotte, NC

[194]

DXT07

[198]

Bhupendra Khatri, MD1, David Rog, MD2, Andrew Chan, MD3, Jose Meca-Lallana, MD4, Patricia K Coyle, MD5, Keith Edwards, MD6, Boris A Kallmann, MD7, Steven Cavalier, MD8, Jennifer S Kullmann, MD9, Elizabeth M Poole, PhD8 and Thorsten Rosenkranz, MD, on behalf of the Teri-PRO and TAURUS-MS I investigators10, (1)Center for Neurological Disorders, Milwaukee, WI, (2)Salford Royal NHS Foundation Trust, Salford, United Kingdom, (3)Ambulantes Neurozentrum, Inselspital, Bern, Switzerland, (4)Unidad de Esclerosis Multiple en Hospital Virgen de la Arrixaca, El Palmar, Spain, (5)Stony Brook University, Stony Brook, NY, (6)MS Center of Northeastern New York, Latham, NY, (7)MS Center Bamberg, Bamberg, Germany, (8)Sanofi, Cambridge, MA, (9)Sanofi, Neu-Isenberg, Germany, (10)Asklepios Klinik St Georg, Hamburg, Germany

[194]

DXT08

[198]

Samuel F Hunter, MD, PhD1, Rany A Aburashed, DO2, Raed Alroughani, MD3, Andrew Chan, MD4, Dominique Dive, MD, PhD5, Sara Eichau, MD, PhD6, Daniel Kantor, MD7, Ho Jin Kim, MD8, Jan Lycke, MD9, Richard AL Macdonell, MD10, Carlo Pozzilli, MD11, Thomas F Scott, MD12, Basil Sharrack, MD, PhD13, Heinz Wiendl, MD14, Luke Chung, MD, MPH15, Nadia Daizadeh, PhD15, Patrick Vermersch, PhD16 and on behalf of the CARE-MS II, CAMMS03409, and TOPAZ Investigators, (1)Advanced Neurosciences Institute, Franklin, TN, (2)Institute for Neurosciences and Multiple Sclerosis, Owosso, MI, (3)Amiri Hospital, Sharq, Kuwait, (4)Ambulantes Neurozentrum, Inselspital, Bern, Switzerland, (5)University Hospital Centre of Liège, Liège, Belgium, (6)Hospital Universitario Virgen Macarena, Seville, Spain, (7)Florida Atlantic University, Boca Raton, FL, (8)Research Institute and Hospital of National Cancer Center, Goyang, Korea, Republic of (South), (9)Sahlgrenska University Hospital, Gothenburg, Sweden, (10)Austin Health and Florey Institute of Neuroscience and Mental Health, Melbourne, VIC, Australia, (11)University of Rome, Rome, Italy, (12)Allegheny General Hospital, Pittsburgh, PA, (13)Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom, (14)University of Munster, Munster, Germany, (15)Sanofi, Cambridge, MA, (16)University of Lille, Lille, France

[194]

DXT09

[198]

Hasna Hakim, DNP, RN, MSN, CCRN, MPHc, Nursing, Dartmouth, Hanover, NH, Pamela K Newland, RN, PhD, CMSRN, 4483 Duncan Avenue, Goldfarb School of Nursing at Barnes Jewish College, St Louis, MO and Brant J. Oliver, PhD, MS, MPH, APRN-BC, Geisel School of Medicine, Hanover, NH

[194]

DXT10

[198]

Carolina Ionete, MD, PhD1, Maria Pia Amato, MD2, Michael Barnett, PhD, MD3, Aaron Boster, MD4, Dominique Dive, MD, PhD5, Donna Graves, MD6, William David Honeycutt, MD7, Christopher LaGanke, MD8, Richard AL Macdonell, MD9, Xavier Montalban, MD, PhD10,11, Kunio Nakamura, PhD12, Celia Oreja-Guevara, MD13, David Rog, MD14, Bernard MJ Uitdehaag, MD, PhD15, Luke Chung, MD, MPH16, Nadia Daizadeh, PhD16, Salman Afsar, MD16, Anthony Traboulsee, MD17 and on behalf of the CARE-MS II, CAMMS03409, and TOPAZ Investigators, (1)Department of Neurology, University of Massachusetts Memorial Medical Center, Worcester, MA, (2)University of Florence, Florence, Italy, (3)University of Sydney, Sydney, NSW, Australia, (4)OhioHealth Multiple Sclerosis Center, Columbus, OH, (5)University Hospital Centre of Liège, Liège, Belgium, (6)Neuroscience Institute-Neurology, Atrium Health, Charlotte, NC, (7)Neurology Associates, Maitland, FL, (8)North Central Neurology Associates, Cullman, AL, (9)Austin Health and Florey Institute of Neuroscience and Mental Health, Melbourne, VIC, Australia, (10)St Michael’s Hospital, University of Toronto, Toronto, ON, Canada, (11)Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d’Hebron, Barcelona, Spain, (12)Cleveland Clinic, Cleveland, OH, (13)University Hospital San Carlos, Madrid, Spain, (14)Salford Royal NHS Foundation Trust, Salford, United Kingdom, (15)VU University Medical Center, Amsterdam, Netherlands, (16)Sanofi, Cambridge, MA, (17)University of British Columbia, Vancouver, BC, Canada

[194]

DXT11

[198]

Sibyl Wray, MD1, Raed Alroughani, MD2, Simon Broadley, MD3, Sara Eichau, MD, PhD4, Hans-Peter Hartung, MD5, Eva K Havrdova, MD, PhD6, Ho Jin Kim, MD7, Kunio Nakamura, PhD8, Carlos Navas, MD9, Carlo Pozzilli, MD10, Alex Rovira, MD11, Barry A Singer, MD12, Patrick Vermersch, PhD13, Luke Chung, MD, MPH14, Nadia Daizadeh, PhD14, Salman Afsar, MD14, Krzysztof W Selmaj, MD15 and on behalf of the CARE-MS II, CAMMS03409, and TOPAZ Investigators, (1)Neurology PC, Knoxville, TN, (2)Amiri Hospital, Sharq, Kuwait, (3)School of Medicine, Gold Coast Campus, Griffith University, Queensland, Australia, (4)Hospital Universitario Virgen Macarena, Seville, Spain, (5)Heinrich-Heine University, Dusseldorf, Germany, (6)First Medical Faculty, Charles University in Prague, Prague, Czech Republic, (7)Research Institute and Hospital of National Cancer Center, Goyang, Korea, Republic of (South), (8)Cleveland Clinic, Cleveland, OH, (9)Clinica Universitaria Colombia, Bogota, Colombia, (10)University of Rome, Rome, Italy, (11)Vall d’Hebron University Hospital, Barcelona, Spain, (12)MS Center for Innovations in Care, Missouri Baptist Medical Center, St. Louis, MO, (13)University of Lille, Lille, France, (14)Sanofi, Cambridge, MA, (15)University of Warmia and Mazury, Olsztyn, Poland

[194]

DXT12

[198]

Alex Rovira, MD1, Young-Min Lim, MD2, Christine Lebrun-Frenay, MD, PhD3, Jerome De Seze, MD, PhD4, Richard Macdonell, MD5, Aaron E Miller, MD6, David KB Li, MD7, Deyanira Ramirez, MD8, Alex L Lublin, PhD9, Jeffery Chavin, MD9, Elizabeth M Poole, PhD9 and Anthony Traboulsee, MD10, (1)Vall d’Hebron University Hospital, Barcelona, Spain, (2)Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South), (3)Pasteur Hospital 2, Nice, France, (4)Clinical Investigation Center (CIC), INSERM 1434, CHU de Strasbourg, Strasbourg, France, (5)Department of Neurology, Austin Health, Heidelberg, Australia, (6)Icahn School of Medicine at Mount Sinai, New York, NY, (7)Department of Radiology, Faculty of Medicine, University of British Columbia, Vancouver, WA, Canada, (8)Collaborative Multiple Sclerosis Group of Central America and Spanish Caribbean Region, Santo Domingo, Dominican Republic, (9)Sanofi, Cambridge, MA, (10)Clinical Trials Research Group, University of British Columbia, Vancouver, WA, Canada

[194]

DXT13

[198]

Angel R Chinea Martinez, Dr1, Lilyana Amezcua, MD, MS2, Brett T Lund, Dr3, Xiangyi Meng, PhD4, Lesley Schofield, PhD4 and Nadia Tenenbaum, MD4, (1)San Juan MS Center, Caribbean Neurological Center, Guaynabo, PR, (2)Keck School of Medicine, University of Southern California, Los Angeles, CA, (3)Keck School of Medicine USC, University of Southern California, Los Angeles, CA, (4)Novartis Pharmaceuticals Corporation, East Hanover, NJ

[194]

DXT14

[198]

Stephen L Hauser, MD1, Ludwig Kappos, MD2, Xavier Montalban, MD, PhD3,4, Richard Hughes, PhD5, John McNamara, BSc MSc CStat6, Ashish Pradhan, MD7, David Wormser, MSc, MPhil PhD5, Harold Koendgen, MD PhD5 and Jerry S Wolinsky, MD8, (1)University of California San Francisco, San Francisco, CA, (2)University Hospital Basel, University of Basel, Basel, Switzerland, (3)Division of Neurology, University of Toronto, Toronto, ON, Canada, (4)Vall d’Hebron University Hospital, Barcelona, Spain, (5)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (6)John McNamara Consulting Limited, Cambridge, United Kingdom, (7)Genentech, Inc., South San Francisco, CA, (8)McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX

[194]

DXT15

[198]

Sibyl Wray, MD1, Sandra Vukusic, MD, PhD2, Ludwig Kappos, MD3, Silvia Bader-Weder, MD4, Regine Buffels, MD4, Julie Napieralski, PhD4, Ashish Pradhan, MD5 and Stephen L Hauser, MD6, (1)Neurology PC, Knoxville, TN, (2)Service de Neurologie et Sclerose en Plaques, Fondation EDMUS pour la Sclerose en Plaques, Hopital Neurologique Pierre Wertheimer, Lyon, France, (3)University Hospital Basel, University of Basel, Basel, Switzerland, (4)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (5)Genentech, Inc., South San Francisco, CA, (6)University of California San Francisco, San Francisco, CA

[194]

DXT16

[198]

Bruce A C Cree, MD, PhD, MAS1, John Corboy, MD2, Barry A Singer, MD3, Edward J. Fox, MD, PhD4, Douglas L Arnold, MD5, Corey C Ford, MD, PhD6, Bianca Weinstock-Guttman, MD7, Amit Bar-Or, MD8, Susanne Mientus, PhD9, Daniel Sienkiewicz, PhD10, Ying Zhang, PhD10, Rajesh Karan, PhD9 and Nadia Tenenbaum, MD10, (1)Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, (2)Department of Neurology, University of Colorado, Aurora, CO, (3)MS Center for Innovations in Care, Missouri Baptist Medical Center, St. Louis, MO, (4)Central Texas Neurology Consultants, Round Rock, TX, (5)NeuroRx Research, Montreal, QC, Canada, (6)Department of Neurology, UNM Health Sciences Center, Albuquerque, NM, (7)Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, (8)Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA, (9)Novartis Pharma AG, Basel, Switzerland, (10)Novartis Pharmaceuticals Corporation, East Hanover, NJ

[194]

DXT17

[198]

Edward J. Fox, MD, PhD1, Sibyl Wray, MD2, Richard Shubin, MD3, Koby Mok, PhD4, Sean Power, BA5, Jenna Bosco, BA5 and Michael Weiss, JD4, (1)Central Texas Neurology Consultants, Round Rock, TX, (2)Neurology PC, Knoxville, TN, (3)SC3 Research Group, Inc, Pasadena, CA, (4)Autoimmune, TG Therapeutics, Inc, New York, NY, (5)TG Therapeutics, New York, NY

[194]

DXT18

[198]

David Wormser, MSc, MPhil PhD1, Joanna Evershed, BSc2, Germano Ferreira, PharmD, MPH, PhD1, Daniela Stokmaier, MSc Pharm PhD1, Qing Wang, PhD1 and Tjalf Ziemssen, MD, PhD3, (1)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (2)Roche Products Ltd, Welwyn Garden City, United Kingdom, (3)Center of Clinical Neuroscience, Carl Gustav Carus University Hospital, Dresden, Germany

[194]

DXT19

[198]

Robert Bermel, MD1, Bruno Brochet, MD2, Mark S Freedman, MSc, MD, FAAN, FRCPC3, Joep Killestein, MD, PhD4, Francesco Patti, MD, PhD5, Regine Buffels, MD6, Richard Hughes, PhD6, Lahar Mehta, PhD7, John McNamara, BSc MSc CStat6 and Hans-Peter Hartung, MD8, (1)Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, (2)University of Bordeaux, Bordeaux, France, (3)THe University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada, (4)Department of Neurology, VU University Medical Center, Amsterdam, Netherlands, (5)GF Ingrassia, Department, Neuroscience Section, University of Catania, Catania, Italy, (6)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (7)Genentech, Inc., South San Francisco, CA, (8)Department of Neurology, UKD, Center of Neurology and Neuropsychiatry and LVR-Klinikum, Heinrich-Heine University Dusseldorf, Dusseldorf, Germany

[194]

DXT20

[198]

Gavin Giovannoni, MBBCh, PhD, FCP, FRCP, FRCPath1, Hans-Peter Hartung, MD2, Stephen L Hauser, MD3, Ludwig Kappos, MD, PhD4, Xavier Montalban, MD, PhD5,6, Anthony Traboulsee, MD7, Jerry S Wolinsky, MD8, Karine Coutant, PhD9, Kalpesh Prajapati, PhD9, Fabian Model, PhD9, Lahar Mehta, PhD10 and Douglas L Arnold, MD11,12, (1)Queen Mary University of London, London, United Kingdom, (2)Department of Neurology, UKD, Center of Neurology and Neuropsychiatry and LVR-Klinikum, Heinrich-Heine University Dusseldorf, Dusseldorf, Germany, (3)University of California San Francisco, San Francisco, CA, (4)University Hospital Basel, University of Basel, Basel, Switzerland, (5)Division of Neurology, University of Toronto, Toronto, ON, Canada, (6)Vall d’Hebron University Hospital, Barcelona, Spain, (7)University of British Columbia, Vancouver, BC, Canada, (8)McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, (9)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (10)Genentech, Inc., South San Francisco, CA, (11)NeuroRx Research, Montreal, QC, Canada, (12)McGill University, Montreal, QC, Canada

[194]

DXT21

[198]

John DeLuca, Ph.D.1, Jeffrey A Cohen, MD2, Bruce A C Cree, MD, PhD, MAS3, Yu Chen, PhD4, Danielle Harvey, MS4, James K Sheffield, MD, MBA, MS4, Diego Silva, MD, PhD4, Giancarlo Comi, MD5 and Ludwig Kappos, MD6, (1)Kessler Foundation, West Orange, NJ; Departments of Physical Medicine and Rehabilitation and Neurology, Rutgers – New Jersey Medical School, Newark, NJ, (2)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, (3)Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, (4)Celgene Corporation, Summit, NJ, (5)University Vita-Salute San Raffaele, Milan, Italy, (6)University Hospital Basel, University of Basel, Basel, Switzerland

[194]

DXT22

[198]

John Osborne, MD1, Brandon Brown, PharmD2, Xiangyi Meng, PhD2, Nina Jaitly, MD, MPH2, Wendy Su, PhD2 and Jamie L Weiss, PhD2, (1)State of the Heart Cardiology, Grapevine, TX, (2)Novartis Pharmaceuticals Corporation, East Hanover, NJ

[194]

DXT23

[198]

Janet Dawson, PhD, Ismahane Touil, PhD, Anja Scheidegger, PhD, Melanie Vogelsanger, PhD, David Leppert, MD and Gisbert Weckbecker, MD, Novartis Pharma AG, Basel, Switzerland

[194]

DXT24

[198]

Mary A Willis, MD1, Devon Conway, MD2, Regina Berkovich, MD3, Xiangyi Meng, PhD4, Scott Kolodny, MD4, Andy Cheadle, PhD4 and Maria Melanson, MD4, (1)Mellen Center, Cleveland Clinic, Cleveland, OH, (2)Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland, OH, (3)USC Medical Center, Los Angeles, CA, (4)Novartis Pharmaceuticals Corporation, East Hanover, NJ

[194]

DXT25

[198]

Jamie Greenfield, MPH1, Colleen Harris, MN, NP, MSCN, MSCS2, Courtney Chandler, MOA, CPhT2 and Luanne M Metz, MD, FRCPC1,2, (1)Clinical Neurosciences, University of Calgary, Calgary, AB, Canada, (2)MS Clinic, University of Calgary, Calgary, AB, Canada

[194]

DXT26

[198]

Lawrence Steinman, MD1, Giancarlo Comi, MD2, Bruce A C Cree, MD, PhD, MAS3, Amit Bar-Or, MD4, Krzysztof W Selmaj, MD5, Douglas L Arnold, MD6, Hans-Peter Hartung, MD7, Xavier Montalban, MD, PhD8, Eva K Havrdova, MD, PhD9, James K Sheffield, MD, MBA, MS10, Vivian Huang, PhD10, Diego Silva, MD, PhD10, Ludwig Kappos, MD11 and Jeffrey A Cohen, MD12, (1)Beckman Center for Molecular Medicine, Stanford University Medical Center, Stanford, CA, (2)Department of Neurology, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy, (3)Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, (4)Center for Neuroinflammation and Experimental Therapeutics, and Multiple Sclerosis Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (5)Center for Neurology, Lodz, Poland, (6)Montreal Neurological Institute and Hospital, Montreal, QC, Canada, (7)Department of Neurology, Medical Faculty, Heinrich-Heine University, Dusseldorf, Germany, (8)Division of Neurology, University of Toronto, Toronto, ON, Canada, (9)Department of Neurology and Center for Clinical Neuroscience, First Medical Faculty, Charles University, Prague, Czech Republic, (10)Celgene Corporation, Summit, NJ, (11)University Hospital and University of Basel, Basel, Switzerland, (12)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH

[194]

DXT27

[198]

Jiwon Oh, MD, PhD, FRCPC1, Sandra Vukusic, MD, PhD2, Klaus Tiel-Wilck, MD, for the NTD research group3, Mauro Zaffaroni, MD4, Stanley Cohan, MD, PhD5, Byoung Joon Kim, MD6, Jihad Said Inshasi, MD7, David Rog, MD8, Darren P Baker, PhD9, Yelena Pyatkevich, MD9, Maxneil Guce, MD9, Elizabeth M Poole, PhD9 and Keith Edwards, MD10, (1)Division of Neurology, University of Toronto, Toronto, ON, Canada, (2)University Hospital of Lyon, Bron, France, (3)Neurologisches Facharztezentrum Berlin, Berlin, Germany, (4)MS Centre, Gallarate Hospital, Gallarate, Italy, (5)Providence Brain and Spine Institute, Portland, OR, (6)Samsung Medical Centre, Seoul, Korea, Republic of (South), (7)Dubai Medical College, Dubai, United Arab Emirates, (8)Greater Manchester Neurosciences Centre, Salford, United Kingdom, (9)Sanofi, Cambridge, MA, (10)MS Center of Northeastern New York, Latham, NY

[194]

DXT28

[198]

Krupa Pandey, MD1, Kathryn Giles, MD, MSc, FRCPC2, Francois H Jacques, MD3, Sami Fam, PhD4, Yang Lei, PhD4, Catherine Miller, PharmD, MPH4 and Cynthia C Jones, PhD4, (1)Hackensack Meridian, Hackensack University Medical Center, Hackensack, NJ, (2)Cambridge Memorial Hospital, Cambridge, ON, Canada, (3)Clinique Neuro-Outaouais, Gatineau, QC, Canada, (4)Biogen, Cambridge, MA

[194]

DXT29

[198]

Claudia Chaves, MD, Daniel Gans, undergraduate student, Jessica Vecchia, RN, MSN, Catia Melo, SC and Ann Camac, MD, Neurology, Lahey Clinic, Lexington, MA

[194]

DXT30

[198]

Hollis O’Nell-Meyer, BA1, Jennifer A. Ruiz, DPT2, Elizabeth S Gromisch, PhD2,3, Lindsay Neto, MPH2 and Peter Wade, MD2, (1)Frank H. Netter Medical School at Quinnipiac University, North Haven, CT, (2)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (3)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT

[194]

DXT31

[198]

Patrick Vermersch, PhD, University of Lille, Lille, France, Gavin Giovannoni, MBBCh, PhD, FCP, FRCP, FRCPath, Queen Mary University of London, London, United Kingdom, Per Soelberg Soerensen, MD, Department of Neurology, University of Copenhagen, Copenhagen, Denmark, Birgit Keller, Diplom, Merck KGaA, Darmstadt, Germany and Dominic Jack, PhD, Merck Serono Ltd, Middlesex, United Kingdom

[194]

DXT32

[198]

Jacqueline A. Nicholas, MD, MPH, OhioHealth Multiple Sclerosis Center, Columbus, OH, Natalie C Edwards, MSc, Health Services Consulting Corporation, Boxborough, MA, Anna Dellarole, PhD, Fair Dynamics Consulting, Milan, Italy, Danielle E Harlow, PhD, US Medical Affairs – Neurology & Immunology, EMD Serono, Inc., Rockland, MA and Amy L Phillips, PharmD, Data Analytics & Value Assessment, EMD Serono, Inc., Rockland, MA

[194]

DXT33

[198]

Jacqueline Nicholas, MD, MPH, Ohio Multiple Sclerosis Center, Columbus, OH, Natalie C Edwards, MSc, Health Services Consulting Corporation, Boxborough, MA, Danielle E Harlow, PhD, US Medical Affairs – Neurology & Immunology, EMD Serono, Inc., Rockland, MA and Amy L Phillips, PharmD, Data Analytics & Value Assessment, EMD Serono, Inc., Rockland, MA

[194]

DXT34

[198]

Jacqueline Nicholas, MD, MPH, Ohio Multiple Sclerosis Center, Columbus, OH, Natalie C Edwards, MSc, Health Services Consulting Corporation, Boxborough, MA, Danielle E Harlow, PhD, US Medical Affairs – Neurology & Immunology, EMD Serono, Inc., Rockland, MA and Amy L Phillips, PharmD, Data Analytics & Value Assessment, EMD Serono, Inc., Rockland, MA

[194]

DXT35

[198]

Mark S Freedman, MSc, MD, FAAN, FRCPC, THe University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada, Alexey N Boyko, MD, Pirogov Russian National Research University & Demyelinating Diseases Center, Usupov Hospital, Moscow, Russia, Jorge Correale, MD, Department of Neurology, FLENI, Buenos Aires, Argentina, Gavin Giovannoni, MBBCh, PhD, FCP, FRCP, FRCPath, Queen Mary University of London, London, United Kingdom, Thomas Leist, MD, Thomas Jefferson University, Philadelphia, PA, Xavier Montalban, MD, PhD, Vall d’Hebron University Hospital, Barcelona, Spain; Division of Neurology, University of Toronto, Toronto, ON, Canada, Kottil Rammohan, MD, University of Miami, Miami, FL, Bassem Yamout, MD, Department of Neurology, American University of Beirut Medical Center, Beirut, Lebanon, Pedro Testi, BSc, Merck KGaA, Darmstadt, Germany and Kristin Gabriel, DO, MPH, EMD Serono Research & Development Institute Inc., Billerica, MA

[194]

DXT36

[198]

Benjamin Greenberg, MD, MHS, Department of Neurology, UT Southwestern, Dallas, TX, Michael Grabner, PhD, HealthCore, Inc., Wilmington, DE, Xian Zhang, PhD, HealthCore Inc., Wilmington, DE, Sanjeev Balu, PhD, MBA, B.Pharmacy, Sandoz, Inc, Princeton, NJ, Steve Hall, Pharm.D., Sandoz, Inc., Princeton, NJ and Daniel Kantor, MD, FAAN, FANA, Florida Atlantic University, Boca Raton, FL

[194]

DXT37

[198]

Ludwig Kappos, MD, University Hospital Basel, University of Basel, Basel, Switzerland, Mark S Freedman, MSc, MD, FAAN, FRCPC, THe University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada, Gilles Edan, MD, CHU Hopital Pontchaillou, Rennes, France, Hans-Peter Hartung, MD, Department of Neurology, UKD, Center of Neurology and Neuropsychiatry and LVR-Klinikum, Heinrich-Heine University Dusseldorf, Dusseldorf, Germany, Xavier Montalban, MD, PhD, Hospital Universitari Vall d’Hebron, Multiple Sclerosis Center of Catalonia (Cemcat), Barcelona, Spain; University of Toronto, St. Michael’s Hospital, Toronto, Canada, Frederik Barkhof, MD, PhD, VU University Medical Center, Amsterdam, Netherlands; Institutes of Neurology and Healthcare Engineering, UCL, London, United Kingdom, Ralf Koelbach, MSc, PAREXEL International, Berlin, Germany and Eva-Maria Wicklein, MD, Bayer Pharma AG, Berlin, Germany

[194]

DXT38

[198]

Jacqueline Nicholas, MD, MPH, Ohio Multiple Sclerosis Center, Columbus, OH, Natalie C Edwards, MSc, Health Services Consulting Corporation, Boxborough, MA, Anna Dellarole, PhD, Fair Dynamics Consulting, Milan, Italy, Danielle E Harlow, PhD, US Medical Affairs – Neurology & Immunology, EMD Serono, Inc., Rockland, MA and Amy L Phillips, PharmD, Data Analytics & Value Assessment, EMD Serono, Inc., Rockland, MA

[194]

DXT39

[198]

Theodore R Brown, MD, MPH, MS Center at Evergreen Health, Evergreen Health, Kirkland WA, WA and Virginia I Simnad, MD, MS, MS Center at Evergreen Health, Evergreen Health, Kirkland, WA

[194]

DXT40

[198]

Lauren Long, Pharm.D. and Ryan Fuller, Pharm.D., Neurology, Hospital of the University of Pennsylvania, Philadelphia, PA

[194]

DXT41

[198]

Sibyl Wray, MD1, Samuel F Hunter, MD, PhD2, Richard Leigh-Pemberton, MD3, Ilda Bidollari, MD, MBA3, Hailu Chen, PhD4, Lili Yang, PhD4, Catherine Miller, PharmD, MPH4 and Jerome Hanna, PhD5, (1)Hope Neurology MS Center, Knoxville, TN, (2)Advanced Neurosciences Institute, Franklin, TN, (3)Alkermes Inc., Waltham, MA, (4)Biogen, Cambridge, MA, (5)Biogen, Maidenhead, United Kingdom

[194]

DXT42

[198]

Mark Gudesblatt, MD1, Sibyl Wray, MD2, Catherine Miller, PharmD, MPH3, Jerome Hanna, PhD4, Maria Lopez-Bresnahan, MD5, Boris Kandinov, PhD5, Hailu Chen, PhD3, Lili Yang, PhD3 and Richard Leigh-Pemberton, MD5, (1)South Shore Neurologic Associates, Patchogue, NY, (2)Hope Neurology MS Center, Knoxville, TN, (3)Biogen, Cambridge, MA, (4)Biogen, Maidenhead, United Kingdom, (5)Alkermes Inc., Waltham, MA

[194]

DXT43

[198]

Tu My To, PhD, MPH1, Erru Yang, MS1, Eddie Jones, BA2, Damian Fiore, Pharm.D1 and Natalie Engmann, PhD, MSc1, (1)Genentech, Inc., South San Francisco, CA, (2)Adelphi Real World, Cheshire, United Kingdom

[194]

DXT44

[198]

Casey V Farin, MD1, Suma Shah, MD1, Jenelle M. Hall, PharmD2, Fletcher L Hartsell III, MD MPH1 and Christopher Eckstein, MD1, (1)Neurology, Duke University, Durham, NC, (2)Duke University, Durham, NC

[194]

DXT45

[198]

Mirela Cerghet, MD, PhD1,2, Lonni Schultz, PhD3, Helena Bulka, DO1 and Stanton Elias, MD1, (1)Neurology, Henry Ford Hospital, Detroit, MI, (2)School of Medicine, Wayne State University, Detroit, MI, (3)Public Health Science, Henry Ford Health System, Detroit, MI

[194]

DXT46

[198]

Shlomo Flechter, MD1, Ariel Miller, MD, PhD2,3, Laura Popper, MD4, Nadav Bleich Kimelman, DMD, PhD4, Shai Rubnov, PhD4, Uri Danon, MBA, B.Sc4, Ehud Marom, B.Sc.4, Ron Milo, MD5,6, Joab Chapman, MD, PhD7,8, Alla Shifrin, MD9, Ronit Gilad, MD10, Chen Hoffmann, MD11, Dimitrios Karussis, MD, PhD12, Talma Brenner, PhD13, Tamir Ben-Hur, MD, PhD14 and Arnon Karni, MD, PhD8,15, (1)Multiple Sclerosis Clinical Research and Therapy Service, Department of Neurology, Assaf Harofeh Medical Center, Zerifin, Israel, (2)Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel, (3)Multiple Sclerosis & Brain Research Center, Carmel Medical Center, Haifa, Israel, (4)Mapi Pharma Ltd, Ness Ziona, Israel, (5)Department of Neurology, Barzilai University Medical Center, Ashkelon, Israel, (6)Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel, (7)Department of Neurology, Sheba Medical Center, Ramat Gan, Israel, (8)Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, (9)Department of Neurology, Rambam Medical Center, Haifa, Israel, (10)Department of Neurology, Kaplan Medical Center, Rehovot, Israel, (11)Diagnostic and Interventional Imaging, Sheba Medical Center, Ramat Gan, Israel, (12)Unit of Neuroimmunology-MS Center, Hadassah Medical Center, Ein Kerem, Jerusalem, Israel, (13)Laboratory of Neuroimmunology, Department of Neurology, The Agnes Ginges Center for Human Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel, (14)Department of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel, (15)Neuroimmunology Clinic, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

[194]

DXT47

[198]

Scott D. Newsome, DO1, Thomas Shoemaker, MD2, Pavan Bhargava, MD1, Sarah Snoops, RN1, Fan Tian, MSE1, Kathryn C Fitzgerald, Sc.M., Sc.D.1, David Cooper, MD3, Jennifer Mammen, MD, MPhil, PhD3, Ellen M Mowry, MD, MCR1 and Peter A Calabresi, MD1, (1)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (2)Neurology, Rush University Medical Center, Chicago, IL, (3)Endocrinology, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

DXT48

[198]

Claudia Chaves, MD, Daniel Gans, undergraduate student, Catia Melo, SC, Jessica Vecchia, RN, MSN and Ann Camac, MD, Neurology, Lahey Clinic, Lexington, MA

[194]

DXT49

[198]

John F Kramer, PA-C, Neurology, St Thomas Medical Partners, Nashville, TN and Adil Javed, MD, Neurology, The University of Chicago, Chicago, IL

[194]

DXT50

[198]

Natalya Belotserkovskaya, MD, Neurology and Rehabilitation, University of Cincinnati, Cincinnati, OH

[194]

DXT51

[198]

Timothy Vollmer, MD1, Enrique Alvarez, MD1, Kavita Nair, PhD1, Jeffrey A Cohen, MD2, Aaron Boster, MD3, Ashish Pradhan, MD4, Bruno Musch, MD, PhD4, Xiaoye Ma, PhD4, Jinglan Pei, PhD4, Ming Yang, PhD4, Brandon Moss, MD2, Bianca Weinstock-Guttman, MD5 and Robert Bermel, MD2, (1)University of Colorado Anschutz Medical Campus, Aurora, CO, (2)Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, (3)OhioHealth Multiple Sclerosis Center, Columbus, OH, (4)Genentech, Inc., South San Francisco, CA, (5)University at Buffalo, Buffalo, NY

[194]

DXT52

[198]

Enrique Alvarez, MD, PhD1, Amit Bar-Or, MD2,3, Guy J Buckle, MD4, Stanley L Cohan, MD, PhD5, Bruce A C Cree, MD, PhD, MAS6, Yang Mao-Draayer, MD, PhD7, Micheline McCarthy, MD, PhD8, Aaron E Miller, MD9, Bianca Weinstock-Guttman, MD10, Nina Jaitly, MD, MPH11, Linda-Ali Cruz, MD11, Scott Kolodny, MD11, Xiangyi Meng, PhD11, Davorka Tomic, PhD12 and Wendy Su, PhD11, (1)Department of Neurology, University of Colorado School of Medicine, Aurora, CO, (2)Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA, (3)Center for Neuroinflammation and Experimental Therapeutics, and Multiple Sclerosis Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (4)Shepherd Center, Atlanta, GA, (5)Providence Multiple Sclerosis Center, The Providence Brain Institute, Portland, OR, (6)Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, (7)University of Michigan, Ann Arbor, MI, (8)Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, (9)Icahn School of Medicine at Mount Sinai, New York, NY, (10)University at Buffalo, Buffalo, NY, (11)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (12)Novartis Pharma AG, Basel, Switzerland

[194]

DXT53

[198]

[194]

DXT54

[198]

Thomas Finnegan, PhD, Catherine Murray, MA and John Maeglin, BA, Medscape Education, New York, NY

[194]

DXT55

[198]

Sven Schippling, MD, Neuroimmunology and Multiple Sclerosis Research, University Hospital Zurich and University of Zurich, Zurich, Switzerland, Maria Pia Sormani, PhD, Biostatistics Unit, University of Genoa, Genoa, Italy, Nicola De Stefano, MD, Department of Neurological and Behavioural Sciences, University of Siena, Siena, Italy, Gavin Giovannoni, MD, Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom, Fernando Dangond, MD, Global Clinical Development Center, EMD Serono, Inc., Billerica, MA, Andrew Galazka, MD, Merck, Aubonne, Switzerland, Birgit Keller, Diplom, Merck KGaA, Darmstadt, Germany and Nektaria Alexandri, MD, MSc, Neurology and Immunology, Merck KGaA, Darmstadt, Germany

[194]

DXT56

[198]

Kottil Rammohan, MD1, Doris Damian, PhD2, Yann Hyvert, PhD3, Fernando Dangond, MD4, Lori Lebson, PhD2 and Gavin Giovannoni, MBBCh, PhD, FCP, FRCP, FRCPath5, (1)Ohio State University Hospital, Columbus, OH, (2)EMD Serono, Inc., Billerica, MA, (3)EMD Serono, Inc., Rockland, MA, (4)Global Clinical Development Center, EMD Serono, Inc., Billerica, MA, (5)Queen Mary University of London, London, United Kingdom

[194]

DXT57

[198]

Barry A Singer, MD1, Kiren Kresa-Reahl, MD2, Gerard Harty, MSc3, Daniel Jones, PhD4, Gary Cutter, PhD5 and Schiffon L Wong, PhD3, (1)MS Center for Innovations in Care, Missouri Baptist Medical Center, St. Louis, MO, (2)Providence MS Center, Portland, OR, (3)EMD Serono, Inc., Billerica, MA, (4)EMD Serono, Inc., Rockland, MA, (5)Department of Biostatistics, UAB School of Public Health, Birmingham, AL

[194]

DXT58

[198]

Stuart Cook, MD1, Gavin Giovannoni, MBBCh, PhD, FCP, FRCP, FRCPath2, Thomas Leist, MD3, Sana Syed, MPH4, Axel Nolting, MD5, Doris Damian, PhD4 and Regina Schick, MD5, (1)Rutgers, The State University of New Jersey, New Jersey Medical School, Newark, NJ, (2)Queen Mary University of London, London, United Kingdom, (3)Thomas Jefferson University, Philadelphia, PA, (4)EMD Serono, Inc., Billerica, MA, (5)Merck KGaA, Darmstadt, Germany

[194]

DXT59

[198]

John D Nieland, PhD, Associate Prof., Department of Health Science and Technology, Aalborg University, Aalborg, Denmark

[194]

DXT60

[198]

Lily Lee, PhD1, Rachna Kasliwal, MPH2, Yogi Patel, PhD3, Jonathan Smith, MSc2, Christophe Hotermans, MD, PhD1, Denise Campagnolo, MD1 and Thos Cochrane, MD, MBA1, (1)Biogen, Cambridge, MA, (2)Biogen, Maidenhead, United Kingdom, (3)Biogen at the time of this work, Maidenhead, United Kingdom

[194]

DXT61

[198]

Marco Battaglini, PhD1, Antonio Giorgio, MD1, Ludovico Luchetti, MS1, Maria Laura Stromillo, MD1, Andrea Visconti, MD2, Maria Pia Sormani, PhD3 and Nicola De Stefano, MD1, (1)Department of Medicine, Surgery, and Neurosciences, University of Siena, Siena, Italy, (2)Medical Affairs Department, Merck Serono, Rome, Italy, (3)Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy

[194]

DXT62

[198]

Youkyung S Roh, BA1, Ellen M Mowry, MD, MCR2 and Kathryn C Fitzgerald, Sc.M., Sc.D.2, (1)Johns Hopkins University School of Medicine, Baltimore, MD, (2)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

DXT63

[198]

Hannah M Geils, B.S., Joshua D Katz, M.D., Ellen S Lathi, MD and India C Stribling, B.S., The Elliot Lewis Center for Multiple Sclerosis Care, Wellesley, MA

[194]

DXT64

[198]

Ralph Kern, MD, MHSc, Clinical, BrainStorm Cell Therapeutics, New York, NY, Jeffrey A Cohen, MD, Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, Tanuja Chitnis, MD, Partners Multiple Sclerosis Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, Daniel Pelletier, MD, Keck School of Medicine of University of Southern California, Los Angeles, CA, Fred Lublin, MD, Icahn School of Medicine at Mount Sinai, New York, NY, Christopher B. Lock, MD, PhD, Stanford School of Medicine, Palo Alto, CA and Yael Gothelf, Ph.D., BrainStorm Cell Therapeutics, Petach Tikva, Isreal and New York, NY

[194]

DXT65

[198]

Stephen Newman, MD1, Yang Mao-Draayer, MD, PhD2, Karen Blitz, DO3, Ray Su, PhD4, Jason P Mendoza, PhD4 and Robin Avila-Carey, PhD4, (1)Neurological Associates, Plainview, NY, (2)Department of Neurology, University of Michigan Medical School, Ann Arbor, MI, (3)Island Neurology Care, Massapequa, NY, (4)Biogen, Cambridge, MA

[194]

DXT66

[198]

[194]

DXT67

[198]

Hannah M Geils, B.S., India C Stribling, B.S., Joshua D Katz, M.D. and Ellen S Lathi, MD, The Elliot Lewis Center for Multiple Sclerosis Care, Wellesley, MA

[194]

DXT68

[198]

Brooke Hayward, SM, MBA1, Sarah Cardoso, MD2, Megan Grosso, PA-C, DPT, PT1, Soudeh Ansari, PhD3 and Salvatore Napoli, MD2, (1)EMD Serono, Inc., Rockland, MA, (2)Neurology Center of New England, Foxboro, MA, (3)Prometrika LLC, Cambridge, MA

[194]

DXT69

[198]

Mark Gudesblatt, MD1, Jared Srinivasan, BA1, Crystal LaBozzetta, BS1, Jeffrey Wilken, PhD2, Myassar Zarif, MD1, Barbara Bumstead, MS, ANCP, MSCN1, Lori Fafard, RN, BSN, CNRN, MSCN, CCRP1, Karen Blitz, DO1, Marijean Buhse, PhD, NP, RN, MSCN1, Carl de Moor, PhD3, Yang Lei, PhD3, Denise Campagnolo, MD3, Christophe Hotermans, MD, PhD3 and Lily Lee, PhD3, (1)South Shore Neurologic Associates, Patchogue, NY, (2)Washington Neuropsychology Research Group LLC, Fairfax, VA, (3)Biogen, Cambridge, MA

[194]

DXT70

[198]

Maria L Naylor, PhD1, Marco Salvetti, MD2, Oksana Mokliatchouk, PhD1, Nicholas Everage, PhD1, Catrinel Popescu, DVM3 and Sibyl Wray, MD4, (1)Biogen, Cambridge, MA, (2)Sapienza University, S. Andrea Hospital, Rome, Italy, (3)Biogen, Maidenhead, United Kingdom, (4)Hope Neurology MS Center, Knoxville, TN

[194]

DXT71

[198]

Rinu Abraham, MD and Bridget A Bagert, MD, Neurology, Ochsner Clinic Foundation, New Orleans, LA

[194]

DXT72

[198]

Samuel F Hunter, MD, PhD1,2, Daniel Kantor, MD1,3 and Dmitriy D Carrigan, MS2, (1)NeuroNexus, Franklin, TN, (2)Advanced Neurosciences Institute, Franklin, TN, (3)Neurology, Florida Atlantic University, Boca Raton, FL

[194]

DXT73

[198]

Rae Bacharach, DO, Ka-ho Wong, BS, Julia Klein, APRN and John W Rose, MD, Neurology, University of Utah School of Medicine, Salt Lake City, UT

[194]

DXT74

[198]

Kolu Clark, DNP, APRN-BC, Providence, RI

[194]

DXT75

[198]

Jerome De Seze, MD, PhD1, Gilles Edan, MD2, Thibault Moreau, MD3, Frederic Sedel, MD, PhD4, Jenifer Patterson, APRN, MSCN4 and Ayman Tourbah, MD, PhD5, (1)Clinical Investigation Center (CIC), INSERM 1434, CHU de Strasbourg, Strasbourg, France, (2)Service de Neurologie, CHU de Rennes, Rennes, France, (3)Department of Neurology, Dijon University, Dijon, France, (4)MedDay Pharmaceuticals, Paris, France, (5)Department of Neurology, CHU de Reims, Reims, France

[194]

DXT76

[198]

Donald A Barone, D.O., Medicine/Neurology, Rowan University-SOM, Stratford, NJ and Kathleen A Barone, B.S.N., R.N., M.S.C.N., IOMSN, Philadelphia, PA

[194]

EG01

[198]

Jeffer E Sasaki, PhD1, Robert W Motl, PhD1, Gary Cutter, PhD2, Ruth A Marrie, PhD3, Tuula Tyry, PhD4 and Amber Salter, PhD5, (1)Department of Physical Therapy, University of Alabama at Birmingham, Birmingham, AL, (2)University of Alabama at Birmingham, Birmingham, AL, (3)Department of Internal Medicine (Neurology), University of Manitoba, Winnipeg, MB, Canada, (4)Dignity Health, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, (5)Washington University in St Louis, St Louis, MO

[194]

EG01

[198]

[194]

EG01

[198]

Aliza Ben-Zacharia, DNP, ANP, MSCN, Neurology, Mount Sinai Hospital, New York, NY

[194]

EG02

[198]

Jeffer E Sasaki, PhD1, Robert W Motl, PhD1 and Edward McAuley, PhD2, (1)Department of Physical Therapy, University of Alabama at Birmingham, Birmingham, AL, (2)Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL

[194]

EG02

[198]

Angel Chinea, MD1, Ivonne Vicente, MD2, Cristina M Rubi, BS2, Guillermo G Garcia, BS3, Astrid Diaz, BS3, Ana Rivera, BS3 and Natalia Hernandez, BS3, (1)San Juan Multiple Sclerosis Center, San Juan, PR, (2)San Juan Multiple Sclerosis Center, Guaynabo, PR, (3)San Juan MS Center, Guaynabo, PR

[194]

EG02

[198]

Dolly B Roy, MD PhD, Neurology, Northridge Hospital Medical Center, Northridge, CA

[194]

EG03

[198]

Jeffer E Sasaki, PhD1, Robert W Motl, PhD1, Gary Cutter, PhD2, Ruth A Marrie, PhD3, Tuula Tyry, PhD4 and Amber Salter, PhD5, (1)Department of Physical Therapy, University of Alabama at Birmingham, Birmingham, AL, (2)University of Alabama at Birmingham, Birmingham, AL, (3)Department of Internal Medicine (Neurology), University of Manitoba, Winnipeg, MB, Canada, (4)Dignity Health, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, (5)Washington University in St Louis, St Louis, MO

[194]

EG03

[198]

Angel Chinea, MD1, Ivonne Vicente, MD2, Cristina M Rubi, BS2, Guillermo G Garcia, BS3, Astrid Diaz, BS3, Natalia Hernandez, BS3 and Ana Rivera, BS3, (1)San Juan Multiple Sclerosis Center, San Juan, PR, (2)San Juan Multiple Sclerosis Center, Guaynabo, PR, (3)San Juan MS Center, Guaynabo, PR

[194]

EG03

[198]

Elizabeth W. Triche, PhD, Department of Epidemiology, Brown University School of Public Health, Providence, RI, Jennifer A. Ruiz, DPT, Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Hartford, CT and Albert C. Lo, MD, PhD, Departments of Neurology and Engineering, Brown University, Providence, RI

[194]

EG04

[198]

Kiren Kresa-Reahl, MD, dence Multiple Sclerosis Center and Providence Center for Parkinson’s Disease, Portland, OR, Natalie C Edwards, MSc, Health Services Consulting Corporation, Boxborough, MA and Amy L Phillips, PharmD, EMD Serono, Inc., Rockland, MA

[194]

EG04

[198]

Brenda Young, BS1, Emmanuelle Waubant, MD, PhD2, Sabeen Lulu, MD2 and Jennifer Graves, MD, PhD, MAS3, (1)San Francisco, CA, (2)UCSF Pediatric MS Center, San Francisco, CA, (3)University of California, San Francisco, San Francisco, CA

[194]

EG04

[198]

Elizabeth W. Triche, PhD1,2, Carolyn J. St. Andre, BS1, Lindsay O. Tuttle, MPH1, Jennifer A. Ruiz, DPT1 and Albert C. Lo, MD, PhD1, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Hartford, CT, (2)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT

[194]

EG05

[198]

Bouchenak Khelladi Djaouad Sr., Professor, Neurology, University of Medecine, Tlemcen, Algeria

[194]

EG05

[198]

Christine Nelson, PharmD, RPh, Kerry McCarthy, BSN, Shawn Burke, PharmD, RPh, Peishan Liu Snyder, PhD and Sarah Buckley, BSN, Biogen, Cambridge, MA

[194]

EG05

[198]

Katelyn S. Kavak, MS1, Barbara E. Teter, PhD, MPH2, Caila B Vaughn, MPH1, Keith R Edwards, MD, FAAN3, Patricia K Coyle, MD3, Lore Garten, MD4, Malcolm Gottesman, MD5, Burk Jubelt, MD6, Ilya Kister, MD3, Lauren Krupp, MD7, Jessica F Robb, MD3, Robert Zivadinov, MD, PhD3 and Bianca Weinstock-Guttman, MD3, (1)Jacobs MS Center of Treatment and Research, Buffalo, NY, (2)Department of Neurology, University at Buffalo, Buffalo, NY, (3)New York State Multiple Sclerosis Consortium, Buffalo, NY, (4)MS Center of Northeastern New York, Latham, NY, (5)Winthrop Comprehensive MS Care Center, Mineola, NY, (6)SUNY Upstate Medical University, Syracuse, NY, (7)NYU Langone Medical Center, New York, NY

[194]

EG06

[198]

Bouchenak Khelladi Djaouad Sr., Professor, Neurology, University of Medecine, Tlemcen, Algeria

[194]

EG06

[198]

Alden R. Smith, PharmD1, Lobat Hashemi, ScD1, Frank Ragone, PhD1 and Deborah A Taira, ScD2, (1)Sanofi Genzyme, Cambridge, MA, (2)University of Hawaii, Hilo, HI

[194]

EG06

[198]

Tanuja Chitnis, MD1, Jennifer Graves, MD, PhD2, Cody S Olsen, MS3, Jayne Ness, MD4, Lauren Krupp, MD5, Anita Belman, MD5, Moses Rodriguez, MD6, Jan Tillema, MD7, Tim Lotze, MD, PhD8, Mark Gorman, MD9, Leslie Benson, MD10, Bianca Weinstock-Guttman, MD11, Greg Aaen, MD12, John Rose, MD13, T. Charles Casper, PhD14 and Emmanuelle Waubant, MD, PhD2, (1)Massachusetts General Hospital for Children, Boston, MA, (2)UCSF Pediatric MS Center, San Francisco, CA, (3)Neurology, University of Utah, Salt Lake City, UT, (4)Alabama Pediatric MS Center, Birmingham, AL, (5)Lourie Center for Pediatric MS, Stony Brook Children’s Hospital, Stony Brook, NY, (6)Department of Neurology, Mayo Clinic, Rochester, MN, (7)Pediatric MS Center, Mayo Clinic, Rochester, MN, (8)Texas Children’s Hospital, Houston, TX, (9)Massachusetts General Hospital, Partners Pediatric MS Center, Boston, MA, (10)Boston Children’s Hospital, Boston, MA, (11)New York State Multiple Sclerosis Consortium, Buffalo, NY, (12)Department of Child Neurology, Loma Linda University, Loma Linda, CA, (13)Department of Neurology University of Utah and Neurovirology Research Laboratory VASLCHCS, Imaging and Neuroscience Center, Salt Lake City, UT, (14)Department of Pediatrics, University of Utah, Salt Lake City, UT

[194]

EG07

[198]

Ana Maria Canzonieri, psychologist1, Thais Mira Simandi, Psychology student2 and Dyana Gervana de Oliveira Fernandes, biomedicine student1, (1)Pesquisa cientifica, ABEM – Brazilian Association of Multiple Sclerosis, Sao Paulo, Brazil, (2)Pesquisa cientifica, ABEM – Brazilian Association of Multiple Sclerosis, sAO pAULO, Brazil

[194]

EG07

[198]

Etienne J Bisson, PhD1, Marcia Finlayson, PhD, OT Reg (Ont), OTR1, Okechukwu Ekuma, MSc2, William D Leslie, MD, MSc, FRCPC3 and Ruth Ann Marrie, MD, PhD, FRCPC3, (1)School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada, (2)Manitoba Centre for Health Policy, Winnipeg, ON, Canada, (3)Department of Medicine, University of Manitoba, Winnipeg, MB, Canada

[194]

EG08

[198]

Kathryn C Fitzgerald, ScD, Johns Hopkins School of Medicine, Baltimore, MD, Amber Salter, PhD, Washington University in St Louis, St Louis, MO, Tuula Tyry, PhD, Dignity Health, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, Robert J Fox, MD, Cleveland Clinic, Cleveland, OH, Gary Cutter, PhD, University of Alabama at Birmingham, Birmingham, AL and Ruth Ann Marrie, MD, PhD, University of Manitoba, Winnipeg, MB, Canada

[194]

EG08

[198]

Kathryn Fitzgerald, ScD, Neurology, Johns Hopkins Hospital, Baltimore, MD, Tuula Tyry, PhD, Barrow Neurological Institute of Saint Joseph’s Hospital and Medical Center, Phoenix, AZ, Gary Cutter, PhD, University of Alabama at Birmingham, Birmingham, AL, Robert J Fox, MD, FAAN, The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, Amber Salter, PhD, Biostatistics, Washington University in St. Louis, St. Louis, MO, Stacey S Cofield, PhD, Biostatistics, University of Alabama at Birmingham, Birmingham, AL and Ruth Ann Marrie, MD, PhD, FRCPC, Department of Medicine, University of Manitoba, Winnipeg, MB, Canada

[194]

EG09

[198]

Kottil Rammohan, MD1, David Jones, MD2, June Halper, MSN, ANP, FAAN3, Sara McCurdy Murphy, BA4 and Lisa Patton, BA4, (1)University of Miami, Miami, FL, (2)UVA, Charlottesville, VA, (3)CEO-CMSC, Hackensack, NJ, (4)CRB, Social & Scientific Systems, Inc., Silver Spring, MD

[194]

EG09

[198]

Kathryn Fitzgerald, ScD, Neurology, Johns Hopkins Hospital, Baltimore, MD, Tuula Tyry, PhD, Barrow Neurological Institute of Saint Joseph’s Hospital and Medical Center, Phoenix, AZ, Gary Cutter, PhD, University of Alabama at Birmingham, Birmingham, AL, Robert J Fox, MD, FAAN, The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, Amber Salter, PhD, Biostatistics, Washington University in St. Louis, St. Louis, MO, Stacey S Cofield, PhD, Biostatistics, University of Alabama at Birmingham, Birmingham, AL and Ruth Ann Marrie, MD, PhD, FRCPC, Department of Medicine, University of Manitoba, Winnipeg, MB, Canada

[194]

EG10

[198]

Michela Ponzio, PhD1, Giampaolo Brichetto, MD, PhD1, Mario Alberto Battaglia, MD2 and Andrea Tacchino, PhD1, (1)Scientific Research Area, Italian MS Society, Genoa, Italy, Genova, Italy, (2)Department of Physiopathology, Experimental Medicine and Public Health, University of Siena, Italy, Siena, Italy

[194]

EPI01

[198]

Clara Wan, BA, University of Alabama at Birmingham, Birmingham, AL, Kendall Curtis, BS, University of Pittsburg, Pittsburg, PA, William Meador, MD, Neurology, UAB, Birmingham, AL and John R Rinker, MD, Neurology, University of Alabama at Birmingham, Birmingham, AL

[194]

EPI01

[198]

Clara Wan, BA1, Stacey S Cofield, PhD2, Kendall Curtis, BS1, William R Meador, MD3 and John R Rinker, MD4, (1)University of Alabama at Birmingham, Birmingham, AL, (2)Biostatistics, University of Alabama at Birmingham, Birmingham, AL, (3)Neurology, Birmingham VA Medical Center, Birmingham, AL, (4)Neurology, University of Alabama at Birmingham, Birmingham, AL

[194]

EPI01

[198]

Smathorn Thakolwiboon, MD1, Amputch Karukote, MD1, Pavida Pachariyanon, MD2 and Mirla Avila, MD1, (1)Neurology, Texas Tech University Health Sciences Center, Lubbock, TX, (2)Internal Medicine, Texas Tech University Health Sciences Center, LUBBOCK, TX

[194]

EPI01

[198]

Albert Aboseif, DO1, Devon S Conway, MD, MS2, Julie Widmar, CNP2, Tucker Harvey, MS3, Amy Kunchok, MD2, Deborah M Miller, PhD, LISW2, Carol Swetlik, MD, MS1 and Justin R Abbatemarco, MD2, (1)Department of Neurology, Cleveland Clinic, Cleveland, OH, (2)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, (3)Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH

[194]

EPI02

[198]

Wen Qin Qiu, BS, University of British Columbia, Vancouver, BC, Canada, Huah Shin Ng, PhD, BPharm, Medicine, University of British Columbia, Vancouver, BC, Canada, Naila Makhani, MD, MPH, Neurology, Yale University School of Medicine, New Haven, CT and Helen Tremlett, PhD, Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada

[194]

EPI02

[198]

Daniel Kantor, MD1, Bruce Bebo, PhD2, Peter Wahl, MLA, MS, ScD3, Patricia K. Coyle, MD4, Edward J Fox, MD, PhD5, Robert A Bermel, MD6, Jon V Riolo, PhD7, Diego Silva, MD7, Christina Wright, PharmD7, Wendi Malley, MPH3, Jud C Janak, PhD, MPH3 and Aaron E Miller, MD8, (1)Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, (2)National Multiple Sclerosis Society, New York, NY, (3)Corrona, LLC, Waltham, MA, (4)Department of Neurology, Stony Brook University, Stony Brook, NY, (5)Central Texas Neurology Consultants, Multiple Sclerosis Clinic of Central Texas, Round Rock, TX, (6)Department of Neurology, Cleveland Clinic Foundation, Cleveland, OH, (7)Bristol Myers Squibb, Princeton, NJ, (8)Icahn School of Medicine at Mount Sinai, The Corinne Goldsmith Dickinson Center for Multiple Sclerosis, New York, NY

[194]

EPI02

[198]

Lucinda J Black, PhD1, Kimberley Baker, BSc1, Robyn Lucas, PhD2,3 and Gavin Pereira, PhD1, (1)School of Public Health, Curtin University, Perth, Australia, (2)National Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University, Canberra, ACT, Australia, (3)Centre for Ophthalmology and Visual Science, The University of Western Australia, Perth, Australia

[194]

EPI02

[198]

Emilette L Marrero-Torres, BS1, David X Carmona-Burgos, BS2,3, Ramon J Vega-Corteguera, BS2,3, Viviana Martinez-Maldonado, BS2,3, Ana P Negron-Garcia, BS1, Kyara M Ostolaza-Oquendo, BS1, Ivonne Vicente, MD4 and Angel Chinea, MD5, (1)San Juan Bautista School of Medicine, Caguas, PR, (2)Caribbean Center for Clinical Research, Guaynabo, PR, (3)San Juan MS Center, Guaynabo, PR, (4)San Juan MS Center, Guaynabo, PR, Puerto Rico, (5)San Juan Bautista School of Medicine, Universidad Central del Caribe School of Medicine, Fundacion Eslerosis Multiple de PR, San Juan MS Center, Guaynabo, PR, Puerto Rico

[194]

EPI03

[198]

Kottil Rammohan, MD1, David Li, MD, FRCPC2, June Halper, MSN, APN-C, MSCN, FAAN3, Sara McCurdy Murphy, BA4, Lisa Patton, BA4, Chao Zheng, MD5 and Seema Khurana, DO5, (1)Department of Neurology, Multiple Sclerosis Center, University of Miami, Miami, FL, (2)Radiology and Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada, (3)Consortium of Multiple Sclerosis Centers, Hackensack, NJ, (4)Social & Scientific Systems, Silver Spring, MD, (5)University of Miami, Miami, FL

[194]

EPI03

[198]

Angel Chinea, MD1, Kottil Rammohan, MD2, David Li, MD, FRCPC3, June Halper, MSN, ANP, FAAN4, Sara McCurdy Murphy, BA5 and Lisa Patton, BA5, (1)San Juan Multiple Sclerosis Center, Guaynabo, PR, (2)University of Miami, Miami, FL, (3)The University of British Columbia, Vancouver, BC, Canada, (4)CEO-CMSC, Hackensack, NJ, (5)CRB, Social & Scientific Systems, Inc., Silver Spring, MD

[194]

EPI03

[198]

Kaylan Fenton, APNP1, Mokshal H Porwal, BSc1, Amber Salter, PhD2, Hope Campbell, MSN, RN1, DeAnna Finnessy, MA1, Samantha O’Dell, BA1 and Ahmed Z Obeidat, MD, PhD1, (1)Neurology, Medical College of Wisconsin, Milwaukee, WI, (2)Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX

[194]

EPI04

[198]

Mahboobeh Fereidan-Esfahani, M.D.1, Paul Decker, M.S.2, Jeanette Eckel Passow, PhD2 and Oliver Tobin, M.B. B.Ch. B.A.O. Ph.D.1, (1)Neurology, Mayo Clinic, Rochester, MN, (2)Health Sciences, Mayo Clinic, Rochester, MN

[194]

EPI04

[198]

Aman Saini, MD, MPH, Office of the Saskatchewan Multiple Sclerosis Clinical Research Chair, University of Saskatchewan College of Medicine, Saskatoon, SK, Canada, Kevin Bach, B.S., Office of the Saskatchewan MS Clinical Research Chair, University of Saskatchewan, Saskatoon, SK, Canada, Ilia Poliakov, MD, Neurology, University of Saskatchewan College of Medicine, Saskatoon, SK, Canada, Katherine Knox, MD, Physical Medicine & Rehabilitation, University of Saskatchewan, Saskatoon, SK, Canada and Michael C Levin, MD, Anatomy, Physiology & Pharmacology, University of Saskatchewan, Saskatoon, SK, Canada

[194]

EPI04

[198]

Kimystian Harrison, MD1, Victoria A. Levasseur, MD2, Alexander P. Conway, BS3, Kavya Bhattiprolu, BS4, Robert T. Naismith, MD2, Kathryn C. Fitzgerald, ScD5, Meghan Beier, PhD4, Abbey J. Hughes, PhD4, Ellen M. Mowry, MD, MCR5 and Jagriti ‘Jackie’ Bhattarai, PhD4, (1)Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (2)Department of Neurology, Washington University in St. Louis School of Medicine, St. Louis, MO, (3)Washington University in St. Louis School of Medicine, St. Louis, MO, (4)Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD, (5)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

EPI05

[198]

Stacey S Cofield, PhD, Biostatistics, University of Alabama at Birmingham, Birmingham, AL, Gary Cutter, PhD, Department of Biostatistics, UAB School of Public Health, Birmingham, AL and Robert J Fox, MD, Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH

[194]

EPI05

[198]

Marion Schauf, Dipl.-Kff.1, Harini Chinthapatla, M.Pharm2, Seema Dimri, M.Pharm2, Edward Li, PharmD MS3 and Daniel Hartung, PharmD, MPH4, (1)Franchise Launches Biopharma, Sandoz International GmbH, Holzkirchen, Germany, (2)Value & Access, Novartis Healthcare Pvt. Ltd, Hyderabad, India, (3)HEOR, Sandoz Inc, Princeton, NJ, (4)College of Pharmacy,, Oregon State University, Portland, OR

[194]

EPI06

[198]

Farren B.S. Briggs, Ph.D. Sc.M.1, Devon Conway, MD2, Daniel Ontaneda, MD3 and Douglas D. Gunzler, Ph.D.1, (1)Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, (2)Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland, OH, (3)Cleveland Clinic, Cleveland, OH

[194]

EPI06

[198]

Matthew H Roberts, MD1, Robert Ungerer, MD2, Sandra Azareli Garcia-Velazquez, MD1, Enrique Rangel, BS3, Gowri Warikoo, BA4, Rola Mahmoud, MD2,5 and Tania Reyna, MD1, (1)Neurology, University of Texas Health San Antonio, San Antonio, TX, (2)Neurology, University of Missouri-Kansas City, Kansas City, MO, (3)Joe R. & Teresa Lozano Long School of Medicine, San Antonio, TX, (4)University of Missouri-Kansas City, Kansas City, MO, (5)Neurology, Saint Luke’s Marion Bloch Neuroscience Institute, Kansas City, MO

[194]

EPI07

[198]

Nihal Voruganti, BS1, Mokshal H Porwal, BSc1, Kaylan Fenton, APNP1, Amber Salter, PhD2, DeAnna Finnessy, MA1, Samantha O’Dell, BA1 and Ahmed Z Obeidat, MD, Ph.D.1, (1)Neurology, Medical College of Wisconsin, Milwaukee, WI, (2)Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX

[194]

EPI08

[198]

Mokshal H Porwal, BSc1, Allison N Block, DO1, Kaylan Fenton, APNP2, Amber Salter, PhD3, Nihal Voruganti, BS1, DeAnna Finnessy, MA1, Samantha O’Dell, BA1 and Ahmed Z Obeidat, MD, PhD1, (1)Neurology, Medical College of Wisconsin, Milwaukee, WI, (2)National Institutes of Health, Bethesda, MD, (3)Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX

[194]

EPI09

[198]

Nikita Stempniewicz, MSc1, Andrea Steffens, MPH2, Kimvi Kim, PharmD, BCPPS, BCOP1, Mary DuCharme, MLIS2, Helen Trenz, PhD2 and David Singer, PharmD, MS1, (1)GSK, Philadelphia, PA, (2)Optum, Eden Prairie, MN

[194]

EPI10

[198]

Luigi Pontieri, PhD1, Nupur Greene, PhD, MPH, BPharm2, Svend Sparre Geertsen, PhD2, Lisa Farnett, PharmD2, Keiko Higuchi, MPH2 and Melinda Magyari, MD, PhD1, (1)The Danish Multiple Sclerosis Registry (DMSR), Copenhagen University Hospital, Rigshospitalet, Denmark, (2)Sanofi, Cambridge, MA

[194]

EPI11

[198]

Seth Hinrichsen, BS1, Randall Graham, MS2, Chantel Sloan-Aagard, PhD1, James Johnston, PhD, MSPH1 and John Beard, PhD, MPH1, (1)Public Health, Brigham Young University, Provo, UT, (2)Chief, Science & Technology Integration Division, National Oceanic and Atmospheric Administration, Kansas City, MO

[194]

EPI12

[198]

Gauruv Bose, MD1,2, Nupur Greene, PhD, MPH, BPharm3, Brian C. Healy, PhD1, Howard L. Weiner, MD4,5, Lisa Farnett, PharmD3, Keiko Higuchi, MPH3 and Tanuja Chitnis, MD5,6, (1)Brigham and Women’s Hospital, Boston, MA, (2)Department of Medicine (Neurology), University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada, (3)Sanofi, Cambridge, MA, (4)Brigham and Women’s Hospital, Boston, MA, (5)Harvard Medical School, Boston, MA, (6)Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

[194]

ET01

[198]

Aliza Ben-Zacharia, DNP, The Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Mount Sinai School of Medicine, New York, NY, Francois Bethoux, MD, Department of Rehabilitation Services, Cleveland Clinic Mellen Center, Cleveland, OH and Angelo Volandes, MD, MPH, Palliative Care, Co-Founder & President ACP Decisions, Harvard School of Medicine, Boston, MA

[194]

ET02

[198]

Hollie Schmidt, MS1, Debra I Frankel, MS OTR2, April Moreno, PhD MPA3, Mitzi J Williams, MD4, Lilyana Amezcua, MD, MS5, Shawn Feliciano, B.S.1, Anita Williams, M.S.1, Daniel Machemer, PhD6, Terrie Livingston, PharmD7, Monique LaRocque, MPH8, Melissa Glim, MPH8 and Daniela Pimentel Maldonado, MD9, (1)Accelerated Cure Project for MS, Waltham, MA, (2)Advocacy, Services and Research Department, National Multiple Sclerosis Society, NY, NY, (3)Biomedical Informatics, UCSD School of Medicine, La Jolla, CA, (4)Multiple Sclerosis Center of Atlanta, Atlanta, GA, (5)Neurology, University of Southern California, Los Angeles, CA, (6)Genentech, Inc., South San Francisco, CA, (7)Biogen, Weston, MA, (8)Feinstein Kean Healthcare, Washington, DC, (9)University of Massachusetts Medical School, Worcester, MA

[194]

FAM01

[198]

Katherine L. Cardwell, BHSc1, Taylor Hume, BHSc1, Odessa J. McKenna, MSc1, Afolasade Fakolade, PhD2 and Lara A. Pilutti, PhD3, (1)Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, Canada, (2)School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada, (3)Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada

[194]

FAM01

[198]

[194]

FAM01

[198]

Marijean Buhse, PhD, NP-C, South Shore Neurologic Associates, Patchogue, NY, Paula Hardeman, PA-C, UT Southwestern Medical Center, Dallas, TX, Mary Pat Bartoszek, MSN, APRN-CNP, Riverhills Neuroscience, Cincinnatti, OH, Patricia Melville, MSN, NP-C, MSCN, MS Comprehensive Care Center, SUNY at Stony Brook, Stony Brook, NY, Stacey Panasci, MS, PA-C, MSCS, Western Mass Neurology, East Longmeadow, MA, Daniel Sellers, MSCS, PA-C, MS Center of Sarasota, Sarasota, FL and Colleen Miller, RN, NP, DNS, Sanofi, Cambridge, MA

[194]

FAM01

[198]

Katherine L. Cardwell, BHSc1, Zain Awadia, MSc2, Odessa J. McKenna, MSc3, Taylor Hume, BHSc1, Julia Ludgate, BHSc4, Mark S Freedman, HBSc, MSc, MD, CSPQ, FANA, FAAN, FRCPC5, Marcia Finlayson, PhD6, Amy Latimer-Cheung, PhD7, Lara A. Pilutti, PhD8 and Afolasade Fakolade, PhD6, (1)Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, Canada, (2)Faculty of Health Sciences, McMaster University, Ottawa, ON, Canada, (3)Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada, (4)Faculty of Health Sciences, University of Ottawa, Ottawa, ON, Canada, (5)University of Ottawa and the Ottawa Hospital Research Institute, Ottawa, ON, Canada, (6)School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada, (7)School of Kinesiology and Health Studies, Queen’s University, Kingston, ON, Canada, (8)Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada

[194]

FAM02

[198]

Ciara M O’Meara, MHSc, M.A.T., BSc, RNT, RGN, Clinical Research Facility, University of Ireland Galway, Galway, Ireland

[194]

FAM02

[198]

Shashi Shankar, BS, MPH1, Brett Adelman, BA2 and Arif Sorathia, BS2, (1)Genentech, Inc., South San Francisco, CA, (2)Karate Health, Washington, DC

[194]

FAM03

[198]

Hollie Schmidt, MS1, Sara Loud, MSEE, MBA1, Theresa Frangiosa, MBA2, Virginia Biggar, BA2, Jason Resendez, BA2 and Stephanie Monroe, JD3, (1)Accelerated Cure Project for Multiple Sclerosis, Waltham, MA, (2)UsAgainstAlzheimer’s, Washington, DC, (3)African Americans Against Alzheimer’s, Washington, DC

[194]

FAM03

[198]

Julia O’Mahony, BSc, Neurosciences and Mental Health Program, The Hospital for Sick Children, Toronto, ON, Canada, Brenda Banwell, MD, Neurology, Children’s Hospital of Philadelphia, Philadelphia, PA and Ruth A Marrie, PhD, Department of Internal Medicine (Neurology), University of Manitoba, Winnipeg, MB, Canada

[194]

FAM04

[198]

Katherine L. Cardwell, BHSc1, Odessa McKenna, BSc1, Afolasade Fakolade, PhD2, Lara A. Pilutti, PhD1 and Jason Steffener, PhD3, (1)Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, Canada, (2)School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada, (3)School of Interdisciplinary Health Sciences, University of Ottawa, Ottawa, ON, Canada

[194]

FC01

[198]

Deborah S Lockridge, RN, BSN, MMFT, Norton Healthcare, Louisville, KY

[194]

FC01

[198]

Charlene A Fink, MSN CNS, Mary A Willis, MD and Janet Perryman, MBA, Mellen Center, Cleveland Clinic, Cleveland, OH

[194]

FC02

[198]

Elizabeth J Halstead, Ph.D, MyHealios, Flemington, NJ, United Kingdom; Health and Social Care, University of Sunderland, London, United Kingdom, Damian Fiore, Pharm.D, Genentech Inc., San Francisco, CA and Kim T Mueser, Ph.D, Center for Psychiatric Rehabilitation, Boston University, Boston, MA; MyHealios, Flemington, NJ

[194]

FC02

[198]

Yolanda C. Harris,, CPNP, PNP-AC, MSCN, University of Alabama School of Nursing and the Department of Pediatric Neurology, University of Alabama at Birmingham, Birmingham, AL

[194]

FC03

[198]

Malory Weber, MBA1, Pete Swauger, RN1, Kim Lansu, Med Sec1, Janet Perryman, MBA1, Tanya Ray, Med Sec1, Mary Roe, Med Sec1, Robin Treece, Med Sec1, Lauren Wyeth, MS2 and Robert Bermel, MD3, (1)Mellen Center, Cleveland Clinic, Cleveland, OH, (2)Continuous Improvement, Cleveland Clinic, Cleveland, OH, (3)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH

[194]

FC04

[198]

Caila B Vaughn, PhD, MPH1,2, Katelyn S. Kavak, MS1,2, Karen Zakalik, MBA1,2, Barbara E. Teter, PhD, MPH1,2, Muhammad Nadeem, MD1, Andrew Goodman, MD2,3, Keith R Edwards, MD2,4, Rozina Rana, MD2,5, Malcolm Gottesman, MD2,5 and Bianca Weinstock-Guttman, MD1,2, (1)Jacobs MS Center for Treatment and Research, Buffalo, NY, (2)New York State Multiple Sclerosis Consortium, Buffalo, NY, (3)Neurology, University of Rochester, Rochester, NY, (4)MS Center of Northeastern New York, Latham, NY, (5)Comprehensive MS Care Center, NYU Winthrop Hospital, Mineola, NY

[194]

IIS01

[198]

Björn Meyer, Ph.D.1, Matthias Zenker, M.D.2, Jana Pöttgen, Ph.D.3, Christoph Heesen, M.D.3 and Stefan Gold, Ph.D.4, (1)Research and Development, Gaia Group, Hamburg, Germany, (2)Gaia Group, Hamburg, Germany, (3)Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Zentrum für Molekulare Neurobiologie (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany, (4)Klinik für Psychiatrie und Psychotherapie, Charité Universitätsmedizin, Berlin, Germany

[194]

IIS01

[198]

A. Suzanne Boyd, PhD, MSW, School of Social Work, The University of North Carolina at Charlotte, Charlotte, NC and Shelby Veri, MPH, CHES, CPH, Department of Public Health Sciences, University of North Carolina at Charlotte, Charlotte, NC

[194]

IIS01

[198]

Michael V Robers, MD MS1, Vanessa I Martinez, MS1, Huiam Mubarak, MD MS1, Aimee Borazanci, MD1 and Lilyana Amezcua, MD, MS2, (1)Neurology, Barrow Neurological Institute, Phoenix, AZ, (2)Keck School of Medicine, University of Southern California, Los Angeles, CA

[194]

IIS02

[198]

Doris Lill, BS, PMP Director Healthcare Access, Advocacy, Services and Research, National Multiple Sclerosis Society, Denver, CO, Kathleen Costello, MS, ANP-BC, MSCN, Can Do MS, Avon, CO, Julie Fiol, MSW, BSN, RN, MSCN, National MS Society, Bel Aire, MD and June Halper, MSN, APN-C, MSCN, FAAN, Consortium of Multiple Sclerosis Centers, Hackensack, NJ

[194]

IIS03

[198]

Michelle H Chen, PhD1, Mindy Ross, BS2, John DeLuca, PhD1 and Alex Leow, MD/PhD2, (1)Kessler Foundation, East Hanover, NJ, (2)University of Illinois at Chicago, Chicago, IL

[194]

IIS04

[198]

Tomicka S McMILLION, RN, DNP, MSCN, SPINAL CORD INJURY AND DISORDERS, VANJHCS, EAST ORANGE, NJ and CMSC Author’s Group

[194]

IM01

[198]

Allison Fryman, MPH1, Michael Lane, MD1,2, Manoj Sammi, PhD3, Frank Bittner, DO1,2, Dennis Bourdette, MD1,2, William Rooney, PhD3 and Vijayshree Yadav, MD1,2, (1)VA Portland Health Care System, Portland, OR, (2)Neurology, Oregon Health & Science University, Portland, OR, (3)Advanced Imaging Research Center, Oregon Health Science University, Portland, OR

[194]

IM01

[198]

Brooke L Guerrero, MD, Neurology, LAC+USC/Keck School of Medicine, Los Angeles, CA

[194]

IM02

[198]

Lyndsay A Hauser, BA1, Lisa H Conti, PhD1, Richard Feinn, PhD1, Carolyn J. St. Andre, BS2, Lindsay Neto, MPH2 and Jennifer A. Ruiz, DPT2, (1)Department of Medical Sciences, Frank H Netter MD School of Medicine, Quinnipiac University, North Haven, CT, (2)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT

[194]

IM02

[198]

Saurabh Jain, Master of Science1,2, Diana M Sima, PhD1,3, Eline Van Vlierberghe, Master of Science1, Benedicte Dubois, PhD/MD4,5, Patrick Dupont, PhD6, Gabriel Kocevar, Master of Science7, Francoise Durand-Dubief, PhD7, Dominique Sappey-Marinier, PhD7, Chenyu Wang, PhD8, Michael H Barnett, PhD/MD8, Sabine Van Huffel, PhD3,9, Frederik Maes, PhD2 and Dirk Smeets, PhD1,10, (1)R&D, icometrix, Leuven, Belgium, (2)Department of Electrical Engineering-ESAT, PSI Medical Image Computing, KU Leuven, Leuven, Belgium, (3)Department of Electrical Engineering-ESAT, STADIUS Center for Dynamical Systems, Signal Processing and Data Analytics, KU Leuven, Leuven, Belgium, (4)Department of Neurology, Universitaire Ziekenhuizen Leuven, Leuven, Belgium, (5)Laboratory for Neuroimmunology, Department of Neurosciences, KU Leuven, Leuven, Belgium, (6)Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium, (7)CREATIS CNRS UMR5220 & INSERM U1206, Universite de Lyon, Universite Claude Bernard-Lyon 1, INSA-Lyon, Villeurbanne, France, (8)Sydney Neuroimaging Analysis Centre, Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia, (9)Imec, Leuven, Belgium, (10)BioImaging Lab, Universiteit Antwerpen, Antwerp, Belgium

[194]

IM03

[198]

Nidhiben Anadani, MBBS, Megan Hyland, MD, Andrew Goodman, MD and Lawrence Samkoff, MD, Neurology, University of Rochester, Rochester, NY

[194]

IM03

[198]

Jacqueline A Luhoway, BSc.1, Manas Sharma, MD2, Suresh Menon, MD3, Heather Rosehart, BScH4 and Sarah A Morrow, MD4, (1)University of Western Ontario, London, ON, Canada, (2)Radiology/Medical Imaging, University of Western Ontario, London Health Sciences Center, London, ON, Canada, (3)Medicine, Division of Neurology, McMaster University, Hamilton, ON, Canada, (4)Clinical Neurological Sciences, University of Western Ontario, London Health Sciences Center, London, ON, Canada

[194]

IM04

[198]

Sara Razmjou, MD, M.Sc1, Fen Bao, MS2, Samuel Lichtman-Mikol, BA1, Kalyan Yarraguntla, MD2, Carla Santiago, MS2, Evanthia Bernitsas, MD3 and Navid Seraji-Bozorgzad, MD, M.Sc1, (1)Neurology, Wayne State School of Medicine, Detroit, MI, (2)Wayne State School of Medicine, Detroit, MI, (3)Neurology, Wayne State University School of Medicine, Detroit, MI

[194]

IM04

[198]

Jason Ledesma, BS1, Bijal Mehta, MD, MPH2, Padma Priya Puttagunta, MD3 and Kristen Berube, BS3, (1)Neurology, LA BIOMED, Torrance, CA, (2)Neurology, Harbor-UCLA Medical Center, Torrance, CA, (3)Neurology, LA Biomed, Torrance, CA

[194]

IMG01

[198]

David KB Li, MD FRCPC1, Samuel Yim, MHA2, Laura Barlow, RTR, RMTR3, Monty Martin, MD FRCPC4, Carolyn Rudden, BSc MA5, June Halper, MSN, APN-C, MSCN, FAAN6, Lori Saslow, MS6 and Anthony Traboulsee, MD7, (1)Radiology and Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada, (2)Vancouver Coastal Health, Vancouver, BC, Canada, (3)UBC MRI Research Centre, Vancouver, BC, Canada, (4)Radiology, University of British Columbia, Vancouver, BC, Canada, (5)British Columbia Ministry of Health, Victoria, BC, Canada, (6)Consortium of Multiple Sclerosis Centers, Hackensack, NJ, (7)University of British Columbia, Vancouver, BC, Canada

[194]

IMG01

[198]

Ekaterina Dobryakova, PhD, Kessler Foundation, East Hanover, NJ

[194]

IMG01

[198]

Pamela K Newland, RN, PhD, CMSRN, 4483 Duncan Avenue, Goldfarb School of Nursing at Barnes Jewish College, St Louis, MO and Ling K Chen, PhD, Biostatistics, Washington University, St Louis, MO

[194]

IMG02

[198]

Blake E Dewey, PhD, Nicole Bou Rjeily, MD, Chen Hu, MS, Christy Hulett, BA, Gabriella Dagher, BS, Alexandra Zambriczki Lee, BS, Anna DuVal, BA, MPH, Peter A Calabresi, MD, Kathryn C. Fitzgerald, ScD and Ellen M. Mowry, MD, MCR, Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

IMG02

[198]

Sachi Patil, BA1, Rachel Kenney, PhD2, Lisena Hasanaj, MS1, Binu Joseph, MBBS1, Steven Galetta, MD1 and Laura Balcer, MD MSCE1, (1)Neurology, New York University Grossman School of Medicine, New York, NY, (2)Neurology, Vanderbilt University Medical Center, Nashville, TN

[194]

IMG02

[198]

Serkan Ozakbas, Professor Of Neurology1, Turhan Kahraman, physiatrist2, Asiye Tuba Ozdogar, physiatrist3, Zuhal Abasiyanik, physiatrist3, Ozge Sagici, Psychologist3 and Pinar Yigit, Psychologist3, (1)Department of Neurology, Dokuz Eylul University, Izmir, Turkey, (2)Izmir Katip Celebi University, Izmir, Turkey, (3)Dokuz Eylul University, Izmir, Turkey

[194]

IMG03

[198]

Robert Zivadinov, MD, PhD1, John DeLuca, PhD2, Jon V. Riolo, MD3, Chun-Yen Cheng, MS3, Sibyl Wray, MD4, Ann Bass, MD5, Edward Fox, MD, PhD, FAAN6, Emily Riser, MD7, Burhan Chaudhry, MD3, Jennifer Reardon, MSN, ANP-BC, CNRN, MSCN3, Diego Silva, MD3 and Robert T. Naismith, MD8, (1)Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, (2)Kessler Foundation, West Orange, New Jersey, and Departments of Physical Medicine and Rehabilitation, and Neurology, Rutgers – New Jersey Medical School, Newark, NJ, (3)Bristol Myers Squibb, Princeton, NJ, (4)Hope Neurology MS Center, Knoxville, TN, (5)Neurology Center of San Antonio, San Antonio, TX, (6)Central Texas Neurology Consultants, Round Rock, TX, (7)Alabama Neurology Associates, Birmingham, AL, (8)Department of Neurology, Washington University in St. Louis School of Medicine, St. Louis, MO

[194]

IMG03

[198]

Maria Ines Meyer, MSc1,2, Ezequiel de la Rosa, MSc1, Greg Dudra, BSc1, Eline Van Vlierberghe, MSc1, Koen Van Leemput, PhD2 and Diana M Sima, PhD1, (1)R&D, icometrix, Leuven, Belgium, (2)Department of Health Technology, Technical University of Denmark, Copenhagen, Denmark

[194]

IMG04

[198]

Ati Ghoreyshi, PhD1, Elisa Sheng, PhD1, Ferhan Qureshi, BS1, Tammy Hoyt, MS2 and John Foley, MD3, (1)Octave Bioscience, Menlo Park, CA, (2)Rocky Mountain MS Research Group, Salt Lake City, UT, (3)Rocky Mountain MS Clinic, Salt Lake City, UT

[194]

IMG04

[198]

Elina Melamed, MD1, David S Titelbaum, MD2, Soleil Samaan, BS1, Jacob A. Sloane, MD PhD1 and Ursela Baber, MD1, (1)Neurology, Beth Israel Deaconess Medical Center, Boston, MA, (2)Shields Health Care, Brockton, MA

[194]

IMG05

[198]

Lianrui Zuo, MSE1,2, Savannah P Hays, BS1, Blake E Dewey, PhD3, Samuel W Remedios, BS4,5, Yuan Xue, PhD1, Sandra D Cassard, ScD3, Carolyn Koch, MA3, Ann Fishman, MBA6, Aaron Carass, MS1, Jerry L Prince, PhD1, Ellen M. Mowry, MD, MCR3 and Scott D Newsome, DO, MSCS3, (1)Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD, (2)National Institute on Aging, National Institutes of Health, Baltimore, MD, (3)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (4)Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD, (5)Computer Science, Johns Hopkins University, Baltimore, MD, (6)Geriatric Psychiatry and Neuropsychiatry, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

IMG05

[198]

Jeeyoon Kang, BS1, Jared Srinivasan, BA2 and Mark Gudesblatt, MD2, (1)South Shore Neurologic, Patchogue, NY, (2)South Shore Neurologic Associates, Patchogue, NY

[194]

IMG06

[198]

Christopher C Hemond, MD1, Mugdha Deshpande, MS1, Idanis Berrios-Morales, MD1, George M Slavich, PhD2 and Steven W Cole, PhD2, (1)Neurology, University of Massachusetts, Worcester, MA, (2)Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA

[194]

IMG07

[198]

David KB Li, MD FRCPC1, Hae Jung Min, BA2, Samuel Yim, MHA3, Adelia Adelia, MSc4, Shelly Au, PhD4, Jason Shewchuk, MD, FRCPC5, Laura Barlow, RTR, RMTR6, Laura Harvey, BA4, Shannon Kolind, PhD4, Roger Tam, PhD7, Bruce Forster, MSc MD FRCPC FCAR5, Monty Martin, MD FRCPC5, Carolyn Rudden, BSc MA8, Lori Saslow, MS9, June Halper, MSN, APN-C, MSCN, FAAN9 and Anthony Traboulsee, MD, FRCPC4, (1)Radiology and Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada, (2)University of British Columbia, Vancouver, BC, Canada, (3)Vancouver Coastal Health, Vancouver, BC, Canada, (4)Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada, (5)Radiology, University of British Columbia, Vancouver, BC, Canada, (6)UBC MRI Research Centre, Vancouver, BC, Canada, (7)Radiology & School of Biomedical Engineering, University of British Columbia, Vancouver, BC, Canada, (8)British Columbia Ministry of Health, Victoria, BC, Canada, (9)Consortium of Multiple Sclerosis Centers, Hackensack, NJ

[194]

IMG07

[198]

Blake E Dewey, PhD1, Lianrui Zuo, MSE2,3, Samuel W Remedios, BS4, Yuan Xue, PhD3, Savannah P Hays, BS3, Sandra D Cassard, ScD1, Carolyn Koch, MA1, Ann Fishman, MBA5, Aaron Carass, MS3, Jerry L Prince, PhD3, Ellen M. Mowry, MD, MCR1 and Scott D Newsome, DO, MSCS1, (1)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (2)National Institute on Aging, National Institutes of Health, Baltimore, MD, (3)Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD, (4)Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD, (5)Geriatric Psychiatry and Neuropsychiatry, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

IMG08

[198]

Dinesh K Sivakolundu, MD, PhD1,2, Mark D Zuppichini, MA3, Kathryn West, PhD4, Gayathri B Maruthy, MS5, Monroe Turner, PhD5, Dema Abdelkarim, BS5, Yuguang Zhao, MS5, Peter Herman, PhD6, Stephan Kaczmarz, PhD7, Fahmeed Hyder, PhD6, Robert Fulbright, MD6, Erin E Longbrake, MD, PhD1, Darin T Okuda, MD8 and Bart Rypma, PhD9, (1)Neurology, Yale University, New Haven, CT, (2)Biological Sciences, University of Texas at Dallas, Dallas, TX, (3)School of Behavioral and Brain Sciences, University of Texas At Dallas, Richardson, TX, (4)Center for BrainHealth, Dallas, TX, (5)University of Texas at Dallas, Dallas, TX, (6)Yale University, New Haven, CT, (7)Technical University of Munich School of Medicine, Munich, Germany, (8)UT Southwestern Medical Center, Dallas, TX, (9)School of Behavioral and Brain Sciences, University of Texas at Dallas, Richardson, TX

[194]

IMG08W

[198]

Blake E Dewey, PhD1, Ann Fishman, MBA2, Sandra D Cassard, ScD1, Lianrui Zuo, MSE3,4, Samuel W Remedios, BS5,6, Yuan Xue, PhD4, Carolyn Koch, MA1, Savannah P Hays, BS4, Aaron Carass, MS4, Jerry L Prince, PhD4, Ellen M. Mowry, MD, MCR1 and Scott D Newsome, DO, MSCS1, (1)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (2)Geriatric Psychiatry and Neuropsychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, (3)National Institute on Aging, National Institutes of Health, Baltimore, MD, (4)Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD, (5)Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD, (6)Computer Science, Johns Hopkins University, Baltimore, MD

[194]

IMG09

[198]

[194]

IMG09

[198]

Karen Winn, NP, MSN, DNP, Seahorn Advisors, Boston, MA, Brant J. Oliver, PhD, MS, MPH, APRN-BC, Geisel School of Medicine at Dartmouth, Lebanon, NH, Karlie Hamilton, MSN, RN, Goldfarb School of Nursing, St Louis, MO, Verna Hendricks-Ferguson, PhD, RN, Saint Louis University School of Nursing, St Louis, MO and Pamela Newland, PhD, RN, CMSRN, Independent Researcher, St. Jacob, IL

[194]

IMG10

[198]

Mark D Zuppichini, MA, School of Behavioral and Brain Sciences, University of Texas At Dallas, Richardson, TX, Dinesh Sivakolundu, MD, Department of Neurology, Yale School of Medicine, New Haven, CT, Kathryn West, PhD, Center for BrainHealth, Dallas, TX, Darin T Okuda, MD, UT Southwestern Medical Center, Dallas, TX and Bart Rypma, PhD, School of Behavioral and Brain Sciences, University of Texas at Dallas, Richardson, TX

[194]

IMG10

[198]

Esther J Moon, BS1, Preksha Kukreja, BS1, Jeta Pol-Patil, MS1, Maria Claudia Manieri, BA2, Tatenda Mahlanza, BA3, Biljana Beretich, MD4, Idanis Berrios Morales, MD5, Ann Cabot, DO6, Claudia Chaves, MD7, Carolina Ionete, MD, PhD8, Joshua D Katz, M.D.9, Eric C Klawiter, MD10, Ellen S Lathi, M.D.9, Andrew J Solomon, MD11 and Maria K Houtchens, MD1, (1)Neurology, Brigham Multiple Sclerosis Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, (2)Georgia State University, Department of Biology, Atlanta, GA, (3)Brigham Multiple Sclerosis Center, Brigham and Womens Hospital, Harvard Medical School, Boston, MA, (4)Multiple Sclerosis Clinic at the Maine Medical Center, Portland, ME, (5)University of Massachusetts Medical Center, Worcester, MA, (6)Multidisciplinary Multiple Sclerosis Clinic at Concord Hospital, Concord, NH, (7)Neurology, Lahey Clinic, Lexington, MA, (8)Multiple Sclerosis Center; Department of Neurology, University of Massachusetts Chan Medical School, Worcester, MA, (9)The Elliot Lewis Center for Multiple Sclerosis Care, Wellesley, MA, (10)Multiple Sclerosis Clinic at Massachusetts General Hospital, Harvard Medical School, Boston, MA, (11)Neurological Sciences, University of Vermont College of Medicine, Burlington, VT

[194]

IMG11

[198]

[194]

IMG11

[198]

Kelly Leyden, MRes1, Tammy Hoyt, MS2, Angel Christensen, BS3, Lynden Bajus, BS1 and John Foley, MD4, (1)Octave, Menlo Park, CA, (2)Rocky Mountain MS Research Group, Salt Lake City, UT, (3)Rocky Mountain Multiple Sclerosis Clinic, Salt Lake City, UT, (4)Rocky Mountain MS Clinic, Salt Lake City, UT

[194]

IMG12

[198]

Sophie Vercruyssen, MSc1, Shannon Kolind, PhD2, Shelly Au, PhD2, Adelia Adelia, MSc2, Diana M Sima, PhD1, Dirk Smeets, PhD3, David Li, MD, FRCPC4 and Anthony Traboulsee, MD, FRCPC2, (1)R&D, icometrix, Leuven, Belgium, (2)Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada, (3)icometrix, Leuven, Belgium, (4)Radiology and Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada

[194]

IMG12

[198]

Liliya M Yausheva, MD1, Jacqueline Do, Medical Student1, Jessica Peterson, Ophthalmic Photographer/Technician2, Samuel Leeman, Research Assistant2, Carolina Ionete, MD, PhD1 and Chistopher Hemond, MD1, (1)Multiple Sclerosis Center; Department of Neurology, University of Massachusetts Chan Medical School, Worcester, MA, (2)Department of Ophthalmology and Visual Sciences, University of Massachusetts Chan Medical School, Worcester, MA

[194]

IMG13

[198]

Sophie Vercruyssen, MSc1, Shannon Kolind, PhD2, Shelly Au, PhD2, Adelia Adelia, MSc2, Diana M Sima, PhD1, Dirk Smeets, PhD3, Anthony Traboulsee, MD, FRCPC2 and David Li, MD, FRCPC4, (1)R&D, icometrix, Leuven, Belgium, (2)Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada, (3)icometrix, Leuven, Belgium, (4)Radiology and Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada

[194]

IMG13

[198]

Lynden Bajus, BS1, Kelly Leyden, MRes1 and Cristina Granziera, MD, PhD2, (1)Octave, Menlo Park, CA, (2)Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland

[194]

IMG14

[198]

Zaenab Dhari, MD1,2, Steven Kracke, MSc3, Marco Pisa, MD4, Gabriele C DeLuca, MD, DPhil4, Albert C. Lo, MD, PhD5, Heather M DelMastro, MSc1,2, Mary Bailey, MD1,2 and Jennifer Ruiz, DPT1,2, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (3)Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, USA, North Haven, CT, (4)Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom, (5)Departments of Neurology and Engineering, Brown University, Providence, RI

[194]

IMG14

[198]

Samuel W Remedios, BS1,2, Blake E Dewey, PhD3, Yuan Xue, PhD4, Lianrui Zuo, MSE4,5, Sandra D Cassard, ScD3, Carolyn Koch, MA3, Ann Fishman, MBA6, Jerry L Prince, PhD4, Ellen M. Mowry, MD, MCR3 and Scott D Newsome, DO, MSCS3, (1)Computer Science, Johns Hopkins University, Baltimore, MD, (2)Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD, (3)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (4)Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD, (5)National Institute on Aging, National Institutes of Health, Baltimore, MD, (6)Geriatric Psychiatry and Neuropsychiatry, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

IMG15

[198]

Zaenab Dhari, MD1,2, Jennifer Ruiz, DPT1,2, Lindsay O Neto, MPH1,2, Marco Pisa, MD3, Gabriele C DeLuca, MD, DPhil3, Mary Bailey, MD1,2 and Elizabeth S Gromisch, PhD1,2,4, (1)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (2)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (3)Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom, (4)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT

[194]

IMG15

[198]

Savannah P Hays, BS1, Lianrui Zuo, MSE1,2, Blake E Dewey, PhD3, Samuel W Remedios, BS4,5, Yuan Xue, PhD1, Sandra D Cassard, ScD3, Carolyn Koch, MA3, Ann Fishman, MBA6, Aaron Carass, MS1, Peter A Calabresi, MD3, Jerry L Prince, PhD1, Ellen M. Mowry, MD, MCR3 and Scott D Newsome, DO, MSCS3, (1)Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD, (2)National Institute on Aging, National Institutes of Health, Baltimore, MD, (3)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (4)Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD, (5)Computer Science, Johns Hopkins University, Baltimore, MD, (6)Geriatric Psychiatry and Neuropsychiatry, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

IMG16

[198]

Anita Shankar, M.S., Heena R. Manglani, M.A., Oyetunde Gbadeyan, Ph.D. and Ruchika S. Prakash, Ph.D., Department of Psychology, The Ohio State University, Columbus, OH

[194]

IMG16

[198]

Sepideh Heydari, PhD1,2, Colleen Lacey, M.Sc.1, Kathryn Stewart-Good, RA1, Chantel Mayo, PhD3, John Ralston, PhD4 and Jodie R Gawryluk, Ph.D., R.Psych.1,2, (1)Psychology, University of Victoria, Victoria, BC, Canada, (2)Institute on Aging and Lifelong Health, Victoria, BC, Canada, (3)Neuropsychology, University of Manitoba, Winnipeg, MB, Canada, (4)Neursantys, Menlo Park, CA

[194]

IMG17

[198]

Shuwen Wei, PhD1, Ji Hee Kim, PhD1, Yihao Liu, MSE1, Lianrui Zuo, MSE1,2, Shiv Saidha, MBBCh, MD, MRCPI3, Kathryn C. Fitzgerald, ScD3, Peter A Calabresi, MD3, Jerry L Prince, PhD1 and Aaron Carass, MS1, (1)Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD, (2)National Institute on Aging, National Institutes of Health, Baltimore, MD, (3)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

IMG18

[198]

Yuan Xue, PhD1, Blake E Dewey, PhD2, Lianrui Zuo, MSE1,3, Samuel W Remedios, BS4,5, Savannah P Hays, BS1, Sandra D Cassard, ScD2, Carolyn Koch, MA2, Ann Fishman, MBA6, Aaron Carass, MS1, Peter A Calabresi, MD2, Jerry L Prince, PhD1, Ellen M. Mowry, MD, MCR2 and Scott D Newsome, DO, MSCS2, (1)Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD, (2)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (3)National Institute on Aging, National Institutes of Health, Baltimore, MD, (4)Computer Science, Johns Hopkins University, Baltimore, MD, (5)Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD, (6)Geriatric Psychiatry and Neuropsychiatry, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

IMG19

[198]

Murali Palathinkara, BS1, Abrahim N Razzak, BS1, Delaney Cairns, BS2 and Ahmed Z Obeidat, MD, Ph.D.1, (1)Neurology, Medical College of Wisconsin, Milwaukee, WI, (2)Medical College of Wisconsin, Milwaukee, WI

[194]

INT01

[198]

Jeri Burtchell, -, Partners in Research, East Palatka, FL; HealthiVibe, LLC, Arlington, VA, Kristen Fetty, -, Fairmont State University, Fairmont, WV, Kit Minden, -, Living for a Cure, Midlothian, VA, Tim Sabutis, -, Omaha, NE and Daniel Kantor, MD, Florida Atlantic University, Boca Raton, FL

[194]

INT02

[198]

Kathleen Costello, MS, CRNP, MSCN, Associate Vice President, Healthcare Access, National Multiple Sclerosis Society, New York, NY

[194]

INT03

[198]

Amber Salter, PhD, Biostatistics, Washington University in St Louis, St Louis, MO, Gary Cutter, PhD, Department of Biostatistics, UAB School of Public Health, Birmingham, AL, Tuula Tyry, PhD, Dignity Health, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, Robert J Fox, MD, Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH and Ruth Ann Marrie, MD, PhD, FRCPC, Department of Medicine, University of Manitoba, Winnipeg, MB, Canada

[194]

IS01

[198]

Kimberly L Cooley, RN, CCRC, Research, OSF Saint Francis Medical Center, Peoria, IL

[194]

IS01

[198]

Ahmed Z Obeidat, MD, PhD, Neurology and Rehabilitation Medicine, University of Cincinnati/ MS PiT Co-Chair, Cincinnati, OH, Yasir N Jassam, MD MRCP(UK), CMSC – MS-PiT Chair, Hackensack, NJ, Rachelle Ramirez, NA, CMSC, Hackensack, NJ and June Halper, MSN, ANP, FAAN, CEO-CMSC, Hackensack, NJ

[194]

IS02

[198]

Professor Dawn Langdon, MA, MPhil, PhD, AFBPS, Department of Psychology Clinical, Health and Social Psychology, Royal Holloway, University of London, Egham, United Kingdom, Peter Rieckmann, MD, Loipl Specialist Clinic for Neurology, Medical Park, Loipl Specialist Clinic for Neurology, Loipl, Germany, Elisabetta Verdun di Cantogno, MD, PhD, Merck KGaA, Darmstadt, Germany and Sarah A Morrow, MD, FRCPC, MS, Clinical Neurological Sciences, London Health Sciences Centre, London, ON, Canada

[194]

IS02

[198]

Brandy Northcutt, _, Richard Muser, _, Michael Russo, _ and Joanne M. Wagner, _, Acorda Therapeutics, Inc, Ardsley, NY

[194]

IS03

[198]

Kanika Sharma, MD1, John A Kamholz, MD, PhD1, Frank R Bittner, MD1 and Piyush Kalakoti, MD2, (1)Neurology, University of Iowa, Iowa City, IA, (2)University of Iowa, Iowa City, IA

[194]

IS03

[198]

Elizabeth Morrison-Banks, MD, Neurology, UC Riverside School of Medicine (UCRSOM), Riverside, CA, Chris Landon, MD, Landon Pediatric Foundation, Ventura County Medical Center (VCMC), Ventura, CA, Ralph Turner, PhD, Biostatistics, Landon Pediatric Foundation, Ventura, CA and Joseph Papador, BS, Telemedicine, Landon Pediatric Foundation, Ventura, CA

[194]

IS04

[198]

John J Ko, Pharm.D., MS1, Larsson Omberg, PhD2, Christine Suver, PhD2, Stanley Cohan, MD, PhD3, Darin Okuda, MD4, Tiffany Surles, PharmD1, Biliana Rotse, PhD1, Stefan Varga, PharmD5, Ashish Pradhan, MD1, Michael Kellen, PhD2, Daniel Grant, PhD1 and Lara Mangravite, PhD2, (1)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (2)Sage Bionetworks, Seattle, WA, (3)Providence Multiple Sclerosis Center, Portland, OR, (4)Department of Neurology and Neurotherapeutics, UTSouthwestern, Dallas, TX, (5)College of Population Heatlh, Thomas Jefferson University, Philadelphia, PA

[194]

IS05

[198]

Peter Rieckmann, Prof. Dr., Chefarzt der Neurologischen Klinik, Bamberg, Germany and On behalf of the entire MS in the 21st Century Steering and Patient Group, N/A, United Kingdom

[194]

IS06

[198]

Viviana I Orozco-Leon, MD and Gishlaine Alfonso, MD, Neurology, University of Puerto Rico, Medical Sciences Campus, San Juan, PR

[194]

LB01

[198]

Landon J Crippes, BS1;Solange M Saxby, PhD, RDN2;Farnoosh Shemirani, PhD2;Linda M Rubenstein, PhD3;Patrick Ten Eyck, PhD4;Lucas J Carr, PhD5;Warren G Darling, PhD5;Karin F. Hoth, PhD6;John A Kamholz, MD, PhD7;Linda G Snetselaar, PhD, RDN3;Tyler J Titcomb, PhD, RDN2 and Terry L Wahls, MD*2, (1)Carver College of Medicine, The University of Iowa, Iowa City, IA, (2)Internal Medicine, University of Iowa, Iowa City, IA, (3)Epidemiology, University of Iowa, Iowa City, IA, (4)Institute for Clinical and Translational Science, University of Iowa, Iowa City, IA, (5)Department of Health and Human Physiology, University of Iowa, Iowa City, IA, (6)Department of Psychiatry, University of Iowa, Iowa City, IA, (7)Neurology, University of Iowa, Iowa City, IA

[194]

LB02

[198]

Patrick Vermersch, MD, PhD1;Cristina Granziera, MD, PhD2,3;Yang Mao-Draayer, MD, PhD4;Gary Cutter, MS, PhD5;Oleksandr Kalbus, MD, PhD6;Ivan Staikov, MD, PhD7;Michal Dufek, PhD8;Stephane Saubadu, MD9;Raphael Bejuit, MD9;Philippe Truffinet, MD9;Erik Wallstroem, MD, PhD10 and Gavin Giovannoni, MD, PhD, FCP, FRCP, FRCPath*11, (1)Univ. Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France, (2)Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland, (3)Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland, (4)Department of Neurology, Autoimmunity Center of Excellence, University of Michigan Medical Center, Michigan, MI, (5)Department of Biostatistics, UAB School of Public Health, Birmingham, AL, (6)Department of Neurology, Dnipro State Medical University, Dnipro, Ukraine, (7)Clinic of Neurology and Sleep Medicine, Acibadem City Clinic University Hospital Tokuda, Sofia, Bulgaria, (8)1st Department of Neurology, St. Anne’s University Hospital, Brno, Czech Republic, (9)Sanofi, Chilly-Mazarin, France, (10)Sanofi, Cambridge, MA, (11)Queen Mary University of London, London, United Kingdom

[194]

LB03

[198]

Jack Halligan, MB BCh BAO LRCP&SI, MBA*1;Luca Capezzuto, PhD2;Simon Dryden, PhD1;Saira Ghafur, Dr, MBChB, MRCP (resp), MSc1;Stanislas Hubeaux, MSc2;Agne Kazlauskaite, PhD2 and Riley Bove, MD3, (1)Prova Health, London, United Kingdom, (2)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (3)UCSF Weill Institute for Neurosciences, San Francisco, CA

[194]

LB04

[198]

Shitiz Sriwastava, MD*, UTHealth, Houston, TX;Suban Amatya, MBBS, Patan academy health science, Kathmandu, Nepal and Rajesh Gupta, MD, University of Texas at Houston, Houston, TX

[194]

LB05

[198]

Shauna M Gales, PA-C*1;Ahmed Z Obeidat, MD, PhD2;Andreina Neall, ARNP3;Kermit A Lloyd, MD4;Nicholas Belviso, PhD5;Seth Levin, MD5;Ivan Bozin, MD6;Jason P. Mendoza, PhD5;James B. Lewin, PharmD5 and Michael D Kornberg, MD PhD MS7, (1)Mellen Center, Cleveland Clinic Foundation, Cleveland, OH, (2)Neurology, Medical College of Wisconsin, Milwaukee, WI, (3)Orlando Health, Orlando, FL, (4)Riverside Neurology Specialists, Newport News, VA, (5)Biogen, Cambridge, MA, (6)Biogen, Baar, Switzerland, (7)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

LB06

[198]

Beth Schneider, BA*, Research, MyHealthTeam, San Francisco, CA;Chris Hardy, MS, Research, Publicis Health Media, New York, NY and Elizabeth Luce, BS, MBA, MyHealthTeam, San Francisco, CA

[194]

LB07

[198]

Maya Zeineddine, PharmD, PHD Candidate*, Neurology Institute, Harley Street Medical Center, Abu Dhabi, United Arab Emirates; Institute of Epidemiology and Tropical Neurology, Limoges University, Limoges, France and Bassem Yamout, MD, American University of Beirut Medical Center, Beirut, Lebanon

[194]

LB08

[198]

Arthur R. Chaves, PhD*, Health Sciences, University of Ottawa, Ottawa, ON, Canada;Sara Tremblay, PhD, Départment de psychoéducation et psychologie, Université du Québec en Outaouais, Gatineau, QC, Canada;Lara A. Pilutti, PhD, Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada;Michelle Ploughman, PhD, Physical Medicine & Rehabilitation, Faculty of Medicine, Memorial University of Newfoundland, St. John’s, NF, Canada and CEPL, Recovery and Performance Lab, and NEST Lab

[194]

LB09

[198]

Amy Perrin Ross, APN, MSN, CNRN, MSCN*1;Jacqueline Nicholas, MD, MPH2;Ming-Hui Tai, PhD3;Stephen Yeung, MD3;Nazneen Fatima Shaikh, PhD4;Helen Chen, BS4;Mariana Fernandes, MS4 and Kevin Hawkins, PhD4, (1)Neuroscience Nurse Consultant, Oak Brook, IL, (2)OhioHealth Multiple Sclerosis Center, 3535 Olentangy River Rd, Suite 1501, Columbus, OH, (3)Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover, NJ, (4)Real World Solutions, IQVIA, 2400 Ellis Road Durham, NC

[194]

LB10

[198]

Riley Bove, MD*1;Matthew Craner, MB ChB FRCP PhD2;Dawn Langdon, PhD3;Daniel Sienkiewicz, PhD4;Javier Ricart, PhD5;Soudeh Ansari, PhD6;Sophie Arnould, MSc7;Ibolya Boer, MD7 and Tobias Derfuss, MD8, (1)University of California San Francisco, San Francisco, CA, (2)John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, United Kingdom, (3)Royal Holloway, University of London, London, United Kingdom, (4)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (5)Novartis Farmacéutica, Barcelona, Spain, (6)Novartis Institutes for Biomedical Research, Cambridge, MA, (7)Novartis Pharma AG, Basel, Switzerland, (8)Neurology Clinic and Policlinic and Research Center for Clinical Neuroimmunology and Neuroscience, Departments of Medicine and Biomedicine, University Hospital and University of Basel, Basel, Switzerland

[194]

LB11

[198]

Dusan Stefoski, MD1;John Foley, MD*2;Cortnee Roman, MSN, FNP-BC2;Karen Smirnakis, MPH3;Kerry McCarthy, BSN3;Robin L. Avila, PhD3;Thuy Luu, MD3;Aaron Galluzzi, PhD4;Liesel Dsilva, PhD3 and Jennifer Lyons, MD3, (1)Rush Medical College, Chicago, IL, (2)Rocky Mountain MS Clinic, Salt Lake City, UT, (3)Biogen, Cambridge, MA, (4)Cytel, Cambridge, MA

[194]

LB12

[198]

Elaine Rudell, CHCP1;Michele F. Ingram, BS1;Alicia Zambri, NA1;Tarjani Agrawal, PhD1;Olga Syritsyna, MD2;Nancy McLinskey, MD2;Patricia Melville, ANP-BC, MSCN3;Brant Oliver, PhD, MS, MPH, APRN-BC, MSCN4 and Patricia K. Coyle, MD*2, (1)Projects In Knowledge Powered by Kaplan, Short Hills, NJ, (2)MS Comprehensive Care Center, Stony Brook Neurosciences Institute, Stony Brook, NY, (3)Dept. of Neurology, MS Comprehensive Care Center, SUNY at Stony Brook, Stony Brook, NY, (4)Chronic Health Improvement Research Program at Dartmouth Health, Hanover, NH

[194]

LB13

[198]

Monica Hendricksen, PT, DPT1;Jake Boyer, PT, DPT1;Kristen Hohl, PT, DPT, NCS1;Edith Graham, MD2;Roumen Balabanov, MD3;Miriam Rafferty, DPT, PhD1 and Dominique Kinnett-Hopkins, PhD*4, (1)Shirley Ryan AbilityLab, Chicago, IL, (2)Northwestern University, Chicago, IL, (3)Rush University Multiple Sclerosis Center, Chicago, IL, (4)School of Kinesiology, University of Michigan, Ann Arbor, MI

[194]

LB14

[198]

Daniel Kantor, MD*, Center for Global Health, University of Pennsylvania, Philadelphia, PA

[194]

LB15

[198]

Magdaliz Gorritz, MPH1;Chi-Chang Chen, PhD1;Rifat Tuly, MPH1;Yifan Gu, MS1;Abhijit Gadkari, PhD2;Brandon Brown, PharmD2;Qiujun Shao, PhD2 and Carrie M Hersh, DO, MS, FAAN*3, (1)IQVIA, Plymouth Meeting, PA, (2)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (3)Mellen Program for Multiple Sclerosis Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV

[194]

LB16

[198]

Peter Sguigna, MD*1;Annette F Okai, MD2;Jeffrey Kaplan, MD3;Kyle Blackburn, MD1;Lauren Tardo, MD1;Lori A Lebson, PhD4;Julie Korich, PhD4;Navid Manouchehri, MD1;Rehana Z Hussain, MSc1 and Olaf Stuve, MD, PhD5, (1)University of Texas Southwestern Medical Center, Dallas, TX, (2)North Texas Institute of Neurology & Headache, Plano, TX, (3)Kansas City Multiple Sclerosis and Headache Center, Overland Park, KS, (4)EMD Serono, Rockland, MA, (5)Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX

[194]

MC01

[198]

Deepmala Nandanwar, MD, Wayne State University / Detroit Medical Center, Detroit, MI and Evanthia Bernitsas, MD, Neurology, Wayne State University School of Medicine, Detroit, MI

[194]

MC01

[198]

Bren Hammond, RN, BSN, MSCN1, Annette Wundes, MD2, Jennie Toro, RN1, Wendy Durand, RN, BSN1 and Deb Cramer, RN, BSN, MSCN1, (1)Multiple Sclerosis Center, University of Washington Medical Center, Seattle, WA, (2)Neurology, University of Washington, Seattle, WA

[194]

MC02

[198]

Jamie Reiter, PhD, Jan Perez, BS, Sharon Tordoff, BS and Whitney Faler, MPA, CME Outfitters, LLC, Bethesda, MD

[194]

MC02

[198]

Jenelle M. Hall, PharmD and Kimberly Mangonon, CPhT, Duke University Health System, Durham, NC

[194]

MC03

[198]

Kanika Sharma, MD1, Yubo Gao, PhD2, Junlin Liao, PhD3, John A Kamholz, MD, PhD1 and Frank R Bittner, MD1, (1)Neurology, University of Iowa, Iowa City, IA, (2)Medicine, University of Iowa, Iowa City, IA, (3)Surgery, University of Iowa, Iowa City, IA

[194]

MC03

[198]

Jeremy Hobart, BSc PhD FRCP Dip Public Health, Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, United Kingdom, Maggie Alexander, CBiol MRSB (Chartered Biologist, Member of the Royal Society of Biology), Consultant in patient involvement in healthcare decision-making, Epidavros, Greece, Amy Bowen, RN, MA, Multiple Sclerosis Trust, Letchworth, United Kingdom, Helmut Butzkueven, MBBS, PhD, Melbourne Brain Centre, Royal Melbourne Hospital, Parkville, VIC, Australia, Gavin Giovannoni, MBBCh, PhD, FCP (Neurol., SA), FRCP, FRCPath, Queen Mary University London, Blizard Institute, Barts and the London School of Medicine and Dentistry, London, United Kingdom, Tom Kenny, BM MSc-PH(HSM) MFPH MBA, Faculty of Health and Social Sciences, University of Bournemouth, Bournemouth, United Kingdom, Gisela Kobelt, PhD, European Health Economics, Mulhouse, France and Tjalf Ziemssen, MD, PhD, Center of Clinical Neuroscience, Carl Gustav Carus University Hospital, Dresden, Germany

[194]

MC04

[198]

Jodi Haartsen, Master of Nursing, Post Graduate Diploma of Neuroscience Nursing, Graduate Diploma of Applied Science, Eastern Health, Victoria, Australia, Jeremy Hobart, BSc PhD FRCP Dip Public Health, Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, United Kingdom, Amy Bowen, CBiol MRSB (Chartered Biologist, Member of the Royal Society of Biology), NHS RightCare, London, United Kingdom, Lucy Eberhard, PhD, PharmaGenesis London, London, United Kingdom, George Pepper, -, Shift.ms, Leeds, United Kingdom and Gavin Giovannoni, MBBCh, PhD, FCP (Neurol., SA), FRCP, FRCPath, Queen Mary University London, Blizard Institute, Barts and the London School of Medicine and Dentistry, London, United Kingdom

[194]

MC04

[198]

John Osborne, MD1, Ashish Pradhan, MD2, Jamie L Weiss, PhD2, Xiangyi Meng, PhD2 and Brandon Brown, PharmD2, (1)State of the Heart Cardiology, Grapevine, TX, (2)Novartis Pharmaceuticals Corporation, East Hanover, NJ

[194]

MC05

[198]

Mary R Rensel, MD, FAAN, The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH and S. Bassi, BS, CWRU, Cleveland, OH

[194]

MC05

[198]

Karolina M Korzeniewski, BSc RD, Nutrition Services, Alberta Health Services, Calgary, AB, Canada and Megan M Parker, MSc OT, Allied Health, Alberta Health Services, Calgary, AB, Canada

[194]

MC06

[198]

Brooke McCartney, BSN, RN, Neurology and Neurotherapeutics, UT Southwestern Medical Center, Dallas, TX, Paula Hardeman, PA-C, Neurology & Neurotherapeutics – MS Clinic, UT Southwestern Medical Center, Dallas, TX and Benjamin Greenberg, MD, MHS, Department of Neurology, UT Southwestern, Dallas, TX

[194]

MC06

[198]

Kimberly L Cooley, RN, CCRC1,2, Carl Asche, PhD3, Jinma Ren, PhD3, Reuben M Valenzuela, MD4 and Dennis J Garwacki, MD4, (1)Research, OSF Saint Francis Medical Center, Peoria, IL, (2)Research, Jump Simulation and Education Center, Peoria, IL, (3)Center For Outcomes Research, University of Illinois College of Medicine at Peoria, Peoria, IL, (4)Neurology, Illinois Neurological Institute, Peoria, IL

[194]

MC06

[198]

Kimberly L Cooley, RN, CCRC1,2, Carl Asche, PhD3, Jinma Ren, PhD3, Reuben M Valenzuela, MD4 and Dennis J Garwacki, MD4, (1)Research, OSF Saint Francis Medical Center, Peoria, IL, (2)Research, Jump Simulation and Education Center, Peoria, IL, (3)Center For Outcomes Research, University of Illinois College of Medicine at Peoria, Peoria, IL, (4)Neurology, Illinois Neurological Institute, Peoria, IL

[194]

MC07

[198]

Jill R Nelson, RN BScN MSCN, Anna Kazimirchik, RN MSCN, Tatstsyana Kadach, MEng and Galina Vorobeychik, MD, FRCPS(C), CMSC, Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada

[194]

MC07

[198]

Mary Filipi, APRN, PhD1, Jennifer Ravenscroft, PA-C, MSCS2, Paul Isikwe, PharmD3, Thomas Barsanti, MD3, Marie Sanchirico, PhD3 and Colleen Miller, DNS3, (1)1University of Nebraska Medical Center, Omaha, NE, (2)Kansas City MS Center, Overland Park, KS, (3)Sanofi Genzyme, Cambridge, MA

[194]

MC08

[198]

Danielle M Taylor, BA1, Refujia Gomez, BS1, Amber Alexander, MSc2, Jennifer Arjona, BA, MS2, Sergio Baranzini, PhD1,3,4, Patrick Barba, BS5, Bruce AC Cree, MD, PhD1, Michael Devereux, B.S.2, Samuel Friedman, BS2, Priya Garcha, BSc2, Jeffrey M Gelfand, MD, MAS1, Douglas S. Goodin, MD1, Jennifer S Graves, M.D. PhD1, Ari J Green, MD1, Ariele Greenfield, MD1, Stephen L Hauser, MD1, Roland Henry, PhD1, Xiaoming Jia, MD1, Liana Kanaaneh, BA2, Kristen Krysko, MD1, Robin Lincoln, BS1, Michael Manguinao, BS2, Naomi Okinishi, MPH2, Jorge Oksenberg, PhD1, Samuel Pleasure, MD, PhD1, Nicholas Ragan, BSc5, Nisha Revirajan, MD2, Andrew Romeo, MD1, Gillian Rush, BSc5, Joseph Sabatino Jr., MD, PhD1, Ryan Schubert, MD1, Nancy Shum, BS2, Sneha Singh, BSc2, Collin Spencer, BS2, Emmanuelle Waubant, MD, PhD1, Michael Wilson, MD1, Scott Zamvil, MD, PhD1 and Riley Bove, MD, MMSc1, (1)UCSF Neurology, Weill Institute for Neurosciences, San Francisco, CA, (2)UCSF Neurology, MS Research Coordinators, San Francisco, CA, (3)Institute for Human Genetics, University of California, San Francisco, CA, (4)Graduate Program in Bioinformatics, University of California, San Francisco, San Francisco, CA, (5)UCSF Neurology, MS EPIC Team, San Francisco, CA

[194]

MC08

[198]

Mostafa A El Khashab, MD, FACS, IFAANS, Neurological Surgery, Hackensack University Medical Center, Hackensack, NJ

[194]

MC09

[198]

Priya Garcha, BSc1, Carolyn J Bevan, MD2, Elizabeth Crabtree-Hartman, MD, MAS2, Ari J Green, MD1, Jeffrey M Gelfand, MD, MAS1 and Riley Bove, MD, MMSc3, (1)UCSF Neurology, Weill Institute for Neurosciences, San Francisco, CA, (2)UCSF Neurology, Weill Institute for the Neurosciences, San Francisco, CA, (3)University of California San Francisco, Weill Institute for Neurosciences, San Francisco, CA

[194]

MC09

[198]

Mostafa A El Khashab, MD, FACS, IFAANS, Neurological Surgery, Hackensack University Medical Center, Hackensack, NJ

[194]

MC10

[198]

Priya Garcha, BSc1, Gillian Rush, BSc1, John Morrissey, BSc1, Chao Zhao, MSc1, Katherine Possin, PhD1, Anthony Feinstein, PhD, MD2, Joaquin Anguera, PhD1 and Riley Bove, MD, MMSc3, (1)UCSF Neurology, Weill Institute for Neurosciences, San Francisco, CA, (2)Psychiatry, University of Toronto, Toronto, ON, Canada, (3)University of California San Francisco, Weill Institute for Neurosciences, San Francisco, CA

[194]

MC10

[198]

Sierra Hill, PharmD1, Felecia Hart, PharmD, MSCS2, Jacquelyn Bainbridge, PharmD, FCCP, MSCS2, Lynn Do, PharmD, BCPS, MSCS3 and Michael Toscani, PharmD1, (1)Rutgers University, Piscataway, NJ, (2)University of Colorado, Aurora, CO, (3)UCSF Medical Center, San Francisco, CA

[194]

MC11

[198]

Anastasie Dunn-Pirio, MD, MS, Suma Shah, MD and Christopher Eckstein, MD, Neurology, Duke University, Durham, NC

[194]

MD01

[198]

Meheroz H Rabadi, MD, MRCPI, FAAN, FANA, Neurology, OKC VA Med Ctenter, Oklahoma City, OK

[194]

MD02

[198]

Meheroz H Rabadi, MD, MRCPI, FAAN, FANA, Neurology, OKC VA Med Ctr, Oklahoma City, OK and Christopher E Aston, Ph.D, Pedeatrics, OU Medical Center, Oklahoma City, OK

[194]

MD03

[198]

John P Conomy, MD JD, Health Systems Design, Inc, Chagrin Falls, OH

[194]

MD04

[198]

Thomas Finnegan, PhD, Medscape LLC, New York, NY, Colleen Harris, MN, NP, MSCN, MSCS, University of Calgary MS Clinic, Hackensack, NJ and Aliza Ben-Zacharia, DNP, ANP, MSCN, Neurology, Mount Sinai Hospital, New York, NY

[194]

MD05

[198]

Virginia R Schobel, MSc, Neurology Market Intelligence, Spherix Global Insights, Exton, PA and Jennifer Robinson, BS, President, Spherix Global Insights, Exton, PA

[194]

MD06

[198]

Maria K Houtchens, MD1, Natalie C Edwards, MSc2, Brooke Hayward, SM, MBA3 and Amy L Phillips, PharmD3, (1)Harvard Medical School, Brigham and Women’s Hospital, Boston, MA, (2)Health Services Consulting Corporation, Boxborough, MA, (3)EMD Serono, Inc., Rockland, MA

[194]

MD07

[198]

Tyler E Smith, MD1, Katherine Baumgarten, MD2, Jonathan Hand, MD2, Amber E Peskin, AGCNS-BC, MSCN3 and Bridget A Bagert, MD1, (1)Neurology, Ochsner Clinic Foundation, New Orleans, LA, (2)Infectious Diseases, Ochsner Clinic Foundation, New Orleans, LA, (3)Ochsner Multiple Sclerosis Center, New Orleans, LA

[194]

MD08

[198]

Alison Kraus, PT, DPT, NCS1,2, Nicole Tester, PhD, MOT, OTR/L1, Tirisham V Gyang, MD2, Lindsay Falk, ARNP, MSCN2, Vineet Nadkarni, BS2 and Augusto Miravalle, MD2, (1)Rehabilitation, UF Health, Gainesville, FL, (2)Neurology, University of Florida, Gainesville, FL

[194]

MD09

[198]

Warren Berger, MD, FRCPC1, Sarah A Morrow, MD, FRCPC, MS1 and Michael WC Payne, MSc, MD, FRCPC2, (1)Clinical Neurological Sciences, London Health Sciences Centre, London, ON, Canada, (2)Department of Physical Medicine and Rehabilitation, St. Joseph’s Health Care, London, ON, Canada

[194]

MD10

[198]

Jamie Head, BSc1, Ana-Luiza Sayao, MD2, Carolyn Taylor, MSc3, Lorne Kastrukoff, MD2, Anthony Traboulsee, MD2,4, Virginia Devonshire, MD2 and Robert Carruthers, MD2, (1)Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada, (2)Neurology, University of British Columbia, Vancouver, BC, Canada, (3)Department of Statistics, University of British Columbia, Vancouver, BC, Canada, (4)University of British Columbia, Vancouver, BC, Canada

[194]

MDC01

[198]

Hoa H. Le, PhD1, Alexander Keenan, MA, MHP1, Michele Cole, PharmD, MS2, Kavita Gandhi, MS2, Nidia Afonso, PharmD2, Lola Adeokun, MPharm2, Eddie Jones, BA3, Mia Berry, BSc3, James Pike, BSc, MPhil3, Nikisha Grant, BSc, MSc3 and Emily Trenholm, BSc3, (1)Johnson & Johnson, Janssen Scientific Affairs, Titusville, NJ, (2)Johnson & Johnson, Research Development, Janssen Pharmaceuticals, Titusville, NJ, (3)Adelphi Real World, Bollington, Cheshire, United Kingdom

[194]

MDC01

[198]

[194]

MDC01

[198]

Jacqueline Smith, BSN, RN-BC1, Jennifer Hartman, MPAS, PA-C2, Keith McKee, MD3 and Francois Bethoux, MD3, (1)Neurological Institute – Mellen Center, CLEVELAND CLINIC, Cleveland, OH, (2)Neurological Institute, Cleveland Clinic Mellen Center, Cleveland, OH, (3)Department of Rehabilitation Services, Cleveland Clinic Mellen Center, Cleveland, OH

[194]

MDC01

[198]

Alexa Kane, PsyD, The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH

[194]

MDC02

[198]

Alice E Dias, Dr, Scientific Research, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil, Mauricio O Bando, Neuropsychologist, Neurorehabilitation, ABEM – Brazilian Multiple Sclerosis Association, Sao Paulo, Brazil, Juliana AR Telles, MSc, Physiotherapy, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil and Bruna H Sciarinni, Physiotherapist, Physiotherapy, Brazilian Multiple Sclerose Association (ABEM), São Paulo, Brazil

[194]

MDC02

[198]

Mauricio O Bando, Neuropsychologist, Neurorehabilitation, ABEM – Brazilian Multiple Sclerosis Association, Sao Paulo, Brazil, Alice E Dias, Dr, Scientific Research, Brazilian Multiple Sclerosis Association (ABEM), Sao Paulo, Brazil, Ana M Canzonieri, Dr, Psychology, Brazilian Multiple Sclerosis Association (ABEM), Sao Paulo, Brazil, Talita D Silva, Dr, Sao Paulo University, Sao Paulo, Brazil and Marcelo Massa, Doctor, EACH, USP – Sao Paulo University, Sao Paulo, Brazil

[194]

MDC02

[198]

Zoe Edwards, MS1, Brian Hutchinson, PT, MSCS1, Tiffany Malone, MSW, MSCS1 and Cynthia Cox, BS2, (1)Multiple Sclerosis Achievement Center, Dignity Health, Citrus Heights, CA, (2)Dignity Health Neurological Institute, Dignity Health, Carmichael, CA

[194]

MDC02

[198]

Alexander Burnham, MS, CCC-SLP, MSCS1, Stephen Koelbel, MD2, Maria K Houtchens, MD3, Jonathan Zurawski, MD4, Kristy Ford, MS, OTR/L5, Lynn Stazzone, NP6 and John M. Sullivan, PA-C4, (1)Rehabilitation Services, The Boston Home, Boston, MA, (2)Spasticity Management, The Boston Home, Boston, MA, (3)Neurology, Brigham Multiple Sclerosis Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, (4)Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital, Boston, MA, (5)Admissions, The Boston Home, Boston, MA, (6)Brigham and Women’s Hospital, Boston, MA

[194]

MDC03

[198]

Christine Hampton, MOT, OTR/L, Anna N Berry, PT, DPT and Laura Glazebrook, PT, DPT, Shepherd Center, Atlanta, GA

[194]

MDC03

[198]

[194]

MDC03

[198]

Emma V Richardson, PhD, Department of Physical Therapy, UAB, Birmingham, AL, Elizabeth Barstow, PhD, Department of Occupational Therapy, University of Alabama at Birmingham, Birmingham, AL, Matthew Fifolt, PhD, Department of Health Care Organization & Policy, University of Alabama at Birmingham, Birmingham, AL and Robert W Motl, PhD, Department of Physical Therapy, University of Alabama at Birmingham, Birmingham, AL

[194]

MDC03W

[198]

Asya Wallach, MD1, Reg Grant, CAT(C), CSCS, RSCC*E2, Jeffrey Portnoy, PhD2, Gautam Bhasin, PsyD2, Thomas Birch, MD2, Brianne Etter, PT, DPT, CLT2, Deborah Bessen, RD2, Tracee Yablon Brenner, RD2, Matthew Hoeppner, PA-C2, Jason Kavountzis, PT, MAS, OCS2, Maxwell Edmiston, MSA, CSCS2 and Mary Ann Picone, MD1, (1)Holy Name MS Center, Teaneck, NJ, (2)Holy Name, Teaneck, NJ

[194]

MDC04

[198]

Mauricio O Bando, Neuropsychologist1, Alice E Dias, Dr2, Juliana AR Telles, MSc3, Demetrios Agourakis, doctor4, Bruna Sciarini, physicaltherapist5, Giovanna Vidigal, physicaltherapist6, André Caetano, physical educator5 and Talita Dias, physicaltherapist6, (1)Neurorehabilitation, ABEM – Brazilian Multiple Sclerosis Association, Sao Paulo, Brazil, (2)Scientific Research, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil, (3)Physiotherapy, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil, (4)neurologia, Associação Brasileira de Esclerose Múltipla, São Paulo, Brazil, (5)Associação Brasileira de Esclerose Múltipla, são paulo, Brazil, (6)Universidade de São Paulo, São Paulo, Brazil

[194]

MDC04

[198]

Aman Saini, MD, MPH1, Ilia Poliakov, BHSc (Hon), MD, FRCPC2, Katherine B. Knox, MD, FRCPC3, Chantal Kahovec, RN(NP)4, Shirley MacGowan, RN, MSCN5, Candace Lahoda, RN4, Colleen Cochran, BA (Hons.)1 and Michael C. Levin, MD, FRCPC, FAAN, FANA6, (1)Office of the Saskatchewan MS Clinical Research Chair, University of Saskatchewan, Saskatoon, SK, Canada, (2)Department of Neurology, University of Saskatchewan, Saskatoon, SK, Canada, (3)Department of Physical Medicine and Rehabilitation, University of Saskatchewan, Saskatoon, SK, Canada, (4)Saskatoon MS Clinic, Saskatchewan Health Authority, Saskatoon, SK, Canada, (5)Saskatchewan MS Drugs Program, Department of Physical Medicine and Rehabilitation, University of Saskatchewan, Saskatoon, SK, Canada, (6)Department of Neurology and Department of Anatomy, Physiology & Pharmacology, University of Saskatchewan, Saskatoon, SK, Canada

[194]

MDC04

[198]

Lisa Aquillano, PharmD, BCPS, Calli Cook, FNP-C, Lyndal Moore, BS and Neil Lava, MD, Neurology, The Emory Clinic, Atlanta, GA

[194]

MDC05

[198]

Sarah E Talbert, PT, DPT, Rehabilitation Care Line, Cincinnati Veteran’s Affairs Medical Center, Cincinnati, OH and Lauren Yacks, MOT, OTR/L, Rehabilitation Care line, Cincinnati Veteran’s Affairs Medical Center, Cincinnati, OH

[194]

MDC05

[198]

Annette F Okai, MD1, Annette M Howard, MD2, Mitzi J Williams, MD3, Justine D Brink, DO, MPH4, Chiayi Chen, RN, PhD4, Tamela L Stuchiner, MA4, Elizabeth Baraban, MPH, PhD4 and Stanley Cohan, MD, PhD5, (1)Multiple Sclerosis Treatment Center of Dallas, Dallas, TX, (2)Multiple Sclerosis Institute of Texas, Houston, TX, (3)Joi Life Wellness MS Center, Atlanta, GA, (4)Providence Brain and Spine Institute, Portland, OR, (5)Providence Multiple Sclerosis Center, Providence Brain Institute, Portland, OR

[194]

MDC05

[198]

Colleen Harris, MN, NP, MSCN, MSCS, MS Clinic, University of Calgary, Calgary, AB, Canada, Naomi Akazawa, RN, BScN, MSCN, The Ottawa Hospital, Ottawa, ON, Canada, Bonnie Blain, RN, MSCN, Medical Specialty Clinic, Red Deer Regional Hospital Centre, Alberta Health Services, Red Deer, AB, Canada, Janet Brown, RN, MSCN, MS Clinic-Eastern Health, St. John’s, NF, Canada, Sheryl Clarke, RN, BScN, MEd, St. Michael’s Hospital, Toronto, ON, Canada, Peggy Cook, RN, BN, Saint John Regional Hospital, Saint John, NB, Canada, Shirley MacGowan, RN, MSCN, Saskatoon City Hospital, Saskatoon, SK, Canada, Lynn McEwan, RN, NP, MSCN, London Health Sciences Centre, London, ON, Canada, Josee Poirier, BSs, MSCN, CR CHUM, Montreal, QC, Canada and Jill R Nelson, RN BScN MSCN, Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada

[194]

MDC05

[198]

Deborah M Miller, PhD, LISW1, Benjamin M Pannell, MS2, Nichole Davis, BA3, Alexa Kane, PsyD4, Desiree Chizmadia, MSN5, Hilary Young, PA-C5, Deja Rose, M.D.6, Kasandra Weigland, BA7, Stephanie Covert, DPT8 and Robert A. Bermel, MD9, (1)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, (2)NA, Cleveland, OH, (3)OR, Cleveland Clinic, Cleveland, OH, (4)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, (5)Mellen Center, Cleveland Clinic, Cleveland, OH, (6)Neurology, Emory University, Atlanta, GA, (7)Workforce Strategies Administration, Cleveland Clinic, Cleveland, OH, (8)Neurological Institute, Cleveland Clinic, Cleveland, OH, (9)Mellen Center for MS, Department of Neurology, Cleveland Clinic, Cleveland, OH

[194]

MDC06

[198]

Stephanie Teixeira-Poit, PhD, MS1, Paige Dalton, JD2, Alicia Flach, PT, DPT3, Betsy Blake, PharmD, BCPS, FNAP3, Erica Gaskins, PT, DPT, MSCS4, Mona Bostick, RDN, LDN, MSCS5, Suma Shah, MD6, Daniel Webb, PhD1 and Cari Sgroi, PT, DPT, MSCS7, (1)College of Health and Human Sciences, North Carolina A&T State University, Greensboro, NC, (2)National Multiple Sclerosis Society, Greensboro, NC, (3)University of South Carolina, Columbia, SC, (4)NA, Chapel Hill, NC, (5)NA, Greensboro, NC, (6)Department of Neurology, Duke University, Durham, NC, (7)Movement Matters Physical Therapy, Huntersville, NC

[194]

MDC06

[198]

Asya I. Wallach, MD, Matthew Schiebel, RN, Christal Radburn, RMA, MSHA, Reena Mathew, RN, Dana Jones, NP and Mary Ann Picone, MD, Holy Name Medical Center, Teaneck, NJ

[194]

MDC06

[198]

Kimberly L Cooley, RN, CCRC, OSF Saint Francis Medical Center, Peoria, IL; Research, Jump Simulation and Education Center, Peoria, IL and Bonnie Paris, PhD, University of Illinois College of Medicine Peoria, Peoria, IL

[194]

MDC06

[198]

Kie Fujii, BA1,2, Katrina Ma, N/A3, Chu Li, MS3, Michael Saugstad, N/A3, Lisa Stolarz, MA2, Michael I Starr, MBA2, Florian P Thomas, MD, PhD1,2,4 and Jon Froehlich, PhD3, (1)Department of Neurology, Hackensack Meridian School of Medicine, Nutley, NJ, (2)National MS Society – NJM Community Council, Bergen County, NJ, (3)Allen School of Computer Science & Engineering, University of Washington, Seattle, WA, (4)Department of Neurology & Neuroscience Instiutute, Hackensack University Medical Center, Hackensack, NJ

[194]

MDC07

[198]

Zaenab Dhari, MD1, Ashely Paro, BS2, Rachel Huselid, BA3, Derek Paradis, BS4, Lori Laddaran, BA4, John Garcia Munoz, MPH, MS4, Evan Thomson, BS4, Sara Tabtabai, MD2, Mary Bailey, MD1, Elizabeth S Gromisch, PhD, MSCS5, Jennifer Ruiz, DPT2,4 and group, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Trinity Health of New England, Mount Sinai Rehabilitation hospital, Hartford, CT, (3)Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, USA, Hartford, CT, (4)Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, USA, North Haven, CT, (5)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT

[194]

MDC07

[198]

Aubrie L Lindner, AA1, Renee Stewart, DNP, APRN-NP2, Kristen Bayly, BSN2, Rana K. Zabad, MD3, Joey Rubenthaler, ATP4, Nathan Reitz, ATP5, Scott Richotte, BS6, Mohamed Darwish, MD7, Kathleen Healey, NP, PhD8 and CMSC Clinical MAHA team and CRT team, (1)Neurological Sciences Program Operations Manager, Nebraska Medicine, Omaha, NE, (2)Neurological Sciences, Nebraska Medicine, Omaha, NE, (3)NEUROLOGICAL SCIENCES, UNIVERSITY OF NEBRASKA MEDICAL CENTER, OMAHA, NE, (4)ATP, Numotion, Omaha, NE, (5)Director of Sales Operations, Numotion, Lincoln, NE, (6)VP of Sales and Clinical Relations, Numotion, Lincoln, NE, (7)Department of Neurology, University Nebraska Medical Center, Omaha, NE, (8)Neurologial Sciences, University of Nebraska, Omaha, NE

[194]

MDC07

[198]

Brian Amorello, PhD1, Florian Thomas, MD, PhD1, Krupa Pandey, MD2 and Elizabeth Kera, PhD1, (1)Neurology, Hackensack University Medical Center, Hackensack, NJ, (2)Hackensack Meridian, Hackensack University Medical Center, Hackensack, NJ

[194]

MDC07W

[198]

Grace E Tworek, Psy.D., The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH

[194]

MDC08

[198]

Janean W Jenkins, MSN, APRN, CNRN, CNS, NBC-HWC, Multiple Sclerosis Makeover, San Antonio, TX

[194]

MDC08

[198]

Rawan Jarrar, Student, Vincent Tran, Student, Paul Miller, Student, Tamara A Miller, MD, Antonio Barbera, MD, Jill Olson, MD and Augusto Miravalle, MD, FAAN, Advanced Neurology of Colorado, Fort Collins, CO

[194]

MDC08

[198]

Nicole Hahn, PharmD, BCACP1, Shilpa Klocke, PharmD, BCPS1, Thomas Delate, PhD, MS2 and Samuel Cohn, MD1, (1)Neurology, Kaiser Permanente Colorado, Denver, CO, (2)National Pharmacy Services, Kaiser Permanente, Aurora, CO

[194]

MDC09

[198]

[194]

MDC09

[198]

Marinella D Galea, MD1,2,3, Ignat Glushko, MBA4, Jesse Robertson, PharmD5, Melissa Ramirez Knezevic, PT, DPT, NCS, ATP6 and Ernest O Acheampong, RN, MSN, CNL6, (1)SCI/D, The JJPVAMC, Bronx, NY, (2)Department of Rehabilitation and Human Performance, The Icahn School of Medicine at Mount Sinai, New York, NY, (3)Medicine, NY Presbyterian Columbia University School of Medicine, New York, NY, (4)JJP VA Medical Center, Bronx, NY, (5)Pharmacy, James J Peters VA Medical Center, Bronx, NY, (6)James J. Peters VA Medical Center, Bronx, NY

[194]

MDC09

[198]

Alaa Maglan, MBBS1, Osama Khojah, MBBS2, Faris Allaf, MBBS3, Saeed Alamoudi, MBBS4, Meral Altayeb, MBBS3, Rawaf Alsharif, MBBS3, Mohamed Eldigire Ahmed, MBBS5 and Seraj Makkawi, MBBS3, (1)College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia, (2)Department of Medicine, Ministry of the National Guard-Health Affairs, Jeddah, Saudi Arabia, (3)King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia, (4)King Khalid Eye Specialist Hospital, Jeddah, Saudi Arabia, (5)King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia

[194]

MDC10

[198]

Lisa Aquillano, PharmD, BCPS, MSCS, Neil Lava, MD and Calli Cook, DNP, FNP-C, FAANP, Neurology, The Emory Clinic, Atlanta, GA

[194]

MDC10

[198]

Gavin Giovannoni, MD, PhD, Queen Mary University of London, Blizard Institute, Barts and the London School of Medicine and Dentistry, London, UK, London, United Kingdom, Pieter van Galen, Degree, MS in the 21st Century Steering Group, Brussels, Belgium, Heidi V Thompson, Degree, Neurology, Southern Health & Social Care Trust, Portadown, United Kingdom, Sarah A Morrow, MD, FRCPC, MS, Clinical Neurological Sciences, London Health Sciences Centre, London, ON, Canada and Nektaria Alexandri, MD, MSc, Neurology and Immunology, Merck KGaA, Darmstadt, Germany

[194]

MDC11

[198]

Christina Burke, PT, DPT1,2, Olivia Kaczmarek, BS3, MaryJo Kaleda, PT, DPT1, Elizabeth Casparian, SPT1, James Forbes, SPT1, Jillian Gallindo, SPT1, Morgan Staten, SPT1, Jared Srinivasan, BA3 and Mark Gudesblatt, MD4, (1)Stony Brook University, Stony Brook, NY, (2)South Shore Neurologic Associates, P.C., Patchogue, NY, (3)South Shore Neurologic Associates, Patchogue, NY, (4)South Shore Neurologic Associates, P.C., Islip, NY

[194]

MDC11

[198]

Sarah J Donkers, PT, PhD1, Sarah Oosman, PT, PhD1, Stephan Milosavljevic, PT, PhD1 and Kristin E Musselman, PT, PhD2,3,4, (1)College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada, (2)University Health Network, Toronto, ON, Canada, (3)University of Toronto, Toronto, ON, Canada, (4)Toronto Rehabilitation Institute, Toronto, ON, Canada

[194]

MDC12

[198]

Bren Hammond, RN, BSN, MSCN1, Deb Cramer, RN, BSN, MSCN2, Heather Prenevost Bennett, Senior Computer Analyst3, Arizona Proctor, Business Operations Analyst3, Jennie Toro, RN4, Wendy Durand, RN BSN4, Lisa Kemp, Patient Services Specialst4 and Deborah Gallaro, RPH4, (1)Multiple Sclerosis Center, Freestanding Infusion Center, UW Medicine, Seattle, WA, (2)University of Washington, Seattle, WA, (3)UW Medicine, Seattle, WA, (4)Multiple Sclerosis Center, UW Medicine, Seattle, WA

[194]

MDC13

[198]

Maria Claudia Manieri, BA1, Tatenda Mahlanza, BA1, Eric C Klawiter, MD2, Andrew J Solomon, MD3, Ellen S Lathi, MD4, Carolina Ionete, MD, PhD5, Idanis Berrios Morales, MD6, Ann Cabot, DO7, Christopher A Severson, MD1, James M Stankiewicz, MD1, Claudia Chaves, MD8, Shamik Bhattacharyya, MD1, Dorlan J Kimbrough, MD1, Biljana Beretich, MD9, Tanuja Chitnis, MD1 and Maria K Houtchens, MD1, (1)Partners Multiple Sclerosis Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, (2)Multiple Sclerosis Clinic at Massachusetts General Hospital, Harvard Medical School, Boston, MA, (3)Neurological Sciences, University of Vermont College of Medicine, Burlington, VT, (4)The Elliot Lewis Center for Multiple Sclerosis Care, Wellesley, MA, (5)Department of Neurology, University of Massachusetts Memorial Medical Center, Worcester, MA, (6)University of Massachusetts Memorial Medical Center, Worcester, MA, (7)Multiudisciplinary Multiple Sclerosis Clinic at Concord Hospital, Concord, NH, (8)Neurology, Lahey Clinic, Lexington, MA, (9)Multiple Sclerosis Clinic at the Maine Medical Center, Portland, ME

[194]

MDC14

[198]

Sharon Peters, RN, BN, MSCN, Jackie Gaythorpe, RN, BN, Janice Lake, RN and Colleen Harris, NP, University of Calgary MS Clinic, Calgary, AB, Canada

[194]

MDC15

[198]

Maria Claudia Manieri, BA1, Tatenda Mahlanza, BA1, Eric C Klawiter, MD2, Andrew J Solomon, MD3, Ellen S Lathi, MD4, Carolina Ionete, MD, PhD5, Idanis Berrios Morales, MD6, Ann Cabot, DO7, Christopher A Severson, MD1, James M Stankiewicz, MD1, Claudia Chaves, MD8, Shamik Bhattacharyya, MD1, Dorlan J Kimbrough, MD1, Biljana Beretich, MD9, Tanuja Chitnis, MD1 and Maria K Houtchens, MD1, (1)Partners Multiple Sclerosis Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, (2)Multiple Sclerosis Clinic at Massachusetts General Hospital, Harvard Medical School, Boston, MA, (3)Neurological Sciences, University of Vermont College of Medicine, Burlington, VT, (4)The Elliot Lewis Center for Multiple Sclerosis Care, Wellesley, MA, (5)Department of Neurology, University of Massachusetts Memorial Medical Center, Worcester, MA, (6)University of Massachusetts Memorial Medical Center, Worcester, MA, (7)Multiudisciplinary Multiple Sclerosis Clinic at Concord Hospital, Concord, NH, (8)Neurology, Lahey Clinic, Lexington, MA, (9)Multiple Sclerosis Clinic at the Maine Medical Center, Portland, ME

[194]

MDC16

[198]

Steven P Merrill, PharmD and Lynn Do, PharmD, Pharmacy, University of California, San Francisco, San Francisco, CA

[194]

MOC01

[198]

Alice E Dias, Dr1, Guilherme Olival Sr., doctor2, Helena A Burock, Designer3 and Lucas F Musa, Marketing3, (1)Scientific Research, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil, (2)neurologia, santa casa de misericórdia de são paulo, São Paulo, Brazil, (3)Marketing, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil

[194]

MOC01

[198]

Alana T Wong, PhD1, Svend S Geertsen, PhD1, Hubert van Hoogstraten, MD, PhD2, Bill Aschenbach, PhD, MBA1 and Jeffrey Chavin, MD, FAAN1, (1)Sanofi, Cambridge, MA, (2)Sanofi, Bridgewater, NJ

[194]

MOC01

[198]

Zachary Contreras, PharmD1, Jeffrey D Dunn, PharmD2, Tamara Howerton, RPh3, Kevin Duhrkopf, PharmD4, Louis Hudspeth, PhD4, Manny Nunez, PharmD4, Michael Raffaele, MD4 and Aaron Boster, MD5, (1)Independent Contractor, Sacramento, CA, (2)Magellan Rx, Salt Lake City, UT, (3)Magellan Rx, Germantown Hills, IL, (4)Sanofi, Cambridge, MA, (5)OhioHealth Multiple Sclerosis Center, Columbus, OH

[194]

MOC02

[198]

Andrea Arzt, LCSW, MSCS, Advocacy and Healthcare Access, The National Multiple Sclerosis Society, New York, NY, Sallie E Stephens, BSJ, MS, Advocacy and Healthcare Access, The National Multiple Sclerosis Society, Cincinnati, OH, Evan L. Smith, PhD, Physical Medicine & Rehabilitation, University of Michigan Medicine, Ann Arbor, MI, Kimberly McGuire, PhD, ABPP, MSCS, Psychology & Neuropsychology Department, Kessler Institute for Rehabilitation, West Orange, NJ, Gretchen Shibl, Psy.D., Gretchen Shibl Wellness Psychology, Laguna Hills, CA, Ronnie Hochberg, MS, CRC, LMHC, Private Practice, Queens, NY and Elizabeth Vincent, MSW, LCSW, CBIS, Rehab Without Walls, Houston, TX

[194]

MOC02

[198]

Gayle R Lewis, Ph.D., MSCS, New York, NY

[194]

MOC02

[198]

Jake J Reznik, B. Kin1, Joseph Chung, B. Sc1, Shell (Xue) Han, B. Sc2 and George Medvedev, MD, FRCPC3, (1)University of British Columbia, Vancouver, BC, Canada, (2)Simon Fraser University, Burnaby, BC, Canada, (3)Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada

[194]

MOC02

[198]

Eric Yeager, MD, Neurology, UT Health San Antonio, San Antonio, TX, Xavier Carrier, MD, Radiology, UT Health San Antonio, san antonio, TX, Mathew Roberts, MD, Neurology, UT Health San Antonio, san antonio, TX and Tania Reyna, MD, Neurology, University of Texas Health San Antonio, San Antonio, TX

[194]

MOC03

[198]

Elizabeth S Gromisch, PhD, MSCS1,2,3, Lindsay O Neto, MPH1,4, Jodie K Haselkorn, MD, MPH5,6,7,8 and Aaron P Turner, Ph.D. ABPP (RP)5,6,8, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (3)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (4)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (5)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (6)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (7)Department of Epidemiology, University of Washington, Seattle, WA, (8)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA

[194]

MOC03

[198]

Jorge Cancela, PhD, MBA, Roche, Basel, Switzerland, Cristina Costantino, PhD, Genentech, South San Francisco, CA and Jumaah Goldberg, DPT, Genentech, Inc., South San Francisco, CA

[194]

MOC03

[198]

Jake J Reznik, Bachelors of Kinesiology, Kinesiology, Mr., Vancouver, BC, Canada, Joseph Chang, Bacelors of Science, UBC, Vancouver, BC, Canada, Shell Han, B. Sc, Simon Fraser University, Burnaby, BC, Canada and George Medvedev, MD, FRCPC, Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada

[194]

MOC03

[198]

Ganiru O Anunike, BA, Vikhyathi Pallerla, BS, MSBS, Boyd M Koffman, M.D., Ph.D and Sabeena I Malik, MD, Neurology, University of Toledo College of Medicine and Life Sciences, Toledo, OH

[194]

MOC04

[198]

Lindsay O Neto, MPH1,2, Jennifer A Ruiz, DPT1,3, Aaron P Turner, Ph.D. ABPP (RP)4,5,6, Jodie K Haselkorn, MD, MPH4,5,6,7 and Elizabeth S Gromisch, PhD, MSCS1,3,8, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (3)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (4)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (5)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (6)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA, (7)Department of Epidemiology, University of Washington, Seattle, WA, (8)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT

[194]

MOC04

[198]

Jorge Cancela, PhD, MBA1, Cristina Costantino, PhD2, Jumaah Goldberg, DPT3, Geraint Davies, BSc1 and JP Guyon, MS, MBA4, (1)Roche, Basel, Switzerland, (2)Genentech, South San Francisco, CA, (3)Genentech, Inc., South San Francisco, CA, (4)Roche, Belmont, CA

[194]

MOC04

[198]

Amy Perrin Ross, APN, MSN, CNRN, MSCN, Loyola University Chicago, Maywood, IL, Rany A Aburashed, DO, Institute for Neurosciences and Multiple Sclerosis, Owosso, MI, Robert K Shin, MD, Georgetown University Medical Center, Washington, DC, Stephen Krieger, MD, Icahn School of Medicine at Mount Sinai, New York City, NY, Regina Berkovich, MD, USC Medical Center, Los Angeles, CA, Barry Hendin, MD, Phoenix Neurological Associates, Phoenix, AZ, Maria K Houtchens, MD, Partners Multiple Sclerosis Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, Samuel F Hunter, MD, PhD, Advanced Neurosciences Institute, Franklin, TN, Augusto Miravalle, MD, Neurology, University of Florida, Gainesville, FL, Bianca Weinstock-Guttman, MD, University at Buffalo, Buffalo, NY, Christen Kutz, PA, PhD, Colorado Springs Neurological Associates, Colorado Springs, CO and Robert C Sergott, MD, Wills Eye Hospital, Philadelphia, PA

[194]

MOC04

[198]

Heather Hua, RN, MSN, MSCN1, Danielle Siniscalchi, MBA1, Deanna Power, RN, MSCN1 and Jennifer Graves, MD, PhD, MAS2, (1)Octave, Menlo Park, CA, (2)University of California San Diego, San Diego, CA

[194]

MOC05

[198]

Mitzi Joi Williams, MD1, Todor I. Totev, MBA2, Camilo Obando, MD, MBA3, Monica Doring, BA3, Lindsey Araujo, PhD3, Charles Shinaver, PhD3, Phung Quach, PharmD3, Aditi Shah, MA4, Katherine Milbers, MScPH4, Dominic Pilon, MA4 and Patrick Lefebvre, MA4, (1)Joi Life Wellness Group, LLC, Atlanta, GA, (2)Analysis Group, Inc., Boston, MA, (3)Janssen Scientific Affairs, LLC, Titusville, NJ, (4)Analysis Group, Inc., Montréal, QC, Canada

[194]

MOC05

[198]

Alexis Crispino, Director of Education & Healthcare Relations (MSAA South-Central), Multiple Sclerosis Association of America, Austin, TX and Kyle E Pinion, Senior Director of Education, Healthcare Relations & Advocacy, Education and Healthcare Relations, Multiple Sclerosis Association of America, Cherry Hill, NJ

[194]

MOC05

[198]

Whitney Feichtner, APRN, FNP-C, Mercy Clinic Neurology, Saint Louis, MO, Rachel Sauer, FNP-BC, Mercy Specialty and Home Infusion, Saint Louis, MO, Robert Street, MBA, RPh, Mercy Specialty and Infusion Pharmacy, Saint Louis, MO, Jessica Schulte, RN, MSCN, Mercy Research Neurology, Saint Louis, MO and Amy Rauchway, DO, Mercy Clinic Neurology/Mercy MS Care, Saint Louis, MO

[194]

MOC05

[198]

Hossein Mousavi, MD1, John W. Lindsey, MD2, Rajesh Gupta, MD3, Jerry S. Wolinsky, MD4 and John A Lincoln, MD3, (1)Neurology, University of Texas Health Center at Houston, Houston, TX, (2)Multiple Sclerosis And Neuroimmunology, McGovern Medical School, Houston, TX, (3)University of Texas at Houston, Houston, TX, (4)Test Department, Test Affiliation, Hackensack, NJ

[194]

MOC06

[198]

Sama Bitarafan, MD, phD1,2,3, Salena Bath, B.Sci, MD student2,3 and Galina Vorobeychik, MD, FRCPS(C), FAAN2,3, (1)Tehran University of medical sciences, Neuroscience institute, Iranian center of neurological research, Tehran, Iran (Islamic Republic of), (2)University of British Columbia, Vancouver, BC, Canada, (3)Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada

[194]

MOC06

[198]

Lars Costers, PhD1,2, Annabel Descamps, MSc1, Steve De Backer, PhD1, Guy Nagels, MD PhD1,2,3,4, Wim Van Hecke, PhD1 and Dirk Smeets, PhD1,2, (1)icometrix, Leuven, Belgium, (2)AIMS, Vrije Universiteit Brussel (VUB), Brussel, Belgium, (3)Neurology, Universitair Ziekenhuis Brussel (UZ Brussel), Brussel, Belgium, (4)St. Edmund Hall, University of Oxford, Oxford, United Kingdom

[194]

MOC06

[198]

Julie Petrin, PhD Candidate1, Marcia Finlayson, PhD, OT Reg (Ont), OTR2, Mary Ann McColl, B.Sc. (OT), M.H.Sc., Ph.D., M.T.S.3 and Catherine Donnelly, B.Sc.(OT), MSc, PhD1, (1)Rehabilitation Sciences, Queen’s University, Kingston, ON, Canada, (2)School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada, (3)Rehabilitation Sciences, Queen’s University, Kinsgton, ON, Canada

[194]

MOC06

[198]

Mara Bahri, MSc, The Ohio State University College of Medicine, Columbus, OH and Kristi Epstein, APRN-CNP, Department of Neurology, The Ohio State University, Columbus, OH

[194]

MOC07

[198]

Shuvro Roy, MD, Janel Haughton, RN and Scott D. Newsome, DO, MSCS, FAAN, FANA, Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

MOC07

[198]

Yolanda S Wheeler, PhD, CRNP, CPNP-AC, MSCN, University of Alabama at Birmingham Center for Pediatric Onset Demyelinating Disease, Birmingham, AL; University of Alabama at Birmingham School of Nursing, Birmingham, AL and Evelyn Hunter, PhD, Department of Special Education, Rehabilitation and Counseling, Auburn University, Auburn, AL

[194]

MOC07

[198]

Jill R Nelson, RN BScN MSCN, Tatstsyana Kadach, MEng, Anna Kazimirchik, RN MSCN and Galina Vorobeychik, MD, FRCPS(C), CMSC, Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada

[194]

MOC07

[198]

Mara Bahri, MSc1, Brooke Gaul, PT, DPT2, Claire Thieneman, PharmD3, Sarah Grim, LISW-S4, Kristi Epstein, APRN-CNP4, Rolanda Robinson, PhD4, Sarita Maturu, DO4 and Yinan Zhang, MD4, (1)The Ohio State University College of Medicine, Columbus, OH, (2)Outpatient Rehabilitation, Neurology, The Ohio State University, Columbus, OH, (3)The Ohio State University, Columbus, OH, (4)Department of Neurology, The Ohio State University, Columbus, OH

[194]

MOC08

[198]

Christine Short, MD, FRCPC, FACP1, Emily Patterson, MD1 and Joanne Courtney-Walker, BSc, RN2, (1)Medicine, Dalhousie University, Halifax, NS, Canada, (2)Nova Scotia Health Authority, Halifax, NS, Canada

[194]

MOC08

[198]

Ross C Crandall, MD, Neurology Residency Program, University of Colorado School of Medicine, Aurora, CO, Aaron Carlson, MD, Neurology, University of Colorado, Anschutz Medical Campus, Denver, CO, Amanda L Piquet, MD, Neurology, University of Colorado School of Medicine, Aurora, CO and Kavita V Nair, PhD, Rocky Mountain Multiple Sclerosis Center at the University of Colorado, Aurora, CO

[194]

MOC09

[198]

Samantha N Roman, MD and Scott D Newsome, DO, MSCS, Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

MOC10

[198]

Sara Esmaeili, Research Fellow, Neurology, University of Cincinnati, Cincinnati, OH and Aram Zabeti, MD, Waddell Center for Multiple Sclerosis, University of Cincinnati, Cincinnati, OH

[194]

MOC11

[198]

Wolfgang Trillo Álvarez, MD PROF, Gabriel A Calderón Paiva, Med Student, Joshua A Medina Suárez, Med Student, Juan I.S. Valdivia Pino, Med Student, Patrick F Gonzales Romero, Med Student, Luis J Delgado Villanueva, Med Student, Angélica M Flores Quispe, Med Student, Grace N García Huaman, Med Student, Pedro G Chirinos Mamani, Med Student and Zelitt Del Castillo Carrasco, Med Student, Human Medicine, SINAPSIS-UCSM, Arequipa, Peru

[194]

MOC12

[198]

A. Suzanne Boyd, PhD, MSW, ACSW, FNAP, School of Social Work, University of North Carolina at Charlotte, Charlotte, NC and Research Team

[194]

MOC13

[198]

Albert Aboseif, DO1, Moein Amin, MD2, Gabrielle Macaron, MD2 and Daniel Ontaneda, MD PhD2, (1)Department of Neurology, Cleveland Clinic, Cleveland, OH, (2)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH

[194]

MOC14

[198]

Afolasade Fakolade, PhD, School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada, Adam Groh, M.Sc., The Montreal Neurological Institute and Hospital, Montreal, QC, Canada, Colleen Lacey, M.Sc., Psychology, University of Victoria, Victoria, BC, Canada; Institute on Aging and Lifelong Health, Victoria, BC, Canada and Fiona Tea, Ph.D., The Research Centre of the University of Montreal Hospital Centre (CRCHUM), Montreal, QC, Canada

[194]

MOC16

[198]

Shuvro Roy, MD, Janel Haughton, RN and Scott D Newsome, DO, MSCS, Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

MOC17

[198]

Gabrielle Busque, BSc, PharmD, ACPR1, Henry Halapy, BScPhm, ACPR, PharmD1, Sharan Lail, BScPhm, ACPR, PharmD1 and Norman Dewhurst, BScPhm, ACPR, PharmD, MHSc2, (1)Pharmacy, Unity Health Toronto, Toronto, ON, Canada, (2)Ambulatory Clinics, Emergency and Medicine Program, Unity Health Toronto, Toronto, ON, Canada

[194]

MOC18

[198]

Katherine Gwin, RN, BSN, MSCS, MSCN, Kaelianne Newbold, RN, BSN, MSCS, MSCN, Autumn Ramsrud, PharmD, CSP, MSCS, Tyler Cress, PharmD, MSCS, Cindy Smith, PharmD, CSP, Angie Critchfield, CPhT and Nina Bozinov, MD, MS, Neurology, Kootenai Clinic, Coeur d’Alene, ID

[194]

MOC19

[198]

Dotty Holcomb Doherty, N/A1, Nicole Delcourt, RN1, Ann Cabot, DO2 and Brant J. Oliver, PhD, MS, MPH, APRN-BC3, (1)Multiple Sclerosis Specialty Care Program, Concord Hospital, Concord, NH, (2)Multidisciplinary Multiple Sclerosis Clinic at Concord Hospital, Concord, NH, (3)Community of Family and Medicine, Dartmouth Health, Lebanon, NH

[194]

MOC20

[198]

Emily Blosberg, BS and Andrea Blosberg, BA, MA, Mr Oscar Monkey, Menomonie, WI

[194]

MOC21

[198]

Eric Garmon, MCHES, MS Navigator Experience, National MS Society, Denver, CO and Aportela, I., Barnola, A., Benson, T., Cohrs, R., Cummings, S., Doherty, E., Fegan, A., Goff, K., Liserio, E., Mastroianni, S., Marshall, J., Saxton, L., Serratoni, M., Stewart, K., Tauchman, J., Wiehardt, G., Wise, J.

[194]

MOC22

[198]

Eric Garmon, MCHES, MS Navigator Experience, National MS Society, Denver, CO and Benson, T., Bostick, M., Goff, K., Henderson, L. Liserio, E., Nearhood, H., Saxton, L., Tauchman, J., Yadav, V., Zackowski, K

[194]

MOC23

[198]

Lily Martinez, MPH, The National Multiple Sclerosis Society, Dallas, TX, Thaís Armangué, MD, PhD, Sant Joan de Deu, Barcelona Hospital, Barcelona, Spain, Brenda Banwell, MD, FRCPC, FAAN, The Children’s Hospital of Philadelphia, Philadelphia, PA, Frederik Barkhof, MD, PhD, Amsterdam University Medical Center, Amsterdam, Netherlands, Jennifer Graves, MD, PhD, MAS, University of California San Diego, San Diego, CA, Cheryl Hemingway, MBChB, PhD, Great Ormond Street Children’s Hospital, London, United Kingdom, Barbara Kornek, MD, Medical University of Vienna, Vienna, Austria, Hope Nearhood, MPH, The National Multiple Sclerosis Society, Denver, CO, Lekha Pandit, MD, DM, PhD, Nitte University, Karnataka, India and Darren Ball, M.Ed., The National Multiple Sclerosis Society, New York, NY

[194]

MOC24

[198]

Michael V Robers, MD MS1, Vanessa I Martinez, MS1, Hollie Schmidt, MS2, Patricia Teran, MS1, Tiffany Tran, BS1, Huiam Mubarak, MD MS1, Aimee Borazanci, MD1 and Lilyana Amezcua, MD, MS3, (1)Neurology, Barrow Neurological Institute, Phoenix, AZ, (2)Accelerated Cure Project for Multiple Sclerosis, Waltham, MA, (3)Keck School of Medicine, University of Southern California, Los Angeles, CA

[194]

MOC25

[198]

Rae Bacharach, DO1, Jikku Zachariah, DO1, Benjamin Bird, MD1 and Elizabeth Sinz, MD2, (1)Neurology, Penn State Milton S. Hershey Medical Center, Hershey, PA, (2)Anesthesiology, Critical Care Medicine, and Neurosurgery, Penn State Milton S. Hershey Medical Center, Hershey, PA

[194]

MOC26

[198]

Mirla Avila, MD, Neurology, Texas Tech University Health Sciences Center, Lubbock, TX, Martin Sandoval, student, Texas Tech Health science center, Lubbock, TX and Hannah Jackson, student, Texas Tech health science center, Lubbock, TX

[194]

MOC27

[198]

Kristen Veal, MD1, Elijah Lackey, MD1 and Suma Shah, MD2, (1)MS and Neuroimmunology, Duke University Hospital, Durham, NC, (2)Department of Neurology, Duke University, Durham, NC

[194]

MOC28

[198]

Stephanie Gandelman, MD, Laura Stein, MD, MSEd and Dina Jacobs, MD, Department of Neurology, University of Pennsylvania, Philadelphia, PA

[194]

NB01

[198]

Jonathan Ciriello, B.S.1, Alexandru Tatomir, M.D.1, Daniel Hewes, B.S.1, Vinh Nguyen, D.D.S.2, Walter Royal III, M.D.3, Violeta Rus, M.D., Ph.D.2 and Horea Rus, M.D., Ph.D.3, (1)Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, (2)Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Maryland School of Medicine, Baltimore, MD, (3)Veterans Administration Multiple Sclerosis Center of Excellence, Baltimore, MD

[194]

NB02

[198]

Andrew Yousef, B.S.1, Michael Devereux, B.S.2, Pierre-Antoine Gourrard, PhD1, Soren Jonzzon, MA1, Leena Suleiman, BA3, Emmanuelle Waubant, MD, PhD4,5, Ari Green, MD1 and Jennifer Graves, MD, PhD, MAS1,4, (1)Neurology, UC San Francisco, San Francisco, CA, (2)Neurology, University of California, San Francisco, CA, (3)Neurology, UCSF, San Francisco, CA, (4)UCSF Pediatric MS Center, San Francisco, CA, (5)UCSF Neurology, Weill Institute for Neurosciences, San Francisco, CA

[194]

NB03

[198]

Christopher Perrone, MD, Joseph Berger, MD and Clyde Markowitz, MD, Neurology, University of Pennsylvania, Philadelphia, PA

[194]

NB04

[198]

Thomas J Shoemaker, MD1, Peter A Calabresi, MD2, Shiv Saidha, MBBCh2, Natalia Gonzalez-Caldito, MD3, Sydney Feldman, BS2, Andrew Aston, BS3, Ohemaa Kwakyi, BS3, Hunter Risher, BS2, Esther Ogboukiri, BS3 and Ellen M Mowry, MD, MCR4, (1)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (2)Neurology, Johns Hopkins University, Baltimore, MD, (3)Neurology, Johns Hopkins Hospital, Baltimore, MD, (4)Neurology, Johns Hopkins School of Medicine, Baltimore, MD

[194]

NB05

[198]

Leena Suleiman, BA1, Andrew Yousef, BS1, Soren Jonzzon, BS, MS1, Jennifer Arjona, BA, MS2, Alireza Akhbardeh, BS, MS, PhD3, Bardia Nourbakhsh, MAS, MD1, Pierre-Antoine Gourraud, PhD, MPH1 and Jennifer Graves, MD, PhD, MAS1, (1)Neurology, UCSF, San Francisco, CA, (2)UCSF Neurology, MS Research Coordinators, San Francisco, CA, (3)Stanford University, Palo Alto, CA

[194]

NB06

[198]

Eric Williamson, MD and Jakob Dobrowolski, BS, Neurology, University of Pennsylvania, Philadelphia, PA

[194]

NB07

[198]

Cheryl Fields, BS/DO Candidate 20181, Anna Srouji, BS, MS1, Allen Tsai, BS2, Kennedy Abbott, BA1, Michael A Ciaramella, BA3, Rock Positano, DPM, MPH4, Howard J Hillstrom, PhD5 and Mary Ann Picone, MD1, (1)Holy Name Medical Center, Teaneck, NJ, (2)HSS, New York, NY, (3)Non-Surgical Foot and Ankle Service, Hospital for Special Surgery, New York, NY, (4)Hospital for Special Surgery, Rehabilitation-LRMALab, New York, NY, (5)Rehabilitation – LRMALab, Hospital for Special Surgery, New York, NY

[194]

NB08

[198]

Candice L Dunn, BSc1, Carmen Yea, MSc2, Heather E Hanwell, PhD3, E. Ann Yeh, MD, MA, FRCPC, Dip ABPN4, Ruth Ann Marrie, MD, PhD, FRCPC5, Amit Bar-Or, MD6, Neda Ebrahimi, PhD2, Brenda Banwell, MD1 and Julia O’Mahony, BSc7, (1)Children’s Hospital of Philadelphia, Philadelphia, PA, (2)The Hospital for Sick Children, Toronto, ON, Canada, (3)Neurosciences and Mental Health, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, (4)Neurology, The Hospital for Sick Children, Toronto, ON, Canada, (5)Department of Medicine, University of Manitoba, Winnipeg, MB, Canada, (6)University of Pennsylvania, Philadelphia, PA, (7)Hospital for Sick Children, Toronto, ON, Canada

[194]

NB09

[198]

Samantha N Roman, B.S.1, Kathryn C Fitzgerald, Sc.M., Sc.D.1 and Ellen M Mowry, MD, MCR2, (1)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (2)Neurology, Johns Hopkins School of Medicine, Baltimore, MD

[194]

NB10

[198]

Samantha N Roman, B.S.1, Kathryn C Fitzgerald, Sc.M., Sc.D.1 and Ellen M Mowry, MD, MCR2, (1)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (2)Neurology, Johns Hopkins School of Medicine, Baltimore, MD

[194]

ND01

[198]

Erica M Rivas, MD, Neurology, University of Southern California, south pasadena, CA

[194]

ND02

[198]

Gautam K Rao, B.S.1, Alexandru Tatomir, M.D.1, Dallas Boodhoo, B.S.1, Jonathan Ciriello, B.S.1 and Horea Rus, M.D., Ph.D.2, (1)Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, (2)Veterans Administration Multiple Sclerosis Center of Excellence, Baltimore, MD

[194]

ND03

[198]

Laura E Baldassari, MD, MHS1, Hanieh Seraj, MS1, C. Dee Husebye, BS1, M. Mateo Paz Soldan, MD, PhD1,2, Thomas Martins, MS3, Noel G Carlson, PhD2,4 and John W Rose, MD1, (1)Neurology, University of Utah, Salt Lake City, UT, (2)Neurology, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT, (3)ARUP Institute for Clinical Research, Salt Lake City, UT, (4)Department of Neurobiology and Anatomy, University of Utah, Salt Lake City, UT

[194]

NDM01

[198]

Jeffrey L Bennett, MD, PhD, Professor of Neurology and Ophthalmology, University of Colorado, School of Medicine, Anschutz Medical Campus, Aurora, CO, Michael A Smith, PhD, Clinical Development, Horizon Therapeutics, Deerfield, IL, Kristina R Patterson, MD, PhD, Medical Affairs, Horizon Therapeutics plc, Deerfield, IL and Brian G Weinshenker, MD, Neurology, Mayo Clinic, Rochester, MN

[194]

NDM01

[198]

Dana Siegel, MD, Wayne State University, School of Medicine, detroit, MI, Meredith Van Harn, MPH, Neurology, Henry ford health system, Detroit, MI, Poonam Bansal, MD, Ophthalmology and Neurology, Henry Ford Health System, Detroit, MI, Mirela Cerghet, MD, PhD, Neurology, Henry Ford Hospital, Detroit, MI and Anza B Memon, MD, Neurology, Henry Ford Health System, Detroit, MI; Neurology, Wayne State University, School of Medicine, Detroit, MI

[194]

NDM01

[198]

Anthony T Reder, MD1, Quentin Howlett-Prieto, BS2, Grace Park, BS2, Yaerin Song, BA2, Chineze Egwudo, BS3 and Xuan Feng, PhD2, (1)Neurology, University of Chicago, Chicago, IL, (2)Neurology, The University of Chicago, Chicago, IL, (3)Neurology, The University of Chicago, c, IL

[194]

NDM02

[198]

Orhan Aktas, MD, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany, Jeffrey L Bennett, MD, PhD, Professor of Neurology and Ophthalmology, University of Colorado, School of Medicine, Anschutz Medical Campus, Aurora, CO, Brian G Weinshenker, MD, Neurology, Mayo Clinic, Rochester, MN, Friedemann Paul, MD, Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité Universitätsmedizin Berlin, Berlin, Germany, Ho Jin Kim, MD, Neurology, Research Institute and Hospital of National Cancer Center, Seoul, Korea, Republic of (South), Hans-Peter Hartung, MD, Heinrich-Heine University, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Sydney, NSW, Australia, William B Rees, PhD, Translational Medicine, Horizon Therapeutics plc, Gaithersburg, MD, Dewei She, PhD, Biometrics, Horizon Therapeutics plc, Gaithersburg, MD, Eliezer Katz, MD, FACS, Clinical Development, Horizon Therapeutics plc, Gaithersburg, MD and Bruce A.C. Cree, MD, UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA

[194]

NDM02

[198]

Austin J Beltrand, Medical Student, University of Maryland SOM, Baltimore, MD, Horea Rus, MD, PhD, Veterans Administration Multiple Sclerosis Center of Excellence, Baltimore, MD and Alexandru Tatomir, MD, Neurology, University of Maryland SOM, Baltimore, MD

[194]

NDM02

[198]

Stephen L Hauser, MD1, Ludwig Kappos, MD, PhD2, Xavier Montalban, MD, PhD3,4, Amit Bar-Or, MD5, Gavin Giovannoni, MBBCh, PhD, FCP, FRCP, FRCPath6, Fabian Model, PhD7, Stanislas Hubeaux, MSc7, Lahar Mehta, PhD8 and Jerry S Wolinsky, MD9, (1)University of California San Francisco, San Francisco, CA, (2)University Hospital Basel, University of Basel, Basel, Switzerland, (3)Division of Neurology, University of Toronto, Toronto, ON, Canada, (4)Vall d’Hebron University Hospital, Barcelona, Spain, (5)Department of Neurology and Center for Neuroinflammation and Experimental Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (6)Queen Mary University of London, London, United Kingdom, (7)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (8)Genentech, Inc., South San Francisco, CA, (9)McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX

[194]

NDM03

[198]

Hannah Kelly, BS, Case Western Reserve University School of Medicine, Cleveland, OH, Jessica Johnson, BS, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, Collin Jakubecz, PharmD, Pharmacy, University Hospitals Cleveland Medical Center, Cleveland, OH, Alessandro Serra, MD, PhD, Multiple Sclerosis and Neuroimmunology program, University Hospitals Cleveland Medical Center, Cleveland, OH and Hesham Abboud, MD, PhD, Multiple Sclerosis and Neuroimmunology Program, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH

[194]

NDM03

[198]

Riley Bove, MD1, Terra Slaton, MS2, Chris M. Kozma, PhD2, Amy L. Phillips, PharmD3, Danielle E. Harlow, PhD3 and Carroline Lobo, PhD3, (1)UCSF Weill Institute for Neurosciences, University of California, San Francisco, CA, (2)CK Consulting Associates, LLC, West Columbia, SC, (3)EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany

[194]

NDM03

[198]

Nikki A McLean, PhD1,2 and Michael C Levin, MD1,2,3, (1)Cameco MS Neuroscience Research Centre, University of Saskatchewan, Saskatoon, SK, Canada, (2)Anatomy, Physiology & Pharmacology, University of Saskatchewan, Saskatoon, SK, Canada, (3)Neurology, University of Saskatchewan, Saskatoon, SK, Canada

[194]

NDM04

[198]

Joy Gupta, MBA1, Maureen A. Mealy, PhD, RN1 and Michael Levy, MD, PhD2, (1)Medical Affairs, Horizon Therapeutics plc, Deerfield, IL, (2)Division of Neuroimmunology & Neuroinfectious Disease and Department of Neurology, Harvard Medical School and Massachusetts General Hospital, Boston, MA

[194]

NDM04

[198]

Kaleigh E Olmsted, B.S., McGovern Medical School, Houston, TX and John W Lindsey, MD, Multiple Sclerosis And Neuroimmunology, McGovern Medical School, Houston, TX

[194]

NDM04

[198]

Dale Wright, PhD and Rick Fitch, PhD, Pharmacology, Mallinckrodt Pharmaceuticals, Hazelwood, MO

[194]

NDM05

[198]

Laura Ghezzi, MD1,2, Claudia Cantoni, PhD3, Daniela Galimberti, PhD2, Elio Scarpini, MD2, Anne Cross, MD1 and Laura Piccio, M.D., Ph.D1,4, (1)Neurology, Washington University in St. Louis, St. Louis, MO, (2)University of Milan, Milan, Italy, (3)Neurology, Washington University in St. Louis, St. louis, MO, (4)Brain and Mind Centre, School of Medical Sciences, University of Sydney, Sydney, NSW, Australia

[194]

NDM05

[198]

Yasemin Beguem Alankus, MD1, Roland Grenningloh, MD2, Philipp Haselmayer, MD1, Andrew Bender, MD2 and Julia Bruttger, MD1, (1)Merck KGaA, Darmstadt, Germany, (2)Research and Development Institute, EMD Serono, Inc., Billerica, MA

[194]

NDM06

[198]

Nicole Kashani, M.D., Borna Vajdi, M.D., Lauren M Anderson, B.S., Gregory Baltayan, B.S., Eve E Kelland, Ph.D., Wendy Gilmore, Ph.D. and Brett T Lund, Ph.D., Neurology, University of Southern California, Los Angeles, CA

[194]

NDM06

[198]

Xuan Feng, PhD1, Quentin Howlett-Prieto, BS1, Yaerin Song, BA1, Grace Park, BS1, Chineze Egwudo, BS1 and Anthony T Reder, MD2, (1)Neurology, The University of Chicago, Chicago, IL, (2)Neurology, University of Chicago, Chicago, IL

[194]

NDM07

[198]

William Meador, MD, Neurology, UAB, Birmingham, AL and Chander Raman, PhD, Medicine, University of Alabama at Birmingham, Birmingham, AL

[194]

NDM07

[198]

Jon P Williams, D.O., Ph.D., Neurology, United States Air Force, Wright-Patterson AFB, OH and Marcel M Daadi, Ph.D., NeoNeuron, LLC, San Antonio, TX

[194]

NE01

[198]

Caroline Altaras, B.A.1, Nicholas A Vissicchio, B.A.1, Shaina Shagalow, B.A.2, Amanda A Parker, B.S.2, Jennifer Miller, B.A.2, Shonna Schneider, B.A.2 and Frederick W Foley, Ph.D.3, (1)Yeshiva University Ferkauf Graduate School of Psychology, Bronx, NY, (2)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (3)School of Psychology, Yeshiva University, New York, NY

[194]

NE02

[198]

Caroline Altaras, B.A.1, Nicholas A Vissicchio, B.A.1, Amanda A Parker, B.S.2, Jennifer Miller, B.A.2, Shonna Schneider, B.A.2, Shaina Shagalow, B.A.2 and Frederick W Foley, Ph.D.3, (1)Yeshiva University Ferkauf Graduate School of Psychology, Bronx, NY, (2)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (3)School of Psychology, Yeshiva University, New York, NY

[194]

NE03

[198]

Joshua Sandry, PhD1, Jessica Rothberg, BA1, Mark Zuppichini, BS1 and John DeLuca, Ph.D.2, (1)Psychology, Montclair State University, Montclair, NJ, (2)Neuropsychology and Neuroscience, Kessler Foundation, West Orange, NJ

[194]

NE04

[198]

Nicholas A Vissicchio, B.A.1, Caroline Altaras, B.A.1, Amanda A Parker, B.S.2, Shonna Schneider, B.A.2, Jennifer Miller, B.A.2, Shaina Shagalow, B.A.2 and Fred Foley, PhD3, (1)Yeshiva University Ferkauf Graduate School of Psychology, Bronx, NY, (2)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (3)Holy Name Medical Center, Teaneck, NJ

[194]

NE05

[198]

Nicholas A Vissicchio, B.A.1, Caroline Altaras, B.A.1, Amanda A Parker, B.S.2, Shonna Schneider, B.A.2, Shaina Shagalow, B.A.2, Jennifer Miller, B.A.2 and Fred Foley, PhD3, (1)Yeshiva University Ferkauf Graduate School of Psychology, Bronx, NY, (2)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (3)Holy Name Medical Center, Teaneck, NJ

[194]

NE06

[198]

Roseann Archetti, B.S.1, Kasey Siegel, M.A.1, Fred Foley, PhD2 and Vance Zemon, Ph.D.1, (1)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (2)Holy Name Medical Center, Teaneck, NJ

[194]

NI01

[198]

Shitiz K Sriwastava, M.D.1, Aaron Desai, M.D.2 and Evanthia Bernitsas, MD1, (1)Neurology, Wayne State University School of Medicine, Detroit, MI, (2)Neurology, Wayne state university, Detroit, MI

[194]

NI01

[198]

Felipe Santana Perez, MD, PhD1, Alina Gonzalez-Quevedo, MD, PhD2, Daymet Grass Fernandez, Registered Nurse3, Mayte Cabrera Gamez, PhD4, Cynthia Chavez Paredes, MD1 and Jose A Cabrera Gomez, MD, PhD5, (1)Reproduction, Institute of Endocrinology, Havana, Cuba, (2)Neurobiology, Institute of Neurology and Neurosurgery, Havana, Cuba, (3)Multiple Sclerosis Clinic, International Center of Neurological Restoration, Havana, Cuba, (4)Hormone Laboratory, Institute of Endocrinology, Havana, Cuba, (5)Neurology, International Center for Neurological Restoration, Havana, Cuba

[194]

NI01

[198]

Ana M Canzonieri, DRA, Mauricio O Bando Sr., Sr, Jean I Francisco, Sr, Fernanda M Marques, Sra and Lucas F.R dos Santos Sr., student, Research, ABEM . Brazilian Association Multiple Sclerosis, São Paulo, Brazil

[194]

NI02

[198]

Anne S. Morkholt, M.Sc., PhD Student1, Michael S Trabjerg, MD, PhD Student1, Ivo Huijbers, PhD2, Colin Pritchard, Technician2, Lona Kroese, Technician2, Soren Nielsen, MD, Prof.1 and John D Nieland, PhD, Associate Prof.1, (1)Department of Health Science and Technology, Aalborg University, Aalborg, Denmark, (2)MCCA transgenic facility, The Netherlands Cancer Institute, Amsterdam, Netherlands

[194]

NI02

[198]

Evan Jameyfield, Medical Student, Frank H. Netter School of Medicine, Qunnipiac University, North Haven, CT, Rebecca Crowell, PhD, Saint Francis Hospital and Medical Center, Hartford, CT, Dorothy Wakefield, MS, University of Connecticut Health Center, Farmington, CT and Elizabeth W. Triche, PhD, Department of Neurology, University of Connecticut School of Medicine, Farmington, CT

[194]

NI02

[198]

Carol Swetlik, BA1, Sarah M Planchon, PhD, CCRP2, Jeffrey A Cohen, MD2 and Daniel Ontaneda, MD2, (1)Cleveland Clinic Lerner College of Medicine, Cleveland, OH, (2)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH

[194]

NI03

[198]

Nilufer Esen, M.D., 421 E. Canfield Str., Wayne State University, Detroit, MI, James Malleis, M.D., Neurology, Wayne State University, Detroit, MI and Paula Dore-Duffy, Ph.D., 49 Lone Pine Rd, Wayne State University, Bloomfield Hills, MI; Detroit, MI

[194]

NI03

[198]

Marwa Kaisey, MD, Neurology, UCLA, los angeles, CA and Barbara Giesser, MD, Neurology, UCLA, Los Angeles, CA

[194]

NI03

[198]

Carolina Tramontini, MD1, Juan Mora, MD1, Jorge Suárez, MD1 and Carlos Navas, MD2, (1)Diagnostic Imaging, Fundación Universitaria Sanitas, Bogota, Colombia, (2)FUNDACION UNIVERSITARIA SANITAS, BOGOTA, Colombia

[194]

NI04

[198]

Andrew J Bouley, MD, Ursela Baber, MD, Emily Egnor, BS and Jacob A. Sloane, MD PhD, Neurology, Beth Israel Deaconess Medical Center, Boston, MA

[194]

NI04

[198]

John Vollmer, n/a1, Mareena Atalla, BS1, Manon Nitta, n/a1 and Nora E Fritz, PhD, PT, DPT, NCS1,2, (1)Neuroimaging and Neurorehabilitation Laboratory, Wayne State University, Detroit, MI, (2)Physical Therapy, Wayne State University, Detroit, MI

[194]

NI04

[198]

John Vollmer, n/a1, Mareena Atalla, BS1, Manon Nitta, n/a1 and Nora E Fritz, PhD, PT, DPT, NCS1,2, (1)Neuroimaging and Neurorehabilitation Laboratory, Wayne State University, Detroit, MI, (2)Physical Therapy, Wayne State University, Detroit, MI

[194]

NI04

[198]

Carolina Tramontini, MD1, Juan Mora, MD1 and Carlos Navas, MD2, (1)Diagnostic Imaging, Fundación Universitaria Sanitas, Bogota, Colombia, (2)FUNDACION UNIVERSITARIA SANITAS, BOGOTA, Colombia

[194]

NI05

[198]

Michael A Lane, MD1, Anna E Orban, BSc2 and Vijayshree Yadav, MD2, (1)Neurology, Portland VA, Portland, OR, (2)Neurology, Oregon Health & Science University, Portland, OR

[194]

NI05

[198]

Jason Ledesma, BS1, Padma Priya Puttagunta, MD2, Kristen Berube, BS2 and Bijal Mehta, MD, MPH3, (1)Neurology, LA BIOMED, Torrance, CA, (2)Neurology, LA Biomed, Torrance, CA, (3)Neurology, Harbor-UCLA Medical Center, Torrance, CA

[194]

NI05

[198]

Carolina Tramontini, MD1, Juan Mora, MD1 and Carlos Navas, MD2, (1)Diagnostic Imaging, Fundación Universitaria Sanitas, Bogota, Colombia, (2)FUNDACION UNIVERSITARIA SANITAS, BOGOTA, Colombia

[194]

NI06

[198]

Scott M Belliston, DO and Kevin Call, MD, Neurology, Intermountain Healthcare, Provo, UT

[194]

NI06

[198]

Elizabeth A Hubbard, MSc1, Nathan C Wetter, MD2, Bradley P Sutton, PhD2, Lara A Pilutti, PhD1 and Robert W Motl, PhD1, (1)Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL, (2)Bioengineering, University of Illinois at Urbana-Champaign, Urbana, IL

[194]

NI07

[198]

Jeffrey Gluckstein, BS1, Gautam Adusumilli, Undergraduate Student2, Samantha Lancia, MS2, Courtney Dula, MS2, Junqian Xu, PhD3, Joanne M Wagner, PT, PhD4 and Robert T Naismith, MD5, (1)Neurology, Washington University, Saint Louis, MO, (2)Department of Neurology, Division of Neuroimmunology, Washington University School of Medicine in St. Louis, St. Louis, MO, (3)Radiology, Mount Sinai School of Medicine, New York, NY, (4)Department of Physical Therapy and Athletic Training, Saint Louis University, St. Louis, MO, (5)Neurology, Washington University School of Medicine, St Louis, MO

[194]

NI08

[198]

Juan Mora, MD1, Jorge Suárez, MD1, Carolina Tramontini, MD1 and Carlos Navas, MD2, (1)Diagnostic Imaging, Fundación Universitaria Sanitas, Bogota, Colombia, (2)FUNDACION UNIVERSITARIA SANITAS, BOGOTA, Colombia

[194]

NI09

[198]

Juan Mora, MD1, Carolina Tramontini, MD1 and Carlos Navas, MD2, (1)Diagnostic Imaging, Fundación Universitaria Sanitas, Bogota, Colombia, (2)FUNDACION UNIVERSITARIA SANITAS, BOGOTA, Colombia

[194]

NI10

[198]

Mirla Avila, MD, Sasikanth Gorantla, MD, Angel O Claudio, MD and John DeToledo, MD, Neurology, Texas Tech, Lubbock, TX

[194]

NI11

[198]

Mohammad Abdoli, MD1, Santanu Chakraborty, MD, MRCP2, Heather MacLean, MD, FRCPC1 and Mark S Freedman, MD3, (1)Neurology, University of Ottawa, Ottawa, ON, Canada, (2)Neuroradiology, University of Ottawa, Ottawa, ON, Canada, (3)University of Ottawa and the Ottawa Hospital Research Institute, Ottawa, ON, Canada

[194]

NI12

[198]

Olivia M Gutgsell, BS1, Luka Vlahovic, MD1 and Matthew McCoyd, MD2, (1)Loyola University Chicago Stritch School of Medicine, Maywood, IL, (2)Loyola University of Chicago MS Clinic, Maywood, IL

[194]

NI13

[198]

Rahil M Dharia, BSc1,2, Esmaeil Davoodi-Bojd, PhD1, Quan Jing, PhD1, Lian Li, PhD1 and Mirela Cerghet, MD, PhD1, (1)Neurology, Henry Ford Hospital, Detroit, MI, (2)School of Medicine, Wayne State University, Detroit, MI

[194]

NIB01

[198]

Ahmed Z Obeidat, MD, Ph.D., Neurology, Medical College of Wisconsin, Milwaukee, WI

[194]

NIB01

[198]

[194]

NIB01

[198]

Evis Havari, MSc1, Nadia Daizadeh, PhD2, Christian Barro, MD3, Zuzanna Michalak, PhD3, David Leppert, MD3, Jean Godin, MD2, Srinivas Shankara, PhD1, Luke Chung, MD, MPH2, Nora Roesch, MD2, Carina Kaiser, MS4, Tarek A Samad, PhD1, Alan Jacobs, MD2, Ludwig Kappos, MD3 and Jens Kuhle, MD3, (1)Sanofi, Framingham, MA, (2)Sanofi, Cambridge, MA, (3)Neurologic Clinic and Policlinic, University Hospital Basel, Basel, Switzerland, (4)Sanofi, Baar, Switzerland

[194]

NIB01

[198]

Andrew M Tarr, MD1,2, Nadia Azad, BS3, Christina Fournier, MD1,2 and William Tyor, MD1,2, (1)Neurology, Atlanta VA Medical Center, Decatur, GA, (2)Neurology, Emory University, Atlanta, GA, (3)School of Medicine, Emory University, Atlanta, GA

[194]

NIB02

[198]

Christopher B. Lock, MD, PhD1, Jeffrey A Cohen, MD2, Fred D. Lublin, MD3, Daniel Pelletier, MD4, Tanuja Chitnis, MD5, Munish Mehra, PhD6, Yael Gothelf, Ph.D.7, Revital Aricha, PhD8, Stacy Lindborg, PhD9, Chaim Lebovits, CEO7 and Ralph Kern, MD, MHSc9, (1)Stanford School of Medicine, Palo Alto, CA, (2)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, (3)Corinne Goldsmith Dickinson Center for Multiple Sclerosis, New York, NY, (4)Keck School of Medicine of University of Southern California, Los Angeles, CA, (5)Brigham and Women’s Hospital, Boston, MA, (6)Tigermed, Somerset, NJ, (7)R&D, Brainstorm Cell Therapeutics, Petach Tikva, NY, Israel, (8)R&D, Brainstorm Cell Therapeutics, Petach Tikva, Israel, (9)R&D, Brainstorm Cell Therapeutics, New York, NY

[194]

NIB02

[198]

[194]

NIB02

[198]

Naseem Zomorodi, MS21, Chirag Patel, MD, PhD Candidate2, Gary Thomas, MD, MBA3, Mark D Meadowcroft, PhD4, Ian S Zagon, PhD2 and Patricia J McLaughlin, DEd2, (1)Penn State University College of Medicine, Hershey, PA, (2)Neural and Behavioral Sciences, Penn State University College of Medicine, Hershey, PA, (3)Neurology, Penn State University College of Medicine, Hershey, PA, (4)Neurosurgery, Penn State University College of Medicine, Hershey, PA

[194]

NIB02

[198]

Paul S. Giacomini, MD1, Natacha Bastien, Ph.D.2, Patrice Voss, Ph.D.3, Francois Blanchette, Ph.D.2, Francis Arseneau, Ms3, Shamiza Hussein, PMP2, Rosemberg Ramos, Ms3 and Etienne de Villers-Sidani, MD3, (1)Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada, (2)Medical Affairs, Novartis Pharma Canada, Dorval, QC, Canada, (3)Innodem Neurosciences, Montreal, QC, Canada

[194]

NIB03

[198]

Ferhan Qureshi, BS1, Tammy Hoyt, MS2, Angel Christensen, BS2, Fatima Rubio da Costa, PhD1, Victor Gehman, PhD1, Fujun Zhang, MS1, David Hughes, BSN1 and John Foley, MD2, (1)Octave Bioscience, Inc., Menlo Park, CA, (2)Rocky Mountain Multiple Sclerosis Clinic, Salt Lake City, UT

[194]

NIB03

[198]

Lindsay Clark, PhD1, Mark Band, PhD2, Jason P. Mendoza, PhD3, Linda Piccinini, PhD3 and Michael D Carrithers, MD, PhD4,5,6, (1)High Performance Biological Computing, Roy J. Carver Biotechnology Center, University of Illinois, Urbana, IL, (2)Functional Genomics, Roy J. Carver Biotechnology Center, University of Illinois, Urbana, IL, (3)Biogen, Cambridge, MA, (4)Neurology, University of Illinois College of Medicine, CHICAGO, IL, (5)Neurology, Jesse Brown Veterans Hospital, Chicago, IL, (6)Physiology and Biophysics, University of Illinois College of Medicine, Chicago, IL

[194]

NIB03

[198]

Sara Esmaeili, Research Fellow, Neurology, University of Cincinnati, Cincinnati, OH and Aram Zabeti, MD, Waddell Center for Multiple Sclerosis, University of Cincinnati, Cincinnati, OH

[194]

NIB04

[198]

Rachel Zolno, MD, Natalie Schanzer, BA, Kayleigh Lewis, N/A, Connor Keuchel, BA, Siefaddeen Sharayah, MD, Cristina Gaudioso, MD and Soe Mar, MD, Neurology, Washington University in St. Louis, St. Louis, MO

[194]

NIB04

[198]

Nico Osier, PhD, RN1,2, Alexa Stuifbergen, PhD, RN, FAAN1, Sawyer Stubbs, BS3 and Tapasvini Paralkar, BS3, (1)School of Nursing, The University of Texas at Austin, Austin, TX, (2)Neurology, Dell Medical School, Austin, TX, (3)University of Texas at Austin, Austin, TX

[194]

NIB04

[198]

Elina Misicka, Ph.D, Case Western Reserve University, Cleveland, OH and Farren B.S. Briggs, PhD, ScM, Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH

[194]

NIB05

[198]

Ruth E Propper, Ph.D.1, Melissa Villafana, B.A.1 and Glenn R Wylie, Ph.D.2, (1)Psychology, Montclair State University, Montclair, NJ, (2)Rocco Ortenzio Neuroimaging Center, Kessler Foundation, West Orange, NJ

[194]

NIB06

[198]

Sage T Hewitt, B.S.1, Derrick Robertson, MD2, Angela Aungst, MPH3 and Christopher James, B.S.1, (1)USF Health Morsani College of Medicine, Tampa, FL, (2)College of Medicine, Neurology, University of South Florida, Tampa, FL, (3)Multiple Sclerosis Division Department of Neurology University of South Florida, Florida, FL

[194]

NIB07

[198]

Sam I Hooshmand, DO1, Khalid El-Salem, MD2, Suha Agaileh, MD2 and Ahmed Z Obeidat, MD, PhD1, (1)Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, (2)Department of Neurosciences, Jordan University of Science and Technology, Irbid, Jordan

[194]

NID01

[198]

Adrian Kielhorn, BA1, Jacqueline Palace, DM2, Nina Eagle, MS2, M Isabel Leite, MS2, Lauren Powell, BSc, MSc, PhD3 and Karissa Johnston, BSc, MSc, PhD3, (1)Alexion, AstraZeneca Rare Disease, Boston, MA, (2)Oxford University Hospital, Oxford, United Kingdom, (3)BroadStreet Health Economics & Outcomes Research, Vancouver, BC, Canada

[194]

NID02

[198]

Alexander J Gill, MD, PhD, Marjan Gharagozloo, PhD, Thomas Garton, B.S., Matt Smith, M.S. and Peter A Calabresi, MD, Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

NID03

[198]

Austin Chen, MD1, Francesca Chinea, BA2, Gary Cutter, PhD3, Lauren Krupp, MD1, Ilya Kister, MD1, Lana Zhovtis Ryerson, M.D.1 and Tyler E Smith, M.D.1, (1)Neurology, NYU Langone Health, New York, NY, (2)NYU, New York, NY, (3)University of Alabama School of Public Health, Birmingham, AL

[194]

NID04

[198]

Evanthia Bernitsas, MD1, Benjamin Osborne, MD2, Natalie Taylor, MPH3, Fanyang Zeng, MPH3, Milena Anatchkova, PhD3 and Adrian Kielhorn, BA4, (1)Wayne State University School of Medicine, Detroit, MI, (2)Department of Neurology, MedStar Georgetown University Hospital, Washington, DC, (3)Evidera, Bethesda, MD, (4)Alexion, AstraZeneca Rare Disease, Boston, MA

[194]

NID05

[198]

Jacob A Cuevas, B.S.1, Alexandru Tatomir, MD1, Vinh Nguyen, DMD2, Tudor Badea, MD/PhD3, Violeta Rus, MD/PhD2 and Horea Rus, MD, PhD4, (1)Neurology, University of Maryland, Baltimore, MD, (2)Medicine, University of Maryland, Baltimore, MD, (3)Research and Development Institute, Transylvania University of Brasov, Brasov, Romania, (4)Veterans Administration Multiple Sclerosis Center of Excellence, Baltimore, MD

[194]

NID06

[198]

Jin Nakahara, MD, PhD1, Ichiro Nakashima, MD, PhD2, Hiroaki Yokote, MD3, Yasuhiro Manabe, MD4, Kazumi Okamura, MD5, Kou Hasegawa, PhD5 and Kazuo Fujihara, MD6,7, (1)Department of Neurology, Keio University School of Medicine, Tokyo, Japan, (2)Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan, (3)Department of Neurology, Nitobe Memorial Nakano General Hospital, Tokyo, Japan, (4)Department of Neurology, National Hospital Organization Okayama Medical Center, Okayama, Japan, (5)Alexion Pharma GK, Tokyo, Japan, (6)Southern TOHOKU Research Institute for Neuroscience (STRINS), Koriyama, Japan, (7)Fukushima Medical University School of Medicine, Fukushima, Japan

[194]

NID07

[198]

Kerstin Allen, MA1, Sean J Pittock, MD2, Michael Levy, MD, PhD3, Jacqueline Palace, DM4, Celia Oreja-Guevara, MD5,6, Ichiro Nakashima, MD, PhD7,8, Achim Berthele, MD9, Jeffrey L Bennett, MD, PhD10, Jerome de Seze, MD, PhD11, Michael Barnett, PhD, MD12,13, Friedemann Paul, MD14, Carlo Pozzilli, MD, PhD15, Yasmin Mashhoon, PhD1, Marcus Yountz, MD1 and Ho Jin Kim, MD16, (1)Alexion, AstraZeneca Rare Disease, Boston, MA, (2)Department of Neurology, Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, (3)Massachusetts General Hospital and Harvard Medical School, Boston, MA, (4)Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, United Kingdom, (5)Department of Neurology, Hospital Clínico Universitario San Carlos, IdISSC, Madrid, Spain, (6)Hospital Clinico San Carlos, Madrid, Spain, (7)Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan, (8)Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan, (9)Department of Neurology, School of Medicine, Technical University of Munich, Munich, Germany, (10)University of Colorado School of Medicine, Aurora, CO, (11)Department of Neurology and Clinical Investigation Center, CHU de Strasbourg, Strasbourg, France, (12)Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia, (13)Department of Neurology, Royal Prince Alfred Hospital, Sydney, NSW, Australia, (14)Experimental and Clinical Research Center and NeuroCure Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, Berlin, Germany, (15)NCL Institute of Neurological Science, Rome, Italy, (16)Department of Neurology, National Cancer Center, Goyang, Korea, Republic of (South)

[194]

NID08

[198]

Bruce A.C. Cree, MD1, Mary Rensel, MD2, Sean J Pittock, MD3, Aram Zabeti, MD4, Ho-Jin Kim, MD5, Friedemann Paul, MD6, Derrick S Robertson, MD7, Kristina R Patterson, MD, PhD8, Qing Li, MD, PhD9, Quinn Dinh, MD9 and Michael Levy, MD, PhD10, (1)Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, (2)Neurology, Cleveland Clinic, Cleveland, OH, (3)Department of Neurology, Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, (4)Waddell Center for Multiple Sclerosis, University of Cincinnati, Cincinnati, OH, (5)Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Korea, Republic of (South), (6)Experimental and Clinical Research Center and NeuroCure Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, Berlin, Germany, (7)Multiple Sclerosis Division, Department of Neurology, University of South Florida, Tampa, FL, (8)Horizon Therapeutics, Deerfield, IL, (9)Horizon Therapeutics plc, Deerfield, IL, (10)Massachusetts General Hospital and Harvard Medical School, Boston, MA

[194]

NID09

[198]

Hans-Peter Hartung, MD, FRCP, FEAN, FAAN, FANA1,2,3,4, Brian G Weinshenker, MD5, Sean J Pittock, MD6, Jeffrey L Bennett, MD, PhD7, Michael A Smith, PhD8, Nanette Mittereder, MS8, William A Rees, PhD8, Daniel Cimbora, PhD8, Kristina R Patterson, MD, PhD8, Friedemann Paul, MD9, Romain Marignier, MD10, Dean M Wingerchuk, MD11, Gary Cutter, MS, PhD12, Ari Green, MD13, Ho-Jin Kim, MD14, Kazuo Fujihara, MD15,16, Michael Levy, MD, PhD17, Orhan Aktas, MD18 and Bruce A.C. Cree, MD19, (1)Department of Neurology, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany, (2)Brain and Mind Centre, University of Sydney, Sydney, Australia, (3)Department of Neurology, Medical University Vienna, Vienna, Austria, (4)Department of Neurology, Palacky University Olomouc, Olomouc, Czech Republic, (5)Department of Neurology, University of Virginia, Charlottesville, VA, (6)Department of Neurology, Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, (7)University of Colorado School of Medicine, Aurora, CO, (8)Horizon Therapeutics, Deerfield, IL, (9)Experimental and Clinical Research Center and NeuroCure Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, Berlin, Germany, (10)Department of Neurology, MS, Myelin Pathologies, and Neuroinflammation, Lyon University Hospital, Lyon, France, (11)Department of Neurology, Mayo Clinic, Scottsdale, AZ, (12)Department of Biostatistics, UAB School of Public Health, Birmingham, AL, (13)Department of Neurology and Department of Ophthalmology, UCSF Weill Institute for Neurosciences, San Francisco, CA, (14)Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Korea, Republic of (South), (15)Multiple Sclerosis and Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience (STRINS), Koriyama, Japan, (16)Fukushima Medical University School of Medicine, Fukushima, Japan, (17)Massachusetts General Hospital and Harvard Medical School, Boston, MA, (18)Medical Faculty, Heinrich-Heine-University, Dusseldorf, Germany, (19)Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA

[194]

NID10

[198]

Pavle Repovic, MD, PhD1, Jongchan Choi, PhD2, Sunga Hong, PhD2, Lik W Lee, PhD3, Darcy B. Gill, PhD3, James D. Bowen, MD1, Peiqing Qian, MD1, Simon Evans, PhD2, Rick Edmark, PhD2, Jason P. Mendoza, PhD4, Robin L. Avila, PhD4, Jim Heath, PhD2 and Jason Goldman, MD, MPH5, (1)Swedish Neuroscience Institute, Seattle, WA, (2)Institute for Systems Biology, Seattle, WA, (3)Adaptive Biotechnologies, Seattle, WA, (4)Biogen, Cambridge, MA, (5)Swedish Medical Center, Seattle, WA

[194]

NID11

[198]

Sean J Pittock, MD1, Michael Barnett, PhD, MD2,3, Jeffrey L Bennett, MD, PhD4, Achim Berthele, MD5, Jerome de Seze, MD, PhD6, Michael Levy, MD, PhD7, Ichiro Nakashima, MD, PhD8,9, Celia Oreja-Guevara, MD10,11, Jacqueline Palace, DM12, Friedemann Paul, MD13, Carlo Pozzilli, MD, PhD14, Kerstin Allen, MA15, Yasmin Mashhoon, PhD15, Marcus Yountz, MD15 and Ho Jin Kim, MD16, (1)Department of Neurology, Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, (2)Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia, (3)Department of Neurology, Royal Prince Alfred Hospital, Sydney, NSW, Australia, (4)University of Colorado School of Medicine, Aurora, CO, (5)Department of Neurology, School of Medicine, Technical University of Munich, Munich, Germany, (6)Department of Neurology and Clinical Investigation Center, CHU de Strasbourg, Strasbourg, France, (7)Massachusetts General Hospital and Harvard Medical School, Boston, MA, (8)Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan, (9)Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan, (10)Department of Neurology, Hospital Clínico Universitario San Carlos, IdISSC, Madrid, Spain, (11)Hospital Clinico San Carlos, Madrid, Spain, (12)Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, United Kingdom, (13)Experimental and Clinical Research Center and NeuroCure Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, Berlin, Germany, (14)Department of Human Neuroscience, La Sapienza University, Rome, Italy, (15)Alexion, AstraZeneca Rare Disease, Boston, MA, (16)Department of Neurology, National Cancer Center, Goyang, Korea, Republic of (South)

[194]

NID12

[198]

Sean J Pittock, MD1, Michael Barnett, PhD, MD2,3, Jeffrey L Bennett, MD, PhD4, Achim Berthele, MD5, Jerome de Seze, MD, PhD6, Michael Levy, MD, PhD7, Ichiro Nakashima, MD, PhD8,9, Celia Oreja-Guevara, MD10,11, Jacqueline Palace, DM12, Friedemann Paul, MD13, Carlo Pozzilli, MD, PhD14, Kerstin Allen, MA15, Yasmin Mashhoon, PhD15, Marcus Yountz, MD15 and Ho Jin Kim, MD16, (1)Department of Neurology, Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, (2)Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia, (3)Department of Neurology, Royal Prince Alfred Hospital, Sydney, NSW, Australia, (4)University of Colorado School of Medicine, Aurora, CO, (5)Department of Neurology, School of Medicine, Technical University of Munich, Munich, Germany, (6)Department of Neurology and Clinical Investigation Center, CHU de Strasbourg, Strasbourg, France, (7)Massachusetts General Hospital and Harvard Medical School, Boston, MA, (8)Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan, (9)Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan, (10)Department of Neurology, Hospital Clínico Universitario San Carlos, IdISSC, Madrid, Spain, (11)Hospital Clinico San Carlos, Madrid, Spain, (12)Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, United Kingdom, (13)Experimental and Clinical Research Center and NeuroCure Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, Berlin, Germany, (14)NCL Institute of Neurological Science, Rome, Italy, (15)Alexion, AstraZeneca Rare Disease, Boston, MA, (16)Department of Neurology, National Cancer Center, Goyang, Korea, Republic of (South)

[194]

NID13

[198]

Shlok Sarin, BS1, Nikhil Modak, MD2, Rongyi Sun, BS3, Omar Subei, MD4, Alessandro Serra, MD, PhD5, Michael Morgan, MD, PhD6 and Hesham Abboud, MD, PhD3, (1)Case Western Reserve School of Medicine – – Cleveland Heights, OH, Cleveland, OH, (2)University Hospitals of Cleveland, Cleveland, OH, (3)Case Western Reserve University School of Medicine, Cleveland, OH, (4)Duke University Medical Center, Durham, NC, (5)Multiple Sclerosis and Neuroimmunology program, University Hospitals Cleveland Medical Center, Cleveland, OH, (6)University Hospitals Cleveland Medical Center, Cleveland, OH

[194]

NID14

[198]

Sean J Pittock, MD, Department of Neurology, Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, Achim Berthele, MD, Department of Neurology, School of Medicine, Technical University of Munich, Munich, Germany, Michael Levy, MD, PhD, Massachusetts General Hospital and Harvard Medical School, Boston, MA, Ichiro Nakashima, MD, PhD, Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan; Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan, Celia Oreja-Guevara, MD, Department of Neurology, Hospital Clínico Universitario San Carlos, IdISSC, Madrid, Spain; Hospital Clinico San Carlos, Madrid, Spain, Stephan Ortiz, Ph.D., Alexion, AstraZeneca Rare Disease, Boston, MA and Ho Jin Kim, MD, Department of Neurology, National Cancer Center, Goyang, Korea, Republic of (South)

[194]

NID15

[198]

Gauruv Bose, MD1,2, Nupur Greene, PhD, MPH, BPharm3, Brian C. Healy, PhD1, Howard L. Weiner, MD4,5, Lisa Farnett, PharmD3, Keiko Higuchi, MPH3 and Tanuja Chitnis, MD5,6, (1)Brigham and Women’s Hospital, Boston, MA, (2)Department of Medicine (Neurology), University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada, (3)Sanofi, Cambridge, MA, (4)Brigham and Women’s Hospital, Boston, MA, (5)Harvard Medical School, Boston, MA, (6)Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

[194]

NN01

[198]

Serkan Ozakbas, Professor Of Neurology, Department of Neurology, Dokuz Eylul University, Izmir, Turkey, Turhan Kahraman, Phd, Katip Celebi University, Izmir, Turkey, Taha Aslan, MD, Dokuz Eylul Univrsity, Izmir, Turkey and Pinar Yigit, Psycologist, Dokuz Eylul University, Izmir, Turkey

[194]

NN02

[198]

Zerbrina Valdespino-Hayden, BA, Alexandra Buchanan, BA and Joshua Sandry, PhD, Psychology, Montclair State University, Montclair, NJ

[194]

NN03

[198]

Philip Yan, BKin, MOT Student1, Susan Forwell, PhD, OT(C), FCAOT1, Mariah Morris, BHK, MOT Student1 and Denise Kendrick, BA, MOT2,3, (1)Occupational Science & Occupational Therapy, University of British Columbia, Vancouver, BC, Canada, (2)Department of Occupational Science and Occupational Therapy, University of British Columbia, Vancouver, BC, Canada, (3)Vancouver Coastal Health, UBC MS/NMOSD Clinic, Vancouver, BC, Canada

[194]

NN04

[198]

Pamela K Newland, RN, PhD, CMSRN, 4483 Duncan Avenue, Goldfarb School of Nursing at Barnes Jewish College, St Louis, MO, Mark Zinn, Phd, Center for Community Research, DePaul University, Chicago, IL, Marcie Zinn, PhD, Cognitive Neuroscience and Data Science, DePaul University, chicago, IL and John Zempel, PhD, MD, Neurology, Washington University, St Louis, MO

[194]

NN05

[198]

Shonna Schneider, B.A.1, Caroline Altaras, B.S.1, Nicholas A Vissicchio, B.A.1, Amanda Najjar, B.A.1, Shaina Shagalow, B.A.1, Amanda Parker, B.S.1 and Frederick W. Foley, Ph.D.2, (1)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (2)MS Center, Holy Name Medical Center, Teaneck, NJ

[194]

NN06

[198]

Emma Ben-Avi, M.A.1,2, Jennifer Miller, B.A.1,2, Jeffrey G. Portnoy, M.A.1,3, Marnina Stimmel, M.A.1,3 and Fred Foley, PhD4, (1)Yeshiva University, Ferkauf Graduate School of Psychology, Bronx, NY, (2)MS Center, Holy Name Medical Center, teaneck, NJ, (3)MS Center, Holy Name Medical Center, Teaneck, NJ, (4)Holy Name Medical Center, Teaneck, NJ

[194]

NN07

[198]

Laura T. Safar, M.D., Psychiatry, Harvard University, Boston, MA

[194]

NN08

[198]

[194]

NN09

[198]

Angel Chinea, MD1, Astrid Diaz, BS2, Ivonne Vicente, MD3, Allan J Reyes, BA4, Karla Flores, BS5, Alejandro Ruiz, BS5, Juan Ojeda, BS5 and Cristina M Rubi, BS3, (1)San Juan Multiple Sclerosis Center, San Juan, PR, (2)San Juan MS Center, Guaynabo, PR, (3)San Juan Multiple Sclerosis Center, Guaynabo, PR, (4)Neurology, San Juan MS Center, Guaynabo, PR, Puerto Rico, (5)San Juan Bautista Medical School, Caguas, PR, Puerto Rico

[194]

NNN01

[198]

Catherine S Bergmann, Psy.D.1, Daija Jackson, B.S.2, Mary Elizabeth Quig, Ph.D.2, Robert L Kane, PhD, ABPP-CN3, Meagan A. Adamson, FNP-BC4 and James Simsarian, M.D.5, (1)Washington Neuropsychology Research Group, Fairfax, VA, (2)Neuropsychology Associates of Fairfax, Fairfax, VA, (3)University of Maryland School of Medicine, Baltimore, MD, (4)Multiple Sclerosis Center, Neurology Center of Fairfax, Fairfax, VA, (5)Neurology Center of Fairfax, Fairfax, VA

[194]

NNN01

[198]

Elizabeth S Gromisch, PhD1,2,3, Aaron P Turner, Ph.D. ABPP (RP)4,5,6, Lindsay O Neto, MPH1,7 and Sarah A Raskin, PhD8,9, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (3)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (4)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (5)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (6)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA, (7)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (8)Neuroscience Program, Trinity College, Hartford, CT, (9)Department of Psychology, Trinity College, Hartford, CT

[194]

NNN01

[198]

Sarah Simmons, MD, PhD1, Marcia Ciol, PhD2, Dawn Ehde, PhD3, Ian Nelson, .4, Arielle Kloss, MD2, James D Bowen, MD5 and George H Kraft, MD, MS3, (1)Rehabilitation Medicine, University of Washington, Seattle, WA, (2)University of Washington, Seattle, WA, (3)Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA, (4)Seattle, WA, (5)MS Center, Swedish Medical Center, Seattle, WA

[194]

NNN01

[198]

Elizabeth S Gromisch, PhD, MSCS1,2,3, Aaron P Turner, Ph.D. ABPP (RP)4,5,6, Lindsay O Neto, MPH1,7 and Sarah A Raskin, PhD8,9, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (3)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (4)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (5)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (6)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA, (7)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (8)Neuroscience Program, Trinity College, Hartford, CT, (9)Department of Psychology, Trinity College, Hartford, CT

[194]

NNN02

[198]

Rachel M Nicholson, M.S. in Clinical Psychology/Current Doctoral Candidate, Neuropsychology Associates of Fairfax, Fairfax, VA; Comprehensive MS Care Center, South Shore Neurologic Associates, P.C., Patchogue, NY

[194]

NNN02

[198]

[194]

NNN02

[198]

Christiane E Whitehouse, BSc, Department of Psychology and Neuroscience, Dalhousie University, Halifax, NS, Canada and John D Fisk, PhD, Nova Scotia Health Authority, Halifax, NS, Canada; Department of Psychiatry, Dalhousie University, Halifax, NS, Canada; Department of Medicine, Dalhousie University, Halifax, NS, Canada

[194]

NNN02

[198]

Elizabeth S Gromisch, PhD, MSCS1,2,3, Aaron P Turner, Ph.D. ABPP (RP)4,5,6, Lindsay O Neto, MPH1,7, Jodie Haselkorn, MD, MPH4,5,6,8 and Sarah A Raskin, PhD9,10, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (3)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (4)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (5)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (6)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA, (7)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (8)Department of Epidemiology, University of Washington, Seattle, WA, (9)Neuroscience Program, Trinity College, Hartford, CT, (10)Department of Psychology, Trinity College, Hartford, CT

[194]

NNN03

[198]

Jeannie Lengenfelder, PhD1, Helen Genova, PhD1, Jacqueline Leddy, BA1, Brea Rivera, BS2 and Nancy D Chiaravalloti, PhD1, (1)Kessler Foundation, East Hanover, NJ, (2)Montclair State University, Montclair, NJ

[194]

NNN03

[198]

Jason A Berard, PhD1,2, Zhuo Fang, PhD3, Lisa A.S. Walker, PhD4,5,6, Alyssa Lindsay-Brown, B.A.(hon)4, Leila Osman, M.A.7, Ian Cameron, PhD8, Roxana Cruce, M.D.4, Greg Cron, PhD8, Mark S Freedman, MSc, MD, FAAN, FRCPC9 and Andra M Smith, Ph.D.3,10,11, (1)University of Ottawa, Ottawa, ON, Canada, (2)Neuroscience, Ottawa Hosptial Research Institute, Ottawa, ON, Canada, (3)Psychology, University of Ottawa, Ottawa, ON, Canada, (4)Neuroscience, Ottawa Hospital Research Institute, Ottawa, ON, Canada, (5)Psychology, University of Ottawa Brain and Mind Research Institute, Ottawa, ON, Canada, (6)Psychology, Carleton University, Ottawa, ON, Canada, (7)St. Paul University, Ottawa, ON, Canada, (8)Ottawa Hospital Research Institute, Ottawa, ON, Canada, (9)THe University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada, (10)The Ottawa Hospital Research Institute, Ottawa, ON, Canada, (11)University of Ottawa Brain and Mind Research Institute, Ottawa, ON, Canada

[194]

NNN03

[198]

Petra Šili?, BS1, Danielle C Jones, MPH2, Brenda Jeng, Ph.D1 and Robert W. Motl, PhD1, (1)Kinesiology and Nutrition, University of Illinois Chicago, Chicago, IL, (2)Physical Therapy, University of Alabama at Birmingham, Birmingham, AL

[194]

NNN04

[198]

Kelly Zalocusky, PhD1, Ryan Gan, PhD, MPH1, Shemra Rizzo, PhD1, Katherine Belendiuk, PhD1, Laura Gaetano, PhD2, Jumaah Goldberg, DPT1, Nicole Bonine, PhD, MPH1, Gillian Hanson, ND3, Kieran Mace, PhD3 and Yifeng Jenny Chia, PhD1, (1)Genentech, Inc., South San Francisco, CA, (2)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (3)PicnicHealth, San Francisco, CA

[194]

NNN04

[198]

Elisea De Somma, M.A.1, Julia O’Mahony, BSc2, Ritobrato Datta, PhD3, Brenda Banwell, MD2,3 and Christine Till, PhD, C.Psych1,2, (1)Psychology, York University, Toronto, ON, Canada, (2)Neurosciences and Mental Health Program, The Hospital for Sick Children, Toronto, ON, Canada, (3)Neurology, Children’s Hospital of Philadelphia, Philadelphia, PA

[194]

NNN04

[198]

Sanghamithra Ramani, BSc1,2, Jordan D. Pumphrey, BSc2,3, Jason A. Berard, PhD4, Matthew Seegobin, MSc.2, Jing Wang, PhD2,4, Jennifer M Lymer, PhD, MD5 and Lisa A.S. Walker, PhD, C. Psych1,2,3,4, (1)Psychology, Carleton University, Ottawa, ON, Canada, (2)Ottawa Hospital Research Institute, Ottawa, ON, Canada, (3)Psychology, University of Ottawa, Ottawa, ON, Canada, (4)University of Ottawa Brain and Mind Research Institute, Ottawa, ON, Canada, (5)University of Ottawa, Ottawa, ON, Canada

[194]

NNN05

[198]

Caitlin S Walker, H.BA., Carleton University, Ottawa, ON, Canada, Jason A Berard, PhD, Neuroscience, Ottawa Hosptial Research Institute, Ottawa, ON, Canada and Lisa A.S. Walker, Ph.D., The Ottawa Hospital Research Institute, Ottawa, ON, Canada

[194]

NNN05

[198]

Emily Barlow-Krelina, MA1, Tracy Fabri, BA1, E Ann Yeh, MD2, Julia O’Mahony, BSc3, Raquel E Gur, MD, PhD4, Ruben Gur, PhD4, Kosha Ruparel, MSE4, Brenda Banwell, MD3,5 and Christine Till, PhD, C.Psych3, (1)Psychology, York University, Toronto, ON, Canada, (2)Department of Paediatrics, Division of Neurology, The Hospital for Sick Children, Toronto, ON, Canada, (3)Neurosciences and Mental Health Program, The Hospital for Sick Children, Toronto, ON, Canada, (4)Penn-CHOP Lifespan Brain Institute and Departments of Psychiatry, Neurology and Radiology, University of Pennsylvania School of Medicine, Philadelphia, PA, (5)Neurology, Children’s Hospital of Philadelphia, Philadelphia, PA

[194]

NNN06

[198]

Melissa Villafana, B.A.1, Glenn R Wylie, Ph.D.2 and Ruth E Propper, Ph.D.1, (1)Psychology, Montclair State University, Montclair, NJ, (2)Rocco Ortenzio Neuroimaging Center, Kessler Foundation, West Orange, NJ

[194]

NNN06

[198]

Alise K Carlson, MD, Neurology, Cleveland Clinic Foundation, Cleveland, OH and Elias A Khawam, MD, Psychiatry, Cleveland Clinic, Cleveland, OH

[194]

NNN07

[198]

Erin M Edwards, B.S.1, Ana M Daugherty, PhD2 and Nora E Fritz, PhD, PT, DPT, NCS1, (1)Neuroimaging and Neurorehabilitation Laboratory, Wayne State University, Detroit, MI, (2)Psychology, Wayne State University, Detroit, MI

[194]

NNN07

[198]

Rhiannon Campden, MSc, Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada, Thomas Edwards, MSc, School of Human Kinetics, University of Ottawa, Ottawa, ON, Canada, Yodit Tesfagiorgis, BSc, Microbiology and Immunology, Western University, London, ON, Canada and Lindsay Berrigan, PhD, Psychology, St. Francis Xavier University, Antigonish, NS, Canada

[194]

NNN08

[198]

Lauren L Frederick, BS1, Ram Sivakumar, BS1, Sharon G Lynch, MD2 and Jennifer Villwock, MD3, (1)University of Kansas Medical Center, Kansas City, KS, (2)Neurology, University of Kansas Medical Center, Kansas City, KS, (3)Otolaryngology, University of Kansas Medical Center, Kansas City, KS

[194]

NNN08

[198]

Mark D Zuppichini, MA1, Kathryn West, PhD2, Dinesh Sivakolundu, MD3 and Bart Rypma, PhD3, (1)School of Behavioral and Brain Sciences, University of Texas At Dallas, Richardson, TX, (2)Center for BrainHealth, Dallas, TX, (3)School of Behavioral and Brain Sciences, University of Texas at Dallas, Richardson, TX

[194]

NNN09

[198]

Sheri L Bunyan, PhD, PT1,2 and Alexander V Ng, PhD2, (1)Physical Therapy, University of Wisconsin – Stevens Point, Stevens Point, WI, (2)Exercise Science, Marquette University, Milwaukee, WI

[194]

NNN09

[198]

Beyza Ciftci-Kavaklioglu, MD1, Giulia Longoni, M.D.1, Stephanie A Grover, MSc, CCRP2, Carmen Yea, MSc2 and E Ann Yeh, MD1, (1)Department of Paediatrics, Division of Neurology, The Hospital for Sick Children, Toronto, ON, Canada, (2)Department of Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada

[194]

NNN10

[198]

Alyssa Lindsay-Brown, B.A.(hon)1, Jason A Berard, PhD2,3 and Lisa A.S. Walker, PhD1,4,5, (1)Neuroscience, Ottawa Hospital Research Institute, Ottawa, ON, Canada, (2)Neuroscience, Ottawa Hosptial Research Institute, Ottawa, ON, Canada, (3)University of Ottawa, Ottawa, ON, Canada, (4)Psychology, Carleton University, Ottawa, ON, Canada, (5)Psychology, University of Ottawa Brain and Mind Research Institute, Ottawa, ON, Canada

[194]

NNN11

[198]

Hannah Salapa, B.S.1, Lian Finch, B.Sc.1,2, Catherine Hutchinson, B.Sc. M.Sc.1, Bogdan Popescu, PhD3 and Michael C Levin, MD1,4,5,6, (1)Office of the Saskatchewan MS Clinical Research Chair, University of Saskatchewan, Saskatoon, SK, Canada, (2)Physiology and Pharmacology, University of Saskatchewan, Saskatoon, SK, Canada, (3)Anatomy, Physiology, and Pharmacology, University of Saskatchewan, Saskatoon, SK, Canada, (4)Neurology, University of Saskatchewan, Saskatoon, SK, Canada, (5)Anatomy, Physiology & Pharmacology, University of Saskatchewan, Saskatoon, SK, Canada, (6)Cameco MS Neuroscience Research Centre, University of Saskatchewan, Saskatoon, SK, Canada

[194]

NP01

[198]

Michael S Trabjerg, MD, PhD Student, Anne S. Morkholt, M.Sc., PhD Student, Soren Nielsen, MD, Prof. and John D Nieland, PhD, Associate Prof., Department of Health Science and Technology, Aalborg University, Aalborg, Denmark

[194]

NP01

[198]

Anne S Moerkholt, MSc1, Kenneth Kastaniegaard, MSc1, Michael Trabjerg, MD1, Gopana Gopalasingam, BSc1, Wanda Niganze, BSc1, Michal K Oklinski, Postdoc2, Agnete Larsen, PhD, Associate Prof.3, Jette GK Nieland, MSc4, Allan Stensballe, PhD, Associate Prof.5, Soren Nielsen, MD, Prof.1 and John D Nieland, PhD, Associate Prof.5, (1)Department of Health Science and Technology, Aalborg University, Aalborg, Denmark, (2)Health Science and Technology, Aalborg University, Aalborg, Denmark, (3)Department of Biomedicine, Aarhus University, Aarhus, Denmark, (4)Meta-IQ ApS, Aarhus, Denmark, (5)Department of Health Science and Technologies, Aalborg University, Aalborg, Denmark

[194]

NP02

[198]

Mary Filipi, APRN, PhD1,2, Samantha Jack, MS1,2, Bruce Chase, PhD3, Eduardo Casas, PhD4 and Julia Ridpath, PhD4, (1)Saunders Medical Center, Wahoo, NE, (2)University of Nebraska Medical Center, Omaha, NE, (3)University of Nebraska-Omaha, Omaha, NE, (4)National Animal Disease Center, Ames, IA

[194]

NP02

[198]

Anne S Moerkholt, MSc1, Kenneth Kastaniegaard, MSc1, Allan Stensballe, PhD, Associate Prof.2, Soren Nielsen, MD, Prof.1 and John D Nieland, PhD, Associate Prof.2, (1)Department of Health Science and Technology, Aalborg University, Aalborg, Denmark, (2)Department of Health Science and Technologies, Aalborg University, Aalborg, Denmark

[194]

NP03

[198]

Pauline T Luczynski, MSc1, Cornelia Laule, PhD2,3,4,5,6, Ging-Yuek Robin Hsiung, MD6,7, G. R. Wayne Moore, MD4,5,6,7 and Helen Tremlett, PhD6,7, (1)MD Undergraduate Program, University of British Columbia, Vancouver, BC, Canada, (2)Radiology, University of British Columbia, Vancouver, BC, Canada, (3)Physics and Astronomy, University of British Columbia, Vancouver, BC, Canada, (4)Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada, (5)International Collaboration on Repair Discoveries (ICORD), Vancouver, BC, Canada, (6)Djavad Mowafaghian Centre for Brain Health, Vancouver, BC, Canada, (7)Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada

[194]

NP03

[198]

Giancarlo Comi, MD1, Aaron E Miller, MD2, Myriam Benamor, MD3, Philippe Truffinet, MD3, Karthinathan Thangavelu, PhD4 and Mark S Freedman, MD5, (1)University Vita-Salute San Raffaele, Milan, Italy, (2)Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, New York, NY, (3)Sanofi Genzyme, Chilly-Mazarin, France, (4)Sanofi Genzyme, Cambridge, MA, (5)University of Ottawa and the Ottawa Hospital Research Institute, Ottowa, ON, Canada

[194]

NP04

[198]

Raffaella Umeton, MD, MMSc1, Evdokia Eleftheriou, MD2, Simona Nedelcu, MD3, Lauren Hall, MS4, Kerime Ararat, MD1, Daniela Pimentel Maldonado, MD5, Ana Luisa Maldonado Contreras, PhD6, Doyle Ward, PhD6, Beth McCormick, PhD6 and Carolina Ionete, MD, PhD1, (1)Neurology, University of Massachusetts Memorial Medical Center, Worcester, MA, (2)Neurology, Maine Medical Center, Portland, ME, (3)Neurology, Harvard Medical School/ Massachusetts General Hospital, Boston, MA, (4)University of Massachusetts Memorial Medical Center, Worcester, MA, (5)University of Massachusetts Medical School, Worcester, MA, (6)Center for Microbiome Research, University of Massachusetts Memorial Medical Center, Worcester, MA

[194]

NP04

[198]

Iris Vanessa Marin Collazo, M.D., Multiple Sclerosis Neurology, Mayo Clinic, Rochester, MN and Orhun Kantarci, M.D., Neurology, Mayo Clinic, Rochester, MN

[194]

NP05

[198]

[194]

NP06

[198]

Philippe Beauchemin, MD1, C. Blake Gilks, MD2, Raffaele Iorio, MD, PHD3, Anthony Traboulsee, MD4, Thalia Field, MD, MHSc5 and Robert Carruthers, MD4, (1)UBC MS Clinic, Vancouver, BC, Canada, (2)Dept of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada, (3)Istituto di Neurologia Università Cattolica del Sacro Cuore, Roma, Italy, (4)Neurology, University of British Columbia, Vancouver, BC, Canada, (5)University of British Columbia, Vancouver, BC, Canada

[194]

NPP01

[198]

[194]

NPP01

[198]

Alexandra B Kornbluh, MD1, Victor M Campano, BS, MS2, Pallavi Dwivedi, MS, MPH3, William Suslovic, BS4 and Ilana Kahn, MD1, (1)Neurology, Children’s National Hospital, Washington, DC, (2)The George Washington University School of Medicine and Health Sciences, Washington, DC, (3)Biostatistics, Children’s National Hospital, Washington, DC, (4)Children’s Research Institute, Children’s National Hospital, Washington, DC

[194]

NPP02

[198]

Amber Anees, BSc., Health Sciences, University of Saskatchewan, Saskatoon, SK, Canada, Michael Levin, FRCPC, Office of the Saskatchewan Multiple Sclerosis Clinical Research Chair, University of Saskatchewan, Saskatoon, SK, Canada, Hannah E Salapa, PhD, Anatomy, Physiology and Pharmacology, University of Saskatchewan, Saskatoon, SK, Canada and Patricia Thibault, PhD, University of Saskatchewan, Saskatoon, SK, Canada

[194]

NPP02

[198]

Mirela Cerghet, MD, PhD1,2, Insha Zahoor, PhD3, Jeffrey Waters, BS3, Indrani Datta, MS4, Laila Poisson, PhD4, Ramandeep Rattan, PhD5 and Shailendra Giri, PhD6, (1)Neurology, Henry Ford Hospital, Detroit, MI, (2)School of Medicine, Wayne State University, Detroit, MI, (3)Neurology, Henry Ford Health System, DETROIT, MI, (4)Public Health Sciences, Henry Ford Health System, Detroit, MI, (5)Gynaecology Oncology, Henry Ford Health System, Detroit, MI, (6)Neurology, Henry Ford Health System, Detroit, MI

[194]

PF01

[198]

Serena D Stevens, PhD and Amy B Sullivan, PsyD, ABPP, Cleveland Clinic Mellen Center for Multiple Sclerosis, Cleveland, OH

[194]

PF01

[198]

[194]

PF02

[198]

Daniel Kantor, MD, Florida Atlantic University, Boca Raton, FL, Kristen Fetty, ., Fairmont State University, Fairmont, WV, Kit Minden, ., Living for a Cure, Midlothian, VA, Katelyn Miller, ., Providence Forge, VA and Jeri Burtchell, ., HealthiVibe, LLC, Arlington, VA; Partners in Research, East Palatka, FL

[194]

PF02

[198]

Caroline Altaras, B.A.1, Nicholas A Vissicchio, B.A.1, Jennifer Miller, B.A.2, Shonna Schneider, B.A.2, Shaina Shagalow, B.A.2, Amanda A Parker, B.S.2 and Frederick W Foley, Ph.D.3, (1)Yeshiva University Ferkauf Graduate School of Psychology, Bronx, NY, (2)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (3)School of Psychology, Yeshiva University, New York, NY

[194]

PF03

[198]

Barbara Willekens, MD1, Gaetano Perrotta, MD2, Sara Vanhoorenbeeck, medical student3, Arash Sarwar, medical student3, Carl-Edward Van Mieghem, medical student3, Wim Van Hecke, PhD4, Bjorn Prins, psychologist5, Paul Parizel, MD, PhD6, Nathalie Cools, PhD7 and Patrick Cras, MD, PhD1, (1)Neurology, Antwerp University Hospital, Edegem, Belgium, (2)Neurology, Hopital Erasme, Brussels, Belgium, (3)University of Antwerp, Wilrijk, Belgium, (4)Icometrix, Leuven, Belgium, (5)Department of Experimental Clinical and Health Psychology, Ghent University, Ghent, Belgium, (6)Radiology, Antwerp University Hospital, Edegem, Belgium, (7)Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium

[194]

PF03

[198]

Deborah M MIller, PhD, LISW1, Sarah M Planchon, PhD, CCRP2, Carol Musil, PhD, RN, FAAN, FGSA3, Sarah Givens, B.S.3, Mary Beth Mercer, MPH4, Hollie Schmidt, MS5 and Stacey S Cofield, PhD6, (1)Mellon Center, Cleveland Clinic, Cleveland, OH, (2)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, (3)Case Western Reserve University, Cleveland, OH, (4)Bioethics, Cleveland Clinic, Cleveland, OH, (5)Accelerated Cure Project for MS, Waltham, MA, (6)Biostatistics, University of Alabama at Birmingham, Birmingham, AL

[194]

PF04

[198]

Laura T. Safar, M.D., Psychiatry, Brigham and Women’s Hospital, Boston, MA

[194]

PF04

[198]

Heena Manglani, B.A., Alisha Janssen, M.A. and Ruchika S. Prakash, Ph.D., Department of Psychology, The Ohio State University, Columbus, OH

[194]

PF05

[198]

Ana Maria Canzonieri, psychologist1, Thais Mira Simandi, Psychology student2, Daniele Batista de Sousa, psychology student3 and Jislaine Oliveira da Silva, Psychology student1, (1)Pesquisa cientifica, ABEM – Brazilian Association of Multiple Sclerosis, Sao Paulo, Brazil, (2)Pesquisa cientifica, ABEM – Brazilian Association of Multiple Sclerosis, sAO pAULO, Brazil, (3)Acolhimento, ABEM – Brazilian Association of Multiple Sclerosis, Sao Paulo, Brazil

[194]

PF05

[198]

Jeffrey G Portnoy, B.A.1,2, Eliana Pasternak, M.A.1, Shonna Schneider, B.A.1, Shaina Shagalow, B.A.1 and Frederick W Foley, Ph.D.1,2, (1)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (2)Holy Name Medical Center, Teaneck, NJ

[194]

PF05

[198]

Jeffrey G Portnoy, B.A.1,2, Eliana Pasternak, M.A.1, Shonna Schneider, B.A.1, Shaina Shagalow, B.A.1 and Frederick W Foley, Ph.D.1,2, (1)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (2)Holy Name Medical Center, Teaneck, NJ

[194]

PF06

[198]

Elizabeth J. Herring, BA1, Brittney Schirda, MA1, Jacqueline A. Nicholas, MD, MPH2 and Ruchika S. Prakash, PhD1, (1)Department of Psychology, The Ohio State University, Columbus, OH, (2)OhioHealth Multiple Sclerosis Center, Columbus, OH

[194]

PF06

[198]

Jeffrey G Portnoy, B.A.1,2, Shaina Shagalow, B.A.2, Eliana Pasternak, M.A.2, Shonna Schneider, B.A.2 and Frederick W Foley, Ph.D.1,2, (1)Holy Name Medical Center, Teaneck, NJ, (2)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY

[194]

PF06

[198]

Jeffrey G Portnoy, B.A.1,2, Shaina Shagalow, B.A.2, Eliana Pasternak, M.A.2, Shonna Schneider, B.A.2 and Frederick W Foley, Ph.D.1,2, (1)Holy Name Medical Center, Teaneck, NJ, (2)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY

[194]

PF07

[198]

Angel Chinea, MD1, Ivonne Vicente, MD2, Cristina M Rubi, BS2, Astrid Diaz, BS3, Allan J Reyes, BA4 and Alejandro Mendez, BA5, (1)San Juan Multiple Sclerosis Center, San Juan, PR, (2)San Juan Multiple Sclerosis Center, Guaynabo, PR, (3)San Juan MS Center, Guaynabo, PR, (4)Neurology, San Juan MS Center, Guaynabo, PR, Puerto Rico, (5)San Juan MS Center, Guaynabo, PR, Puerto Rico

[194]

PF08

[198]

Gillian Rush, BSc1, Priya Garcha, BSc1, Chao Zhao, MSc1, Katherine Possin, PhD1, John Morrissey, BSc1, Anthony Feinstein, MPhil, PhD, FRCP2, Joaquin Anguera, PhD1 and Riley Bove, MD, MMSc3, (1)UCSF Neurology, Weill Institute for Neurosciences, San Francisco, CA, (2)Department of Psychiatry, University of Toronto, Sunnybrook Health Sciences Centre, Toronto, ON, Canada, (3)University of California San Francisco, Weill Institute for Neurosciences, San Francisco, CA

[194]

PF08

[198]

Sarah M Planchon, PhD, CCRP1, Stacey S Cofield, PhD2, Carol Musil, PhD, RN, FAAN, FGSA3, Sarah Givens, B.S.3, Hollie Schmidt, MS4, MaryBeth Mercer, MPH5 and Deborah M MIller, PhD, LISW6, (1)Mellen Center, Cleveland Clinic, Cleveland, OH, (2)Biostatistics, University of Alabama at Birmingham, Birmingham, AL, (3)Case Western Reserve University, Cleveland, OH, (4)Accelerated Cure Project for MS, Waltham, MA, (5)Bioethics, Cleveland Clinic, Cleveland, OH, (6)Mellon Center, Cleveland Clinic, Cleveland, OH

[194]

PF08

[198]

Sarah M Planchon, PhD, CCRP1, Stacey S Cofield, PhD2, Carol Musil, PhD, RN, FAAN, FGSA3, Sarah Givens, B.S.3, Hollie Schmidt, MS4, MaryBeth Mercer, MPH5 and Deborah M MIller, PhD, LISW6, (1)Mellen Center, Cleveland Clinic, Cleveland, OH, (2)Biostatistics, University of Alabama at Birmingham, Birmingham, AL, (3)Case Western Reserve University, Cleveland, OH, (4)Accelerated Cure Project for MS, Waltham, MA, (5)Bioethics, Cleveland Clinic, Cleveland, OH, (6)Mellon Center, Cleveland Clinic, Cleveland, OH

[194]

PG01

[198]

Kelli-Jane L Lazarus, Bachelor of Nursing, Edith CINC, Bachelor of Nursing, Belinda Bardsley, Bachelor of Nursing, Melanie McMurtrie, Bachelor of Nursing, Elise Heriot, Bachelor of Nursing, Joanne Dimovitis, Clinical Research Administrative Assistant and Melanie Howard, Administrative Assitant, Neurology, Austin Health, Heidelberg, Australia

[194]

PG02

[198]

Kathleen A Meunier, RN, Galesville, WI

[194]

PG03

[198]

Karen Vernon, BSc (hons). RGN.1, Fran Jackson, SRN1, David Rog, MD, MRCP2, Paul Talbot, MB ChB MD FRCP1, Tatiana Milahova, MUDr3, Nazar Sharaf, MD4 and Adrian Pace, MD4, (1)Neurosciences, Salford Royal NHS Trust, Salford, United Kingdom, (2)Salford Royal NHS Foundation Trust, Salford, United Kingdom, (3)Neurology, Salford Royal NHS Foundation Trust, Saford, United Kingdom, (4)Neurology, Salford Royal NHS Foundation Trust, Salford, United Kingdom

[194]

PG04

[198]

Kathleen M Healey, ARNP, PhD, NEUROLOGICAL SCIENCES, UNIVERSITY OF NEBRASKA MEDICAL CENTER, OMAHA, NE

[194]

PG05

[198]

Cassandra Santos, BSc, MOT Student1, Nathaniel Susilo, BSc, MOT Student1, Denise Kendrick, BA, MOT2, Susan Forwell, PhD (OT), MA (OT), BSC (OT), FCAOT1 and Nancy Forseth, BSC (OT)1, (1)Department of Occupational Science and Occupational Therapy, University of British Columbia, Vancouver, BC, Canada, (2)Vancouver Coastal Health, UBC MS/NMOSD Clinic, Vancouver, BC, Canada

[194]

PG06

[198]

Daryl Kucera, Bachelors Fitness Science, MSforward, Omaha, NE

[194]

PGM01

[198]

Nora Garland, MSW, LSW, MSCS, Hannah Gilmore, BA, Dina Jacobs, MD, Sona Narula, MD and Vanessa Zimmerman, MSN, RN, MSCN, Neurology, University of Pennsylvania, Philadelphia, PA

[194]

PGM01

[198]

Carole Drexel, PhD1, Elizabeth L. del Nido, BA1, Scott D. Newsome, DO, MSCS, FAAN, FANA2, June Halper, MSN, APN-C, MSCN, FAAN3 and Wendy Turell, DrPH1, (1)PlatformQ Health Education, Needham, MA, (2)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (3)Consortium of Multiple Sclerosis Centers, Hackensack, NJ

[194]

PGM01

[198]

Lisa S. DeSantis, JD, Continuing Education, CMSC, Hackensack, NJ, Tina Trott, NA, CMSC, Hackensack, NJ and June Halper, MSN, ANP, FAAN, CEO-CMSC, Hackensack, NJ

[194]

PGM01

[198]

Eric Garmon, MCHES, MS Navigator Experience, National MS Society, Denver, CO and Anzada, P., Bennett, D., Benson, T., Carlson, W., Farsaci, N., Henderson, L, Lerdahl, M., Liserio, E., MacIsaac, S., Mazzella, S., Tauchman, J., Vohs, L., Smoczynski, J.

[194]

PGM02

[198]

Piper Reynolds, BS, Director Healthcare Provider Engagement, National Multiple Sclerosis Society, New York, NY

[194]

PGM02

[198]

Dina Jacobs, MD1, Nora Garland, MSW, LSW1, Vanessa Zimmerman, MSN, RN, MSCN1 and Sarah M Weinstein, MS2, (1)Neurology, University of Pennsylvania, Philadelphia, PA, (2)Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

[194]

PGM02

[198]

Lionel Thevathasan, MD FRCS, Medical Strategy, Medscape LLC, Paris, France

[194]

PGM02

[198]

Laura Allen, Director of Programs1, Abbey J. Hughes, PhD2, Rosalind Kalb, PhD1 and Kathleen Costello, MS, CRNP, MSCN1, (1)Programs, Can Do Multiple Sclerosis, Avon, CO, (2)Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

PGM03

[198]

Eric Garmon, MCHES, MS Navigator Experience, National MS Society, Denver, CO and Hooper K, Marshall J, Stewart K

[194]

PGM03

[198]

Kathleen Healey, NP, PhD1, Renee Stewart, DNP2, Aubrie Lindner, MA2, Daryl Kucera, BS3 and Rana K. Zabad, MD4, (1)Neurologial Sciences, University of Nebraska, Omaha, NE, (2)Neurological Sciences, Nebraska Medicine, Omaha, NE, (3)MSforward, Omaha, NE, (4)NEUROLOGICAL SCIENCES, UNIVERSITY OF NEBRASKA MEDICAL CENTER, OMAHA, NE

[194]

PGM03

[198]

Paul Hanusch, RN, BSN, MHA1, Kian Jalaleddini, PhD1, Danielle Siniscalchi, MBA1, Alpna Wayal, PhD1 and Jennifer Graves, MD, PhD, MAS2, (1)Octave, Menlo Park, CA, (2)University of California San Diego, San Diego, CA

[194]

PGM04

[198]

Eric Garmon, MCHES, MS Navigator Experience, National MS Society, Denver, CO and Liserio E, Tauchman J, Fiol J, Szafran E, Barnola A, Costello K

[194]

PGM04

[198]

Shaina Meyer, OTR/L, MSCS1, Jennifer Nash, PT, DPT, NCS, CEEAA, MSCS, CDP1, Laura Kruskall, PhD, RDN, CSSD, LD, FACSM, FAND2, Kimberly Castello, C-IAYT, YTRX, E-RYT 500 Yoga Therapist3, Kara Barton, MSW, LCSW4, Marie LeGrand, MPH5, Amy B Sullivan, PsyD, ABPP6 and Carrie M Hersh, DO, MS1, (1)Lou Ruvo Center for Brain Health, Cleveland Clinic, Las Vegas, NV, (2)Nutrition Sciences, University of Nevada Las Vegas, Las Vegas, NV, (3)Kimberly Castello Yoga, Las Vegas, NV, (4)Leslie P. Weiner Center for Neurological Care and Research, Keck Medicine of USC, Los Angeles, CA, (5)Multiple Sclerosis Association of America, Chicago, IL, (6)Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH

[194]

PGM05

[198]

Eric Garmon, MCHES, MS Navigator Experience, National MS Society, Denver, CO and Liserio E, Tauchman J, Herrmann B, Anzada P, Benson T, Gasper-Krueger A, Baker C, Cohrs R, Jensen A, Roper E, Ovsepian N

[194]

PGM05

[198]

Ka-Ho Wong, BS1,2, Jun Feng Lin, MBA2, Kai Yao Jiang, MBA2, Xi Yuan Huang, BPT2,3, Qiaoyi Ho, LCSW2,4 and Yue Huang, MD2,5, (1)Neurology, University of Utah, Salt Lake City, UT, (2)Essenelf HealthCare Managment Institute, GuangZhou, China, (3)Physical medicine and rehabilitation, The Fifth Affiliated Hospital Sun Yat-Sen University, GuangZhou, China, (4)Social Work, Guangdong General Hospital, GuangZhou, China, (5)Neurology, Guangdong General Hospital, GuangZhou, China

[194]

PGM06

[198]

Kevin N Alschuler, PhD1,2, Darren Ball, M.Ed.3, Annette Wundes, MD4, Salim Chahin, MD5, Mark Skeen, MD6 and Gloria von Geldern, MD4, (1)Department of Neurology, University of Washington School of Medicine, Seattle, WA, (2)Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA, (3)National Multiple Sclerosis Society, New York, NY, (4)Neurology, University of Washington, Seattle, WA, (5)Washington University in St. Louis, St. Louis, MO, (6)Neurology, Duke University, Durham, NC

[194]

PGM06

[198]

Lynette Coleman, Director MS Professional Workforce Development, Services – Healthcare Access, National Multiple Sclerosis Society, New York, NY

[194]

PGM07

[198]

Lynda R Hillman, DNP, MS Center of Excellence, West, VA Puget Sound Healthcare, Seattle, WA and Nancy Harris, MN, RN, VA-ECHO, VA Puget Sound Healthcare System, Seattle, WA

[194]

PGM07

[198]

Katelyn Jarvis, SPT, Samantha D’Silva, SPT, Alexandra Wileman, SPT, Stacy Coffyn, SPT, Stacia Troshynski Brown, DPT, OCS and Catherine Siengsukon, PT, PhD, Physical Therapy and Rehabilitation Science, University of Kansas Medical Center, Kansas City, KS

[194]

PGM08

[198]

Piper Reynolds, BS, Director Healthcare Provider Engagement, National Multiple Sclerosis Society, New York, NY, Gloria von Geldern, MD, Neurology, University of Washington, Seattle, WA, Lucas McCarthy, MD, MS, Virginia Mason, Seattle, WA, Annette Wundes, MD, University of Washington, Seattle, WA, Jodie K Haselkorn, MD, MPH, Department of Epidemiology, University of Washington, Seattle, WA, Angeli Mayadev, MD, MS Center, Swedish Medical Center, Seattle, WA, Stacy Donlon, MD, MultiCare Neuroscience, Tacoma, WA, Kathleen Burgess, MD, VA MS Center of Excellence-West, Seattle, WA and Lynda R Hillman, DNP, MS Center of Excellence, West, VA Puget Sound Healthcare, Seattle, WA

[194]

PGM08

[198]

Colleen Cochran, B.S.1, Sarah J Donkers, PT, PhD2, Katherine Knox, MD3, Pawan Kumar, B.A.1, Aman Saini, MD, MPH4, Audrey R Zucker-Levin, PhD, PT, MBA5 and Michael C Levin, MD6,7, (1)Office of the Saskatchewan MS Research Chair, University of Saskatchewan, Saskatoon, SK, Canada, (2)College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada, (3)Physical Medicine and Rehabilitation, University of Saskatchewan College of Medicine, Saskatoon, SK, Canada, (4)Office of the Saskatchewan Multiple Sclerosis Clinical Research Chair, University of Saskatchewan College of Medicine, Saskatoon, SK, Canada, (5)Physical Therapy, University of Saskatchewan, Saskatoon, SK, Canada, (6)Anatomy, Physiology & Pharmacology, University of Saskatchewan, Saskatoon, SK, Canada, (7)Office of the Saskatchewan MS Clinical Research Chair, University of Saskatchewan, Saskatoon, SK, Canada

[194]

PGM09

[198]

Renee Stewart, DNP, APRN-NP1, Rana K. Zabad, MD2, Kristen Bayly, BSN1, Aubrie L Lindner, AA3, Kathleen Healey, NP, PhD4 and Mohamed Darwish, MD5, (1)Neurological Sciences, Nebraska Medicine, Omaha, NE, (2)NEUROLOGICAL SCIENCES, UNIVERSITY OF NEBRASKA MEDICAL CENTER, OMAHA, NE, (3)Neurological Sciences Program Operations Manager, Nebraska Medicine, Omaha, NE, (4)Neurologial Sciences, University of Nebraska, Omaha, NE, (5)Department of Neurology, University Nebraska Medical Center, Omaha, NE

[194]

PGM10

[198]

Stacy Tyrrell, PharmD, BCACP1, Shannon Panther, PharmD, BCACP2, Aimie Inthoulay, BA3 and Jason Chau, PharmD, MSCS, BCPS, BCACP3, (1)Kaiser Permanente, Tacoma, WA, (2)Kaiser Permanente, Spokane, WA, (3)Kaiser Permanente, Renton, WA

[194]

PO01

[198]

Allison LaRussa, BA1, Alicia S Chua, M.S.2, Brian C Healy, PhD1, Fiona Stuart, BA1, Kaitlynne Leclaire, BA1, Riley Bove, MD1, Maria K Houtchens, MD1, Sandra Cook, RN1, Tanuja Chitnis, MD3, Howard L Weiner, MD1 and Bonnie I Glanz, PhD4, (1)Neurology, Brigham and Women’s Hospital, Brookline, MA, (2)Partners MS Center, Brigham and Women’s Hospital, Brookline, MA, (3)Massachusetts General Hospital for Children, Boston, MA, (4)Partners Multiple Sclerosis Center, Brigham and Women’s Hospital, Brookline, MA

[194]

PO02

[198]

Amber Salter, PhD, Division of Biostatistics, Washington University in St. Louis, St. Louis, MO, Nina Thomas, MPH, Genentech, Inc, South San Francisco, CA, Gary Cutter, PhD, University of Alabama at Birmingham, Birmingham, AL, Tuula Tyry, PhD, Dignity Health, St. Joseph’s Hospital and Medical Center, Phoenix, AZ and Ruth Ann Marrie, MD, PhD, University of Manitoba, Winnipeg, MB, Canada

[194]

PO03

[198]

Amy Bowen, RN, MA, Multiple Sclerosis Trust, Letchworth, United Kingdom of Great Britain and Northern Ireland

[194]

PO04

[198]

Sibyl Wray, MD1, Barry A Singer, MD2, Brooke Hayward, SM, MBA3 and Choon Cha, MD3, (1)Hope Neurology Multiple Sclerosis Center, Knoxville, TN, (2)The MS Center for Innovations in Care, Missouri Baptist Medical Center, St Louis, MO, (3)EMD Serono, Inc., Rockland, MA

[194]

PO05

[198]

Cynthia B. Guerra, MBA1, Brandy Northcutt, _1, Richard Muser, _1, Michael Russo, _1, Joe McBride, _2 and Adrian L. Rabinowicz, MD1, (1)Acorda Therapeutics, Inc, Ardsley, NY, (2)Studio PMG, Irvine, NY

[194]

PO06

[198]

Donald Barone, DO1, Mark Gudesblatt, MD2, Susan E Bennett, PT, DPT, EdD, NCS, MSCS3, Megan Weigel, DNP, ARNP-C, MSCN4, Amy Perrin Ross, APN, MSN, CNRN, MSCN5, Brooke Hayward, SM, MBA6 and Frederick Munschauer, MD6, (1)Rowan University, Stratford, NJ, (2)South Shore Neurologic Associates, Patchogue, NY, (3)State University of New York at Buffalo, Buffalo, NY, (4)Baptist Neurology Beaches Division, South Jacksonville Beach, FL, (5)Loyola University Chicago, Maywood, IL, (6)EMD Serono, Inc., Rockland, MA

[194]

PO07

[198]

Doug Taylor, BSc1, Nipa Patel, BA2 and Philip Sjostedt, BPharm2, (1)Institute for Evidence Based Medicine, New Hope, PA, (2)The Medicine Group, New Hope, PA

[194]

PO08

[198]

Edward J. Fox, MD, PhD1, John Ko, Pharm.D, MS2, Paul Wicks, PhD3, Yujin Park, PharmD4, Pronabesh DasMahapatra, MD, MPH3, Kathryn Kendall, MBA3, Walter Hong, MD2, Erik Burton, MD2, Kathleen Hawker, MD2, Irina Kosoy, BBA5, Dimitri Liakhovitski, PhD5 and Vivian Herrera, DDS, MIA, MPH2, (1)Central Texas Neurology Consultants, Round Rock, TX, (2)Health Economics & Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ, (3)PatientsLikeMe Inc., Cambridge, MA, (4)Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD, (5)North America, Gfk, New York, NY

[194]

PO09

[198]

Fiona Stuart, BA1, Alicia S Chua, M.S.2, Allison LaRussa, BA1, Kaitlynne Leclaire, BA1, Sandra Cook, RN1, Tanuja Chitnis, MD3, Howard L Weiner, MD1, Brian C Healy, PhD4 and Bonnie I Glanz, PhD5, (1)Neurology, Brigham and Women’s Hospital, Brookline, MA, (2)Partners MS Center, Brigham and Women’s Hospital, Brookline, MA, (3)Massachusetts General Hospital for Children, Boston, MA, (4)Biostatistics Center, Massachusetts General Hospital, Boston, MA, (5)Partners Multiple Sclerosis Center, Brigham and Women’s Hospital, Brookline, MA

[194]

PO10

[198]

Gregory D Salinas, PhD1, Brandon Coleman, BS1, Eleana Hardy, BA2, Jeffrey Smith, MS MBA2, Leslie Meltzer, PhD2 and Terrie Livingston, PharmD2, (1)CE Outcomes, LLC, Birmingham, AL, (2)Biogen, Cambridge, MA

[194]

PO11

[198]

Heidi Crayton, MD1, Brian Steingo, MD2, DeRen Huang, MD, PhD3, Xiangyi Meng, PhD4, Lesley Schofield, PhD4, Kristen Johnson, PhD4, Nadia Tenenbaum, MD4 and * on behalf of the PREFERMS investigators, **please delete**5, (1)MS Center of Greater Washington, Vienna, VA, (2)Sunrise Medical Group, Sunrise, FL, (3)Neurology and Neuroscience Associates, Akron, OH, (4)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (5)**please delete**, **please delete**, NJ

[194]

PO12

[198]

Hollie Schmidt, MS1, Robert N. McBurney, PhD1, Deborah Backus, PT, PhD2, Laura Kolaczkowski, BA1, Sara Loud, MSEE, MBA1 and Revere P. Kinkel, MD3, (1)Accelerated Cure Project for MS, Waltham, MA, (2)Multiple Sclerosis Institute, Shepherd Center, Atlanta, GA, (3)University of California San Diego, San Diego, CA

[194]

PO13

[198]

Jacqueline Nicholas, MD, MPH1, John Ko, Pharm.D, MS2, Yujin Park, PharmD3, Prakash Navaratnam, Rph, MPH, PhD4, Howard Friedman, PhD4, Frank Ernst, Pharm.D, MS5, Erik Burton, MD2, Walter Hong, MD2 and Vivian Herrera, DDS, MIA, MPH2, (1)Neuroscience, Ohio Health, Columbus, OH, (2)US Health Economics & Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ, (3)Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD, (4)DataMed Solutions LLC., Hilliard, OH, (5)Health Economics & Outcomes Research, Indegene TTM, Kennesaw, GA

[194]

PO14

[198]

John Foley, MD, Tamara Hoyt, MS, Cortnee Roman, NP, Angelene Christensen, BS and Ryan Metzger, PhD, Rocky Mountain MS Research Group, Salt Lake City, UT

[194]

PO15

[198]

Joss Cohen, MD candidate1, Katelyn S. Kavak, MS2, Caila B Vaughn, MPH2,3,4, Robert Zivadinov, MD, PhD2,5, Jessica F Robb, MD2,6, Burk Jubelt, MD2,7, Lore Garten, MD2,8, Ilya Kister, MD2,9, Lauren Krupp, MD2,9, Malcolm Gottesman, MD2,10, Barbara E. Teter, PhD, MPH4 and Bianca Weinstock-Guttman, MD2,3,4, (1)Neurology, University at Buffalo Jacobs School of Medicine, Buffalo, NY, (2)New York State Multiple Sclerosis Consortium, Buffalo, NY, (3)Jacobs MS Center of Treatment and Research, Buffalo, NY, (4)Department of Neurology, University at Buffalo, Buffalo, NY, (5)Department of Neurology, State University of New York at Buffalo, Buffalo Neuroimaging Analysis Center, Buffalo, NY, (6)University of Rochester Medical Center, Rochester, NY, (7)SUNY Upstate Medical University, Syracuse, NY, (8)MS Center of Northeastern New York, Latham, NY, (9)NYU Langone Medical Center, New York, NY, (10)Winthrop Comprehensive MS Care Center, Mineola, NY

[194]

PO16

[198]

Kelsey Zorn, BA1, Katherine J Kim, MPH2, Louis S. Matza, PHD2, Glenn Phillips, PhD3, Kitty S. Chan, PHD4, Sandra D. Cassard, ScD5, Katherine C Smith, PhD1 and Ellen Mowry, MD, MCR5, (1)Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, (2)Evidera, Bethesda, MD, (3)Biogen, Cambridge, MA, (4)Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, (5)Neurology, Johns Hopkins School of Medicine, Baltimore, MD

[194]

PO17

[198]

Kiren Kresa-Reahl, MD1, Pavle Repovic, MD, PhD2, Derrick S Robertson, MD3, Macaulay Okwuokenye, DrPH4, Leslie Meltzer, PhD4 and Jason Mendoza, PhD4, (1)Providence Multiple Sclerosis Center, Portland, OR, (2)Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA, (3)Neurology, University of South Florida, Tampa, FL, (4)Biogen, Cambridge, MA

[194]

PO18

[198]

Andrew J Solomon, MD1, Haiyan Qu, PhD, MHSA2, Vicky Springmann, MSc3, Carolina Ionete, MD, PhD4, Enrique Alvarez, MD5, Lori Pbert, PhD4, Carolyn Griffin, RN6, Brenda Tierman, RN7, Ashli Hopson, BA7, Christen Kutz, PA, PhD8, Idanis Idanis Berriosmorales, MD4, Glenn Phillips, PhD9 and Nananda F Col, MD, MPH, MPP, FACP7, (1)Neurological Sciences, University of Vermont College of Medicine, Burlington, VT, (2)Minority Health & Health Disparities Research Center; Health Services Administration, University of Alabama, Birmingham, Birmingham, AL, (3)Public Health Ontario, Toronto, ON, Canada, (4)University of Massachusetts Memorial Medical Center, Worcester, MA, (5)Neurology, University of Colorado, Aurora, CO, (6)Department of Neurology, University of Massachusetts Medical School, Worcester, MA, (7)Shared Decision Making Resources, Georgetown, ME, (8)Colorado Springs Neurological Associates, Colorado Springs, CO, (9)Biogen Idec Inc., Weston, MA, USA, Cambridge, MA

[194]

PO19

[198]

Patricia K Coyle, MD1, Chris LaGanke, MD2, Bhupendra Khatri, MD3, Keith R Edwards, MD4, Steve Cavalier, MD5, Pascal Rufi, MD6, Sandrine Brette, MSc7, Miqun Robinson, MD, PhD8, Matt Mandel, MD5 and Ralf Gold, MD9, (1)Stony Brook University, Stony Brook, NY, (2)North Central Neurology Associates, Cullman, AL, (3)The Regional MS Center, Center for Neurological Disorders, Wheaton Franciscan Health Care, Milwaukee, WI, (4)Multiple Sclerosis Center of Northeastern New York, Latham, NY, (5)Genzyme, a Sanofi company, Cambridge, MA, (6)Genzyme, a Sanofi company, Chilly-Mazarin, France, (7)Lincoln, Boulogne-Billancourt, France, (8)Sanofi, Bridgewater, NJ, (9)St. Josef-Hospital, Ruhr University Bochum, Bochum, Germany

[194]

PO20

[198]

Robert L Knobler, MD, PhD, KIND Clinic, Knobler Institute of Neurologic Disease, Fort Washington, PA

[194]

PO21

[198]

Samantha Domingo, Psy.D.1, Lael A. Stone, M.D.2, Shauna Clement, PA-C2, Nicolas Thompson, M.S.3 and Amy Sullivan, Psy.D.4, (1)The Mellen Center for Multiple SclerosisTreatment and Research, Cleveland Clinic, Cleveland, OH, (2)Mellen Center for Multiple Sclerosis, Cleveland Clinic Foundation, Cleveland, OH, (3)Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH, (4)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH

[194]

PO22

[198]

Wanda Castro-Borrero, MD1, Mariko Kita, MD2, Eva Havrdova, MD, PhD3, Bhupendra Khatri, MD4, Keith R Edwards, MD5, Bruce AC Cree, MD, PhD6, Shulian Shang, PhD1, Glenn Phillips, PhD1 and Ying Liu, PhD1, (1)Biogen, Cambridge, MA, (2)Virginia Mason Multiple Sclerosis Center, Seattle, WA, (3)Department of Neurology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic, (4)The Regional MS Center, Center for Neurological Disorders, Wheaton Franciscan Health Care, Milwaukee, WI, (5)Multiple Sclerosis Center of Northeastern New York, Latham, NY, (6)University of California San Francisco, San Francisco, CA

[194]

PO23

[198]

Eduardo R Estades, MD1, Angel Chinea, MD2, Yatzka G Hernandez Silvestrini, MD1, Ivonne Vicente, MD2 and Cristina Rubi, BS2, (1)Research/Clinic, San Juan MS Center, Guaynabo, PR, (2)San Juan Multiple Sclerosis Center, Guaynabo, PR

[194]

PSF01

[198]

Esti Chapman, BA1, Talia Schiff, BA1, Zoe Rimler, CCRC2, Allyson Reid, BA2, Tamar Bacon, BA2 and Joshua Bacon, PhD3,4, (1)Yeshiva University, New York, NY, (2)Multiple Sclerosis Comprehensive Care Center, NYU Langone Health, New York, NY, (3)Neurology, NYU School of Medicine, New York, NY, (4)Psychology, Yeshiva University, New York, NY

[194]

PSF02

[198]

Janet Morrison, PhD, RN, MSCN, Heather Becker, PhD, Research Scientist and Alexa Stuifbergen, PhD, RN, FAAN, Dean, School of Nursing, The University of Texas at Austin, Austin, TX

[194]

PSF03

[198]

Krina Patel, BS1,2, Abbey J Hughes, PhD2, Aeysha Brown, MA1,2, Meghan Beier, PhD2, Ellen M Mowry, MD, MCR3 and Kathryn C Fitzgerald, ScD3, (1)American School of Professional Psychology at Argosy University – Northern Virginia, Arlington, VA, (2)Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD, (3)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

PSF04

[198]

Benjamin A Jones, MD1, William A Kilgo, MD2 and John R Rinker, MD1, (1)Neurology, University of Alabama at Birmingham, Birmingham, AL, (2)Neurology, University of South Alabama, Mobile, AL

[194]

PSF05

[198]

Elizabeth Herring, B.A., Stephanie Fountain-Zaragoza, M.A., Bryce Boron, B.S. and Ruchika S. Prakash, Ph.D., Department of Psychology, The Ohio State University, Columbus, OH

[194]

PSF06

[198]

Rachel Galioto, PhD, Mellen Center, Cleveland Clinic, Cleveland, OH

[194]

PSF07

[198]

[194]

PSF08

[198]

Yujie Wang, MD, Fan Tian, MSE, Peter A Calabresi, MD and Ellen M Mowry, MD, MCR, Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

PSF09

[198]

Jennifer K. Altman, Ph.D.1, Dawn Ehde, PhD2, Kevin N Alschuler, PhD3 and Mark Jensen, Ph.D.1, (1)Rehabilitation Medicine, University of Washington, Seattle, WA, (2)Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA, (3)Neurology, University of Washington School of Medicine, Seattle, WA

[194]

PSY01

[198]

Amy Sullivan, Psy.D.1, Alexa Kane, PsyD1, Grace E Tworek, Psy.D.1 and Tucker Harvey, MS2, (1)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, (2)Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH

[194]

PSY01

[198]

Andrea Arzt, LCSW, MSCS, Advocacy and Healthcare Access, The National Multiple Sclerosis Society, New York, NY, Amber Landers, PhD, PsyD, Clinical Psychology, Alliant International University, San Franscisco, CA, Katelyn Michtich, MBA, Advocacy and Healthcare Access, National Multiple Sclerosis Society, Southern California & Nevada Chapter, Los Angeles, CA, Rhoda Olkin, PhD, PsyD, Clinical Psychology, Alliant International University, San Francisco, CA, Linda Trettin, PhD, PsyD, Clinical Neuropsychology, Folsom Neurology/Dignity Health, Sacramento, CA and Pearl Werfel, PhD, PsyD, private practice, San Francisco, CA

[194]

PSY01

[198]

Maha Abu-AlHawa, M.A.1, Mark S Freedman, MSc, MD, FAAN, FRCPC2, Harold Atkins, MD3 and Lisa A.S. Walker, PhD1,4,5, (1)Neuroscience, Ottawa Hospital Research Institute, Ottawa, ON, Canada, (2)THe University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada, (3)Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, Canada, (4)Psychology, Carleton University, Ottawa, ON, Canada, (5)Psychology, University of Ottawa Brain and Mind Research Institute, Ottawa, ON, Canada

[194]

PSY02

[198]

Avery Largent, BA1, Odelin Charron, MSc, MSE1, Diana Andino, MD1, Amanda Montague, EdM2, Alexis Crispino, BA2, Joseph Wozny, MPH3, Trudy Millard Krause, DrPH, MS3, Ethan Meltzer, MD1, Ethan Huson, BSA Neuroscience1 and Leorah Freeman, MD, PhD1, (1)Neurology, Dell Medical School, The University of Texas at Austin, Austin, TX, (2)Multiple Sclerosis Association of America, Cherry Hill, NJ, (3)Center for Healthcare Data, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX

[194]

PSY02

[198]

Aprille Gangi, HS1, Frederick W Foley, Ph.D.2,3, Jennifer A Ruiz, DPT4,5, Heather M DelMastro, MS5,6, Lindsay O Neto, MPH5,6, Zaenab Dhari, MD5,6, Albert C. Lo, MD, PhD5, Aaron P Turner, Ph.D. ABPP (RP)7,8,9, Thomas P Agresta, MD, MBI10,11 and Elizabeth S Gromisch, PhD, MSCS4,5,12, (1)Trinity College, Hartford, CT, (2)Holy Name Medical Center, Teaneck, NJ, (3)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (4)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (5)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (6)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (7)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (8)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (9)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA, (10)Department of Family Medicine, University of Connecticut Health Center, Farmington, CT, (11)Center for Quantitative Medicine, University of Connecticut Health Center, Farmington, CT, (12)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT

[194]

PSY02

[198]

Abbey J Hughes, PhD1, Aeysha Brown, MA1,2, Krina Patel, BS1,2 and Meghan Beier, PhD1, (1)Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD, (2)American School of Professional Psychology at Argosy University – Northern Virginia, Arlington, VA

[194]

PSY03

[198]

Peixuan Zheng, PhD1, Lara A. Pilutti, PhD2,3, Noah G. DuBose, MS1 and Robert W. Motl, PhD1, (1)Kinesiology and Nutrition, University of Illinois Chicago, Chicago, IL, (2)Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, Canada, (3)Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada

[194]

PSY03

[198]

Catherine S Bergmann, Psy.D., Washington Neuropsychology Research Group, Fairfax, VA, Mary Elizabeth Quig, Ph.D., Neuropsychology Associates of Fairfax, Fairfax, VA, Robert L Kane, PhD, ABPP-CN, University of Maryland School of Medicine, Baltimore, MD, Meagan A. Adamson, FNP-BC, Multiple Sclerosis Center, Neurology Center of Fairfax, Fairfax, VA and James Simsarian, M.D., Neurology Center of Fairfax, Fairfax, VA

[194]

PSY03

[198]

Abbey J Hughes, PhD1, Aeysha Brown, MA1,2, Krina Patel, BS1,2, Trisha Chaffee, MS1 and Meghan Beier, PhD1, (1)Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD, (2)American School of Professional Psychology at Argosy University – Northern Virginia, Arlington, VA

[194]

PSY04

[198]

Petra Silic, BS1, Brenda Jeng, PhD1, Catherine D Jones, MSPH2, Trinh Huynh, MPH2, Jennifer Duffecy, PhD3 and Robert W. Motl, PhD1, (1)Kinesiology and Nutrition, University of Illinois Chicago, Chicago, IL, (2)Physical Therapy, University of Alabama at Birmingham, Birmingham, AL, (3)Psychiatry, University of Illinois Chicago, Chicago, IL

[194]

PSY04

[198]

Grace E Tworek, Psy.D.1, Alexa Kane, PsyD1, Nicolas Thompson, M.S.2 and Amy Sullivan, Psy.D.1, (1)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, (2)Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH

[194]

PSY04

[198]

Ruchika S. Prakash, Ph.D., Heena R. Manglani, M.A., Stephanie Fountain-Zaragoza, M.A., Anita Shankar, M.A. and Daniel Evans, B.A., Department of Psychology, The Ohio State University, Columbus, OH

[194]

PSY05

[198]

Sarah C Stoney, MSW, LSW1, Chelsea C Black, Ph.D., ABPP-CN2, Isabella Sobejano, (BA expected completion May 2024)1, Elizabeth Kunzelman, BSN, RN1, Amy T Waldman, M.D., M.S.C.E.1, Sarah E Hopkins, MD, MSPH3, Sona Narula, M.D.1 and Brenda Banwell, MD, FRCPC, FAAN4, (1)Neurology, The Children’s Hospital of Philadelphia, Philadelphia, PA, (2)Neuropsychology, The Children’s Hospital of Philadelphia, Philadelphia, PA, (3)Neurology, Children’s Hospital of Philadelphia, Philadelphia, PA, (4)The Children’s Hospital of Philadelphia, Philadelphia, PA

[194]

PSY05

[198]

Jaklin Gukasyan, B.A., Keck School of Medicine of USC, Los Angeles, CA, Kimberly Gokoffski, MD, PhD, Ophthalmology, Keck School of Medicine of USC, Los Angeles, CA, Alexander Brandt, MD, Neurology, University of California, Irvine, School of Medicine, Irvine, CA and Lilyana Amezcua, MD, Keck School of Medicine, University of Southern California, Los Angeles, CA

[194]

PSY05

[198]

Alexa Stuifbergen, RN, PhD, FAAN, Heather Becker, PhD, Research Scientist and Wenhui Zhang, BSN; PhD Candidate, School of Nursing, The University of Texas at Austin, Austin, TX

[194]

PSY06

[198]

Tymon Krzywinski, BA, Washington University in St. Louis, Saint Louis, MO and Salim Chahin, MD, MSCE, Department of Neurology, Washington University in St. Louis, St. Louis, MO

[194]

PSY06

[198]

Caroline Altaras, MA1, Jennifer Miller, MA2, Nicholas Vissichio, MA2 and Fred Foley, PhD2,3, (1)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (2)Ferkauf Graduate School of Psychology, Yeshiva University, New York, NY, (3)Holy Name Medical Center, Teaneck, NJ

[194]

PSY07

[198]

Aliza B. Ben-Zacharia, PhD, DNP, ANP, FAAN1, Andrea Bartels, MSN, FNP-BC, APRN2, Helen Brugger, MSN, RN2, Jena Malchiodi, JD, RN2, Stephanie Carbone, AD, RN2, Eva Wallace, DNP, FNP-BC, APRN, ACHPN3, Angelo Volandes, MD, MPH4 and Francois Bethoux, MD5, (1)Phillips School of Nursing at Mount Sinai, New York, NY, (2)New Haven Hospital, New Haven, CT, (3)New Haven Hospital, Greenwich, CT, (4)Palliative Care, Co-Founder & President ACP Decisions, Harvard School of Medicine, Boston, MA, (5)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH

[194]

PSY08

[198]

Aprille Gangi, HS1, Sarah A Raskin, PhD2,3, Aaron P Turner, Ph.D. ABPP (RP)4,5,6, Frederick W Foley, Ph.D.7,8, Lindsay O Neto, MPH9,10 and Elizabeth S Gromisch, PhD, MSCS9,11,12, (1)Trinity College, Hartford, CT, (2)Department of Psychology, Trinity College, Hartford, CT, (3)Neuroscience Program, Trinity College, Hartford, CT, (4)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (5)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (6)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA, (7)Holy Name Medical Center, Teaneck, NJ, (8)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (9)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (10)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (11)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (12)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT

[194]

PSY09

[198]

Alexa Stuifbergen, PhD, RN, FAAN, Nico Osier, PhD, RN, Sungju M Lim, MSN, Heather Becker, PhD, Research Scientist and Eliana Gill, BSN, School of Nursing, The University of Texas at Austin, Austin, TX

[194]

PSY09

[198]

Delaney Cairns, BS, Medical College of Wisconsin, Milwaukee, WI, Ashley Zeidler, MLIS, Medical College of Wisconsin Libraries, Medical College of Wisconsin, Milwaukee, WI and Ahmed Z Obeidat, MD, PhD, Neurology, Medical College of Wisconsin, Milwaukee, WI

[194]

PSY10

[198]

Olivia Kaczmarek, BS1, Avtej Sethi, MS2, Gina Koch, Student2, Barbara Bumstead, MS, ANCP, MSCN2, Marijean Buhse, NP-C, PhD1, Myassar Zarif, MD1, Jeffrey Wilken, PhD3, Daniel Golan, MD4 and Mark Gudesblatt, MD5, (1)South Shore Neurologic Associates, Patchogue, NY, (2)South Shore Neurologic Associates, P.C., Patchogue, NY, (3)Washington Neuropsychology Research Group, Washington, DC, (4)Rapparport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel, (5)South Shore Neurologic Associates, P.C., Islip, NY

[194]

PSY10

[198]

Kayla Gomes, PT, DPT, NCS1,2, Kaitlin E Riegler, MS3,4, Jennifer Ruiz, DPT5,6, Heather M DelMastro, MS6,7, Aaron P Turner, Ph.D. ABPP (RP)8,9,10, Lindsay O Neto, MPH6,7 and Elizabeth S Gromisch, PhD, MSCS5,6,11, (1)Rehabilitation Care Service, VA Connecticut Healthcare System, Newington, CT, (2)Outpatient Rehabilitation, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (3)Psychology Service, VA Connecticut Healthcare System, West Haven, CT, (4)Department of Psychology, The Pennsylvania State University, University Park, PA, (5)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (6)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (7)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (8)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (9)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (10)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA, (11)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT

[194]

PSY11

[198]

Elizabeth S Gromisch, PhD1,2,3, Aaron P Turner, Ph.D. ABPP (RP)4,5,6, Lindsay O Neto, MPH1,7, Jennifer A. Ruiz, DPT1,3, Albert C. Lo, MD, PhD1, Thomas P Agresta, MD, MBI8,9 and Frederick W Foley, Ph.D.10,11, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (3)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (4)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (5)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (6)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA, (7)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (8)Department of Family Medicine, University of Connecticut Health Center, Farmington, CT, (9)Center for Quantitative Medicine, University of Connecticut Health Center, Farmington, CT, (10)Holy Name Medical Center, Teaneck, NJ, (11)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY

[194]

PSY11

[198]

Elizabeth S Gromisch, PhD, MSCS1,2,3, Aaron P Turner, Ph.D. ABPP (RP)4,5,6, Lindsay O Neto, MPH1,7, Heather M DelMastro, MS1,7, Jennifer Ruiz, DPT1,3, Albert C. Lo, MD, PhD1, Thomas P Agresta, MD, MBI8,9 and Frederick W Foley, Ph.D.10,11, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (3)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (4)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (5)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (6)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA, (7)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (8)Department of Family Medicine, University of Connecticut Health Center, Farmington, CT, (9)Center for Quantitative Medicine, University of Connecticut Health Center, Farmington, CT, (10)Holy Name Medical Center, Teaneck, NJ, (11)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY

[194]

PSY12

[198]

Elizabeth S Gromisch, PhD1,2,3, Jodie K Haselkorn, MD, MPH4,5,6,7, Sarah A Raskin, PhD8,9, Lindsay O Neto, MPH1,10 and Aaron P Turner, Ph.D. ABPP (RP)4,5,7, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (3)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (4)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (5)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (6)Department of Epidemiology, University of Washington, Seattle, WA, (7)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA, (8)Neuroscience Program, Trinity College, Hartford, CT, (9)Department of Psychology, Trinity College, Hartford, CT, (10)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT

[194]

PSY12

[198]

Josephe Archie Honorat, MD.PhD., Jonathan Solis Ramirez, MD, Yaacov Anziska, MD and Susanna O’Kula, MD, Neurology Department, SUNY Downstate Health Science University, Brooklyn, NY

[194]

PSY13

[198]

Erica Weber, PhD, Anthony Lequerica, PhD and Lauren B Strober, Ph.D., Kessler Foundation, East Hanover, NJ

[194]

PSY13

[198]

Paul Y Yoo, PhD, OT, Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada, Sonika Kumari, BSc, The Hospital for Sick Children, Toronto, ON, Canada, Samantha Stephens, PhD, Department of Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada and Ann Yeh, M.D., Dept. of Paediatrics, Div. of Neurology, The Hospital for Sick Children, Toronto, ON, Canada

[194]

PSY14

[198]

Joelle Massouh, MSN, MSCN, Beirut, Lebanon

[194]

PSY14

[198]

Farnoosh Shemirani, PhD1, Tyler J Titcomb, PhD, RDN1, Solange M Saxby, PhD, RDN1, Patrick Ten Eyck, PhD2, Linda M Rubenstein, PhD3, Linda G Snetselaar, PhD, RDN3 and Terry L Wahls, MD1, (1)Internal Medicine, University of Iowa, Iowa City, IA, (2)Institute for Clinical and Translational Science, University of Iowa, Iowa City, IA, (3)Epidemiology, University of Iowa, Iowa City, IA

[194]

PSY15

[198]

Nina Rose, MA, Clinical Health Psychology PhD, Ferkauf Graduate School of Professional Psychology, Brooklyn Heights, NY

[194]

PSY16

[198]

Odessa J. McKenna, MSc1,2, Afolasade Fakolade, PhD3, Katherine L. Cardwell, BHSc1 and Lara A. Pilutti, PhD1,4, (1)Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, Canada, (2)Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada, (3)School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada, (4)Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada

[194]

PSY18

[198]

Babita Bisht, PT, PhD1, Tyler J. Titcomb, PhD, RDN1, Warren G Darling, PhD2, Lucas J Carr, PhD2, Karin F. Hoth, PhD3, Patrick Ten Eyck, PhD4, Linda Rubenstein, PhD5, John A Kamholz, MD, PhD6, Linda G. Snetselaar, PhD, RDN5 and Terry L. Wahls, MD1, (1)Department of Internal Medicine, University of Iowa, Iowa City, IA, (2)Department of Health and Human Physiology, University of Iowa, Iowa City, IA, (3)Department of Psychiatry, University of Iowa, Iowa City, IA, (4)Institute for Clinical and Translational Science, University of Iowa, Iowa City, IA, (5)Department of Epidemiology, University of Iowa, Iowa City, IA, (6)Neurology, University of Iowa, Iowa City, IA

[194]

PSY19

[198]

Dinika Anand, Masters, New Delhi, India, Soumi Awasthy, PhD, Defence Institute of Psychological Research, New Delhi, India and Rajiv Anand, MD, Dr. B.L.Kapoor Superspeciality Hospital, New Delhi, India

[194]

PSY20

[198]

Jagriti ‘Jackie’ Bhattarai, PhD, MS, Physical Medicine and Rehabilitation, Johns Hopkins School of Medicine, Baltimore, MD

[194]

PSY21

[198]

Zain Awadia, BHSc, Faculty of Health Sciences, University of Ottawa, Ottawa, ON, Canada, Thomas Edwards, MSc, School of Human Kinetics, University of Ottawa, Ottawa, ON, Canada, Jason A Berard, PhD, Neuroscience, Ottawa Hosptial Research Institute, Ottawa, ON, Canada, Lisa A.S. Walker, Ph.D., The Ottawa Hospital Research Institute, Ottawa, ON, Canada and Lara A. Pilutti, PhD, Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, Canada

[194]

QL01

[198]

Brenda Jeng, MS, University of Alabama at Birmingham, Birmingham, AL, Brian Sandroff, PhD, Department of Physical Therapy, UAB, Birmingham, AL and Robert W Motl, PhD, Department of Physical Therapy, University of Alabama at Birmingham, Birmingham, AL

[194]

QL01

[198]

[194]

QL01

[198]

Ana M Canzonieri, DRA, Mauricio O Bando Sr., Sr, Lucas F.R dos Santos Sr., student and Jean I Francisco, Sr, Research, ABEM . Brazilian Association Multiple Sclerosis, São Paulo, Brazil

[194]

QL02

[198]

Elizabeth S Gromisch, Ph.D.1,2, Robert D Kerns, Ph.D.1,3,4 and John Beauvais, Ph.D.1,4, (1)Psychology Service, VA Connecticut Healthcare System, West Haven, CT, (2)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Hartford, CT, (3)Pain Research, Informatics, Multimorbidities and Education (PRIME) Center, VA Connecticut Healthcare System, West Haven, CT, (4)Yale University School of Medicine, New Haven, CT

[194]

QL02

[198]

Angel Chinea, MD1, Ivonne Vicente, MD2, Cristina M Rubi, BS2, Guillermo G Garcia, BS3, Astrid Diaz, BS3, Ana Rivera, BS3 and Natalia Hernandez, BS3, (1)San Juan Multiple Sclerosis Center, San Juan, PR, (2)San Juan Multiple Sclerosis Center, Guaynabo, PR, (3)San Juan MS Center, Guaynabo, PR

[194]

QL02

[198]

Andrea Salmon, BAppSci(Occup Therapy), Services Innovation, Multiple Sclerosis Limited, Melbourne, Australia

[194]

QL03

[198]

Amanda Greene, DNP, MS Specialist, Neurology – MS Specialist, University of Mississippi Medical Center, Jackson, MS and Robert Herndon, MD, MS Specialist, Neurology – MS Specialist, UMMC, Jackson, MS

[194]

QL03

[198]

Anne Gilbert, BS, Programs, Can Do Multiple Sclerosis, Avon, CO

[194]

QL03

[198]

Bari Talente, JD, National MS Society, Washington, DC

[194]

QL04

[198]

Malik M Adil, MD and Bridget A Bagert, MD, Neurology, Ochsner Clinic Foundation, New Orleans, LA

[194]

QL04

[198]

Annette Okai, MD1, Bhupendra Khatri, MD2, Keith R Edwards, MD3, Steve Cavalier, MD4, Pascal Rufi, MD5, Soman Chowdhury, MSc6, Myriam Benamor, MD5, Ralf Gold, MD7 and Patricia K Coyle, MD8, (1)Multiple Sclerosis Treatment Center of Dallas, Dallas, TX, (2)The Regional MS Center, Center for Neurological Disorders at Wheaton Franciscan Healthcare, Milwaukee, WI, (3)Multiple Sclerosis Center of Northeastern New York, Latham, NY, (4)Sanofi Genzyme, Cambridge, MA, (5)Sanofi Genzyme, Chilly-Mazarin, France, (6)Cytel Statistical Software and Services, Pune, Maharashtra, India, (7)St Josef Hospital, Ruhr University Bochum, Bochum, Germany, (8)Stony Brook University, Stony Brook, NY

[194]

QL04

[198]

Caila B Vaughn, MPH1,2,3, Katelyn S. Kavak, MS1,2, Barbara E. Teter, PhD, MPH3, Patricia K Coyle, MD2,4, Keith R Edwards, MD, FAAN2,5, Karen Zakalik, MBA1, Muhammad Nadeem, MD3, Lana Zhovtis Ryerson, MD2,6, Allan Perel, MD2,7, Michael Lenihan, MD2,8, Robert Zivadinov, MD, PhD2,9, Lore Garten, MD2,10, Jessica F Robb, MD2,11, Burk Jubelt, MD2,12, Ilya Kister, MD2,6,13, Lauren Krupp, MD2,6, Malcolm Gottesman, MD2,14, Andrew Goodman, MD2,11 and Bianca Weinstock-Guttman, MD1,2,3, (1)Jacobs MS Center of Treatment and Research, Buffalo, NY, (2)New York State Multiple Sclerosis Consortium, Buffalo, NY, (3)Department of Neurology, University at Buffalo, Buffalo, NY, (4)Department of Neurology, Stony Brook University Medical Center, Stony Brook, NY, (5)Multiple Sclerosis Center of Northeastern New York, Latham, NY, (6)NYU Langone Medical Center, New York, NY, (7)Comprehensive Multiple Sclerosis Center of Staten Island, Staten Island, NY, (8)Adirondack Neurology Associates, Glens Falls, NY, (9)Department of Neurology, State University of New York at Buffalo, Buffalo Neuroimaging Analysis Center, Buffalo, NY, (10)MS Center of Northeastern New York, Latham, NY, (11)Neurology, University of Rochester, Rochester, NY, (12)SUNY Upstate Medical University, Syracuse, NY, (13)Department of Neurology, New York University Medical Center, New York, NY, (14)Winthrop Comprehensive MS Care Center, Mineola, NY

[194]

QL05

[198]

Erika Mitchell, DNP, FNP-C, Neurology, MedStar Georgetown University Hospital, Washington, DC

[194]

QL05

[198]

Terrie Livingston, PharmD1, Eric Peacock, CEO2 and Beth Schneider, Research Director2, (1)Biogen Idec, Cambridge, MA, (2)MyHealthTeams, San Francisco, CA

[194]

QL05

[198]

Aisha Bushra, MD1,2, Caila B Vaughn, MPH1,2,3, Katelyn S. Kavak, MS1,2,3, Katia Noyes, PhD, MPH4, Robert Zivadinov, MD, PhD2,5, Jessica F Robb, MD2,6, Burk Jubelt, MD7, Ilya Kister, MD2,8,9, Lauren Krupp, MD2,9, Malcolm Gottesman, MD2,10, Lore Garten, MD2,11 and Bianca Weinstock-Guttman, MD1,2,3, (1)Jacobs MS Center of Treatment and Research, Buffalo, NY, (2)New York State Multiple Sclerosis Consortium, Buffalo, NY, (3)Department of Neurology, University at Buffalo, Buffalo, NY, (4)University of Rochester School of Medicine, Rochester, NY, (5)Department of Neurology, State University of New York at Buffalo, Buffalo Neuroimaging Analysis Center, Buffalo, NY, (6)University of Rochester Medical Center, Rochester, NY, (7)SUNY Upstate Medical University, Syracuse, NY, (8)Department of Neurology, New York University Medical Center, New York, NY, (9)NYU Langone Medical Center, New York, NY, (10)Winthrop Comprehensive MS Care Center, Mineola, NY, (11)MS Center of Northeastern New York, Latham, NY

[194]

QL06

[198]

Elaine Rudell, CHCP1, Patty Peterson, CHCP1, Andrea L Griffin, na2 and James D Bowen, MD3, (1)@Point of Care, Livingston, NJ, (2)Multiple Sclerosis Association of America, Cherry Hill, NJ, (3)Swedish Medical Center, Seattle, WA

[194]

QL06

[198]

Terrie Livingston, PharmD1, Eric Peacock, CEO2, Beth Schneider, Research Director2 and Heather Lapidus Glassner, Research Director2, (1)Biogen Idec, Cambridge, MA, (2)MyHealthTeams, San Francisco, CA

[194]

QL06

[198]

Tiffany M. Shih, Ph.D.1, Ning Wu, Ph.D.2, Craig Wakeford, M.A.3 and Darius N. Lakdawalla, Ph.D.1, (1)Precision Health Economics, Los Angeles, CA, (2)Global Health Economics and Outcomes Research, Biogen, Cambridge, MA, (3)Health Economics and Outcomes Research, Biogen, Cambridge, MA

[194]

QL07

[198]

Maria K Houtchens, MD1, Natalie C Edwards, MSc2, Brooke Hayward, SM, MBA3 and Amy L Phillips, PharmD3, (1)Harvard Medical School, Brigham and Women’s Hospital, Boston, MA, (2)Health Services Consulting Corporation, Boxborough, MA, (3)EMD Serono, Inc., Rockland, MA

[194]

QL07

[198]

Bianca Weinstock-Guttman, MD1,2,3, Caila B Vaughn, PhD, MPH1,2,3, Katelyn S. Kavak, MS1,2,3, Shulian Shang, PhD4 and Crystal Watson, MS4, (1)Jacobs MS Center of Treatment and Research, Buffalo, NY, (2)New York State Multiple Sclerosis Consortium, Buffalo, NY, (3)Department of Neurology, University at Buffalo, Buffalo, NY, (4)Biogen, Cambridge, MA

[194]

QL07

[198]

Bianca Weinstock-Guttman, MD1,2,3, Caila B Vaughn, PhD, MPH1,2,3, Katelyn S. Kavak, MS1,2,3, Shulian Shang, PhD4 and Crystal Watson, MS4, (1)Jacobs MS Center of Treatment and Research, Buffalo, NY, (2)New York State Multiple Sclerosis Consortium, Buffalo, NY, (3)Department of Neurology, University at Buffalo, Buffalo, NY, (4)Biogen, Cambridge, MA

[194]

QL07

[198]

Bianca Weinstock-Guttman, MD1,2,3, Caila B Vaughn, PhD, MPH1,2,3, Katelyn S. Kavak, MS1,2,3, Shulian Shang, PhD4 and Crystal Watson, MS4, (1)Jacobs MS Center of Treatment and Research, Buffalo, NY, (2)New York State Multiple Sclerosis Consortium, Buffalo, NY, (3)Department of Neurology, University at Buffalo, Buffalo, NY, (4)Biogen, Cambridge, MA

[194]

QL07

[198]

Craig D Wesley, MPA, Advocacy, Services, & Research, National MS Society, New York, NY

[194]

QL08

[198]

Lindsay Neto, MPH1, Elizabeth S Gromisch, PhD1, Jessica H Sloan, BA2, Tuula Tyry, PhD3 and Frederick W Foley, Ph.D.2,4, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (3)Dignity Health, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, (4)Holy Name Medical Center, Teaneck, NJ

[194]

QL08

[198]

Doris Lill, BS, Advocacy, Services and Research, National Multiple Sclerosis Society, Denver, CO and Anne Lee Gilbert, BS, Can Do MS, Avon, CO

[194]

QL08

[198]

Deborah M Miller, Ph.D., LISW1, Carol Musil, PhD, RN, FAAN, FGSA2, Sarah Planchon-Pope, PhD, CCRP1, Tuula Tyry, PhD3, Amber Salter, PhD4, Sandre McNeal, MS5, Gary Cutter, PhD5, Robert J Fox, MD, FAAN6 and Stacey S Cofield, PhD5, (1)Mellen Center, Cleveland Clinic, Cleveland, OH, (2)Case Western Reserve University, Cleveland, OH, (3)Dignity Health, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, (4)Biostatistics, Washington University in St. Louis, St. Louis, MO, (5)Biostatistics, University of Alabama at Birmingham, Birmingham, AL, (6)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH

[194]

QL09

[198]

Matthew T McAdams, MD, Nicole Tester, PhD, MOT, OTR/L, Vineet Nadkarni, BS, Natalie Buchwald, MD, Jonathan Cho, BS, Alison Kraus, PT, DPT, NCS, Lindsay Falk, ARNP, MSCN, Tirisham V Gyang, MD and Augusto Miravalle, MD, Neurology, University of Florida, Gainesville, FL

[194]

QL09

[198]

Emily K White, Ph.D.1, Amy Sullivan, Psy.D.1 and Michelle Drerup, Psy.D., C.BSM2, (1)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, (2)Sleep Disorders Center, Cleveland Clinic, Cleveland, OH

[194]

QL09

[198]

Douglas Mager, MA1, Mary Dorholt, PharmD.1, Gail Bridges, PharmD.2 and Rochelle Henderson, PhD.1, (1)Express Scripts Inc., St. Louis, MO, (2)Accredo Health, Memphis, TN

[194]

QL10

[198]

Kelli A Reiling, OTD, OTR/L, MSCS, Occupational Therapy, MSAC at KUMC, Kansas City, KS, Stacia Troshynski Brown, PT, DPT, MSCS, Physical Therapy, MSAC at KUMC, Kansas City, KS and Sharon G Lynch, MD, Neurology, University of Kansas Medical Center, Kansas City, KS

[194]

QL10

[198]

Giampaolo Brichetto, MD, PhD1, Samuele Fiorini, PhD2, Michela Ponzio, PhD1, Annalisa Barla, PhD2, Alessandro Verri, PhD2 and Andrea Tacchino, PhD1, (1)Scientific Research Area, Italian MS Society, Genoa, Italy, Genova, Italy, (2)DIBRIS, University of Genoa, Genova, Italy

[194]

QL10

[198]

Jeffrey G Portnoy, B.A.1, Roseann Archetti, B.S.1, Marnina B Stimmel, B.A.1 and Frederick W Foley, Ph.D.2, (1)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (2)School of Psychology, Yeshiva University, New York, NY

[194]

QL11

[198]

Christine Leithead, BSN, RN, Nursing, Rutgers School of Nursing, Newark, NJ and Molly Bradshaw, DNP, APRN, FNP-BC, WHNP-BC, Baccalaureate and Graduate Nursing, Eastern Kentucky University, Richmond, KY

[194]

QL11

[198]

Heather M Hawks, MS1, Elizabeth W. Triche, PhD2, Jennifer A. Ruiz, DPT1, Kayla M. Olson, MA1 and Albert C. Lo, MD, PhD1, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Hartford, CT, (2)Department of Epidemiology, Brown University, Providence, RI

[194]

QL11

[198]

Jemima Akinsanya, M.S., Touro College of Osteopathic Medicine, New York, NY, Mary Ann Picone, M.D., Holy Name Medical Center, Teaneck, NJ and Frederick W Foley, Ph.D., School of Psychology, Yeshiva University, New York, NY

[194]

QL12

[198]

Tiffany Malone, MSW, MSCS and Brian Hutchinson, PT, MSCS, Multiple Sclerosis Achievement Center, Dignity Health, Citrus Heights, CA

[194]

QL12

[198]

Jamie Reiter, PhD, Jan Perez, CHCP, Sharon Tordoff, CHCP and Whitney Faler, MPA, CME Outfitters, LLC, Bethesda, MD

[194]

QL12

[198]

Jennifer Kalina, MS, OTR/L, CCRC, MSCS, Rivka R Green, BA and Robert E Charlson, MD, MS Comprehensive Care Center, NYU Langone, New York, NY

[194]

QL13

[198]

[194]

QL13

[198]

Julia Morawski, MSc1, Fred Cox, PhD1, Soman Chowdhury, MSc2 and Karthinathan Thangavelu, PhD1, (1)Sanofi Genzyme, Cambridge, MA, (2)Cytel Statistical Software and Services, Pune, Maharashtra, India

[194]

QL13

[198]

Emma s Matthews, RN BSc Hons1, Kathy Franklin, RGN QN MSCN2 and Amanda Andrews, RGN MA2, (1)MS CNS – Neurology, Northampton General Hospital, Northampton, United Kingdom of Great Britain and Northern Ireland, (2)Neurology, Northampton General Hospital, Northampton, United Kingdom of Great Britain and Northern Ireland

[194]

QL14

[198]

Evan T Cohen, PT, MA, PhD, NCS, Rehabilitation and Movement Sciences, Rutgers, The State University of New Jersey, Blackwood, NJ and Herb Karpatkin, PT, DSc, NCS, MSCS, Physical Therapy, Hunter College, New York, NY

[194]

QL14

[198]

Malik M Adil, MD and Bridget A Bagert, MD, Neurology, Ochsner Clinic Foundation, New Orleans, LA

[194]

QL14

[198]

Kiira M Tietjen, BSN, RN, MSCN, College of Nursing, Rush University, Chicago, IL; Neurology, Kootenai Health, Coeur d’Alene, ID

[194]

QL15

[198]

Vanessa Zimmerman, MSN, RN, MSCN, Erin Hendricks, BSN, RN, Meghan Garabedian, CRNP, MSCN and Caitlin Pileggi, MSN, MSCN, Neurology, University of Pennsylvania, Philadelphia, PA

[194]

QL15

[198]

Margaret Cho, MPH1, Ellen S Lathi, MD2, John Foley, MD3, Ben W Thrower, MD4, Vivien Ong, MPH1, Kellee Howard, MA, MSc1, Huan Wang, BS, BA1, Jie Ting, PhD, MSPH5, Crystal Watson, MS5 and Sarah Naoshy, MPH5, (1)ICON, San Francisco, CA, (2)The Elliot Lewis Center for Multiple Sclerosis Care, Brighton, MA, (3)Rocky Mountain MS Research Group, Salt Lake City, UT, (4)Shepherd Center, Atlanta, GA, (5)Biogen, Cambridge, MA

[194]

QL15

[198]

Nicola Graham, BSc – Health Science, Services Innovation, Multiple Sclerosis Limited, Melbourne, Australia

[194]

QL16

[198]

Fiona McDougall, PhD, 1F. Hoffmann-La Roche Ltd, Basel, Switzerland, Deborah Miller, PhD, Mellen Cener, Cleveland Clinic, Cleveland, OH, Michelle Brown, PhD, RTI-HS, Kansas City, NC, Christina Slota, PhD, RTI-HS, Philadelphia, PA, Lynda Doward, PhD, RTI-HS, Manchester, United Kingdom, Shibeshih Belachew, MD, PhD, F. Hoffmann-La Roche Ltd, Basel, Switzerland and Laura Julian, PhD, Genentech, Inc., South San Francisco, CA

[194]

QL16

[198]

[194]

QL17

[198]

Katelyn S. Kavak, MS1, Robert Zivadinov, MD2,3, Dejan Jakimovski, MD3, Diane Cookfair, PhD2, Murali Ramanathan, PhD2, Bianca Weinstock-Guttman, MD1,2 and Caila B Vaughn, PhD, MPH2,4, (1)Jacobs MS Center for Treatment and Research, Buffalo, NY, (2)Neurology, University at Buffalo, Buffalo, NY, (3)Buffalo Neuroimaging Analysis Center, Buffalo, NY, (4)Neurology, Jacobs MS Center for Treatment and Research, Buffalo, NY

[194]

QL17

[198]

Meghan C Romba, MD1, Kathryn Fitzgerald, ScD2, Moira Baynes, RN3, Peter A Calabresi, MD3 and Kathleen M Zackowski, PhD, OT3, (1)Neuroimmunology, Johns Hopkins Hospital, Baltimore, MD, (2)Neurology, Johns Hopkins Hospital, Baltimore, MD, (3)Neurology, Johns Hopkins University, Baltimore, MD

[194]

QL18

[198]

Austin C Griffin, BA1, Justin Abbatemarco, MD2, Jennifer Hartman, MPAS, PA-C3, Noble Jones, BS, MS4, Keith McKee, MD5, Andre Machado, M.D., Ph.D.6, Nagel Sean, MD7 and Francois Bethoux, MD5, (1)Case Western Reserve University School of Medicine, Cleveland, OH, (2)Neurological Institute, Cleveland Clinic, Cleveland, OH, (3)Neurological Institute, Cleveland Clinic Mellen Center, Cleveland, OH, (4)Neurology, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, (5)Department of Rehabilitation Services, Cleveland Clinic Mellen Center, Cleveland, OH, (6)Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, (7)Center for Neurological Restoration, Cleveland Clinic, Cleveland, OH

[194]

QL18

[198]

Padma Priya Puttagunta, MD1, Jason Ledesma, BS2, Kristen Berube, BS1 and Bijal Mehta, MD, MPH3, (1)Neurology, LA Biomed, Torrance, CA, (2)Neurology, LA BIOMED, Torrance, CA, (3)Neurology, Harbor-UCLA Medical Center, Torrance, CA

[194]

QL19

[198]

Amanda Parker, B.S.1, Renee M. Root, M.A.1, Elizabeth K. Seng, Ph.D.1, Nicole Butler, B.A.1, Shonna Schneider, B.A.1, Shaina Shagalow, B.A.1 and Frederick W. Foley, Ph.D.1,2, (1)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (2)MS Center, Holy Name Medical Center, Teaneck, NJ

[194]

QL19

[198]

Patricia Mulero, MD1, Luciana Midaglia, MD1, Xavier Montalban, MD, PhD2, Jennifer Graves, MD, PhD, MAS3, Stephen L Hauser, MD3, Laura Julian, PhD4, Mike Baker, BSc, MSc5, Jan Schadrack, MD5, Christian Gossens, PhD, MBA5, Fiona Mc Dougall, PhD, ClinPsyD6, Alf Scotland, MSc5, Yang-Ping Zhang Schaerer, PhD5, Andrew Creagh, BA, BAI, MAI5, Shibeshih Belachew, MD, PhD5 and Michael Lindemann, MD, PhD5,7, (1)Multiple Sclerosis Center of Catalonia, Hospital Vall d’Hebron University, Barcelona, Spain, (2)Vall d’Hebron University Hospital, Barcelona, Spain, (3)University of California, San Francisco, San Francisco, CA, (4)Genentech Inc., South San Francisco, CA, (5)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (6)Roche Products Limited, Welwyn Garden City, United Kingdom, (7)Baden-Wuerttemberg Cooperative State University, Loerrach, Germany

[194]

QL20

[198]

Brant J. Oliver, PhD, MS, MPH, APRN-BC1,2,3, Terrie Livingston, PharmD4, Michelle Patel, BA4, Amy E Hall, MS1, Randy Messier, MT, MSA, PCMH CCE5 and Carolyn Schwartz, Sc.D.6,7, (1)Dartmouth Hitchcock Medical Center, Lebanon, NH, (2)The Dartmouth Institute, Hanover, NH, (3)Geisel School of Medicine, Hanover, NH, (4)Biogen, Weston, MA, (5)Randy Messier, LLC, Fairfield, VT, (6)DeltaQuest Foundation, Inc., Concord, MA, (7)Medicine and Orthopaedic Surgery, Tufts University Medical School, Boston, MA

[194]

QL20

[198]

Mark Rametta, D.O., FACOI, FACP1, Rebecca Germino, MA2, Kim Mcleod, MPH3, Melissa McCart, PharmD, MS4 and Apryl Quillen, MS3, (1)US Medical Affairs, Neurology, Bayer HealthCare Pharmaceuticals, Whippany, NJ, (2)US Health Economics and Outcomes Research, Bayer Healthcare Pharmaceuticals, Whippany, NJ, (3)Prospective Research, Xcenda, LLC, Palm Harbor, FL, (4)Global Health Economics and Outcomes Research, Xcenda, LLC, Palm Harbor, FL

[194]

QL21

[198]

Caroline Altaras, B.S.1, Shaina Shagalow, B.A.1, Amanda Najjar, B.A.1, Jenna Cohen, M.A.1, Nicholas A Vissicchio, B.A.1, Shonna Schneider, B.A.1, Amanda Parker, B.S.1, Vance Zemon, Ph.D.1 and Frederick W Foley, Ph.D.1,2, (1)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (2)Holy Name Medical Center, Teaneck, NJ

[194]

QL21

[198]

Robert N. McBurney, PhD1, Yibai Zhao, MS2, Hollie Schmidt, MS1, Sara Loud, MSEE, MBA1, Laura Kolaczkowski, BA3 and Raji Balasubramanian, Sc.D.2, (1)Accelerated Cure Project for MS, Waltham, MA, (2)University of Massachusetts, Amherst, Amherst, MA, (3)iConquerMS Patient-Powered Research Network, Waltham, MA

[194]

QL22

[198]

Shaina Shagalow, B.A.1, Caroline Altaras, B.S.1, Jenna Cohen, M.A.1, Amanda Najjar, B.A.1, Shonna Schneider, B.A.1, Nicholas A Vissicchio, B.A.1, Amanda Parker, B.S.1 and Frederick W. Foley, Ph.D.2, (1)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (2)MS Center, Holy Name Medical Center, Teaneck, NJ

[194]

QL22

[198]

Robert W Motl, PhD, Department of Physical Therapy, University of Alabama at Birmingham, Birmingham, AL, Brian M Sandroff, PhD, Kessler Foundation, East Hanover, NJ and Edward McAuley, PhD, Department of Kinesiology and Community Health, University of Illinois at Urbana Champaign, Urbana, IL

[194]

QL23

[198]

Shaina Shagalow, B.A.1, Caroline Altaras, B.S.1, Amanda Najjar, B.A.1, Jenna Cohen, M.A.1, Amanda Parker, B.S.1, Shonna Schneider, B.A.1, Nicholas A Vissicchio, B.A.1 and Frederick W. Foley, Ph.D.2, (1)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (2)MS Center, Holy Name Medical Center, Teaneck, NJ

[194]

QL23

[198]

Samantha Domingo, Psy.D., The Mellen Center for Multiple SclerosisTreatment and Research, Cleveland Clinic, Cleveland, OH, Michelle Drerup, Psy.D., C.BSM, Sleep Disorders Center, Cleveland Clinic, Cleveland, OH and Amy B. Sullivan, Psy.D., Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH

[194]

QL24

[198]

Donna Van Alst, PhD1, Peter Damiri, BA2 and Amanda Montague, Ed.M2, (1)College of St. Rose, Albany, NY, (2)Multiple Sclerosis Association of America, Cherry Hill, NJ

[194]

QL24

[198]

Sibyl Wray, MD1, Samuel F Hunter, MD, PhD2, Jacqueline Nicholas, MD, MPH3, Tamara A Miller, MD4, Jinjun Liang, MD5, Camille Martinet, N/A5, Mary-Jean Fanelli, MD, MBA6 and Laura Saltonstall, MD, MBA6, (1)Hope Neurology MS Center, Knoxville, TN, (2)Advanced Neurosciences Institute, Franklin, TN, (3)OhioHealth Multiple Sclerosis Center, Columbus, OH, (4)Advanced Neurology of Colorado, Fort Collins, CO, (5)Sanofi, Bridgewater, NJ, (6)Sanofi Genzyme, Cambridge, MA

[194]

QL25

[198]

Marie Moore, NP1, Jill M Conway, MD, MA, MSCE1 and Donna Graves, MD2, (1)Neurology, Carolinas Healthcare System, Charlotte, NC, (2)Neurology, Carolinas Healthcare system, Charlotte, NC

[194]

QL25

[198]

Sneha Natarajan, PhD1, Robert J Fox, MD, FAAN1, Carol Cosenza, MSW2, Lauren Cripps, MA2, Gary Cutter, PhD3,4, Paul Ford, Ph.D.5, MaryBeth Mercer, MPH5, Amber Salter, PhD6, Tuula Tyry, PhD7 and Stacey S Cofield, PhD4, (1)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, (2)Center for Survey Research, University of Massachusetts, Boston, Boston, MA, (3)University of Alabama at Birmingham, Birmingham, AL, (4)Biostatistics, University of Alabama at Birmingham, Birmingham, AL, (5)Bioethics, Cleveland Clinic, Cleveland, OH, (6)Biostatistics, Washington University in St. Louis, St. Louis, MO, (7)Dignity Health, St. Joseph’s Hospital and Medical Center, Phoenix, AZ

[194]

QL26

[198]

Scott M Belliston, DO, Neurology, Intermountain Healthcare, Provo, UT, Tomas L Griebling, MD MPH, Urology, University of Kansas Medical Center, Kansas City, UT and Sharon G Lynch, MD, Neurology, University of Kansas Medical Center, Kansas City, KS

[194]

QL26

[198]

Suepattra May, PhD, MPH1, Caroline Huber, MPH1, Mark Embrett, PhD1, Supriya K Yagnik, MPH2, Sarah Donelson, MA2, Jennifer Whiteley, EdD MSc, MA2, Mikele Bunce, MPH, PhD, FACHE2, Laura Julian, PhD2 and Lawrence Steinman, MD3, (1)Precision Health Economics, Los Angeles, CA, (2)Genentech Inc., South San Francisco, CA, (3)Stanford University School of Medicine, Stanford, CA

[194]

QL27

[198]

Tara Berenbaum, BSc1, Stephanie A Grover, MSc, CCRP2, Samantha Stephens, PhD2, Shelly Weiss, MD, FRCPC1, Indra Narang, MEDSCI, MBBCH, FRCPCH, MD3 and E. Ann Yeh, MD, MA, FRCPC, Dip ABPN1, (1)Neurology, The Hospital for Sick Children, Toronto, ON, Canada, (2)Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada, (3)Respiratory Medicine, The Hospital for Sick Children, Toronto, ON, Canada

[194]

QL28

[198]

Wenhui Zhang, BSN, Heather Becker, PhD, Research Scientist, Alexa Stuifbergen, PhD, RN, FAAN, Dean and Adama Brown, PhD, Research Scientist, School of Nursing, The University of Texas at Austin, Austin, TX

[194]

QOL01

[198]

Alexandra Jackson, PhD Candidate, Rebekah Sandhu, PhD Student and Marcia Finlayson, PhD, School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada

[194]

QOL01

[198]

Afiah Hasnie, Psy.D., Neurology, Cleveland Clinic Mellen Center for MS, Cleveland, OH

[194]

QOL01

[198]

Elizabeth S Gromisch, PhD1,2,3, Robert D Kerns, Ph.D.4,5,6,7 and John Beauvais, Ph.D.2,4, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Psychology Service, VA Connecticut Healthcare System, West Haven, CT, (3)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (4)Department of Psychiatry, Yale University School of Medicine, New Haven, CT, (5)Pain Research, Informatics, Multimorbidities and Education (PRIME) Center, VA Connecticut Healthcare System, West Haven, CT, (6)Department of Psychology, Yale University, New Haven, CT, (7)Department of Neurology, Yale University School of Medicine, New Haven, CT

[194]

QOL01

[198]

Aidan L Peters, MSc, BSc1,2, Kyara Somers, BSc2, Emilie Risdon, BSc3 and Lindsay Berrigan, PhD2, (1)Human Kinetics, University of Ottawa, Ottawa, ON, Canada, (2)Psychology, St. Francis Xavier University, Antigonish, NS, Canada, (3)Health Sciences, St. Francis Xavier University, Antigonish, NS, Canada

[194]

QOL02

[198]

Alice E Dias, Dr1, Gisele R Barboza, Social Worker2, Gecila AF Santos, Social Worker3 and Priscila S Santos, Social Worker2, (1)Scientific Research, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil, (2)Social Service, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil, (3)Social Service, Brazilian Multiple Sclerose Association (ABEM), São Paulo, Brazil

[194]

QOL02

[198]

Alexander J. Keenan, MA, MHP1, Tatiana Scherz, MD2, Brian Hennessy, PhD2, Hilke Kracker, PhD2 and Janssen R&D, (1)Janssen Research & Development, Titusville, NJ, (2)Janssen R&D, Allschwil, Switzerland

[194]

QOL02

[198]

Alexa Kane, PsyD and Amy Sullivan, Psy.D., The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH

[194]

QOL02

[198]

Alaina G Tiani, PhD1, Nicolas Thompson, M.S.2, Alexa Kane, PsyD1, Alicia Roth, PhD, D.BSM3, Michelle Drerup, Psy.D., D.BSM3, Robert A. Bermel, MD4 and Amy B Sullivan, PsyD, ABPP1, (1)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, (2)Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH, (3)Sleep Disorders Center, Cleveland Clinic, Cleveland, OH, (4)Mellen Center for MS, Department of Neurology, Cleveland Clinic, Cleveland, OH

[194]

QOL03

[198]

Amber Salter, PhD, Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, Alexander Keenan, MA, MHP, Janssen Scientific Affairs, LLC, Titusville, NJ, Hoa H. Le, PhD, Real World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, NJ, Kavita Gandhi, MS, Janssen Global Market Access, LLC, Titusville, NJ, Michele Cole, PharmD, MS, Research and Development, Janssen Pharmaceuticals, Titusville, NJ, Maria Ait-Tihyaty, PhD, Janssen Global Medical Affairs, LLC, Titusville, NJ, Samantha Lancia, MS, Biostatistics, Washington University School in St. Louis, School of Medicine, St Louis, MO and Robert J Fox, MD, Mellen Center for Treatment and Research in Multiple Sclerosis, Cleveland Clinic, Cleveland, OH

[194]

QOL03

[198]

Amir Khakban, Msc., Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, Elisabet Rodriguez Llorian, PhD, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, Scott B Patten, MD, PhD, Community Health Sciences & Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada, Anthony L. Traboulsee, MD, Neurology, The University of British Columbia, Vancouver, BC, Canada and Larry Lynd, PhD, . Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada

[194]

QOL03

[198]

Tiffany Malone, MSW, MSCS and Brian Hutchinson, PT, MSCS, Multiple Sclerosis Achievement Center, Dignity Health, Citrus Heights, CA

[194]

QOL03

[198]

Alexandra Jackson, PhD Candidate and Marcia Finlayson, PhD, School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada

[194]

QOL04

[198]

Anthony Cordisco, MA, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA and Christopher Perrone, MD, Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

[194]

QOL04

[198]

Avtej Sethi, MS1, Olivia Kaczmarek, BS2, Jack Petroski, Student1, Emma Malone, Student1, Barbara Bumstead, MS, ANCP, MSCN1, Marijean Buhse, NP-C, PhD2, Myassar Zarif, MD2, Daniel Golan, MD3, Jeffrey Wilken, PhD4 and Mark Gudesblatt, MD5, (1)South Shore Neurologic Associates, P.C., Patchogue, NY, (2)South Shore Neurologic Associates, Patchogue, NY, (3)Rapparport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel, (4)Washington Neuropsychology Research Group, Washington, DC, (5)South Shore Neurologic Associates, P.C., Islip, NY

[194]

QOL04

[198]

[194]

QOL04

[198]

Alexandra Pfister, MD1, Meggi Sweeney Smith, MA2, Camryn Lane, BA3, Neel Desai, PhD3, Vanessa Zimmerman, MSN, RN, MSCN4 and Dina Jacobs, MD5, (1)Neurology, University of Pennsylvannia, Philadelphia, PA, (2)New York University, New York City, NY, (3)University of Pennsylvannia, Philadelphia, PA, (4)Neurology, University of Pennsylvania, Philadelphia, PA, (5)Department of Neurology, University of Pennsylvania, Philadelphia, PA

[194]

QOL05

[198]

Bonnie Blain, RN, CNN(C) MSCN1, Lou-Anne Robertson, RN BScN2, Siobhan Bast, RN BScN MSCN2, Victoria Christiansen, BScAHN RD2, Diana Ehlers, Data Analyst2, Ashley A Hunter, Bachelor of Social Work3, Cassandra Stewart, BA, MScOT, Reg. OT (AB)2 and Golda Catalon, BScOT2, (1)Medical Specialty Clinic, Red Deer Regional Hospital Centre, Alberta Health Services, Red Deer, AB, Canada, (2)Central Alberta MS Clinic, Red Deer, AB, Canada, (3)Medical Specialty Clinic, Alberta Health Services, Red Deer, AB, Canada

[194]

QOL05

[198]

Beth Schneider, Senior Research Director, MyHealthTeams, San Francisco, CA

[194]

QOL05

[198]

[194]

QOL05

[198]

Alexandra C Simpson, MD, MA, Chen Hu, MS, Kathryn C Fitzgerald, ScD and Bardia Nourbakhsh, MD, MAS, Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

[194]

QOL06

[198]

Pamela K Newland, PhD, RN, Goldfarb School of Nursing, St Louis, IL, Ling Chen, PhD, Washington University St Louis, St Louis, MO and Brant J. Oliver, PhD, MS, MPH, APRN-BC, Geisel School of Medicine at Dartmouth, Lebanon, NH

[194]

QOL06

[198]

Barry Hendin, MD, Phoenix Neurological Associates, Phoenix, AZ; Neurology, University of Arizona, Tucson, AZ, Richard A. Brook, MS, MBA, Better Health Worldwide, Inc., Newfoundland, NJ, Ian A. Beren, BS, WorkPartners, LLC, Loveland, CO, Nathan L. Kleinman, PhD, WorkPartners, LLC, Cheyenne, WY, Amy L. Phillips, PharmD, EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany, Rockland, MA and Carroline Lobo, PhD, EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA, Darmstadt, MA, Germany

[194]

QOL06

[198]

[194]

QOL06

[198]

Alexis C El-Khouri, PharmD, RPh, Specialty Pharmacy, Trellis Rx, Akron, OH

[194]

QOL07

[198]

Camila Ishueva, BS and Ahmed Z Obeidat, MD, Ph.D., Neurology, Medical College of Wisconsin, Milwaukee, WI

[194]

QOL07

[198]

Barry Hendin, MD, Neurology, University of Arizona, Tucson, AZ, Richard A. Brook, MS, MBA, Better Health Worldwide, Inc., Newfoundland, NJ, Ian A. Beren, BS, WorkPartners, LLC, Loveland, CO, Nathan L. Kleinman, PhD, WorkPartners, LLC, Cheyenne, WY, Cindy Fink, BSc, Care Partner Adviser, Cleveland Heights, OH, Amy L. Phillips, PharmD, EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany, Rockland, MA and Carroline Lobo, PhD, EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA, Darmstadt, MA, Germany

[194]

QOL07

[198]

Lindsay Neto, MPH1, Elizabeth S Gromisch, PhD1,2, Jessica H Sloan, PhD3, Tuula Tyry, PhD4 and Frederick W. Foley, Ph.D.5,6, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (3)Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, CO, (4)Dignity Health, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, (5)MS Center, Holy Name Medical Center, Teaneck, NJ, (6)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY

[194]

QOL07

[198]

Anisha M Patel, PhD, MS1, Robert Schuldt, MD1, Denise M Boudreau, PhD1, Nikki Win, PhD1, Bryan R Cobb, PhD1 and Marisa McGinley, DO2, (1)Genentech, Inc., South San Francisco, CA, (2)Cleveland Clinic Foundation, Cleveland, OH

[194]

QOL08

[198]

Clara Wan, BA, University of Alabama at Birmingham, Birmingham, AL, Kendall Curtis, BS, University of Pittsburg, Pittsburg, PA, William Meador, MD, Neurology, UAB, Birmingham, AL and John R Rinker, MD, Neurology, University of Alabama at Birmingham, Birmingham, AL

[194]

QOL08

[198]

Craig Riccardo, PharmD, CSP, MSCS and Kate Jelline, PharmD, MSCS, CSP, Ardon Health, Portland, OR

[194]

QOL08

[198]

Megan Weigel, DNP, ARNP-C, MSCN, First Coast Integrative Medicine, Ponte Vedra Beach, FL and Ashley Von Esche, BS, CHES, Jacksonville, FL

[194]

QOL08

[198]

Beth Schneider, BA, Research, MyHealthTeam, San Francisco, CA

[194]

QOL09

[198]

Pengcheng Xun, PhD1, Natalia Sadetsky, MD, PhD2, Kiren Kresa-Reahl, MD1, Sasha Bogdanovich, MD, PhD1, Arie Barlev, PharmD, MS2 and Crystal Watson, MS2, (1)Atara Biotherapeutics, Thousand Oaks, CA, (2)Atara Biotherapeutics, South San Francisco, CA

[194]

QOL09

[198]

Crystal Watson, MS1, Kayla Scippa, BA2, Arie Barlev, PharmD1 and Jason C Cole, PhD2, (1)Atara Biotherapuetics, South San Francisco, CA, (2)ZS Associates, Thousand Oaks, CA

[194]

QOL09

[198]

Ilya Kister, MD1,2, Hans-Peter Hartung, MD3, Patrick Vermersch, PhD4, Regine Buffels, MD5, Robert Kuhelj, PhD5, Susanne Clinch, PhD6, Wei Wei, PhD5 and Gary Cutter, PhD7, (1)Multiple Sclerosis Comprehensive Care Center, New York University Langone Medical Center, New York, NY, (2)Multiple Sclerosis Comprehensive Care Center, Barnabas Health Medical Group, Livingston, NJ, (3)Department of Neurology, UKD, Center of Neurology and Neuropsychiatry and LVR-Klinikum, Heinrich-Heine University Dusseldorf, Dusseldorf, Germany, (4)University of Lille, Lille, France, (5)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (6)F. Hoffmann-La Roche Ltd, Welwyn Garden City, United Kingdom, (7)Department of Biostatistics, UAB School of Public Health, Birmingham, AL

[194]

QOL09

[198]

Cristina A.F. Román, Ph.D., Kessler Foundation, West Orange, NJ, Mitzi J. Williams, MD, Joi Life Wellness Group, Atlanta, GA and Sarah C. Pillemer, Ph.D., Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI

[194]

QOL10

[198]

Daija Jackson, M.A.1, Rachel Nicholson, M.A.2, Catherine S Bergmann, Psy.D.3, Jeffrey Wilken, PhD4, Olivia Kaczmarek, BS5, Barbara Bumstead, MS, ANP-C, MSCN5, Marijean Buhse, NP-C, PhD6, Myassar Zarif, MD6 and Mark Gudesblatt, MD7, (1)The Chicago School of Professional Psychology, Washington, DC, (2)Immaculata University, Immaculata, PA, (3)Washington Neuropsychology Research Group, Fairfax, VA, (4)Washington Neuropsychology Research Group, Washington, DC, (5)South Shore Neurologic Associates, Patchogue, NY, (6)South Shore Neurologic Associates, P.C., Patchogue, NY, (7)South Shore Neurologic Associates, P.C., Islip, NY

[194]

QOL10

[198]

Danielle Bryan, PharmD1, Rebekah Finley, PharmD candidate2, Autumn Zuckerman, PharmD, BCPS, AAHIVP, CSP1, Megan Peter, PhD1, Ryan Moore, MS3 and Leena Choi, PhD3, (1)Vanderbilt Specialty Pharmacy, Vanderbilt University Medical Center, Nashville, TN, (2)Lipscomb University, Nashville, TN, (3)Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN

[194]

QOL10

[198]

Johan van Beek, PhD1, Rita Freitas, PharmD, MSc1, Corrado Bernasconi, MD, PhD1, Xavier Montalban, MD, PhD2,3, Helmut Butzkueven, MBBS, PhD4, Ludwig Kappos, MD, PhD5, Jiwon Oh, MD, PhD, FRCPC3, Gavin Giovannoni, MBBCh, PhD, FCP, FRCP, FRCPath6, Riley Bove, MD, MMSc7, Laura Julian, PhD8, Mike Baker, BSc, MSc1 and Michael Lindemann, MD, PhD1, (1)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (2)Vall d’Hebron University Hospital, Barcelona, Spain, (3)Division of Neurology, University of Toronto, Toronto, ON, Canada, (4)Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia, (5)University Hospital Basel, University of Basel, Basel, Switzerland, (6)Queen Mary University of London, London, United Kingdom, (7)Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, San Francisco, CA, (8)Genentech, Inc., South San Francisco, CA

[194]

QOL10

[198]

Elham Heidari, PharmD, MSc1,2, Crystal Watson, MS3, Dhanalakshmi Thirumulai, PhD, MPH1, Arie Barlev, PharmD, MS3, Eddie Jones, BA4, Sasha Bogdanovich, MD, PhD1 and Kiren Kresa-Reahl, MD1, (1)Atara Biotherapeutics, Thousand Oaks, CA, (2)College of Pharmacy, The University of Texas at Austin, Austin, TX, (3)Atara Biotherapeutics, South San Francisco, CA, (4)Adelphi Real World, Bollington, Cheshire, United Kingdom

[194]

QOL11

[198]

Dana Jones, NP1, Anthony M Iuso, DO2, Joseph Sarni, n/a3, Karen Blitz, DO4, Frederick W Foley, Ph.D.5 and Mary Ann Picone, MD1, (1)Holy Name Medical Center, Teaneck, NJ, (2)Clinical Research, Holy Name Medical Center, Teaneck, NJ, (3)NJ, (4)South Shore Neurologic Associates, Patchogue, NY, (5)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY

[194]

QOL11

[198]

Eleanor Bryan, M.Ed1, Falguni Mehta, MS, MBA1 and Brant J. Oliver, PhD, MS, MPH, APRN-BC2, (1)Department of Community & Family Medicine, Dartmouth Hitchcock Health, Lebanon, NH, (2)Geisel School of Medicine at Dartmouth, Lebanon, NH

[194]

QOL11

[198]

Katherine Belendiuk, PhD1, David Wormser, MSc, MPhil PhD2, Laura Julian, PhD1, Michael Martinec, PhD2, Kieran Mace, PhD1, Mike Baker, BSc, MSc2, Gillian Hanson, ND3, Yucheng Pan, BA3, Troy Astorino, PhD3 and Noga Leviner, PhD3, (1)Genentech, Inc., South San Francisco, CA, (2)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (3)PicnicHealth, San Francisco, CA

[194]

QOL11

[198]

Devon S Conway, MD, MS, Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, Karlo Toljan, MD, Neurology, Cleveland Clinic Foundation, Cleveland, OH, Kathleen A Harris, APRN, CNP, Mellen Center, Cleveland Clinic, Cleveland, OH, Farren B.S. Briggs, PhD, ScM, Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH and Carrie M Hersh, DO, MS, FAAN, Mellen Program for Multiple Sclerosis Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV

[194]

QOL12

[198]

Derrick S Robertson, MD1, Gabriel Pardo, MD, FAAN2, Mitzi J Williams, MD3, Joseph R Berger, MD, FACP, FAAN, FANA4, David Meyer, MD, MBA5, Daniel S Bandari, MD, MS6, Harold Moses, MD7, Fernando X Cuascut, MD, MPH8, Alexis Jameson, BA9, Jeffrey Carter, PhD9, Laura Simone, PhD9 and Larissa Jarzylo, PhD9, (1)Neurology, University of South Florida Morsani College of Medicine, Tampa, FL, (2)MS Center of Excellence, Oklahoma Medical Research Foundation, Oklahoma City, OK, (3)Joi Life Wellness, MS Neurology Center, Smyrna, GA, (4)Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, (5)Wake Forest Baptist Health, Winston-Salem, NC, (6)Multiple Sclerosis Center of California and Research Group, Laguna Hills, CA, (7)Department of Neurology, Neuroimmunology Division, Vanderbilt University Medical Center, Nashville, TN, (8)Baylor College of Medicine, Houston, TX, (9)PRIME Education, Fort Lauderdale, FL

[194]

QOL12

[198]

Erin M Faraclas, PT, DPT, PhD(c), MSCS, Do